<SEC-DOCUMENT>0001213900-25-078182.txt : 20250819
<SEC-HEADER>0001213900-25-078182.hdr.sgml : 20250819
<ACCEPTANCE-DATETIME>20250819091253
ACCESSION NUMBER:		0001213900-25-078182
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		29
FILED AS OF DATE:		20250819
DATE AS OF CHANGE:		20250819

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Global Interactive Technologies, Inc.
		CENTRAL INDEX KEY:			0001911545
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
		ORGANIZATION NAME:           	06 Technology
		EIN:				000000000
		STATE OF INCORPORATION:			X1
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-288665
		FILM NUMBER:		251229813

	BUSINESS ADDRESS:	
		STREET 1:		160, YEOUISEO-RO
		STREET 2:		YEONGDEUNGPO-GU
		CITY:			SEOUL
		STATE:			M5
		ZIP:			07231
		BUSINESS PHONE:		82-2-564-8588

	MAIL ADDRESS:	
		STREET 1:		160, YEOUISEO-RO
		STREET 2:		YEONGDEUNGPO-GU
		CITY:			SEOUL
		STATE:			M5
		ZIP:			07231

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Hanryu Holdings, Inc.
		DATE OF NAME CHANGE:	20220216
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>ea0253651-s1a2_global.htm
<DESCRIPTION>AMENDMENT NO. 2 TO FORM S-1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.5pt; text-align: center"> <B>As filed with the Securities
and Exchange Commission on August 19, 2025.</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.5pt; text-align: right"><B>Registration No.&nbsp;333-288665</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.5pt; text-align: center"><B></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.5pt; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.5pt; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.5pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>Amendment No. 2</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>to</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM S-1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>REGISTRATION STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I>UNDER</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I>THE SECURITIES ACT OF 1933</I></B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 14pt"><B>Global
Interactive Technologies, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Exact name of registrant as specified
in its charter)</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; width: 32%; font-size: 10pt; text-underline-color: black; text-align: center"><FONT STYLE="font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; vertical-align: bottom; width: 2%; font-size: 10pt; text-underline-color: black">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; width: 32%; font-size: 10pt; text-underline-color: black; text-align: center"><FONT STYLE="font-size: 10pt"><B>7370</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; vertical-align: bottom; width: 2%; font-size: 10pt; text-underline-color: black">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; width: 32%; font-size: 10pt; text-underline-color: black; text-align: center"><FONT STYLE="font-size: 10pt"><B>88-1368281</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(State or other jurisdiction of</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>incorporation or organization)</B></P></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-underline-color: black">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Primary Standard Industrial</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Classification Code Number)</B></P></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-underline-color: black">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(I.R.S.&nbsp;Employer</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Identification Number)</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.5pt; text-indent: -12.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>160, Yeouiseo-ro, Yeongdeungpo-gu</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Seoul, Republic of Korea,&nbsp;07231</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>+82-2-564-8588</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Address, including zip code, and
telephone number, including</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>area code, of registrant<FONT STYLE="font-family: Times New Roman, Times, Serif">&rsquo;</FONT>s
principal executive offices)</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 2pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Taehoon Kim</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Chief Executive Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Global Interactive Technologies,
Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>160, Yeouiseo-ro, Yeongdeungpo-gu</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Seoul, Republic of Korea,&nbsp;07231</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>+82-2-564-8588</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Name, address, including zip code,
and telephone number, including area code, of agent for service)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.5pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 2pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.5pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I>Copies to:</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I></I></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>Spencer G. Feldman, Esq.</B> </P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>Olshan Frome Wolosky LLP</B> </P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>1325 Avenue of the Americas, 15<SUP>th</SUP>
    Floor</B> </P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>New York, New York 10019</B> </P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>(212) 451-2300</B> </P></TD>
    <TD STYLE="width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt 0pt 0; text-align: center"> <B>Faith L. Charles, Esq.</B> </P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt 0pt 0; text-align: center"> <B>Thompson Hine LLP</B> </P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt 0pt 0; text-align: center"> <B>300 Madison Avenue, 27th
    Floor</B> </P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt 0pt 0; text-align: center"> <B>New York, New York 10017</B> </P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.5pt 0pt 0; text-align: center"> <B>(212) 344-5680</B> </P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Approximate date of commencement
of proposed sale to public:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>As soon as practicable after this
Registration Statement is declared effective.</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">If any of the securities being registered on this Form are
to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box.&ensp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">If this Form is filed to register additional securities
for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering.&ensp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">If this Form is a post-effective amendment filed pursuant
to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering.&ensp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">If this Form is a post-effective amendment filed pursuant
to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering.&ensp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions
of <FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;</FONT>large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo;
&ldquo;smaller reporting company&rdquo; and <FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;</FONT>emerging growth company&rdquo;
in Rule 12b-2 of the Exchange Act.</P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 24%; text-underline-color: black"><FONT STYLE="font-size: 10pt">Large&nbsp;accelerated&nbsp;filer</FONT></TD>
    <TD STYLE="width: 1%; text-underline-color: black">&nbsp;</TD>
    <TD STYLE="width: 47%; text-underline-color: black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="width: 2%; text-underline-color: black">&nbsp;</TD>
    <TD STYLE="width: 19%; text-underline-color: black"><FONT STYLE="font-size: 10pt">Accelerated filer</FONT></TD>
    <TD STYLE="width: 1%; text-underline-color: black">&nbsp;</TD>
    <TD STYLE="width: 6%; text-underline-color: black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-underline-color: black"><FONT STYLE="font-size: 10pt">Non-accelerated&nbsp;filer</FONT></TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><FONT STYLE="font-size: 10pt">Smaller&nbsp;reporting&nbsp;company</FONT></TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><FONT STYLE="font-size: 10pt">Emerging growth&nbsp;company</FONT></TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">&nbsp;</P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">If an emerging growth company, indicate by check mark if
the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided to Section&nbsp;7(a)(2)(B) of the Securities Act.&ensp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: center"></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>The Registrant hereby amends this Registration Statement on such
date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states
that this Registration Statement shall thereafter become effective in accordance with Section&nbsp;8(a) of the Securities Act of 1933
or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to
said Section&nbsp;8(a), may determine.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: Red"><B>The information contained in this preliminary
prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities
and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities, and it is not soliciting
an offer to buy these securities in any state where the offer or sale is not permitted.</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Red">SUBJECT TO COMPLETION</FONT><BR>
<FONT STYLE="color: Red">PRELIMINARY PROSPECTUS DATED AUGUST 19, 2025</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> Up to 2,252,252 Shares
of Common Stock<BR>
Up to 2,252,252 Pre-Funded Warrants to Purchase up to 2,252,252 Shares of Common Stock<BR>
Up to 2,252,252 Common Warrants to Purchase up to 2,252,252 Shares of Common Stock&nbsp; </P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"> Up to 4,504,504 Shares of Common Stock Underlying
the Common Warrants and Pre-Funded Warrants </P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 90.75pt; width: 188.25pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We are offering on a &ldquo;reasonable best
efforts&rdquo; basis up to 2,252,252 shares of common stock, par value $0.001 per share (the &ldquo;common stock&rdquo;), together with
common warrants (the &ldquo;Common Warrants&rdquo;) to purchase up to 2,252,252 shares of common stock. Each share of our common stock,
or pre-funded warrant (the &ldquo;Pre-Funded Warrant&rdquo;) in lieu thereof, is being sold together with a Common Warrant to purchase
one share of our common stock. The shares of common stock and Common Warrants are immediately separable and will be issued separately
in this offering but must be purchased together in this offering. The assumed public offering price for each share of common stock and
accompanying Common Warrant is $2.22, which was the closing price of our common stock on The Nasdaq Capital Market on August 15, 2025. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We are offering Pre-Funded Warrants to purchase
up to 2,252,252 shares of common stock to those purchasers whose purchase of shares of common stock in this offering would result in
the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% of our outstanding common
stock immediately following the consummation of this offering, in lieu of shares of common stock that would result in beneficial ownership
in excess of 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding common stock. Each Pre-Funded Warrant is exercisable
for one share of our common stock at an exercise price equal to $0.0001, the exercise price of each Pre-Funded Warrant. Each Pre-Funded
Warrant is being offered together with the Common Warrants at price equal to the purchase price of one share of common stock and accompanying
Common Warrant in this offering minus the exercise price of each Pre-Funded Warrant. The Pre-Funded Warrants and Common Warrants are
immediately separable and will be issued separately in this offering but must be purchased together in this offering. For each Pre-Funded
Warrant that we sell, the number of shares of common stock we are offering will be reduced on a one-for-one basis. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to this prospectus, we are also offering
the shares of common stock issuable upon the exercise of Pre-Funded Warrants and Common Warrants offered hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The shares of our common stock, Pre-Funded
Warrants and Common Warrants being offered will be sold in a single closing. The shares issuable upon exercise of the Pre-Funded Warrants
or Common Warrants will be issued upon the exercise thereof. Because there is no minimum number of securities or minimum aggregate amount
of proceeds for this offering to close, we may sell fewer than all of the securities offered hereby, and investors in this offering will
not receive a refund in the event that we do not sell an amount of securities sufficient to pursue the business goals outlined in this
prospectus. Because there is no escrow account and there is no minimum offering amount, investors could be in a position where they have
invested in our company, but we are unable to fulfill our objectives due to a lack of interest in this offering. Also, any proceeds from
the sale of securities offered by us will be available for our immediate use, despite uncertainty about whether we would be able to use
such funds effectively. The offering of the shares of our common stock, Pre-Funded Warrants and Common Warrants will terminate no later
than September 30, 2025; however, the shares of our common stock underlying the Pre-Funded Warrants and the Common Warrants will be offered
on a continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;). </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Our
                                            common stock trades on The Nasdaq Capital Market under the symbol &ldquo;GITS.&rdquo; The
                                            closing price of our common stock on Nasdaq on August&nbsp;15, 2025 was $2.22 per share.
                                            There is no established public trading market for the Pre-Funded Warrants and the Common
                                            Warrants, and we do not expect a market to develop. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Without an active trading market, the liquidity
of the Pre-Funded Warrants and the Common Warrants will be limited. In addition, we do not intend to apply for a listing of the Pre-Funded
Warrants or the Common Warrants on any national securities exchange or other nationally recognized trading system.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Certain information in this prospectus is based
on an assumed combined public offering price of $2.22 per share and accompanying Common Warrant (the last reported sale price of our
common stock on Nasdaq on August&nbsp;15, 2025). The actual combined public offering price per share and accompanying Common Warrant
will be determined between us and prospective investors in consultation with D. Boral Capital LLC (the &ldquo;Placement Agent&rdquo;),
as the placement agent, based on market conditions at the time of pricing, and may be at a discount to the current market price of our
common stock. The Placement Agent is not required to buy or sell any specific number or dollar amount of the securities offered hereby,
but they will use their reasonable best efforts to solicit offers to purchase the securities offered by this prospectus. See the section
entitled &ldquo;Plan of Distribution&rdquo; of this prospectus. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You should read this prospectus carefully, together
with additional information described under the heading &ldquo;Where You Can Find More Information,&rdquo; before you invest in any of
our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">There is substantial doubt
about our ability to continue as a going concern. As a reasonable best efforts offering in which no minimum number or dollar amount of
securities is required to be sold, we may be unable to raise sufficient capital to extend our cash runway through the end of this year.
For additional information, see <FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;</FONT>Risk Factors &mdash; Our auditor
has included an explanatory paragraph in their opinion expressing substantial doubt about our ability to continue as a going concern.
If we are unable to continue as a going concern, our securities will have little or no value.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"> <B>Investing in our
securities is highly speculative and involves a high degree of risk. See <FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;</FONT><U>Risk
Factors</U>&rdquo; beginning on page 13 of this prospectus </B>and <B>in the documents incorporated by reference into this prospectus
for a discussion of information that should be considered in connection with an investment in our securities.</B> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Per Share and<BR> Related&nbsp;Warrant</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Per Pre-Funded<BR> Warrant and<BR> Related&nbsp;Warrant</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%">Public offering price</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Placement agent fees (1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Proceeds to us, before expenses (2)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>We have agreed to pay the Placement Agent a cash placement commission up to 6.0% of the aggregate gross proceeds from this offering.
We have also agreed to reimburse the Placement Agent for certain expenses. See &ldquo;Plan of Distribution&rdquo; for additional information.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>The amount of the offering proceeds to us presented in this table does not give effect to any exercise of the Pre-Funded Warrants
or Common Warrants being issued in this offering.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus.
Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Delivery of the securities being offered pursuant
to this prospectus is expected to be made on or about&emsp;&nbsp;, 2025, subject to the satisfaction of certain closing conditions.</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Sole Placement Agent</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: windowtext"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 45pt; width: 174pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus is&emsp;&emsp;&emsp;&emsp;,
2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Table of Contents</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Page</B></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 91%"><A HREF="#glo_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABOUT THIS PROSPECTUS</FONT></A></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#glo_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS SUMMARY</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#glo_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE OFFERING</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#glo_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#glo_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#glo_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#glo_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MARKET PRICE OF OUR COMMON STOCK</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#tc_001">DIVIDEND INFORMATION</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">26</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#glo_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DILUTION</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#glo_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAPITALIZATION</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#glo_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF CAPITAL STOCK</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#glo_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF SECURITIES WE ARE OFFERING</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#glo_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#glo_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#glo_014"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#glo_015"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#glo_016"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="glo_001"></A>ABOUT THIS PROSPECTUS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We incorporate important information into this
prospectus by reference. You may obtain the information incorporated by reference without charge by following the instructions under &ldquo;Where
You Can Find More Information.&rdquo; You should carefully read this prospectus as well as additional information described under &ldquo;Incorporation
of Certain Information by Reference,&rdquo; before deciding to invest in our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Neither we nor the Placement Agent have authorized
anyone to provide you with information different from or inconsistent with the information contained in or incorporated by reference in
this prospectus. We and the Placement Agent take no responsibility for and can provide no assurance as to the reliability of, any other
information that others may give you. You should assume that the information appearing in this prospectus and the documents incorporated
by reference in this prospectus is accurate only as of the date of those respective documents, regardless of the time of delivery of those
respective documents. Our business, financial condition, results of operations and prospects may have changed since those dates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The information incorporated by reference or provided
in this prospectus contains statistical data and estimates, including those relating to market size and competitive position of the markets
in which we participate, that we obtained from our own internal estimates and research, as well as from industry and general publications
and research, surveys and studies conducted by third parties. Industry publications, studies and surveys generally state that they have
been obtained from sources believed to be reliable. While we believe our internal company research is reliable and the definitions of
our market and industry are appropriate, neither this research nor these definitions have been verified by any independent source.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We further note that the representations, warranties
and covenants made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference into this prospectus
were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among
the parties to such agreement, and should not be deemed to be a representation, warranty or covenant to you. Moreover, such representations,
warranties or covenants were accurate only as of the date when made. Accordingly, such representations, warranties and covenants should
not be relied on as accurately representing the current state of our affairs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We are offering to sell, and seeking offers
to buy, shares of our common stock, Pre-Funded Warrants and Common Warrants only in jurisdictions where offers and sales are permitted.
The distribution of this prospectus and the offering of our common stock, Pre-Funded Warrants and Common Warrants in certain jurisdictions
may be restricted by law. Persons outside the United States who come into possession of this prospectus must inform themselves about,
and observe any restrictions relating to, the offering of our securities and the distribution of this prospectus outside the United States.
This prospectus does not constitute, and may not be used in connection with, an offer to sell, or a solicitation of an offer to buy,
any securities offered by this prospectus by any person in any jurisdiction in which it is unlawful for such person to make such an offer
or solicitation. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">When we refer to &ldquo;we,&rdquo; &ldquo;our,&rdquo;
&ldquo;us&rdquo; and the &ldquo;Company&rdquo; in this prospectus, we mean Global Interactive Technologies, Inc. and its consolidated
subsidiaries, unless otherwise specified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This prospectus contains, or incorporates by reference,
trademarks, tradenames, service marks and service names of the Company and its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="glo_002"></A>PROSPECTUS SUMMARY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>This summary highlights information contained
elsewhere in this prospectus. This summary does not contain all of the information that you should consider before deciding to invest
in our securities. You should read this entire prospectus carefully, including the &ldquo;Risk Factors&rdquo; section in this prospectus
and under similar captions in the documents incorporated by reference into this prospectus. If any of the risks materialize, our business,
financial condition, operating results and prospects could be materially and adversely affected. In that event, the price of our securities
could decline, and you could lose part or all of your investment.</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Global Interactive Technologies, Inc. is a technology-driven
platform company connecting global fans of modern Korean culture through innovative digital experiences. We operate Faning, a comprehensive
interactive social media platform designed to facilitate content discovery, monetization, user-generated content and deep community engagement
among global &ldquo;fandom&rdquo; communities. We focus on leveraging technology to expand Korean culture (referred to as Hallyu) beyond
traditional K-pop to span digital media, entertainment and interactive platform services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Faning allows fans to interact within their fandoms
and discuss, create and share content and interact through a number of channels including (i) secure direct messaging, (ii) open social
pages and (iii) virtual spaces known as &ldquo;Faning Clubs.&rdquo; Faning Clubs concentrate on a specific topic, allowing moderators
to control the Club functions and Club members to aggregate their rewards of Faning Points (FP). Integrated within each Faning Club is
a &ldquo;Club Vault,&rdquo; which is a service provided by Faning that allows individual members of a Club to donate their personal FP
to an account held by the Club. The Club Vault allows the Club&rsquo;s members to aggregate their FP and increase their purchasing power.
This increase in purchasing power allows the Club&rsquo;s individual users to more rapidly accumulate FP and pool their rewards with other
users in order to purchase services such as fan events or the ability to live stream a concert from their favorite music group. Decisions
regarding the use of the accumulated FP within the Club Vault are determined by a vote of the Club members.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: windowtext"><IMG SRC="image_003.jpg" ALT="" STYLE="height: 141pt; width: 251.25pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our users are the core of our business. We provide
our users with customized experiences including unique interactions within the Faning community. Faning algorithms curate individual user
experiences, recommending content, clubs to join and users to connect with, and enabling users to subscribe to keywords and access automatic
content geared towards their interests. Through these services, Faning provides the fandom community a way to stay connected and up to
date with their fandom communities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Faning further offers each user the ability to
freely create, upload and monetize their own content by earning in-platform rewards of FP. Faning removes language barriers, providing
live chat ability between users worldwide and global access to platform content, as the Faning platform supports automatic, real-time
translation services for 17 languages. Faning also offers a fast, secure and easy-to-use commerce and user-to-user transaction system.
These unique features are designed to allow Faning to generate user loyalty, maintain user interest in the platform and attract new users.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For future growth, we intend to develop short content,
typically of approximately two minutes in duration, that will focus on interesting pop music and cultural topics. These videos will be
distributed through Faning while concurrently being shown on third-party social media platforms and video-sharing websites. This is a
key aspect of our growth strategy. We believe these videos will enhance the strength of our Faning community by fostering a greater degree
of engagement and will allow for greater visibility for K-pop on a global basis.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</DIV>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The Faning Ecosystem</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We designed Faning as an ecosystem that is easy
for users to adapt and use all features throughout the platform, and for us to develop and roll-out new technologies and functionality.
Faning&rsquo;s launch included a rollout of our messenger, community and club technologies, along with our reward system for users. Since
Faning&rsquo;s launch in May 2021, the platform has attracted more than 26.6 million registered users as of December 31, 2024 from the
regions in the following chart:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: windowtext"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 183pt; width: 188.25pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The main age groups that compose our use base are
the 20-29 year old age group and 30-39 year old age group as set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: windowtext"><IMG SRC="image_005.jpg" ALT="" STYLE="height: 190.5pt; width: 150pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The combined age groups of 20-39 years old have
the highest purchasing power among commercial and entertainment industries and account for more than 80% of all Faning users with a median
age of 27 years old. Faning is available to individuals 12 years and older and has an age restriction set that will not allow users under
the age of 12 years to sign up.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

</DIV>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">User Reward System</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: windowtext"><IMG SRC="image_006.jpg" ALT="" STYLE="height: 131.25pt; width: 270pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The reward system is the basis of the Faning ecosystem.
Users earn FP based on the level of each user&rsquo;s activity within the Faning platform and the revenue we derive from Faning&rsquo;s
advertising sales. At midnight of each day, all advertising revenue for that day is accumulated, and 50% of that day&rsquo;s total net
advertising profits are distributed as FP to users, based upon their level of contribution within the Faning platform. From the 50% of
any future profits that are distributed to users as FP, approximately 30% of the distribution of rewards will go to users who are content
creators and the remaining 20% will be issued to general users who participate on the platform. For calculating advertising profits allocated
for user rewards, the amount of FP issued will be exchanged at a ratio of one FP for every 100 South Korean won (or approximately $0.07).
The issuance of FP from advertising revenue is limited to advertising revenue generated within the Faning platform, and we may earn revenue
from advertising outside of the Faning platform that would not result in the issuance of FP.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Faning Points</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">FP is a measurement of reward points within the
Faning platform. Accruing FP allows users to redeem FP for a wide variety of products and services within Faning, including content from
other users and artists available on Faning, and K-Culture merchandise. FP will be stored and quantified as rewards point within the platform
under the in-platform reward system structure that consists of (i) our FP reserve account, (ii) our active account for collected advertising
revenue which was converted into FP and ready to distribute to users based on user contributions to the Faning platform, (iii) our recycled
FP account, which stores FP after being spent by users to make purchases within the application, and (iv) each user&rsquo;s individual
account stores. The value of FP is set at a fixed ratio of 1:100 FP to Korean Won. We do not intend to repurchase FP from users now or
in the future. FP does not expire, and FP that is not redeemed by a user will accumulate in such user&rsquo;s account unless and until
such user deactivates their account, at which time such FP will be forfeited and moved to our reserve account for redistribution.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">FP Storage and Security</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">FP are stored and managed through a database that
is separate and apart from other databases used to store and manage other Faning app data. The separate FP database is operated to ensure
maximum data confidentiality by minimizing access to the database and limiting the number of individuals who are able to access such database.
Access to the database is limited to permitted IP bands, and the backup function of the cloud service used to store data can be restored
within a few hours in the event of a disaster recovery event such as a server failure.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">User-to-User Interactions</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We developed Faning to include numerous opportunities
for our users to engage with the platform, including clubs, community forums, chat functions, and functionality to create user-generated
content, each of which are intended to build the Faning brand and deepen the loyalty of our users.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: windowtext"><IMG SRC="image_007.jpg" ALT="" STYLE="height: 141.75pt; width: 316.5pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Faning Clubs</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Faning Clubs are user-created based upon areas
of interest in order to link users across the globe and create friendships. Users have the ability to create clubs based upon topics of
their own choosing, such as favorite artists, television series, movies, video games and sports. A club can be customized by its moderator
according to various policies and preferences to cultivate a close group of users based upon a shared culture. Integrated within each
Faning Club is a &ldquo;Club Vault,&rdquo; a service provided by Faning that allows the individual members of a Club to donate their personal
FP to an account held by the Club. The Club Vault allows the Club&rsquo;s members to aggregate their FP and increase their purchasing
power. This increase in purchasing power allows the Club&rsquo;s users to more rapidly accumulate FP and pool their rewards, in order
to purchase services such as fan events or the ability to live stream a concert from their favorite band. Decisions regarding the use
of accumulated FP within the Club Vault are determined by a vote of the Club members.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Faning Communities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Faning communities are open forums where user-generated
content is socially promoted and curated by Faning users. Once user requests for a community based around a certain topic exceed a pre-determined
threshold, the Faning platform will create such a community based upon the users submitting the requests.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Faning Chats</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Real-time multilingual translation capability,
currently offered in 17 languages, allows both private messages and open chats via the Faning chats function without language barriers.
Messages and chats are protected utilizing end-to-end encryption to prevent leakage of personal information. End-to-end encryption is
a system of secured communication to prevent third parties from accessing chat messages, increasing the level of security.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Faning Content</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>User-Created Content</B>. Core to our business
is moving into a user-based content creation model that allows users varying ways to create and sell fandom content to other Faning users,
including the content types described below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;<FONT STYLE="font-family: Symbol"></FONT></TD><TD>Fanart is artwork created by fans relating to artists, movies and dramas they like.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>Web novels are user written novels, uploaded by users to the Faning platform. Readers can make comments at very specific areas within
the novel. Novels can be viewed in the language of each user&rsquo;s choice. If the desired language is not available, users can request
or suggest the corresponding language translation. Through the process of &ldquo;translation matching,&rdquo; writers can search for translators
while translators can ask writers for permissions to obtain the right to translate their stories. Once the writer and translator approve
and consent, these translated stories can be sold to users. Any profit will be distributed automatically by Faning based on their prior
agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>Webtoons are user-created digital comics, uploaded by users to the Faning platform. Users can also buy and sell user-translated copies
of these webtoons through the &ldquo;translation matching&rdquo; services referenced above, allowing users across the globe to enjoy their
favorite webtoons in their own language.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>User-generated content also includes any other content created and sold by Faning users, such as the Faning shop offerings described
below.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Faning-Created Content</B>. We also create and
distribute our own content. Content is distributed within the Faning platform both for free and for sale for premium content. We currently
have 12 key employees broken up into a number of content-creating teams that cast entertainers for creating original video content, primarily
uploaded on Faning TV within the Faning platform. As the business grows, we intend to hire more employees and produce high-quality content
that engages the users into the Faning platform. In addition to the content types similar to the categories listed above for user-generated
content, Faning original content also includes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>Faning original shows and web series are shows and web series produced by Faning. This original content is exclusively available on
the Faning platform. From time to time, we may sell such content for distribution on other third-party channels and platforms.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>Concerts are hosted by Faning for its users across numerous musical genres, from Korean pop to independent music, in venues of all
sizes, from stadiums to small stages. Users that cannot attend these concerts in person can access these concerts on Faning via our online
streaming service, and tickets can be purchased, using FP or cash, in the Faning Shop, also known as the &ldquo;Fanshop.&rdquo;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Third Party Content</B>. Third party content
includes content from trusted third-party media companies. Third party content can be uploaded to Faning pursuant to certain agreements
between our company and third-party providers. These articles and videos are provided in real time, with automatic translation support
in 17 languages.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Faning Fanshop</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Faning Fanshop is the e-commerce service provided
through the Faning platform to its users. Through the Fanshop, users can purchase various items directly from Faning, such as gifts for
artists, pre-paid cards, concert tickets, and other fandom goods using FP or cash. To the extent that items are purchased by us to sell
within the Faning Fanshop, we use cash to purchase the products and then list the items in the Fanshop. The Fanshop will also offer a
video commerce service, intended to be an online version of traditional home shopping networks on cable television. For example, users
can purchase items relating to their favorite K-pop artist, such as the artist&rsquo;s latest album, at the same time such user is streaming
the artist&rsquo;s live event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: windowtext"><IMG SRC="image_008.jpg" ALT="" STYLE="height: 150pt; width: 327.75pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Within the Fanshop, Faning users can also participate
in user-to-user transactions, such as selling or purchasing the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>Emojis used within chats on the Faning platform. Users have the ability to create emojis and register them in the Fanshop to generate
sales by selling them to other users, generating FP in such transactions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>Augmented reality (&ldquo;AR&rdquo;) filters used in videos within the Faning platform. Users have the ability to create and sell
registered AR filters within the Fanshop to other users.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>Digital stickers used within the Faning platform. Users have the ability to create and sell registered digital stickers within the
Fanshop to other users.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For both user-to-user transactions and transactions
with our company, payment can be made either by credit card through a secure, third-party payment system built into the Faning platform,
or by settling the total with the use of FP. Sales settled in FP will be charged a transaction fee based upon the specific item sold,
ranging between 7% to 15% of the sale price. For user-to-user transactions, the selling user receives the proceeds upon the purchaser&rsquo;s
confirmation of receipt of the good sold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If the item sold in the user-to-user transaction
requires shipping, we intend on partnering with providers such as Qxpress to provide shipping services for which the fee will be bundled
into the total transaction cost. Alternatively, users can ship the item directly using another third-party shipping service.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Our Market Opportunity</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The global expansion of the &ldquo;Korean Wave&rdquo;
(Hallyu) has transformed Korean culture into a powerful force shaping entertainment, fashion and consumer behavior worldwide. According
to the Korea Foundation&rsquo;s 2023 Global Hallyu Trends Report, the global K-Culture fan base reached approximately 229 million across
119 countries, up nearly 50% from 156.6 million in 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of 2022, the Korean Foundation for International
Cultural Exchange (KOFICE) reported 178 million K-Culture fans globally, with China (86.32 million fans), the United States (27.17 million
fans), and Thailand (17.37 million fans) among the top markets. While updated country-level data is unavailable, the 2025 Overseas Hallyu
Survey (reflecting 2024 trends) indicates continued growth, with global audiences spending an average of 14 hours per month consuming
Korean content, an increase of 2.3 hours over the prior year. Favorability rates remain especially high in Indonesia (86.3%), India (84.5%)
and Thailand (83%), according to that survey. Due to regulatory restrictions, we do not operate in China, Hong Kong or Macau.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">K-Culture&rsquo;s economic impact continues to
expand. The Korea Creative Content Agency (KOCCA) estimated global purchasing power tied to K-Culture at $147.3 billion as of 2023. In
2024, KOCCA reported a 48.6% increase in export contract volume across its 25 global business centers, with K-dramas and webtoons driving
international demand through platforms such as Netflix and Webtoon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This momentum is fueled by mobile-first consumption.
As of January 2023, over 5.6 billion people worldwide used mobile phones, and more than 60% of the global population was active on social
media, according to DataReportal. K-Culture content is primarily accessed through mobile platforms such as YouTube, TikTok, Spotify and
Webtoon, with streaming, digital fandoms and virtual events forming the backbone of global engagement, particularly in emerging markets
where mobile access outpaces traditional infrastructure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The market for virtual experiences also continues
to scale. BTS&rsquo;s Bang Bang Con: The Live, held in June 2020, drew 756,000 concurrent viewers from 107 countries and set a Guinness
World Record for the most viewers for a paid online concert. According to Grand View Research, the global virtual events market was valued
at $98.07 billion in 2024 and is projected to grow to $297.16 billion by 2030, at a compound annual growth rate (CAGR) of 20.0%. The Asia
Pacific region, including South Korea, accounted for over a quarter of the global market share in 2023, reflecting the region&rsquo;s
leadership in immersive, mobile-first digital experiences.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We believe Faning is positioned to serve this demand.
With real-time engagement tools, multilingual support (17 languages), monetization features and cross-platform accessibility, the platform
aligns with how global audiences consume and participate in K-Culture. Supported by an integrated reward system, partnerships across the
Korean entertainment industry and a growing user base, Faning is built to become a player in the global digital K-Culture experience economy.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</DIV>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Our Value Proposition</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Faning is designed as an all-in-one, user-centric
platform that enhances the global fan experience by consolidating fandom-related content, community engagement and monetization tools
in one place. The platform offers access to entertainment news, pop culture updates, discussion forums, live shows and fan-created content,
curated to serve the diverse interests of fandom communities worldwide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Faning supports 17 languages and features real-time
translation services, enabling seamless communication among users across different geographies without language barriers. For languages
not yet covered by real-time translation, Faning offers a peer-based translation matching service, allowing users to collaborate in translating
content accurately and expanding accessibility for a broader global audience.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> In addition to content consumption and community
interaction, Faning empowers users to create and monetize their own content through a secure, user-to-user marketplace. Our integrated
reward system, Faning Points, incentivizes platform engagement by rewarding users for active participation, creative contributions and
user referrals. FP can be redeemed for goods and services within the platform, increasing users&rsquo; purchasing power and deepening
their connection to the Faning ecosystem. </P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Our Competitive Strengths</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We differentiate ourselves from competing social
networks through the power of a fully integrated platform and established partnerships with leaders in the entertainment industry within
South Korea. Our platform and partnerships enable our users to create clubs, communities, and gather over similar fandoms, all while monetizing
their content and contributing to the Faning platform experience. Our core strengths include the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><B><I>Value Creation through Revenue Derived from User Activity</I></B>. We intend to generate revenue from the sale of goods and/or
services within the Faning platform from one user to another. Revenue is derived from user-to-user sales as follows: (i) from the sale
of emojis and online stickers, from which we will collect 30% of the price paid by the purchaser, with the remaining 70% being remitted
to the seller; (ii) from web novels and webtoons. If posted for free, the creator will only receive rewards in FP in relation to the number
of views and likes; however, if the creator charges for the content, we intend to collect 30% of the price paid by the user, with the
remaining 70% being remitted to the seller; (iii) users can offer the service of translation matching, where a user offers to translate
another user&rsquo;s content for a commission (in either cash or FP), and the parties agree to split the sales revenue from the translated
content at a pre-determined ratio, for which we will collect 30% of each sale, and remit the remainder to the creator and translator based
on a split determined by the parties; and (iv) for transactions between users involving tangible goods or other non-platform based fandom
items (such as concert tickets), we intend to charge a fee of 3.5% of the total value of the transaction at the time of sale.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><B><I>Faning&rsquo;s Direct Advertising Platform</I></B>. We intend to directly engage with our advertisers. Without the need for
third-party engagement, we can leverage the Faning platform to better understand advertisers and their expectations, ensuring we can create
highly curated advertising products that will promote high levels of engagement and sales conversions for advertisers. We believe this
will increase advertising revenue and build sustainable relationships with advertisers, while concurrently increasing the attractiveness
of the Faning platform to new advertisers and users interested in the products advertised within the Faning platform.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><B><I>High User Engagement</I></B>. We intend to drive user engagement by offering a one-stop fandom platform and by offering an in-platform
reward system. These features are intended to allow the Faning platform to keep and maintain a highly engaged user base, loyal to the
Faning platform and its brand. This brand loyalty will assist by reducing our advertising costs by replacing it with non-paid platform
promotion through the word-of-mouth of our current user base.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</DIV>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<DIV STYLE="padding: 5pt; border: Black 1.5pt solid">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Our Growth Strategy</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our core strategy is to pursue initiatives that
promote the growth of our user base and, in doing so, drive advertising revenue, user-generated revenue and create other revenue streams.
Our focus on user acquisition and retention provides the primary lens to view our plans for community growth, engagement and long-term
brand equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><B><I>Attract Global Users</I></B>. Our core business strategy is to promote the Faning platform and grow our global user base, which
will drive revenue growth by increasing advertising revenue and user activity-based revenue.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><B><I>Broaden Product and Service Offerings</I></B>. Within the Faning platform, our objective is for users to benefit from a wide
range of products and services offered, and we intend to continuously expand our product and service offerings as the user-base and revenue
grow. Broadening our product offerings will ensure Faning grows along with the fandom community in which it operates, eventually creating
a one-stop platform for our users across all fandoms.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><B><I>Continue Research and Tech Development</I></B>. We intend to continue to invest in developing and implementing the newest technologies
to ensure a better and more secure user experience compared to other social media platforms.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our revenue growth strategy spans multiple time
horizons. In the short term, we aim to generate revenue through virtual events hosted on the Faning platform, monetizing both commissions
and operational profits. Additionally, we plan to establish a base of steady monthly income by offering premium subscription services
tailored to both individual users and institutional partners. In the mid-term, we intend to drive revenue growth by leveraging Faning&rsquo;s
advertising infrastructure, which will include affiliate marketing partnerships and platform-driven advertising sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Recent Developments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Financial Mismanagement and Operational
Challenges Following Our IPO. </B>In August 2023, we completed our initial public offering and listed our shares of common stock on Nasdaq,
raising approximately $8.77 million through the issuance of 877,328 shares at $10.00 per share. As disclosed in our initial public offering
prospectus, the intended use of proceeds was for general corporate purposes, including technology development, sales and marketing, staffing
and capital expenditures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> While a portion of the net proceeds was used
appropriately, such as covering public listing expenses and supporting operational and administrative costs, an internal investigation
initiated by our Board of Directors (the &ldquo;Board&rdquo;) in February 2024 determined that a substantial amount of the funds was
not allocated in line with the stated objectives. By May 2024, our primary U.S. bank account had been fully depleted. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The investigation identified significant deficiencies
in our internal financial controls, including inadequate expense tracking and lack of proper oversight. These failures severely limited
our ability to support key operational initiatives, including product development, talent acquisition and long-term growth strategies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In response, the Board took immediate corrective
action. Between February and March 2024, we replaced the former Chief Executive Officer, terminated key members of senior management
and appointed new leadership. We also restructured our Board to strengthen governance, re-establish financial discipline and set a more
focused strategic direction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Regulatory and Financial Status. </B>Since
early 2025, we have responded to information requests from the U.S. Securities and Exchange Commission regarding the use of our initial
public offering proceeds and certain trading activities. As of the date of this filing, no enforcement actions or formal proceedings
have been initiated. We remain committed to full cooperation with any ongoing or future regulatory reviews.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Due to the financial challenges described above,
we have not had sufficient resources to operate the business as originally planned. Currently, we maintain limited cash reserves and
do not have adequate liquidity to fund operations over the next 12 months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Throughout 2024, we raised internal capital
to sustain limited operations and preserve platform continuity. Based on our current projections, we estimate that between $2.0 million
and $3.0 million in additional funding will be required to support operations over the coming 12 months. We are actively evaluating strategic
alternatives, including equity financing, partnerships and potential business combinations, to secure the necessary capital for long-term
growth. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Korean Securities and Futures Commission Administrative
Fine</B>. On November 6, 2024, the Securities Futures and Exchange Commission (the &ldquo;SFC&rdquo;) under the Financial Services Commission
of the Republic of Korea imposed an administrative fine of KRW 142.1 million (or approximately $104,750) against us for alleged violations
of Korean securities regulations. The fine was issued pursuant to Article 119(1) and Article 429(1)(2) of the Capital Market and Financial
Investment Business Act and Article 25 of the Regulations on Capital Market Investigations in connection with a failure to submit a securities
registration statement for a private placement that took place between April 20, 2023 and July 31, 2023 in which we raised approximately
KRW 5.92 billion (or approximately $4,628,500) through the issuance of 462,847 shares of common stock to 124 Korean investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

</DIV>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On January 2, 2025, we filed with the SFC a formal
objection to the regulatory sanction. On March 27, 2025, the SFC dismissed our objection. In accordance with Korean administrative law,
we retain the right to seek further redress by filing an appeal. On June 24, 2025, we filed an administrative appeal challenging the sanction
as we believe that the sanction is without merit and we have adequate defenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif">To
date, </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">we have <FONT>not paid the administrative
fine because the fine is the subject of the appeal. </FONT>The SFC has not imposed any sanctions or restrictions on any member of current
management or on any currently serving directors. </FONT> <FONT>See also &ldquo;Risk Factors - We may be the
subject of an administrative fine by the Korean Securities and Futures Commission (the &ldquo;SFC&rdquo;), and any adverse outcome in
the related proceedings could negatively impact our business, financial condition and results of operations.<B>&rdquo;</B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><B>PixelArc
Debt-to-Equity Conversion.</B> On February 18, 2025, we entered into a Promissory Note (the &ldquo;February 2025 Note&rdquo;) payable
to PixelArc, LLC (&ldquo;PixelArc&rdquo;), a California limited liability company in which Amy Xianglin Shi, a director of our company,
holds a direct ownership interest and serves in a managerial capacity. The February 2025 Note evidences a loan of $86,660 extended by
PixelArc to support essential operating obligations during a period of limited liquidity. The note accrued interest at 8% per annum, had
a maturity date of March 14, 2026, and included a 5% late fee and 12% default interest rate, along with customary default provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On April 18, 2025, we executed a second Promissory
Note (the &ldquo;April 2025 Note&rdquo;) payable to PixelArc, evidencing a short-term, interest-free loan of $86,000 used to satisfy outstanding
Nasdaq listing fees and maintain our continued listing. The note matured on May 15, 2025, and contained the same late fee and default
interest terms as the February 2025 Note. In connection with the April 2025 Note, we also entered into a Security Agreement, dated April
18, 2025 (the &ldquo;Security Agreement&rdquo;), with PixelArc to secure repayment obligations under both notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Following nonpayment of the April 2025 Note, PixelArc
became entitled to exercise its rights under the Security Agreement. On May 19, 2025, PixelArc submitted a proposal to convert its outstanding
loan balances into equity. On May 20, 2025, PixelArc delivered a formal Notice of Conversion to us, pursuant to which the combined $172,666
in principal amount under the February 2025 and April 2025 Notes were converted into 246,666 shares of our common stock at a price of
$0.70 per share (the &ldquo;PixelArc Conversion&rdquo;). While the conversion price was below the then fair market value of our common
stock, the transaction was structured to enhance our financial flexibility and did not constitute equity compensation for Ms. Shi in her
capacity as a director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The February 2025 Note, April 2025 Note and
Security Agreement were submitted to and approved by the Board, including disinterested members. The PixelArc Conversion proposal was
subsequently circulated to the Board for review and received unanimous support without objection. The Board acknowledged that, under
our circumstances, the transactions served the best interests of our company and our stockholders by addressing immediate financial obligations
in a responsible manner. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the PixelArc Conversion, PixelArc
expressly reserved the right to receive equivalent or superior terms, including, but not limited to, warrants or other equity-linked securities,
on terms no less favorable than those offered to similarly situated investors in capital transactions occurring between February 2025
and December 2025. PixelArc also reserved the right to board-level participation, including the designation of a non-voting observer or
equivalent strategic consultation rights, for so long as it directly or indirectly holds 5% or more of our outstanding equity securities.
These rights were expressly reserved in the Notice of Conversion and implemented by our company in accordance with our applicable governance
procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><B>Implications of Being an Emerging Growth Company
and a Smaller Reporting Company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We qualify as an &ldquo;emerging growth company&rdquo;
as defined in the Jumpstart Our Business Startups Act&nbsp;of&nbsp;2012 (the &ldquo;JOBS Act&rdquo;). For as long as we remain an emerging
growth company, we may take advantage of specified reduced reporting requirements and other burdens that are otherwise applicable generally
to other public companies. These provisions include, but are not limited to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">reduced obligations with respect to financial data, including
presenting only two&nbsp;years of audited financial statements and selected financial data, and only two&nbsp;years of related Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operations disclosure in our initial registration statement;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">an exemption from the auditor attestation requirement in the
assessment of our internal control over financial reporting pursuant to the Sarbanes-Oxley&nbsp;Act&nbsp;of&nbsp;2002, as amended;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">reduced disclosure about executive compensation arrangements
in our periodic reports, registration statements and proxy statements; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">exemptions from the requirements to seek non-binding&nbsp;advisory
votes on executive compensation or stockholder approval of any golden parachute arrangements.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We may take advantage of some or all of these provisions
until we are no longer an emerging growth company. We will remain an emerging growth company until the earliest of (i)&nbsp;the last&nbsp;day
the fiscal year following the fifth anniversary of the completion of our initial public offering, (ii)&nbsp;the last&nbsp;day of the first
fiscal year in which our annual gross revenues exceed $1.235&nbsp;billion, (iii)&nbsp;the date on which we have, during the immediately
preceding three-year&nbsp;period, issued more than $1.0&nbsp;billion in non-convertible&nbsp;debt securities and (iv)&nbsp;the date on
which we are deemed to be a large accelerated filer under the rules of the SEC.&nbsp;We may choose to take advantage of some but not all
of these reduced burdens. For example, we have taken advantage of the reduced reporting requirements with respect to disclosure regarding
our executive compensation arrangements, have presented only two&nbsp;years of audited financial statements and only two&nbsp;years of
related &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations&rdquo; disclosure in this prospectus,
and have taken advantage of the exemption from auditor attestation on the effectiveness of our internal control over financial reporting.
To the extent that we take advantage of these reduced burdens, the information that we provide stockholders may be different than what
you might obtain from other public companies in which you hold shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, the JOBS Act permits emerging growth
companies to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies.
We have elected to use this extended transition period. As a result of this election, our timeline to comply with new or revised accounting
standards will in many cases be delayed as compared to other public companies that are not eligible to take advantage of this election
or have not made this election. Therefore, our financial statements may not be comparable to those of companies that comply with the public
company effective dates for these accounting standards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are also a &ldquo;smaller reporting company&rdquo;
as defined in the Securities Exchange&nbsp;Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), and have elected to take advantage
of certain of the scaled disclosures available to smaller reporting companies. To the extent that we continue to qualify as a &ldquo;smaller
reporting company&rdquo; as such term is defined in Rule&nbsp;12b-2&nbsp;under the Exchange&nbsp;Act, after we cease to qualify as an
emerging growth company, certain of the exemptions available to us as an &ldquo;emerging growth company&rdquo; may continue to be available
to us, including exemption from compliance with the auditor attestation requirements pursuant to the Sarbanes-Oxley&nbsp;Act and reduced
disclosure about our executive compensation arrangements. We will continue to be a &ldquo;smaller reporting company&rdquo; until we have
$250&nbsp;million or more in public float (based on our common stock) measured as of the last business&nbsp;day of our most recently completed
second fiscal quarter or, in the event we have no public float (based on our common stock) or a public float (based on our common stock)
that is less than $700&nbsp;million, annual revenues of $100&nbsp;million or more during the most recently completed fiscal year.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Corporate Background and Information</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We were incorporated in the State of Delaware on
October 20, 2021 as Hanryu Holdings, Inc. On December 5, 2024, we formally changed our corporate name to Global Interactive Technologies,
Inc. pursuant to an amendment to our Certificate of Incorporation filed with the Secretary of State of Delaware. In connection with our
name change, we changed our Nasdaq ticker symbol to GITS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our primary operating subsidiary is Faning Korea,
LLC, a wholly owned subsidiary based in Seoul, Republic of Korea. Faning Korea oversees the development, maintenance and operation of
the Faning application and related web services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In July 2023, we completed our initial public
offering and the listing of our shares on Nasdaq, raising approximately $8.77 million through the issuance of 877,328 shares of common
stock at $10.00 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our address is 160, Yeouiseo-ro, Yeongdeungpo-gu,
Seoul, Republic of Korea, 07231 and our telephone number is +82-2-564-8588. Our corporate website is www.gitechnologies.com. Our website
and the information contained on, or that can be accessed through, our website shall not be deemed to be incorporated by reference in,
and are not considered part of, this prospectus. You should not rely on any such information in making your decision whether to purchase
our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="glo_003"></A>THE OFFERING</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Stock Offered:</P></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 63%; text-underline-color: black"> Up to 2,252,252 shares. </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black">Pre-Funded Warrants Offered:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black"> We are offering to certain purchasers whose purchase of shares of common stock in this
    offering would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more
    than 4.99% of our outstanding shares of common stock immediately following the closing of this offering, the opportunity to purchase,
    if such purchasers so choose, Pre-Funded Warrants, in lieu of shares of common stock that would otherwise result in any such purchaser&rsquo;s
    beneficial ownership, together with its affiliates and certain related parties, exceeding 4.99% (or, at the election of such purchaser,
    9.99%) of our outstanding shares of common stock immediately following the consummation of this offering. The purchase price of each
    Pre-Funded Warrant is equal to the purchase price of the shares of common stock in this offering minus $0.0001, the exercise price
    of each Pre-Funded Warrant. Each Pre-Funded Warrant is immediately exercisable and may be exercised at any time until it has been
    exercised in full. For each Pre-Funded Warrant we sell, the number of shares of common stock we are offering will be decreased on
    a one-for-one basis. This offering also relates to the shares of common stock issuable upon exercise of any Pre-Funded Warrants sold
    in this offering. </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black">Common Stock Outstanding after this Offering:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black"> Up to 5,801,077 shares of common stock, assuming (i) no sales of Pre-Funded Warrants which,
    if sold, would reduce the number of shares of common stock that we are offering on a one-for-one basis and (ii) no conversion of
    the Common Warrants. </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black">Common Warrants:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black"> Each share of common stock, or Pre-Funded Warrant in lieu thereof, will be sold together with a Common Warrant to purchase one
    share of common stock. Each Common Warrant has an assumed exercise price per share equal to $2.22 (subject to potential full ratchet
    anti-dilution adjustment as a result of a stock issuance or sale at a price less than the exercise price in effect, as provided in
    the Common Warrant) and expires on the fifth anniversary of the original issuance date. Because we will issue a Common Warrant for
    each share of common stock and for each Pre-Funded Warrant sold in this offering, the number of Common Warrants sold in this offering
    will not change as a result of a change in the mix of shares of common stock and Pre-Funded Warrants sold. This offering also relates
    to the shares of common stock issuable upon exercise of any Common Warrants sold in this offering. </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black">Reasonable Best Efforts:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">We have agreed to issue and sell the securities offered hereby to the purchasers through the Placement Agent. The Placement Agent is not required to buy or sell any specific number or dollar amount of the securities offered hereby, but they will use their reasonable best efforts to solicit offers to purchase the securities offered by this prospectus. See the section entitled &ldquo;Plan of Distribution&rdquo; of this prospectus.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black; width: 35%">Use of Proceeds:</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-underline-color: black; width: 63%"> We estimate that the net proceeds of this offering, after deducting placement
    agent fees and estimated offering expenses, will be approximately $4.5&nbsp;million if all of the securities offered hereby are sold
    in this offering. However, this is a reasonable best efforts offering with no minimum number of securities or amount of proceeds
    as a condition to closing, and we may not sell all or any of the securities offered pursuant to this prospectus; and, as a result,
    we may receive significantly less in net proceeds in this offering. For example, if we sell only 10%, 25%, 50% or 75% of the maximum
    amount offered, our net proceeds will be approximately $0.3&nbsp;million, $1.0&nbsp;million, $2.2&nbsp;million or $3.3&nbsp;million,
    respectively. We intend to use all of the net proceeds we receive from this offering for working capital and general corporate purposes,
    including investing in our sales and marketing efforts. See &ldquo;Use of Proceeds.&rdquo; </TD></TR>
</TABLE>
<P STYLE="margin: 0">&nbsp;</P>

</DIV>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black; width: 35%">Lock-up:</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-underline-color: black; width: 63%"> All of our directors and executive officers have agreed with the Placement
    Agent, subject to certain exceptions, not to sell, transfer or dispose of, directly or indirectly, any of our common stock or securities
    convertible into or exercisable or exchangeable for our common stock for a period of 90 days after the closing of this offering.
    In addition, we have agreed that, subject to certain exceptions, we will not conduct any issuances of our common stock for a period
    of 90 days after the closing of this offering. See &ldquo;Plan of Distribution&rdquo; for more information. </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black"> Risk Factors: </TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> Investment in our securities involves a high degree of risk
    and could result in a loss of your entire investment. See &ldquo;Risk Factors&rdquo; beginning on page 13, and the other information
    included and incorporated by reference in this prospectus for a discussion of the factors you should consider carefully before deciding
    to invest in our securities. </P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There is substantial doubt about our ability
    to continue as a going concern. As a reasonable best efforts offering in which no minimum number or dollar amount of securities is required
    to be sold, we may be unable to raise sufficient capital to extend our cash runway through the end of this year. For additional information,
    see &ldquo;Risk Factors &mdash; Our auditor has included an explanatory paragraph in their opinion expressing substantial doubt about
    our ability to continue as a going concern. If we are unable to continue as a going concern, our securities will have little or no value.&rdquo;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-underline-color: black">Nasdaq Capital Market Symbol:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">GITS</TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The above discussion is based on 3,548,825
shares of our common stock outstanding as of August&nbsp;15, 2025, does not give effect to the shares of common stock issuable upon exercise
of the Pre-Funded Warrants and Common Warrants issued in this offering, and excludes (unless otherwise indicated), as of such date: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman">&#9679;</FONT> </TD><TD> 332,505
                                            shares of common stock issuable upon the exercise of warrants issued in connection with the
                                            Debt-to-Equity Conversion; and </TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman">&#9679;</FONT> </TD><TD> an aggregate
                                            of 1,500,000 shares of common stock reserved for future issuance under our 2020 Omnibus Equity
                                            Incentive Plan as of August&nbsp;15, 2025. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"> &nbsp; </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Unless expressly indicated or the context requires
otherwise, all information in this prospectus assumes (i) no investor elects to purchase Pre-Funded Warrants, (ii) no exercise of the
Common Warrants offered hereby and (iii) no conversion of outstanding warrants after August&nbsp;15, 2025. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All shares and per share information in this prospectus
reflect, and where appropriate, is restated for, a 1-for-20 reverse stock split of our outstanding shares of common stock, effective January
27, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

</DIV>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="glo_004"></A>RISK FACTORS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>An investment in our common stock involves a
high degree of risk. Before deciding whether to invest in our securities, you should carefully consider the risks and uncertainties described
below, together with the information under the heading &ldquo;Risk Factors&rdquo; in our most recent Annual Report on Form 10-K for the
year ended December 31, 2024 filed with the Securities and Exchange Commission, all of which are incorporated herein by reference, as
updated or superseded by the risks and uncertainties described under similar headings in the other documents that are filed after the
date hereof and incorporated by reference into this prospectus, together with all of the other information contained or incorporated by
reference in this prospectus, and any free writing prospectus that we have authorized for use in connection with this offering before
you make a decision to invest in our securities. The risks and uncertainties we have described are not the only ones we face. Additional
risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our operations. Past financial
performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends
in future periods. If any of these risks actually occurs, our business, business prospects, financial condition or results of operations
could be seriously harmed. This could cause the trading price of our common stock to decline, resulting in a loss of all or part of your
investment. Please also read carefully the section below entitled &ldquo;Cautionary Note Regarding Forward-Looking Statements.&rdquo;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Risks Related to Our Business</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>We have incurred significant losses since
our inception, and we intend to continue to invest in our business. We have no sales. As a result, we may continue to experience losses
in the future.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We incurred a net loss of approximately $1.2
million, $6.2 million and $9.4 million for the six months ended June 30, 2025 and the years ended December 31, 2024 and 2023, respectively.
For these three fiscal periods, we had no or nominal sales and limited cash. As of June 30, 2025, we had an accumulated deficit of approximately
$39.1 million and a working capital deficiency of approximately $0.5 million. The audited report of our independent registered public
accounting firm to the financial statements for the years ended December 31, 2024 and 2023 contains an explanatory paragraph stating
that our recurring losses from operations, accumulated deficit and negative working capital raise substantial doubt about our ability
to continue as a going concern. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We expect to continue to invest heavily in
our product development and operations, to focus on our Faning platform to increase our user base to support future growth, and to meet
our expanded reporting and compliance obligations as a public company. We may not generate sufficient revenue to offset such costs to
achieve or sustain profitability in the future. Based on our current projections, we estimate that between $2.0 million and $3.0 million
in additional funding will be required to support operations over the coming 12 months. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We believe our current cash, net proceeds from
debt issuances and the amount raised from future issuances of common stock will be sufficient to fund our working capital requirements
for the next 12&nbsp;months. This belief assumes, among other things, that we will be able to raise additional equity financing, will
continue to be successful in implementing our business strategy and that there will be no material adverse developments in our business,
liquidity or capital requirements. If one or more of these factors do not occur as expected, it could have a material adverse impact
on our activities, including (i)&nbsp;reduction or delay of our business activities, (ii)&nbsp;forced sales of material assets, (iii)&nbsp;defaults
on our obligations, or (iv)&nbsp;insolvency. Our planned investments may not result in increased revenue or growth of our business. We
cannot assure you that we will be able to generate revenue sufficient to offset our expected cost increases and planned investments in
our business and platform. As a result, we may incur significant losses for the foreseeable future and may not be able to achieve and/or
sustain profitability. If we fail to achieve and sustain profitability, then we may not be able to achieve our business plan, fund our
business or continue as a going concern. The financial statements included in our public filings do not contain any adjustments which
might be necessary if we were unable to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><B><I>Our auditor has
included an explanatory paragraph in their opinion expressing substantial doubt about our ability to continue as a going concern. If we
are unable to continue as a going concern, our securities will have little or no value.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">OneStop Assurance PAC,
our independent registered public accounting firm for the years ended December 31, 2024 and December 31, 2023, has included an explanatory
paragraph in their opinion that accompanies our audited consolidated financial statements as of and for the years ended December 31, 2024
and December 31, 2023, indicating that our recurring losses from operations and a working capital deficiency raise substantial doubt about
our ability to continue as a going concern. If we are unable to obtain profitability or improve our liquidity position, we may not be
able to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We anticipate that we
will continue to generate operating losses and use cash in operations through the foreseeable future. As further set forth below, we anticipate
that we will need significant additional capital, or we may be required to curtail or cease operations. No assurance can be provided that
this offering or any other capital raise conducted by us will be in a sufficient amount to address these liquidity concerns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><B><I>To continue as a
going concern, we will require significant additional capital, which we may be unable to obtain.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We have had no sales in
the last two fiscal years. Therefore, we will need to raise additional capital in the future to continue our operations. We anticipate
that our principal sources of liquidity will not be sufficient to fund our activities to obtain long-term, sustainable profitability.
To have sufficient cash to fund our operations to obtain long-term, sustainable profitability, we will need to raise additional equity
or debt capital. There can be no assurance that additional funds will be available when needed from any source or, if available, will
be available on terms that are acceptable to us. We will be required to pursue sources of additional capital through various means, including
debt or equity financing. Future financing through equity investments will be dilutive to existing stockholders. The terms of securities
we may issue in future capital transactions may be more favorable for new investors. Newly issued securities may include preferences,
superior voting rights, the issuance of warrants or other derivative securities, and the issuances of incentive awards under our Omnibus
Equity Incentive Plan, all of which will have additional dilutive effects. Further, we may incur substantial costs in pursuing future
capital and/or financing, including investment banking fees, legal fees, accounting fees, printing and distribution expenses and other
costs. We may also be required to recognize non-cash expenses in connection with certain securities we may issue, such as convertible
notes and warrants, which may adversely impact our financial condition. Our ability to obtain needed financing may be impaired by such
factors as the capital markets and our history of losses, which could impact the availability and cost of future financing. If the amount
of capital we can raise from financing activities, together with our revenues and profits from operations, is not sufficient to satisfy
our capital needs, even to the extent that we reduce our operations accordingly, we may be required to curtail or cease operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"> Additionally, even
if this offering is successful, we will only be able to extend our cash runway for approximately 12 to 15 months. Further, as a reasonable
best efforts offering in which no minimum number or dollar amount of securities is required to be sold, we may be unable to raise sufficient
capital to extend our cash runway through the end of this year. See &ldquo;Risk Factors &mdash; This is a reasonable best efforts offering,
in which no minimum number or dollar amount of securities is required to be sold, and we may not raise the amount of capital we believe
is required for our business plans.&rdquo; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>We are a development stage company, and we
may not be able to sustain our growth, effectively manage our anticipated future growth or implement our business strategies.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have a limited operating history. Although we
have experienced growth since Faning was launched, our historical growth rate may not be indicative of our future performance due to our
limited operating history and the evolution of our business model, including a focus on the Faning application. We may not be able to
achieve similar results or accelerate growth at the same rate as we have historically. As our application offerings continue to develop,
we may adjust our strategy and business model to adapt. These adjustments may not achieve expected results and may have a material and
adverse impact on our financial condition and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, our growth and expansion have placed,
and continue to place, significant strain on our management and resources. This level of significant growth may not be sustainable or
achievable at all in the future. We believe that our continued growth will depend on many factors, including our ability to develop new
sources of revenues, diversify monetization methods including advertising revenue, attract and retain users, increase engagement on our
Faning platform, continue developing innovative technologies and application uses in response to shifting demand in the market, increase
brand awareness, and expand into new markets. We cannot assure you that we will achieve any of the above, and our failure to do so may
materially and adversely affect our business and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Global Interactive Technologies is a holding
company with no business operations of its own and manages a network of South Korean subsidiaries, subject to South Korean regulation.
Further, as we have no business operations of our own, we will depend on the cash flow and business of our subsidiaries to make payments
to us and meet our obligations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Global Interactive Technologies is
a&nbsp;holding&nbsp;company&nbsp;with no independent operations of our own. Our South Korean subsidiaries, including Faning Korea,
LLC, conduct substantially all of our business operations. Managing the regulatory compliance activities for each of these
subsidiaries is a complicated task, and we may expend significant resources doing so. However, we cannot guarantee that we will be
able to keep abreast of the changing legal and regulatory landscapes for each of the jurisdictions in which our subsidiaries exist.
If any of the regulatory environments applicable to our subsidiaries change materially, and we fail to adapt to such changes, our
business and financial results may be harmed. Applicable tax laws may also subject such payments to us by our subsidiaries to
further taxation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Additionally, as a holding company, we may rely
on our operating subsidiaries for distributions or payments for cash flow. Therefore, our ability to fund and conduct our business, service
any debt, and pay dividends, if any, in the future may depend on the ability of our South Korean subsidiaries to make upstream cash distributions
or payments to us, which may be impacted, for example, by their ability to generate sufficient cash flow or limitations on the ability
to repatriate funds, whether as a result of currency liquidity restrictions, monetary or exchange controls, regulatory restrictions, or
otherwise. Further, our subsidiaries&rsquo; ability to make payments to us will depend on:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-underline-color: black">&#9679;</TD>
    <TD STYLE="text-underline-color: black">their earnings;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&#9679;</TD>
    <TD STYLE="text-underline-color: black">covenants contained in any debt agreements to which we may then be subject, including any debt agreements of our subsidiaries;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&#9679;</TD>
    <TD STYLE="text-underline-color: black">covenants contained in other agreements to which we or our subsidiaries are or may become subject;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&#9679;</TD>
    <TD STYLE="text-underline-color: black">business and tax considerations; and</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black">&#9679;</TD>
    <TD STYLE="text-underline-color: black">applicable law, including any restrictions under South Korean law that may be imposed on our subsidiaries and affiliates, that would restrict our ability to make payments to us.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We cannot assure you that the operating results
of our subsidiaries at any given time will be sufficient to make distributions or other payments to us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>We are subject to risks associated with operating
in a rapidly developing industry and a relatively new market.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Many elements of our business are unique, evolving
and relatively unproven. Our business and prospects depend on the continuing development of the social media market, which is relatively
new, rapidly developing and subject to significant challenges. Our business relies upon our ability to cultivate and grow an active online
community, and our ability to successfully monetize such community through methods that include, without limitation, advertising revenue.
In addition, our continued growth depends, in part, on our ability to respond to constant changes in the industry, including rapid technological
evolution, continued shifts in user trends. Developing and integrating new content, products, services or infrastructure could be expensive
and time-consuming, and these efforts may not yield the benefits we expect to achieve at all. We cannot assure you that we will succeed
in any of these aspects or that the industry will continue to grow as rapidly as it has in the past.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Our success depends on our ability to develop
products and services to address the rapidly evolving market for the content creation and social media platform industry and, if we are
not able to implement successful enhancements and new features for our products and services, our business could be materially and adversely
affected.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We expect that new services and technologies applicable
to the content creation and social media platform industry in which we operate will continue to emerge and evolve. Rapid and significant
technological changes continue to confront the industries in which we operate, including developments in the social media platform and
content creation industry. Incorporating new technologies into our products and services may require substantial expenditures and take
considerable time, and we may not be successful in realizing a return on these development efforts in a timely manner or at all. There
can be no assurance that any new products or services we develop and offer to our customers will achieve significant commercial acceptance.
Our ability to develop new products and services may be inhibited by industry-wide standards, laws and regulations, resistance to change
from buyers or sellers, or third parties<FONT STYLE="font-family: Times New Roman, Times, Serif">&rsquo; </FONT>intellectual property
rights. Our success will depend on our ability to develop new technologies and to adapt to technological changes and evolving industry
standards. If we are unable to provide enhancements and new features for our products and services or to develop new products and services
that achieve market acceptance or that keep pace with rapid technological developments and evolving industry standards, our business would
be materially and adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The success of enhancements, new features, products
and services depends on several factors, including the timely completion, introduction and market acceptance of the enhancements or new
features or services. We often rely not only on our own initiatives and innovations, but also on third parties, including some of our
competitors, for the development of and access to new technologies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT>In addition,
because our products and services are designed to operate with a variety of systems, infrastructures and devices, we need to continuously
modify and enhance our products and services to keep pace with changes in mobile, software, communication and database technologies. We
may not be successful in either developing these modifications and enhancements or in bringing them to the market in a timely and cost-effective
manner. Any failure of our products and services to continue to operate effectively with third-party infrastructures and technologies
could reduce the demand for our products and services, result in dissatisfaction of our sellers or their customers, and materially and
adversely affect our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>As a creator and a distributor of digital
media content, we face liability and expenses for legal claims based on the nature and content of the materials that we create or distribute,
including materials provided by third parties. If we are required to pay damages or expenses in connection with these legal claims, our
business and results of operations may be harmed.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We display original content and&nbsp;third-party&nbsp;content&nbsp;on
our websites and in our marketing messages. As a result, we have faced and will continue to&nbsp;face potential liability based on a variety
of theories, including deceptive advertising and copyright or trademark infringement. We generally rely on&nbsp;the <FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;</FONT>fair
use&rdquo; exception for our use of third-party brand names and marks, but these third parties may disagree, and the laws governing the
fair use of these third-party materials are imprecise and adjudicated on a case-by-case basis. We also create content we believe to be
original for our websites.&nbsp;While we do not believe that this content&nbsp;infringes on any third-party copyrights or other intellectual
property rights, owners of competitive websites that present similar content have taken and may take the position that our content infringes
on their intellectual property rights.&nbsp;We are also exposed to the risk that content provided by third parties is inaccurate or misleading,
and for material posted to our websites by users and other third parties. These claims could divert management time and attention away
from our business and result in significant costs to investigate and defend, regardless of the merit of these claims. The general liability
insurance we maintain&nbsp;may not cover potential claims of this type or may not be adequate to indemnify us for all liability that may
be imposed. Any imposition of liability that is not covered by insurance, or is in excess of insurance coverage, could materially adversely
affect our business, financial condition and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Our dependence on third-party relationships
with content producers and distribution channels to develop and distribute entertainment content is critical to the success of the Faning
platform.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We rely on third party relationships with content
producers and distribution channels to develop and distribute entertainment content. Our financial performance may be adversely affected
by our relationships with content producers and distribution channels. Some of our content producers may have their own or other distribution
capabilities in the markets in which we operate. These&nbsp;third-party&nbsp;content&nbsp;producers and distribution channels may decide,
or be required by their respective parent companies, to use their intracompany distribution or content production capabilities rather
than posting such content with us. Our business may be harmed if the content producers and distribution channels with which we work stop
or reduce the amount of content they produce for us, or otherwise demand less favorable terms to us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Our decision not to provide products and
services and to restrict user access in China (including Hong Kong and Macau) will limit our total addressable market and may limit our
ability to grow our business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">China and Hong Kong could represent a large market
opportunity for our business. However, although we believe that such a decision may benefit our company in the long run, by choosing not
to provide products and services, and restricting user access in China (including Hong Kong and Macau), we are sacrificing potential business
opportunities that may negatively impact us. As a result, our total addressable market and potential growth may be limited and, as a result,
the market price of our common stock may significantly decrease or become worthless.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>If our content streaming initiatives are
unsuccessful, our business, financial condition or results of operations could be adversely affected.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Content streaming is intensely competitive and
cash intensive and there can be no assurance that our content creation initiatives will be profitable or otherwise successful. Our ability
to attract, engage and retain users within the Faning platform, as well as the corresponding advertising revenues they generate, will
depend on our ability to consistently provide appealing and differentiated content globally, effectively market our content and services
and provide a quality experience for selecting and viewing that content. Our success will require significant investments to produce original
content and acquire the rights to&nbsp;third-party&nbsp;content, as well as the establishment and maintenance of key content and distribution
partnerships.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We must continually add new users and meaningfully
engage with existing users to manage turnover, or <FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;</FONT>churn,&rdquo;
to grow our business. If we are unable to successfully compete with competitors in attracting, engaging with and retaining users as well
as creative talent, our business, financial condition or results of operations could be adversely affected. The relative service levels,
content offerings, promotions and pricing and related features of our competitors<FONT STYLE="font-family: Times New Roman, Times, Serif">&rsquo;
</FONT>services may adversely impact our ability to attract, engage and retain users. If consumers do not consider our platform to be
of value compared to our competitors<FONT STYLE="font-family: Times New Roman, Times, Serif">&rsquo; </FONT>platforms, including because
we fail to introduce attractive new content and features, do not maintain competitive pricing, terminate or modify promotional or trial
period offerings, experience technical issues, or change the mix of content in a manner that is unfavorably received, we may not be able
to attract, engage and retain users. If we are not able to attract new users, or our existing users decide to not continue using our services
for any reason, including a perception that they do not use our platform sufficiently, the need to cut household expenses, unsatisfactory
content, promotions or offers expire or are modified, competitive platforms provide a better value or experience or customer service or
technical issues are not satisfactorily resolved, our business, financial condition or results of operations could be adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>We are dependent on the continued services
and on the performance of key third party content contributors, the loss of which could adversely affect our business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We rely on content contributed by third party providers,
which has in turn attracted users that drive advertising revenue. The loss of the services of any of such key contributors could have
a material adverse effect on our business, operating results and financial condition. We also depend on our ability to identify, attract
and retain other highly skilled third-party content contributors. Competition for such contributors is intense, and there can be no assurance
that we will be able to successfully attract, assimilate or retain them. The loss or limitation of the services of any of our key third
party contributors, or the inability to attract and retain additional qualified key contributors, could have a material adverse effect
on our business, financial condition or results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Substantial and increasingly intense competition
in the social media platform and content creation industry may harm our business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We compete in markets characterized by vigorous
competition, changing technology, evolving industry standards and frequent introductions of new products and services. We expect competition
to intensify in the future as existing and new competitors introduce new services or enhance existing services. We compete against many
companies to attract customers, and some of these companies have greater financial resources and substantially larger bases of customers
than we do, which may provide them with significant competitive advantages. These companies may devote greater resources to the development,
promotion and sale of products and services, and they may introduce their own innovative products and services that adversely impact our
growth. Mergers and acquisitions by these companies may lead to even larger competitors with more resources. We also expect new entrants
to offer competitive products and services. If we are unable to differentiate ourselves from and successfully compete with our competitors,
our business will be materially and adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We may also face pressures from competitors for
user engagement and, in the future, advertising revenues. Some potential competitors are able to offer greater returns on content sales
to content creators for similar services by cross subsidizing their payments services through other services they offer. Such competition
may result in the need for us to alter the amount we charge creators in content-sales transactions and could reduce our gross profit.
In addition, as we grow, influential creators may demand more customized and favorable pricing from us, and competitive pressures may
require us to agree to such pricing, further reducing our gross profit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Systems failures, interruptions, delays in
service, catastrophic events and resulting interruptions in the availability of our products or services could harm our business and our
brand, and subject us to substantial liability.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our systems and those of our third-party data center
facilities may experience service interruptions, denial-of-service and other cyber-attacks, human error, earthquakes, hurricanes, floods,
fires, natural disasters, power losses, disruptions in telecommunications services, fraud, military or political conflicts, terrorist
attacks and other geopolitical unrest, computer viruses, or other events. Our systems are also subject to break-ins, sabotage, and acts
of vandalism. Some of our systems are not fully redundant, and our disaster-recovery planning is not sufficient for all eventualities.
In addition, as a provider of payments solutions, we are subject to increased scrutiny by regulators that may require specific business
continuity and disaster recovery plans and more rigorous testing of such plans. This increased scrutiny may be costly and time-consuming
and may divert our resources from other business priorities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We may, and are likely to, experience denial-of-service
attacks, system failures, and other events or conditions that interrupt the availability or reduce the speed or functionality of our products
and services. These events, should they occur, would likely result in loss of revenue. In addition, they could result in significant expense
to repair or replace damaged equipment and remedy resultant data loss or corruption. A prolonged interruption in the availability or reduction
in the speed or other functionality of our products or services could materially harm our reputation and business. Frequent or persistent
interruptions in our products and services could cause users to believe that our products and services are unreliable, leading them to
switch to our competitors or to avoid our products and services, and could permanently harm our reputation and business. Moreover, to
the extent that any system failure or similar event results in damages to customers or their businesses, these customers could seek compensation
from us for their losses, and those claims, even if unsuccessful, would likely be time-consuming and costly for us to address.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Our success depends largely on the continued
service and availability of key personnel.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Much of our future success depends on the continued
availability and service of key personnel, including Taehoon Kim, our Chief Executive Officer, and our executive team and other highly
skilled employees. Since the technology industry is characterized by high demand and intense competition for talent, we cannot assure
you that we will be able to attract or retain qualified staff or other highly skilled employees. In addition, as we are relatively young,
our ability to train and integrate new employees into our operations may not meet the growing demands of our business which may materially
and adversely affect our ability to grow our business and hence our results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>From time to time, we may become involved
in legal proceedings, claims, litigation and government investigations or inquiries.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">From time to time, we may become subject to legal
proceedings, claims, litigation and government investigations or inquiries, as noted in the next paragraph, which could be expensive,
lengthy, disruptive to normal business operations and occupy a significant amount of our employees<FONT STYLE="font-family: Times New Roman, Times, Serif">&rsquo;
</FONT>time and attention. In addition, the outcome of any legal proceedings, claims, litigation, investigations or inquiries may be difficult
to predict and could have a material adverse effect on our business, operating results or financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>We may be the subject of an administrative
fine by the Korean Securities and Futures Commission (the &ldquo;SFC&rdquo;) and any adverse outcome in the related proceedings could
negatively impact our business, financial condition and results of operations. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="color: windowtext">On November 6,
2024, the SFC imposed an administrative fine of KRW 142.1 million (or approximately $104,760) against us for alleged violations of Korean
securities regulations. On January 2, 2025, we filed with the SFC a formal objection to this regulatory sanction, but on March 7, 2025,
the SFC dismissed the objection. </FONT>On June 24, 2025, we filed an administrative appeal challenging the sanction, as we believe the
sanction is without merit and that we have adequate defenses. Under applicable Korean law, we are not required to pay the fine while the
appeal is pending, and we have not made any payment to date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There can be no assurance as to the outcome of
the pending appeal or any future proceedings. If we are unsuccessful in our challenge, we may be required to pay the fine and could face
ongoing increased scrutiny from Korean regulatory authorities. In addition, any adverse outcome could damage our reputation, distract
management and result in legal costs or other expenses, any of which could adversely affect our business, financial condition and results
of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>The preparation of our financial statements
involves the use of good faith estimates, judgments and assumptions, and our financial statements may be materially affected if such good
faith estimates, judgments or good faith assumptions prove to be inaccurate</I></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Financial statements prepared in accordance with
accounting principles generally accepted in the United&nbsp;States of America (&ldquo;GAAP&rdquo;) typically require the use of good faith
estimates, judgments and assumptions that affect the reported amounts. Often, different estimates, judgments and assumptions could reasonably
be used that would have a material effect on such financial statements, and changes in these estimates, judgments and assumptions may
occur from period to period over time. Significant areas of accounting requiring the application of management<FONT STYLE="font-family: Times New Roman, Times, Serif">&rsquo;</FONT>s
judgment include, but are not limited to, determining the fair value of assets, share-based compensation and the timing and amount of
cash flows from assets. These estimates, judgments and assumptions are inherently uncertain and, if our estimates were to prove to be
wrong, we would face the risk that charges to income or other financial statement changes or adjustments would be required. Any such charges
or changes would require a restatement of our financial statements and could harm our business, including our financial condition and
results of operations and the price of our securities. See <FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;</FONT>Management<FONT STYLE="font-family: Times New Roman, Times, Serif">&rsquo;</FONT>s
Discussion and Analysis of Financial Condition and Results of Operations&rdquo; in our Annual Report on Form 10-K for the year ended December
31, 2024 for a discussion of the accounting estimates, judgments and assumptions that we believe are the most critical to an understanding
of our financial statements and our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>We currently have ineffective internal control
over financial reporting as evidenced by the restatement of the 2022 financial statements.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Management has identified control deficiencies
regarding inadequate accounting resources, the lack of segregation of duties and the need for a stronger internal control environment,
as further evidenced by the restatement of our 2022 financial statements. We have historically outsourced our accounting to small firms
and also replaced our accounting firm with another small firm, the transition of which has caused a lack of continuity and loss of efficiency
in the preparation of our financial statements. We intend to remediate this weakness by hiring more permanent, qualified and experienced
accounting personnel at our company and/or hire a larger accounting firm with more resources and expertise. If our remediation measures
are insufficient to address the deficiencies in our internal control over financial reporting, we may not detect errors in a timely manner,
our financial statements could be misstated, we could face a loss of confidence by stakeholders, or we could be subject to regulatory
scrutiny, sanctions or litigation, any of which could harm our business, financial condition, results of operations, or the market price
of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Risks Related to This Offering</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">We are currently in compliance with the continued listing
requirements of The Nasdaq Capital Market but have a history of non-compliance and should we fail to maintain compliance with the continued
listing requirements of Nasdaq, Nasdaq may delist our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are required to comply with Nasdaq continued
listing requirements, including a minimum bid price for our common stock and timely filing requirements of all required periodic reports
with the SEC. If we fail in the future to maintain compliance with any of those requirements, our common stock could be delisted from
Nasdaq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> On February 5, 2024, we received a delinquency
compliance alert notice from Nasdaq stating that we were not in compliance with the minimum bid price requirement for continued listing
on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2), because the closing bid price of our common stock had been
below $1.00 for the previous 30 consecutive business days. To regain compliance with the minimum bid price requirement, our common stock
was required to maintain a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days during the 180
calendar-day period from February 5, 2024 to August 4, 2024, which was subsequently extended to February 3, 2025. Subsequently, on February
5, 2025, we received a determination letter from the Nasdaq staff stating that we were subject to delisting for failing to meet the minimum
bid price requirement under Nasdaq Listing Rule 5550(a)(2). In order to resolve the deficiency, we implemented a reverse stock split
on January 27, 2025. Following the reverse split, the closing bid price of our common stock met or exceeded $1.00 for ten consecutive
business days and, on February 10, 2025, we received a notice from Nasdaq confirming that we had regained compliance with the minimum
bid price requirement and that the matter was closed. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On April 18, 2024, we received a delinquency compliance
alert notice from Listing Qualifications Department of The Nasdaq Stock Market LLC advising us that due to our failure to timely file
our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, with the SEC, we are not in compliance with Nasdaq&rsquo;s
continued listing requirements under Nasdaq Listing Rule 5250(c)(1), which requires the timely filing of all required periodic reports
with the SEC. Nasdaq requested that we submit a plan to address the noncompliance issue by June&nbsp; 17, 2024. We submitted the plan
on June 14, 2024. Subsequently, on July 16, 2024, we filed our Annual Report on Form 10-K for the year ended December 31, 2023, thereby
resolving the basis for delisting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On May 21, 2024, we received a delinquency compliance
alert notice from Nasdaq. The notice stated that we were not in compliance with Nasdaq&rsquo;s continued listing requirements under Nasdaq
Listing Rule 5250(c)(1), as we had failed to timely file our Quarterly Report on Form 10-Q for the period ended March 31, 2024, and remained
delinquent in filing our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, with the SEC. Subsequently, we filed
our Quarterly Report on Form 10-Q for the first quarter on September 30, 2024, thereby resolving the basis for delisting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On August 20, 2024, we received a delinquency compliance
alert notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC. The notice stated that we were not in compliance
with Nasdaq&rsquo;s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) because we failed to timely file our Quarterly
Report on Form 10-Q for the period ended June 30, 2024, with the SEC. Subsequently, we filed the Form 10-Q for the second quarter on October
15, 2024, thereby resolving the basis for delisting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On April 24, 2025, we received written notice from
the Listing Qualifications Department of Nasdaq notifying us that we did not timely file our Annual Report on Form 10-K for the year ended
December 31, 2024, as required for continued listing on The Nasdaq Stock Market pursuant to Nasdaq Listing Rule 5250(c)(1).&nbsp;On April
30, 2025, we received written notice from Nasdaq notifying us that, based on the April 30, 2025 filing of the 2024 Form 10-K, we are in
compliance with Nasdaq rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If, for any reason, Nasdaq should delist
our common stock from trading on its exchange and we are unable to obtain listing on another national securities exchange or take action
to restore our compliance with the Nasdaq continued listing requirements, a reduction in some or all of the following may occur, each
of which could have a material adverse effect on our stockholders:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the liquidity of our common stock;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the market price of our common stock;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>we will become a &ldquo;penny stock,&rdquo; which will make trading of our common stock much more difficult;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>our ability to obtain financing for the continuation of our operations;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the number of institutional and general investors that will consider investing in our common stock;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the number of investors in general that will consider investing in our common stock;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the number of market makers in our common stock;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the availability of information concerning the trading prices and volume of our common stock; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the number of broker-dealers willing to execute trades in shares of our common stock.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The delisting of our common stock from Nasdaq may
make it more difficult for us to raise capital on favorable terms in the future. Such a delisting would likely have a negative effect
on the price of our common stock and would impair your ability to sell or purchase our common stock when you wish to do so. Further, if
our common stock were to be delisted from Nasdaq, it would cease to be recognized as covered securities and we would be subject to regulation
in each state in which we offer our securities. Moreover, there is no assurance that any action that we take to restore our compliance
with the minimum bid price requirement would stabilize the market price or improve the liquidity of our common stock, prevent our common
stock from falling below the minimum bid price required for continued listing again, or prevent future non-compliance with Nasdaq&rsquo;s
listing requirements.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">Management will have broad discretion as to the use of
the proceeds from this offering, and we may not use the proceeds effectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our management will have broad discretion in the
application of the net proceeds from this offering, including for any of the purposes described in the section entitled &ldquo;Use of
Proceeds,&rdquo; and could spend the proceeds in ways that do not improve our results of operations or enhance the value of our common
stock. Our failure to apply these funds effectively could have a material adverse effect on our business and cause the price of our common
stock to decline.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">You will experience immediate and substantial dilution
in the net tangible book value per share of the common stock you purchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Based on an assumed combined public offering
price of $2.22 per share and accompanying Common Warrant (the last reported sales price of our common stock on Nasdaq on August 15, 2025),
if you purchase shares of our common stock and related warrants in this offering, you will suffer immediate and substantial dilution
of $1.27 per share with respect to the net tangible book value of the common stock. See the section entitled &ldquo;Dilution&rdquo; below
for a more detailed discussion of the dilution you will incur if you purchase common stock in this offering. </P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">You may experience future dilution as a result of future
equity offerings and other issuances of our common stock or other securities. In addition, this offering and future equity offerings and
other issuances of our common stock or other securities may adversely affect our common stock price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> In order to raise additional capital, we may
in the future offer additional shares of our common stock or other securities convertible into or exchangeable for our common stock at
prices that may not be the same as the price per share in this offering. We may not be able to sell shares or other securities in any
other offering at a price per share that is equal to or greater than the price per share paid by investors in this offering, and investors
purchasing shares or other securities in the future could have rights superior to existing stockholders. The price per share at which
we sell additional shares of our common stock or securities convertible into common stock in future transactions may be higher or lower
than the price per share in this offering. The Common Warrants being issued in this offering contain a full ratchet anti-dilution adjustment
which, subject to limited circumstances, would reduce the exercise price of the Common Warrants in the event that we in the future issue
common stock, or securities convertible into or exercisable to purchase common stock, at a price per share lower than the exercise price
then in effect. You will incur dilution upon exercise of any outstanding stock options, warrants or upon the issuance of shares of common
stock under our Omnibus Equity Incentive Plan. In addition, the sale of shares in this offering and any future sales of a substantial
number of shares of our common stock in the public market, or the perception that such sales may occur, could adversely affect the price
of our common stock. We cannot predict the effect, if any, that market sales of those shares of common stock or the availability of those
shares of common stock for sale will have on the market price of our common stock. </P>
<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">There is no public market for the Pre-Funded Warrants and
Common Warrants being offered in this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There is no established public trading market for
the Pre-Funded Warrants and Common Warrants being offered in this offering, and we do not expect a market to develop. In addition, we
do not intend to apply to list the Pre-Funded Warrants and Common Warrants on any securities exchange or nationally recognized trading
system. Without an active market, the liquidity of the Pre-Funded Warrants and Common Warrants will be limited.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">Holders of our Pre-Funded Warrants and Common Warrants
will have no rights as common stockholders until they acquire our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Until you acquire shares of common stock upon
exercise of your Pre-Funded Warrants or Common Warrants, you will have no rights with respect to the shares of common stock issuable
upon exercise of your Pre-Funded Warrants or Common Warrants. Upon exercise of your Pre-Funded Warrants or the Common Warrants, you will
be entitled to exercise the rights of a holder of shares only as to matters for which the record date occurs after the exercise date. </P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">The Pre-Funded Warrants and the Common Warrants are speculative
in nature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The Pre-Funded Warrants and Common Warrants
offered hereby do not confer any rights of common stock ownership on their holders, such as voting rights or the right to receive dividends,
but rather merely represent the right to acquire shares of common stock at a fixed price. Specifically, commencing on the date of issuance,
holders of the Pre-Funded Warrants may acquire the common stock issuable upon exercise of such warrants at an exercise price of $0.0001
per share and holders of the Common Warrants may acquire the common stock issuable upon exercise of such warrants at an exercise price
per share equal to the combined public offering price per share and accompanying Common Warrant in this offering (subject to potential
full ratchet anti-dilution adjustment as a result of a stock issuance or sale at a price less than the exercise price in effect, as provided
in the Common Warrant). Moreover, following this offering, the market value of the Pre-Funded Warrants and the Common Warrants is uncertain,
and there can be no assurance that the market value of the Pre-Funded Warrants or the Common Warrants will equal or exceed their public
offering price. </P>
<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">The Common Warrants may not have any value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Common Warrant has an exercise price per share
equal to the combined public offering price per share of common stock and accompanying Common Warrant in this offering (subject to potential
full ratchet anti-dilution adjustment as a result of a stock issuance or sale at a price less than the exercise price in effect, as provided
in the Common Warrant) and expires on the fifth anniversary of its original issuance date. In the event the market price per share of
common stock does not exceed the exercise price of the Common Warrants during the period when the Common Warrants are exercisable, the
Common Warrants may not have any value.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">This is a reasonable best efforts offering, in which no
minimum number or dollar amount of securities is required to be sold, and we may not raise the amount of capital we believe is required
for our business plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Placement Agent has agreed to use its reasonable
best efforts to solicit offers to purchase the securities in this offering. The Placement Agent has no obligation to buy any of the securities
from us or to arrange for the purchase or sale of any specific number or dollar amount of the securities. There is no required minimum
number of securities that must be sold as a condition to completion of this offering. Because there is no minimum offering amount required
as a condition to the closing of this offering, the actual offering amount, placement agent fees and proceeds to us are not presently
determinable and may be substantially less than the maximum amounts set forth herein. We may sell fewer than all of the securities offered
hereby, which may significantly reduce the amount of proceeds received by us, and investors in this offering will not receive a refund
in the event that we do not sell an amount of securities sufficient to support our operations. Thus, we may not raise the amount of capital
we believe is required for our operations in the short term and may need to raise additional funds to complete such short-term operations.
Such additional fundraises may not be available or available on terms acceptable to us.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">Certain provisions of the Pre-Funded Warrants and Common
Warrants could discourage an acquisition of us by a third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Certain provisions of the Pre-Funded Warrants and
Common Warrants could make it more difficult or expensive for a third party to acquire us. The Pre-Funded Warrants and Common Warrants
prohibit us from engaging in certain transactions constituting &ldquo;fundamental transactions&rdquo; unless, among other things, the
surviving entity assumes our obligations under the Pre-Funded Warrants and Common Warrants. Further, the Common Warrants provide that,
in the event of certain transactions constituting &ldquo;fundamental transactions,&rdquo; with some exception, holders of such warrants
will have the right, at their option, to require us to repurchase such Common Stock Warrants at a price described in such warrants. These
and other provisions of the Pre-Funded Warrants and Common Warrants could prevent or deter a third party from acquiring us even where
the acquisition could be beneficial to you.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"> <B><I>Purchasers who purchase our securities
in this offering pursuant to a securities purchase agreement may have rights not available to purchasers that purchase without the benefit
of a securities purchase agreement.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> In addition to rights and remedies available
to all purchasers in this offering under U.S. federal securities and state law, the purchasers that enter into a securities purchase
agreement will also be able to bring claims of breach of contract against us. The ability to pursue a claim for breach of contract provides
those investors with the means to enforce the covenants uniquely available to them under the securities purchase agreement including:
(i) timely delivery of shares; (ii) agreement to not enter into variable rate financings for 180 days from closing, subject to certain
exceptions; (iii) agreement to not enter into any equity sales for 180 days from closing, unless the Placement Agent provides its prior
written consent; and (iv) indemnification for breach of contract. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"> <B><I>Significant holders or beneficial holders
of our common stock may not be permitted to exercise Pre-Funded Warrants that they hold.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> A holder of a Pre-Funded Warrant will not be
entitled to exercise any portion of any Pre-Funded Warrants which, upon giving effect to such exercise, would cause the aggregate number
of shares of our common stock beneficially owned by the holder (together with its affiliates) to exceed 4.99% (or, at the election of
the purchaser, 9.99%) of the number of shares of our common stock outstanding immediately after giving effect to the exercise. Such percentage
may be increased or decreased by written notice by the holder of the Pre-Funded Warrants to any other percentage not in excess of 9.99%.
Such increase or decrease will not be effective until the 61st day after such notice is delivered to us. As a result, you may not be
able to exercise your Pre-Funded Warrants for shares of our common stock at a time when it would be financially beneficial for you to
do so. In such circumstances, you could seek to sell your Pre-Funded Warrants to realize value, but you may be unable to do so in the
absence of an established trading market for the Pre-Funded Warrants. </P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="glo_005"></A>CAUTIONARY NOTE
REGARDING FORWARD-LOOKING STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The information in this prospectus and the documents
incorporated by reference herein and any free writing prospectus that we have authorized for use in connection with this offering contain
forward-looking statements and information within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act,
which are subject to the &ldquo;safe harbor&rdquo; created by those sections. These forward-looking statements include, but are not limited
to, statements regarding our future results of operations and financial position, business strategy, prospective platform enhancements,
features, products and services, their expected performance and likelihood of success, plans and objectives of management for future operations
and future results of anticipated platform developments. These statements involve known and unknown risks, uncertainties and other important
factors that may cause our actual results, performance or achievements to be materially different from any future results, performance
or achievements expressed or implied by the forward-looking statements. In some cases, you can identify forward-looking statements by
terms such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;expect,&rdquo; &ldquo;plan,&rdquo; &ldquo;anticipate,&rdquo;
&ldquo;could,&rdquo; &ldquo;intend,&rdquo; &ldquo;target,&rdquo; &ldquo;project,&rdquo; &ldquo;contemplate,&rdquo; &ldquo;believe,&rdquo;
&ldquo;estimate,&rdquo; &ldquo;forecast,&rdquo; &ldquo;predict,&rdquo; &ldquo;potential&rdquo; or &ldquo;continue&rdquo; or the negative
of these terms or other similar expressions. These risks and uncertainties include, among other things, the risk that we may not be able
to successfully implement our growth strategy due to the following reasons:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>overall strength and stability of general economic conditions and of the social media platform and content creation industry in the
United States and globally;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>our ability to continue as a going concern;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the accuracy of our estimates regarding expenses, future revenue, capital requirements and needs for additional financing;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>changes in consumer demand for, and acceptance of, our services, including our platform, as well as social media platforms in general;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>changes in the competitive environment, including adoption of technologies, services and products that compete with our own;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>our expectations regarding our future operating and financial performance;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the accuracy of our estimates regarding expenses, future revenue, capital requirements, and needs for additional financing;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>our ability to continue as a going concern;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>our ability to effectively execute our business plan and continue to expand internationally;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>our ability to recruit, retain and motivate skilled personnel, including key members of senior management;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>changes in the price of equipment, network infrastructure, hosting and maintenance;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>uncertainties around the successful improvement and modification of our existing applications and development of new products and
services, which may require significant expenditures and time;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>changes in laws or regulations governing our business and operations;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>our ability to maintain adequate liquidity and financing sources and an appropriate level of debt on terms favorable to us;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>our ability to effectively market our services;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>costs and risks associated with legal proceedings, claims, litigation and government investigations or inquiries brought against us;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>our ability to obtain and protect our existing intellectual property protections, including trademarks and copyrights;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>changes in accounting principles, or their application or interpretation, and our ability to make estimates and the assumptions underlying
the estimates, which could have an effect on earnings;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>our ability to maintain the listing of our shares on The Nasdaq Capital Market or any other exchange; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>other risks described from time to time in periodic and current reports that we file with the SEC.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As more fully described under the heading &ldquo;Risk
Factors&rdquo; and elsewhere in this prospectus and under &ldquo;Risk Factors&rdquo; in our Annual Report on Form 10-K for the year ended
December 31, 2024 and any additional documents incorporated by reference herein and any free writing prospectus, many important factors
affect our ability to achieve our stated objectives and to develop our Faning platform. We may not actually achieve the plans, intentions
or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements.
These forward-looking statements involve risks and uncertainties that could cause our actual results to differ materially from those in
the forward-looking statements, including, without limitation, the risks and uncertainties set forth in our filings with the SEC and incorporated
by reference herein. You should read this prospectus and the documents incorporated by reference herein and any free writing prospectuses
that we have authorized for use in this offering with the understanding that our actual results or events could differ materially from
the plans, intentions and expectations disclosed in the forward-looking statements that we make. The forward-looking statements are applicable
only as of the date on which they are made, and we do not assume any obligation to update any forward-looking statements, whether as a
result of new information, future events or otherwise, except as required by U.S. federal securities law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You should read this prospectus and the documents
that we incorporate by reference in this prospectus and have filed as exhibits to the registration statement of which this prospectus
is a part completely and with the understanding that our actual future results may be materially different from what we expect. We qualify
all of our forward-looking statements by these cautionary statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="glo_006"></A>USE OF PROCEEDS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We estimate that the net proceeds from this
offering will be approximately $4.5 million, assuming the number of shares of common stock and Pre-Funded Warrants offered by us, as
set forth on the cover page of this prospectus, remains the same, assuming no exercise of the Common Warrants issued in connection with
this offering, and after deducting placement agent fees and estimated offering expenses payable to us. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> However, this is a reasonable best efforts
offering with no minimum number of securities or amount of proceeds as a condition to closing, and we may not sell all or any of the
securities offered pursuant to this prospectus; and, as a result, we may receive significantly less in net proceeds in this offering.
For example, if we sell only 10%, 25%, 50% or 75% of the maximum amount offered, our net proceeds will be approximately $0.3 million,
$1.0 million, $2.2 million or $3.3 million, respectively. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We intend to use the net proceeds from the offering
for working capital and general corporate purposes, including investing in our sales and marketing efforts. As of the date of this prospectus,
we cannot specify with certainty all of the particular uses for the net proceeds from this offering. The amounts and timing of our actual
expenditures will depend on numerous factors, including factors described under &ldquo;Risk Factors&rdquo; in this prospectus and the
documents incorporated by reference herein. Pending our use of the net proceeds from this offering, we intend to invest the net proceeds
in a variety of capital preservation investments, including short-term, investment-grade, interest-bearing instruments and U.S. government
securities.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="glo_007"></A>MARKET PRICE OF
OUR COMMON STOCK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Our
                                            common stock trades on The Nasdaq Capital Market under the symbol &ldquo;GITS.&rdquo; On
                                            August 15, 2025, the last reported sale price of our common stock on Nasdaq was $2.22 per
                                            share. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> As of August 15, 2025, there were approximately
60 holders of record of our common stock. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"> <B><A NAME="tc_001"></A>DIVIDEND INFORMATION</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We have never paid cash dividends on our common
stock and do not anticipate doing so in the foreseeable future. The payment of dividends on our common stock will depend on earnings,
financial condition and other business and economic factors affecting us at such time as our Board may consider relevant. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="glo_008"></A>DILUTION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If you invest in our securities in this offering,
assuming no sale of any Pre-Funded Warrants and no exercise of the Common Warrants issued in connection with this offering, your ownership
interest will be immediately diluted to the extent of the difference between the assumed combined public offering price per share of our
common stock and accompanying Common Warrant and the as adjusted net tangible book value per share of our common stock immediately after
this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The net tangible book value of our common stock
as of June 30, 2025, was approximately $971,685, or approximately $0.27 per share of common stock based on 3,548,825 shares of common
stock outstanding at that time. &ldquo;Net tangible book value&rdquo; is the amount of our total tangible assets minus our total liabilities.
&ldquo;Net tangible book value per share&rdquo; is net tangible book value divided by the total number of shares outstanding as of June
30, 2025. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> After giving effect to the sale of shares of
common stock in this offering at an assumed combined public offering price of $2.22 per share and accompanying Common Warrant (the last
reported sale price of our common stock on Nasdaq on August 15, 2025), assuming no sale of any Pre-Funded Warrants and no exercise of
the Common Warrants issued in connection with this offering, and after deducting placement agent fees and estimated offering expenses
payable by us, our as adjusted net tangible book value as of June 30, 2025 would have been approximately $5,486,985, or approximately
$0.95 per share of common stock. This amount represents an immediate increase in as adjusted net tangible book value of $0.68 per share
to our existing stockholders and an immediate dilution of $1.27 per share to investors participating in this offering, as illustrated
by the following table: </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; text-indent: -0.125in; padding-left: 0.125in"> Assumed combined public offering price
    per share and accompanying Common Warrant </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"></TD><TD STYLE="width: 9%; text-align: right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%"></TD>
    <TD STYLE="width: 1%; text-align: left"> $ </TD><TD STYLE="width: 9%; text-align: right"> 2.22 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> Net tangible book value per share of common stock as of June&nbsp;30, 2025 </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> 0.27 </P></TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"></P></TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> As adjusted net tangible book value per share after this offering </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> 0.95&nbsp; </P></TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> Dilution per share to new investors purchasing shares in this offering </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> 1.27&nbsp; </P></TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Each $1.00 increase or decrease in the assumed
combined public offering price of $2.22 per share and accompanying Common Warrant, which was the last reported sale price of our common
stock on Nasdaq on August 15, 2025, would increase or decrease the as adjusted net tangible book value per share by $0.39 per share and
the dilution per share to investors participating in this offering by $0.61 per share, assuming that the number of shares offered by
us, as set forth on the cover page of this prospectus, remains the same, assuming no sale of any Pre-Funded Warrants and no exercise
of the Common Warrants issued in connection with this offering, and after deducting placement agent fees and estimated offering expenses
payable by us. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We may also increase or decrease the number
of shares we are offering. A 100,000 share increase in the number of shares offered by us, as set forth on the cover page of this prospectus,
would increase the as adjusted net tangible book value per share by approximately $0.04 and decrease the dilution per share to new investors
participating in this offering by approximately $0.04, based on an assumed combined public offering price of $2.22 per share and accompanying
Common Warrant, which was the last reported sale price of our common stock on Nasdaq on August 15, 2025, remaining the same, assuming
no sale of any Pre-Funded Warrants and no exercise of the Common Warrants issued in connection with this offering, and after deducting
placement agent fees and estimated offering expenses payable by us. Similarly, a 100,000 share decrease in the number of shares offered
by us, as set forth on the cover page of this prospectus, would decrease the as adjusted net tangible book value per share by approximately
$0.04 and increase the dilution per share to new investors participating in this offering by approximately $0.04, based on an assumed
combined public offering price of $2.22 per share and accompanying Common Warrant, which was the last reported sale price of our common
stock on Nasdaq on August 15, 2025, remaining the same, assuming no sale of any Pre-Funded Warrants and no exercise of the Common Warrants
issued in connection with this offering, and after deducting placement agent fees and estimated offering expenses payable by us. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The information above is based on 3,548,825
shares of our common stock outstanding as of June 30, 2025, and excludes as of such date (unless otherwise indicated), the following: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"> &nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> &#9679; </TD><TD> 332,505 shares of common stock issuable upon the exercise
                                            of warrants issued in connection with the Debt-to-Equity Conversion; and </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> &#9679; </TD><TD> an aggregate of 1,500,000 shares of common stock reserved
                                            for future issuance under our 2022 Omnibus Equity Incentive Plan as of June 30, 2025. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">To the extent that outstanding exercisable options
or warrants are exercised, you may experience further dilution. In addition, we may need to raise additional capital and to the extent
that we raise additional capital by issuing equity or convertible debt securities your ownership will be further diluted. The information
discussed above is illustrative only and will adjust based on the actual public offering price and other terms of this offering determined
at pricing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="glo_009"></A>CAPITALIZATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The following table sets forth our cash and
cash equivalents, as well as our capitalization, as of June 30, 2025, as follows: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> &#9679; </TD><TD> on an actual basis; and </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> &#9679; </TD><TD> on an as adjusted basis to give effect to the sale by us of
                                            2,252,252 shares of our common stock in this offering at the assumed public offering price of $2.22
                                            per share of common stock and accompanying Common Warrant (assuming no sale of any Pre-Funded
                                            Warrants and no exercise of the Common Warrants being sold in this offering), and after deducting
                                            placement agent fees and estimated offering expenses payable by us. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You should consider this table in conjunction with
&ldquo;Use of Proceeds&rdquo; above, as well as our &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results
of Operations&rdquo; and our consolidated audited and unaudited financial statements and the notes to those financial statements incorporated
by reference into this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> As of June&nbsp;30, 2025 </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Actual </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> As Adjusted for this Offering </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD COLSPAN="6"> &nbsp; </TD><TD> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"> Cash and cash equivalents </TD><TD STYLE="width: 1%; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; width: 1%; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; width: 9%; text-align: right"> 10,883 </TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; width: 1%; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; width: 9%; text-align: right"> 4,526,183 </TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in"> Stockholders&rsquo; deficit: </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in"> Common Stock, 100,000,000 shares authorized; 3,548,825 shares issued and
    outstanding as of June&nbsp;30, 2025, actual; 5,798,825 shares issued and outstanding as of June&nbsp;30, 2025, as adjusted </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 70,977 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 116,022 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in"> Additional paid-in capital </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 45,071,398 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 49,541,653 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in"> Accumulated deficit </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> (39,146,031 </TD><TD STYLE="text-align: left"> ) </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> (39,146,031 </TD><TD STYLE="text-align: left"> ) </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.25in"> Accumulated other comprehensive
    loss </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> (206,302 </TD><TD STYLE="text-align: left"> ) </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> (206,302 </TD><TD STYLE="text-align: left"> ) </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.25in"> Total stockholders&rsquo; equity </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 5,790,042 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 10,305,342 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"> Total capitalization </TD><TD STYLE="padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"> 5,790,042 </TD><TD STYLE="padding-bottom: 4pt; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"> 10,305,342 </TD><TD STYLE="padding-bottom: 4pt; text-align: left"> &nbsp; </TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The information above is based on 3,548,825
shares of our common stock outstanding as of June 30, 2025, and excludes as of such date (unless otherwise indicated), the following: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> &#9679; </TD><TD> 332,505 shares of common stock issuable upon the exercise
                                            of warrants issued in connection with the Debt-to-Equity Conversion; and </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"> &#9679; </TD><TD> an aggregate of 1,500,000 shares of common stock reserved
                                            for future issuance under our 2022 Omnibus Equity Incentive Plan as of June 30, 2025. </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We may also increase or decrease the number
of shares we are offering. A 100,000 share increase in the number of shares offered by us, as set forth on the cover page of this prospectus,
would increase the as adjusted total capitalization by approximately $222,000, based on an assumed combined public offering price of
$2.22 per share and accompanying Common Warrant, which was the last reported sale price of our common stock on Nasdaq on August 15, 2025,
remaining the same, assuming no sale of any Pre-Funded Warrants and no exercise of the Common Warrants issued in connection with this
offering, no change in the estimated valuation of the Common Warrants liabilities, and after deducting placement agent fees and estimated
offering expenses payable by us. Similarly, a 100,000 share decrease in the number of shares offered by us, as set forth on the cover
page of this prospectus, would decrease the as adjusted total capitalization by approximately $222,000, based on an assumed combined
public offering price of $2.22 per share and accompanying Common Warrant, which was the last reported sale price of our common stock
on Nasdaq on August 15, 2025, remaining the same, assuming no sale of any Pre-Funded Warrants and no exercise of the Common Warrants
issued in connection with this offering, no change in the estimated valuation of the Common Warrants liabilities, and after deducting
placement agent fees and estimated offering expenses payable by us. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The information discussed above is illustrative
only and will adjust based on the actual public offering price and other terms of this offering determined at pricing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="glo_010"></A>DESCRIPTION OF
CAPITAL STOCK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The following description of our capital stock
is not complete and may not contain all the information you should consider before investing in our capital stock. This description is
summarized from, and qualified in its entirety by reference to, our certificate of incorporation, which has been publicly filed with
the SEC. See &ldquo;Where You Can Find More Information&rdquo; and &ldquo;Incorporation of Certain Information by Reference.&rdquo; </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our authorized capital stock consists of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>100,000,000 shares of common stock, $0.001 par value; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>10,000,000 shares of preferred stock, $0.001 par value.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Our certificate of incorporation currently
authorizes 100,000,000&nbsp;shares of common stock, par value $0.001 per share, for issuance. As of August&nbsp;15, 2025, there were
3,548,825 shares of our common stock issued and outstanding, which were held by approximately 60 stockholders of record, and 1,500,000&nbsp;shares
of common stock authorized and available for issuance pursuant to our 2022 Omnibus Equity Incentive Plan. Each holder of common stock
is entitled to one vote for each share of common stock held on all matters submitted to a vote of the stockholders, including the election
of directors. Our certificate of incorporation and bylaws do not and will not provide for cumulative voting rights. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Holders of our common stock have no preemptive,
conversion or subscription rights, and there are no redemption or sinking fund provisions applicable to the common stock. The rights,
preferences and privileges of the holders of common stock are subject to, and may be adversely affected by, the rights of the holders
of shares of any series of our preferred stock that we may designate and issue in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>Preferred Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under our certificate of incorporation, our Board
of Directors has the authority, without further action by our stockholders, to issue up to 10,000,000&nbsp;shares of preferred stock,
par value $0.001 per share, in one or more series and to fix the voting powers, designations, preferences and the relative participating,
optional or other special rights and qualifications, limitations and restrictions of each series, including, without limitation, dividend
rights, dividend rates, conversion rights, voting rights, terms of redemption, liquidation preferences and the number of shares constituting
any series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> As of August 15, 2025, no shares of our authorized
preferred stock are outstanding. Because our Board of Directors has the power to establish the preferences and rights of the shares of
any additional series of preferred stock, it may afford holders of any preferred stock preferences, powers and rights, including voting
and dividend rights, senior to the rights of holders of our common stock, which could adversely affect the holders of the common stock
and could delay, discourage or prevent a takeover of us even if a change of control of our company would be beneficial to the interests
of our stockholders. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> As of August 15, 2025, warrants to purchase
a total of 332,505&nbsp;shares of common stock were outstanding, consisting of 250,766 shares at an exercise price of $1.42 per share
and 81,739 shares at an exercise price of $1.29 per share, all exercisable through May 7, 2030. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B></B></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>Anti-Takeover Matters</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B><I>Charter and Bylaw Provisions</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The provisions of Delaware law, our certificate
of incorporation and our bylaws include a number of provisions that may have the effect of delaying, deferring or discouraging another
person from acquiring control of our company and discouraging takeover bids. These provisions may also have the effect of encouraging
persons considering unsolicited tender offers or other unilateral takeover proposals to negotiate with our Board rather than pursue non-
negotiated takeover attempts. These provisions include the items described below.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B><I>Board Composition and Filling Vacancies</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our bylaws provide that any vacancy on our Board
may only be filled by the affirmative vote of a majority of our directors then in office, even if less than a quorum. Further, any directorship
vacancy resulting from an increase in the size of our Board of Directors, may be filled by election of the Board of Directors, but only
for a term continuing until the next election of directors by our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B><I>No Cumulative Voting</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Delaware General Corporation Law (DGCL) provides
that stockholders are not entitled to the right to cumulate votes in the election of directors unless certificate of incorporation of
the company in which they own stock provides otherwise. Neither our certificate of incorporation nor our bylaws provide that our stockholders
shall be entitled to cumulative voting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B><I>Delaware&nbsp;Anti-Takeover&nbsp;Statute</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are subject to the provisions of Section&nbsp;203
of the DGCL.&nbsp;In general, Section&nbsp;203 prohibits persons deemed to be &ldquo;interested stockholders&rdquo; from engaging in a
&ldquo;business combination&rdquo; with a publicly held Delaware corporation for three&nbsp;years following the date these persons become
interested stockholders unless the business combination is, or the transaction in which the person became an interested stockholder was,
approved in a prescribed manner or another prescribed exception applies. Generally, an &ldquo;interested stockholder&rdquo; is a person
who, together with affiliates and associates, owns, or within three&nbsp;years prior to the determination of interested stockholder status
did own, 15% or more of a corporation&rsquo;s voting stock. Generally, a &ldquo;business combination&rdquo; includes a merger, asset or
stock sale, or other transaction resulting in a financial benefit to the interested stockholder. The existence of this provision may have
an anti-takeover&nbsp;effect with respect to transactions not approved in advance by the Board. A Delaware corporation may &ldquo;opt
out&rdquo; of these provisions with an express provision in its original certificate of incorporation or an express provision in its certificate
of incorporation or bylaws resulting from an amendment approved by at least a majority of the outstanding voting shares. We have not opted
out of these provisions. As a result, mergers or other takeover or change in control attempts of us may be discouraged or prevented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><B><I>Choice of Forum</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our bylaws provide that Delaware will be the exclusive
forum for any derivative action or proceeding brought on our behalf; any action asserting a breach of fiduciary duty; any action asserting
a claim against us arising pursuant to the DGCL, our certificate of incorporation or our bylaws; or any action asserting a claim against
us that is governed by the internal affairs doctrine. Such exclusive forum provision does not apply to suits brought to enforce any liability
or duty created by the Securities Act&nbsp;of&nbsp;1933, as amended, or the Securities Exchange&nbsp;Act&nbsp;of&nbsp;1934, as amended.
The enforceability of similar choice of forum provisions in other companies&rsquo; certificates of incorporation has been challenged in
legal proceedings, and it is possible that a court could find these types of provisions to be inapplicable or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>Listing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our common stock trades on The Nasdaq Capital Market
under the symbol &ldquo;GITS.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>Transfer Agent and Registrar</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our transfer agent is Colonial Stock Transfer whose
address is 66 Exchange Place, Suite 100, Salt Lake City, Utah 84111 and its telephone number is (801)&nbsp;355-5740.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="glo_011"></A>DESCRIPTION OF
SECURITIES WE ARE OFFERING</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The material terms and provisions of our common
stock are described in the section titled, &ldquo;Description of Capital Stock&rdquo; in this prospectus.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pre-Funded Warrants</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>The following summary of certain terms and provisions
of Pre-Funded Warrants that are being offered hereby is not complete and is subject to, and qualified in its entirety by, the provisions
of the Pre-Funded Warrant, the form of which is filed as an exhibit to the registration statement of which this prospectus forms a part.
Prospective investors should carefully review the terms and provisions of the form of Pre-Funded Warrant for a complete description of
the terms and conditions of the Pre-Funded Warrants.</I></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Duration and Exercise Price</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Each Pre-Funded Warrant offered hereby will
have an assumed initial exercise price of $0.0001 per share. The Pre-Funded Warrants will be immediately exercisable and may be exercised
at any time until the Pre-Funded Warrants are exercised in full. The exercise price and number of shares of common stock issuable upon
exercise is subject to appropriate adjustment in the event of stock dividends, stock splits, reorganizations or similar events affecting
our common stock and the exercise price, as described in the Pre-Funded Warrant. </P>
<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Exercisability</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Pre-Funded Warrants will be exercisable, at
the option of each holder, in whole or in part, by delivering a duly executed exercise notice accompanied by payment in full for the number
of shares purchased upon such exercise (except in the case of a cashless exercise as discussed below). A holder (together with its affiliates)
may not exercise any portion of the Pre-Funded Warrant to the extent that the holder would own more than 4.99% of the outstanding common
stock immediately after exercise, except that upon at least 61 days&rsquo; prior notice from the holder to us, the holder may increase
the amount of ownership of outstanding stock after exercising the holder&rsquo;s Pre-Funded Warrants up to 9.99% of the number of shares
of common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance
with the terms of the Pre-Funded Warrants. No fractional shares of common stock will be issued in connection with the exercise of a Pre-Funded
Warrant. In lieu of fractional shares, we will pay the holder an amount in cash equal to the fractional amount multiplied by the exercise
price.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Cashless Exercise</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In lieu of making the cash payment otherwise contemplated
to be made to us upon such exercise in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise
(either in whole or in part) the net number of shares of common stock determined according to a formula set forth in the Pre-Funded Warrants.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Fundamental Transactions</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the event of a fundamental transaction, as described
in the Pre-Funded Warrants and generally including any reorganization, recapitalization or reclassification of our common stock pursuant
to which the shares of common stock are converted or exchanged for other securities, cash, or property, the sale, transfer or other disposition
of all or substantially all of our properties or assets, our consolidation or merger with or into another person pursuant to which we
are not the surviving entity, the acquisition of more than 50% of our outstanding voting securities, the holders of the Pre-Funded Warrants
will be entitled to receive upon exercise of the Pre-Funded Warrants the kind and amount of securities, cash or other property that the
holders would have received had they exercised the Pre-Funded Warrants immediately prior to such fundamental transaction.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Transferability</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Subject to applicable laws, a Pre-Funded Warrant
may be transferred at the option of the holder upon surrender of the Pre-Funded Warrant together with the appropriate instruments of transfer.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Exchange Listing</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We do not intend to list the Pre-Funded Warrants
on any securities exchange or nationally recognized trading system.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Rights as a Stockholder</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Except as otherwise provided in the Pre-Funded
Warrants or by virtue of such holder&rsquo;s ownership of, the holders of the Pre-Funded Warrants do not have the rights or privileges
of holders of our common stock, including any voting rights, until they exercise their Pre-Funded Warrants.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Warrants</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>The following summary of certain terms and provisions
of the Common Warrants that are being offered hereby is not complete and is subject to, and qualified in its entirety by, the provisions
of the Common Warrants, the form of which is filed as an exhibit to the registration statement of which this prospectus forms a part.
Prospective investors should carefully review the terms and provisions of the form of Common Warrant for a complete description of the
terms and conditions of the Common Warrants.</I></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Duration and Exercise Price</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Each Common Warrant offered has an assumed
exercise price of $2.22 per share (the last reported sales price of our common stock on Nasdaq on August 15, 2025). The Common Warrants
will be exercisable immediately and will expire on the fifth anniversary of the issuance date. The shares of common stock (or Pre-Funded
Warrants, as applicable) and the Common Warrants will be issued separately and will be immediately separable upon issuance but will be
purchased together in this offering. For each share of common stock (or Pre-Funded Warrant, as applicable) purchased in this offering,
one Common Warrant will be issued. Each whole Common Warrant is exercisable for one share of common stock. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Anti-Dilution Adjustments to Exercise Price</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The exercise price and number of shares of
common stock issuable upon exercise is subject to appropriate adjustment in the event of stock dividends, stock splits, reorganizations
or similar events affecting our common stock and the exercise price, as described in the Common Warrant. <FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, if we issue or sell (or are deemed to have issued or sold) any common stock or securities convertible or exercisable into common
stock, but excluding shares of common stock or securities deemed to have been issued or sold by us in an Exempt Issuance (as defined
in the Common Warrant) or to extend the term of such securities, for a consideration per share (the &ldquo;New Issuance Price&rdquo;)
less than a price equal to the exercise price in effect immediately prior to such issuance or sale or deemed issuance or sale (each of
the foregoing, a &ldquo;Dilutive Issuance&rdquo;), then immediately after such Dilutive Issuance, the exercise price then in effect shall
be reduced to an amount equal to the New Issuance Price (known as a &ldquo;full ratchet&rdquo;), provided that such price shall not be
lower than a floor price equal to 20% of the actual purchase price per share in this offering.</FONT> </P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Exercisability</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Common Warrants will be exercisable, at the
option of each holder, in whole or in part, by delivering a duly executed exercise notice accompanied by payment in full for the number
of purchased upon such exercise (except in the case of a cashless exercise as discussed below). A holder (together with its affiliates)
may not exercise any portion of the Common Warrant to the extent that the holder would own more than 4.99% of the outstanding common stock
immediately after exercise, except that upon at least 61 days&rsquo; prior notice from the holder to us, the holder may increase the amount
of ownership of outstanding stock after exercising the holder&rsquo;s Common Warrants up to 9.99% of the number of shares of common stock
outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of
the Common Warrants. No fractional shares of common stock will be issued in connection with the exercise of a Common Warrant. In lieu
of fractional shares, we will pay the holder an amount in cash equal to the fractional amount multiplied by the exercise price.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Cashless Exercise</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If, at the time a holder exercises its Common Warrants,
a registration statement registering the issuance of the shares of common stock underlying the Common Warrants under the Securities Act
is not then effective or available, then in lieu of making the cash payment otherwise contemplated to be made to us upon such exercise
in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the
net number of shares of common stock determined according to a formula set forth in the Common Warrants.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Fundamental Transaction</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the event of a fundamental transaction, as described
in the Common Warrants and generally including any reorganization, recapitalization or reclassification of our common stock pursuant to
which the shares of common stock are converted or exchanged for other securities, cash, or property, the sale, transfer or other disposition
of all or substantially all of our properties or assets, our consolidation or merger with or into another person pursuant to which we
are not the surviving entity, the acquisition of more than 50% of our outstanding voting securities, the holders of the Common Warrants
will be entitled to receive upon exercise of the Common Warrants the kind and amount of securities, cash or other property that the holders
would have received had they exercised the Common Warrants immediately prior to such fundamental transaction. In addition, the holders
of the Common Warrants have the right to require us or a successor entity to redeem the Common Warrant for the cash paid in the fundamental
transaction in the amount of the Black Scholes value of the unexercised portion of the Common Warrant on the date of the consummation
of the fundamental transaction.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Transferability</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Subject to applicable laws, a Common Warrant may
be transferred at the option of the holder upon surrender of the Common Warrant together with the appropriate instruments of transfer.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Exchange Listing</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We do not intend to list the Common Warrants on
any securities exchange or nationally recognized trading system.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Right as a Stockholder</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Except as otherwise provided in the Common Warrants
or by virtue of such holder&rsquo;s ownership of, the holders of the Common Warrants do not have the rights or privileges of holders of
our common stock, including any voting rights, until they exercise their Common Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="glo_012"></A>PLAN OF DISTRIBUTION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Pursuant to a placement agency agreement to
be entered into between D. Boral Capital LLC (&ldquo;D. Boral&rdquo; or the &ldquo;Placement Agent&rdquo;) and us, we will engage D.
Boral to act as our exclusive placement agent in connection with this offering. The Placement Agent is not purchasing or selling any
of the securities offered by this prospectus, nor is it required to arrange the purchase or sale of any specific number or dollar amount
of securities but has agreed to use its reasonable best efforts to arrange for the sale of all of the securities offered hereby. Therefore,
we may not sell the entire amount of securities offered pursuant to this prospectus. We will enter into a securities purchase agreement
directly with the investors, at the investor&rsquo;s option, who purchase our securities in this offering. Investors who do not enter
into a securities purchase agreement shall rely solely on this prospectus in connection with the purchase of our securities in this offering.
The Placement Agent may engage one or more subagents or selected dealers in connection with this offering. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We will deliver the securities being issued to
the investors upon receipt of such investor funds for the purchase of the securities offered pursuant to this prospectus. We expect to
deliver the securities being offered pursuant to this prospectus on or about&emsp;&emsp;&emsp;&emsp;, 2025, subject to the satisfaction
of customary closing conditions.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fees and Expenses</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We have engaged D. Boral as our exclusive placement
agent in connection with this offering. This offering is being conducted on a &ldquo;reasonable best efforts&rdquo; basis, and the Placement
Agent has no obligation to buy any of the securities from us or to arrange for the purchase or sale of any specific number or dollar
amount of securities. The following table shows the public offering price, placement agent fees, and proceeds (before expenses) to us,
assuming the sale of all securities in this offering and no exercise of any warrants. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Per Share and<BR> Related&nbsp;Warrant</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Per Pre-Funded<BR> Warrant and<BR> Related&nbsp;Warrant</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Public offering price</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 64%; text-align: left">Placement agent fees (1)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Proceeds to us, before expenses (2)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"> (1) </TD><TD STYLE="text-align: left"> We have agreed to pay the Placement Agent a cash
                                            placement commission equal to 6.0% of the gross proceeds from this offering. We have also
                                            agreed to reimburse the Placement Agent for certain expenses incurred in connection with
                                            this offering. </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">The amount of the offering proceeds to us presented in this
table does not give effect to any exercise of the Pre-Funded Warrants or Common Warrants being issued in this offering.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> We have also agreed to pay or reimburse the
Placement Agent at closing all reasonable out-of-pocket costs and expenses incident to the performance of the obligations of the Placement
Agent, including without limitation, the reasonable and documented fees and expenses of the Placement Agent&rsquo;s legal counsel, in
an aggregate amount not to exceed $100,000 without our prior approval. We estimate the total expenses payable by us for this offering,
excluding placement agent fees and expenses, will be approximately $80,000. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Placement Agent may be deemed to be an underwriter
within the meaning of Section 2(a)(11) of the Securities Act, and any commissions received by it and any profit realized on the resale
of the shares sold by it while acting as principal might be deemed to be underwriting discounts or commissions under the Securities Act.
As an underwriter, the Placement Agent would be required to comply with the requirements of the Securities Act and the Exchange Act, including,
without limitation, Rule 415(a)(4) under the Securities Act and Rule 10b-5 and Regulation M under the Exchange Act. These rules and regulations
may limit the timing of purchases and sales of shares by the Placement Agent acting as principal. Under these rules and regulations, the
Placement Agent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>may not engage in any stabilization activity in connection with our securities; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>may not bid for or purchase any of our securities or attempt to induce any person to purchase any of our securities, other than as
permitted under the Exchange Act, until it has completed its participation in the distribution.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indemnification</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have agreed to indemnify the Placement Agent
against specified liabilities, including liabilities under the Securities Act, and to contribute to payments the Placement Agent may be
required to make in respect thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Tail Financing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"> We have granted the Placement
Agent the right to receive a cash fee equal to 6.0% of the gross proceeds received by us from the public or private offering or other
financing or capital-raising transaction, including equity, debt and/or equity derivative instruments, of any kind (&ldquo;Tail Financing&rdquo;)
to the extent that such Tail Financing is (A) provided to the Company by investors that were, during the term of the placement agency
agreement, actually introduced to the Company by the Placement Agent and (B) consummated at any time within the 12-month period following
the expiration or termination of the placement agency agreement, provided that such Tail Financing is by a party actually introduced
to the Company in an offering in which the Company has direct knowledge of such party&rsquo;s participation. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lock-up Agreements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Our directors and executive officers have agreed
to enter into lock-up agreements. Under these agreements, these individuals have agreed, subject to specified exceptions, not to sell
or transfer any shares of common stock or securities convertible into, or exchangeable or exercisable for, our shares of common stock
during a period ending 90 days after the closing of this offering, without first obtaining the written consent of the Placement Agent.
Specifically, these individuals have agreed, in part, not to: </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>sell, offer, contract or grant any option to sell (including any short sale), pledge, transfer, establish an open &ldquo;put equivalent
position&rdquo; within the meaning of Rule 16a-l(h) under the Securities Exchange Act of 1934, as amended;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership
of our securities, whether any such transaction is to be settled by delivery of our shares of common stock, in cash or otherwise;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>make any demand for or exercise any right with respect to the registration of any of our securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>publicly disclose the intention to make any offer, sale, pledge or disposition, or to enter into any transaction, swap, hedge;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>or other arrangement relating to any of our securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Notwithstanding these limitations, these shares
of common stock may be transferred under limited circumstances, including, without limitation, by gift, will or intestate succession.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> In addition, we have agreed that, subject to
certain exceptions, we will not conduct any issuances of, or enter into any agreement to issue or announce the issuance of proposed issuances
of, our common stock or securities convertible into, or exchangeable or exercisable for, our shares of common stock for a period of 90
days after the closing of this offering. </P>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Discretionary Accounts</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Placement Agent does not intend to confirm
sales of the securities offered hereby to any accounts over which it has discretionary authority.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"> <B>Electronic Offer, Sale and Distribution of
Securities</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> A prospectus in electronic format may be made
available on the websites maintained by the Placement Agent, if any, and the Placement Agent may distribute prospectuses electronically.
Other than the prospectus in electronic format, the information on these websites is not part of this prospectus or the registration
statement of which this prospectus forms a part, has not been approved or endorsed by us or the Placement Agent, and should not be relied
upon by investors. </P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Other Activities and Relationships</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Placement Agent and certain of its affiliates
are full service financial institutions engaged in various activities, which may include securities trading, commercial and investment
banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities.
The Placement Agent and certain of its affiliates have, from time to time, performed, and may in the future perform, various commercial
and investment banking and financial advisory services for us and our affiliates, for which they received or will receive customary fees
and expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the ordinary course of their various business
activities, the Placement Agent and certain of its affiliates may make or hold a broad array of investments and actively trade debt and
equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the
accounts of their customers, and such investment and securities activities may involve securities and/or instruments issued by us and
our affiliates. If the Placement Agent or its affiliates have a lending relationship with us, they routinely hedge their credit exposure
to us consistent with their customary risk management policies. The Placement Agent and its affiliates may hedge such exposure by entering
into transactions that consist of either the purchase of credit default swaps or the creation of short positions in our securities or
the securities of our affiliates, including potentially the common stock offered hereby. Any such short positions could adversely affect
future trading prices of the common stock offered hereby. The Placement Agent and certain of its affiliates may also communicate independent
investment recommendations, market color or trading ideas and/or publish or express independent research views in respect of such securities
or instruments and may at any time hold, or recommend to clients that they acquire, long and/or short positions in such securities and
instruments.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"> <B>Listing</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Our common stock is traded on The Nasdaq Capital
Market under the symbol &ldquo;GITS.&rdquo; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"> <B>Transfer Agent and Registrar</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The transfer agent and registrar for our common
stock is Colonial Stock Transfer Company, Inc. </P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Offer Restrictions Outside the United States</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Other than in the United States, no action has
been taken by us or the Placement Agent that would permit a public offering of the securities offered by this prospectus in any jurisdiction
where action for that purpose is required. The securities offered by this prospectus may not be offered or sold, directly or indirectly,
nor may this prospectus or any other offering material or advertisements in connection with the offer and sale of any such securities
be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable rules and
regulations of that jurisdiction. Persons into whose possession this prospectus comes are advised to inform themselves about and to observe
any restrictions relating to the offering and the distribution of this prospectus. This prospectus does not constitute an offer to sell
or a solicitation of an offer to buy any securities offered by this prospectus in any jurisdiction in which such an offer or a solicitation
is unlawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="glo_013"></A>LEGAL MATTERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Olshan Frome Wolosky LLP will pass upon certain
legal matters relating to the issuance and sale of the securities offered hereby on behalf of Global Interactive Technologies, Inc. D.
Boral Capital LLC is being represented in connection with this offering by Thompson Hine LLP. </P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="glo_014"></A>EXPERTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The consolidated financial statements of Global
Interactive Technologies, Inc. (the Company) as of December 31, 2024 and 2023 and for each of the two years in the period ended December
31, 2024 incorporated by reference in this Prospectus and in the Registration Statement have been so incorporated in reliance on the report
of OneStop Assurance PAC, an independent registered public accounting firm, given on the authority of said firm as experts in auditing
and accounting. The report on the consolidated financial statements contains an explanatory paragraph regarding the Company&rsquo;s ability
to continue as a going concern.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="glo_015"></A>WHERE YOU CAN FIND
MORE INFORMATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This prospectus is part of a registration statement
we filed with the SEC. This prospectus does not contain all of the information set forth in the registration statement and the exhibits
to the registration statement. The registration statement, its exhibits and the documents incorporated by reference in this prospectus
and their exhibits, all contain information that is material to the offering of the securities hereby. Whenever a reference is made in
this prospectus to any of our contracts or other documents, the reference may not be complete. You should refer to the exhibits that are
a part of the registration statement in order to review a copy of the contract or documents. You may obtain copies of the registration
statement and its exhibits via the SEC&rsquo;s EDGAR database.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We file annual, quarterly and current reports,
proxy statements and other information with the SEC. The SEC maintains an Internet site at http://www.sec.gov that contains reports, proxy
and information statements, and other information regarding issuers, such as us, that file electronically with the SEC. Additionally,
you may access our filings with the SEC through our website at www.gitechnologies.com. We have included our website address as an inactive
textual reference only and our website and the information contained on, or that can be accessed through, our website will not be deemed
to be incorporated by reference in, and are not considered part of, this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We will provide you without charge, upon your oral
or written request, with an electronic or paper copy of any or all reports, proxy statements and other documents we file with the SEC,
as well as any or all of the documents incorporated by reference in this prospectus (other than exhibits to such documents unless such
exhibits are specifically incorporated by reference into such documents). Requests for such copies should be directed to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Global Interactive Technologies, Inc.<BR>
160, Yeouiseo-ro, Yeongdeungpo-gu<BR>
Seoul, Republic of Korea, 07231</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Attn.: Chief Financial Officer<BR>
+82-2-564-8588</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You should rely only on the information in this
prospectus and the additional information described above and under the heading &ldquo;Incorporation of Certain Information by Reference&rdquo;
below. We have not authorized any other person to provide you with different information. If anyone provides you with different or inconsistent
information, you should not rely upon it. We are not making an offer to sell these securities in any jurisdiction where such offer or
sale is not permitted. You should assume that the information in this prospectus was accurate on the date of the front cover of this prospectus
only. Our business, financial condition, results of operations and prospects may have changed since that date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="glo_016"></A>INCORPORATION OF
CERTAIN INFORMATION BY REFERENCE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The SEC allows us to &ldquo;incorporate by reference&rdquo;
information that we file with it into this prospectus, which means that we can disclose important information to you by referring you
to those documents. The information incorporated by reference is an important part of this prospectus. The information incorporated by
reference is considered to be a part of this prospectus, and information that we file later with the SEC will automatically update and
supersede information contained in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We incorporate by reference the following information
or documents that we have filed with the SEC:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our Annual Report on <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025036973/ea0239736-10k_global.htm">Form 10-K</A> for the year ended December
31, 2024, filed on April 30, 2025;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"> &#9679; </TD><TD STYLE="text-align: justify"> our Quarterly
                                            Reports on Form 10-Q for the quarter ended March 31, 2025, filed on <A HREF="http://www.sec.gov/Archives/edgar/data/1911545/000121390025045898/ea0242753-10q_globalint.htm">May
                                            20, 2025</A>, and the quarter ended June 30, 2025, filed on <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025077460/ea0253370-10q_global.htm">August
                                            15, 2025</A>; </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">our Current Reports
                                            on Form 8-K filed on <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025001235/ea0226847-8k_global.htm">January
                                            6, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025005691/ea0228448-8k_global.htm">January
                                            23, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025011753/ea0230503-8k_global.htm">February
                                            10, 2025</A>, March 31, 2025, <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025036233/ea0239688-8k_global.htm">April
                                            29, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025039447/ea0240860-8k_global.htm">May
                                            5, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025046902/ea0243224-8k_globalint.htm">May
                                            22, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025057462/ea0246891-8k_globalint.htm">June
                                            25, 2025</A> and <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025060743/ea0247980-8k_global.htm">July
                                            2, 2025</A>, and Form 8-K/A on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1911545/000121390025063765/ea0248624-8ka1_global.htm" STYLE="-sec-extract: exhibit">July
                                            14, 2025</A>; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: left">the description of our common stock contained in our Registration
Statement on <A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390023061163/ea182453-8a12b_hanryuhold.htm">Form 8-A</A> filed with the SEC on July 31, 2023, including any amendments and reports filed for the purpose of updating such
description.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> All reports and other documents (other than
current reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed in such forms that are related to such items unless
such Form 8-K expressly provides to the contrary) we subsequently file pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange
Act, subsequent to the date of this prospectus until the termination of this offering will also be incorporated by reference in this
prospectus and deemed to be part of this prospectus from the date of the filing of such reports and documents. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any statement contained in a document incorporated
or deemed to be incorporated by reference in this prospectus shall be deemed modified, superseded or replaced for purposes of this prospectus
to the extent that a statement contained in this prospectus, or in any subsequently filed document that also is deemed to be incorporated
by reference in this prospectus, modifies, supersedes or replaces such statement. Any statement so modified, superseded or replaced shall
not be deemed, except as so modified, superseded or replaced, to constitute a part of this prospectus. None of the information that we
disclose under Items 2.02 or 7.01 of any Current Report on Form 8-K or any corresponding information, either furnished under Item 9.01
or included as an exhibit therein, that we may from time to time furnish to the SEC will be incorporated by reference into, or otherwise
included in, this prospectus, except as otherwise expressly set forth in the relevant document. Subject to the foregoing, all information
appearing in this prospectus is qualified in its entirety by the information appearing in the documents incorporated by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> Up to 2,252,252 Shares of Common Stock<BR>
Up to 2,252,252 Pre-Funded Warrants to Purchase up to 2,252,252 Shares of Common Stock<BR>
Up to 2,252,252 Common Warrants to Purchase up to 2,252,252 Shares of Common Stock </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"> <B>Up to 4,504,504 Shares
of Common Stock Underlying the Common Warrants and Pre-Funded Warrants</B> </P>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: windowtext"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 90.75pt; width: 188.25pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; padding-top: 4pt; padding-right: 4pt; padding-left: 4pt; text-align: center; text-underline-color: black"> <FONT STYLE="font-size: 10pt"><B>PRELIMINARY
    PROSPECTUS</B></FONT> </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 143.75pt; text-indent: -143.75pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 143.75pt; text-indent: -143.75pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 143.75pt; text-indent: -143.75pt">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Sole Placement Agent</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 50.25pt; width: 193.5pt"><BR></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-style: normal">&emsp;&emsp;</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-style: normal">&emsp;&emsp;,
2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">PART II<BR></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">INFORMATION NOT REQUIRED IN PROSPECTUS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item&thinsp;13.&#9;Other Expenses of Issuance and Distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table indicates the expenses to be
incurred in connection with the offering described in this registration statement, other than underwriting discounts and commissions,
all of which will be paid by us. All amounts are estimated except the Securities and Exchange Commission registration fee and the Financial
Industry Regulatory Authority, Inc., or FINRA, filing fee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"> Amount </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left"> Securities and Exchange Commission registration fee </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> $ </TD><TD STYLE="width: 9%; text-align: right"> 1,531.00 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> FINRA filing fee </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 1,109.90 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> Accountants&rsquo; fees and expenses </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 6,300.00 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> Legal fees and expenses </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 70,000.00 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt"> Miscellaneous </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 1,059.10 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"> Total expenses </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> 80,000.00 </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> &nbsp; </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item&thinsp;14.&#9;Indemnification of Directors and Officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section 145(a) of the Delaware General Corporation
Law (&ldquo;DGCL&rdquo;) provides, in general, that a Delaware corporation may indemnify any person who was or is a party, or is threatened
to be made a party, to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative
(other than an action by or in the right of the corporation) because that person is or was a director, officer, employee or agent of the
corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation or
other enterprise. The indemnity may include expenses (including attorneys&rsquo; fees), judgments, fines and amounts paid in settlement
actually and reasonably incurred by the person in connection with such action, so long as the person acted in good faith and in a manner
he or she reasonably believed was in or not opposed to the corporation&rsquo;s best interests, and, with respect to any criminal action
or proceeding, had no reasonable cause to believe his or her conduct was unlawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section 145(b) of the DGCL provides, in general,
that a Delaware corporation may indemnify any person who was or is a party, or is threatened to be made a party, to any threatened, pending
or completed action or suit by or in the right of the corporation to obtain a judgment in its favor because the person is or was a director,
officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee
or agent of another corporation or other enterprise. The indemnity may include expenses (including attorneys&rsquo; fees) actually and
reasonably incurred by the person in connection with the defense or settlement of such action, so long as the person acted in good faith
and in a manner the person reasonably believed was in or not opposed to the corporation&rsquo;s best interests, except that no indemnification
shall be permitted without judicial approval if a court has determined that the person is to be liable to the corporation with respect
to such claim. Section 145(c) of the DGCL provides that, if a present or former director or officer has been successful in defense of
any action referred to in Sections 145(a) and (b) of the DGCL, the corporation must indemnify such officer or director against the expenses
(including attorneys&rsquo; fees) he or she actually and reasonably incurred in connection with such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 46; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Section 145(g) of the DGCL provides, in general,
that a corporation may purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of
the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation
or other enterprise against any liability asserted against and incurred by such person, in any such capacity, or arising out of his or
her status as such, whether or not the corporation could indemnify the person against such liability under Section 145 of the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our certificate of incorporation, as amended, and
our bylaws, as amended, provide for the indemnification of our directors and officers to the fullest extent permitted under the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We also expect to enter into separate indemnification
agreements with our directors and officers in addition to the indemnification provided for in our certificate of incorporation and bylaws.
These indemnification agreements will provide, among other things, that we will indemnify our directors and officers for certain expenses,
including damages, judgments, fines, penalties, settlements and costs and attorneys&rsquo; fees and disbursements, incurred by a director
or officer in any claim, action or proceeding arising in his or her capacity as a director or officer of our company or in connection
with service at our request for another corporation or entity. The indemnification agreements also provide for procedures that will apply
in the event that a director or officer makes a claim for indemnification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We also maintain a directors&rsquo; and officers&rsquo;
insurance policy pursuant to which our directors and officers are insured against liability for actions taken in their capacities as directors
and officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions
or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed
in the Securities Act and is, therefore, unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">See also the undertakings set out in response to
Item 17 of this Registration Statement.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item&thinsp;15.&#9;Recent Sales of Unregistered Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On January&nbsp;4, 2023 through March&nbsp;8, 2023,
warrants of $1,813,120 were exercised with an exercise price of $1.27 to purchase 1,427,653 shares of common stock by cash of $1,420,144
and debt conversion of $392,776.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In February and March 2023, the Company closed
two private placements solely to accredited investors (as defined by Rule&nbsp;501(a)&nbsp;of Regulation&nbsp;D of the Securities Act)
pursuant to which the Company sold an aggregate amount of 240,000 shares of common stock for $10.00 per share, resulting in gross proceeds
of $2,400,000. The purchase price of the common stock purchased in the private placements is subject to adjustment to the price of the
common stock sold in the Company&rsquo;s initial public offering (IPO), such that additional common stock shall be issued to the purchasers
if the price of common stock sold in the IPO is less than $10.00 per share, or the purchasers shall return common stock to the Company
if the price of the common stock sold in the IPO is greater than $10.00 per share, in each case resulting in the purchasers purchasing
an aggregate amount of $2,400,000 of Company common stock at the IPO price. The offerings were exempt from registration under Section&nbsp;4(a)(2)&nbsp;of
the Securities Act. The subscription agreements pursuant to which the common stock was sold to accredited investors contain customary
representations and warranties of the Company and the investors and customary indemnification rights and obligations of the parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On March&nbsp;24, 2023, warrants of $8,400 were
exercised with an exercise price of $0.42 to purchase 20,000 shares of common stock by cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On April&nbsp;13, 2023, warrants of $420,000 were
exercised with an exercise price of $0.42 to purchase 1,000,000 shares of common stock by cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Between April 20, 2023 and July 31, 2023, Hanryu
Holdings, Inc., now known as Global Interactive Technologies, Inc., raised approximately KRW 5.92 billion (or approximately $4,628,500)
through the issuance of 462,847 shares of common stock at a price of KRW 1,279 (or $10.00) per share in a private placement to 124 Korean
investors. The issuance and sale of these shares of common stock were exempt from registration under the Securities Act pursuant to Section
4(a)(2) of the Securities Act and Regulation S promulgated thereunder. The issuance and sale of the shares of common stock were made pursuant
to an offshore transaction with non-U.S. persons and no directed selling efforts were made in the United States by the Company, a distributor,
any of their respective affiliates, or any person acting on behalf of any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On May&nbsp;4, 2023 through May 8, 2023, warrants
of $3,894,666 were exercised with an exercise price of $1.27 to purchase 3,066,66 shares of common stock by cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On May&nbsp;31, 2023, the Company completed a private
placement to solely to an accredited investor (as defined by Rule&nbsp;501(a)&nbsp;of Regulation&nbsp;D of the Securities Act) pursuant
to which the Company sold an aggregate amount of 760,000 shares of common stock for $10.00 per share, resulting in gross proceeds of $7,600,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On February 18, 2025, the Company entered into
that certain Debt Conversion Agreement (the <FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;</FONT>Debt Conversion Agreement&rdquo;)
with Evan Trust, a trust for which Amy Shi, a director of the Company, serves as the trustee (the <FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;</FONT>Trust&rdquo;).
Pursuant to the Debt Conversion Agreement, the Company and the Trust agreed to convert certain debt in the amount of $210,000 owed by
the Company to Evan Trust, into 300,000 shares of the Company<FONT STYLE="font-family: Times New Roman, Times, Serif">&rsquo;</FONT>s
common stock. The transaction was conducted pursuant to Regulation S. As a result, the total number of issued shares increased to 2,940,402.
Each holder of common stock is entitled to one vote per share at all meetings of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On February 18, 2025, the Company entered into
a Promissory Note (the &ldquo;February 2025 Note&rdquo;) payable to PixelArc, LLC (&ldquo;PixelArc&rdquo;), a California limited liability
company in which Amy Xianglin Shi, a director of the Company, holds a direct ownership interest and serves in a managerial capacity. The
February 2025 Note evidenced a loan of $86,660 extended by PixelArc to support essential operating obligations during a period of limited
liquidity. The note accrued interest at 8% per annum, had a maturity date of March 14, 2026, and included a 5% late fee and 12% default
interest rate, along with customary default provisions. On April 18, 2025, the Company executed a second Promissory Note (the &ldquo;April
2025 Note&rdquo;) payable to PixelArc, evidencing a short-term, interest-free loan of $86,000 used to satisfy outstanding Nasdaq listing
fees and maintain the Company&rsquo;s continued listing. The note matured on May 15, 2025, and contained the same late fee and default
interest terms as the February 2025 Note. In connection with the April 2025 Note, the Company also entered into a Security Agreement,
dated April 18, 2025 (the &ldquo;Security Agreement&rdquo;), with PixelArc to secure repayment obligations under both notes. Following
nonpayment of the April 2025 Note, PixelArc became entitled to exercise its rights under the Security Agreement. On May 19, 2025, PixelArc
submitted a proposal to convert its outstanding loan balances into equity. On May 20, 2025, PixelArc delivered a formal Notice of Conversion
to the Company, pursuant to which the combined $172,666 in principal amount under the February 2025 and April 2025 Notes were converted
into 246,666 shares of the Company&rsquo;s common stock at a price of $0.70 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The foregoing issuances of common stock were made
to accredited investors in transactions that were exempt from registration under Section 4(a)(2) of the Securities Act and/or Regulation
D or Regulation S thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item&thinsp;16.&#9;Exhibits and Financial Statement Schedules.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 9%"><B>Exhibit Number</B></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 90%"><B>Description</B></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black"> 1.1* </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"><A HREF="ea025365101ex1-1_global.htm"> Form of Placement Agency Agreement. </A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black">3.1</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025036973/ea023973601ex3-1_global.htm">Amended and Restated Certificate of Incorporation of the Company.<SUP>(1)</SUP></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black">3.2</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390024108011/ea022439201ex3-1_global.htm">Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company.<SUP>(2)</SUP></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black">3.3</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025005691/ea022844801ex3-1_global.htm">Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company.<SUP>(3)</SUP></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black">3.4</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025036973/ea023973601ex3-2_global.htm">Bylaws of the Company.<SUP>(1)</SUP></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black">3.5</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390024108011/ea022439201ex3-2_global.htm">Amendment to the Bylaws of the Company.<SUP>(2)</SUP></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black">4.1</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025036973/ea023973601ex4-1_global.htm">Form of Common Stock Certificate of the Company.<SUP>(1)</SUP></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black"> 4.3* </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"><A HREF="ea025365101ex4-3_global.htm"> Form of Common Warrant of the Company to be issued
    in this offering. </A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black"> 4.4* </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"><A HREF="ea025365101ex4-4_global.htm"> Form of Pre-Funded Warrant of the Company to be
    issued in this offering. </A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black"> 5.1* </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="ea025365101ex5-1_global.htm">Opinion of Olshan Frome Wolosky LLP.</A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black">10.2</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025036973/ea023973601ex10-2_global.htm">2022 Omnibus Equity Incentive Plan of the Company.<SUP>(1)</SUP></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black">10.3</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025036973/ea023973601ex10-3_global.htm">Employment Agreement by and between Taehoon Kim and the Company (formerly Hanryu Holdings, Inc.), dated April 1, 2024.<SUP>(1)</SUP></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black">10.4</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025036973/ea023973601ex10-4_global.htm">Employment Agreement by and between Juhyon Shin and the Company (formerly Hanryu Holdings, Inc.), dated April 1, 2024.<SUP>(1)</SUP></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black">10.5</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025036973/ea023973601ex10-5_global.htm">Employment Agreement by and between David Gregg and the Company (formerly Hanryu Holdings, Inc.), dated April 1, 2023.<SUP>(1)</SUP></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black">10.6</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025036973/ea023973601ex10-6_global.htm">Business Transfer Agreement, dated June 22, 2022, by and between Hanryu Bank Co., Ltd., and Kingdom Coin Holdings, a corporation incorporated in the Cayman Islands.<SUP>(1)</SUP></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black">10.8</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000101376225000590/ea023473301ex10-1_global.htm">Debt Conversion Agreement between the Company and Evan Trust.<SUP>(4)</SUP></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black">10.9</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025046902/ea024322401ex10-1_globalint.htm">Promissory Note, dated February 18, 2025, by the Company in favor of PixelArc.<SUP>(5)</SUP></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black">10.10</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025046902/ea024322401ex10-2_globalint.htm">Promissory Note, dated April 18, 2025, by the Company in favor of PixelArc.<SUP>(5)</SUP></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black">10.11</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025046902/ea024322401ex10-3_globalint.htm">Security Agreement, dated April 18, 2025, between the Company and PixelArc.<SUP>(5)</SUP></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black">10.12</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025046902/ea024322401ex10-4_globalint.htm">Notice of Conversion, dated May 20, 2025, between the Company and PixelArc.<SUP>(5)</SUP></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black"> 10.13* </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"><A HREF="ea025365101ex10-13_global.htm"> Form of Securities Purchase Agreement. </A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black">21.1</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><A HREF="https://www.sec.gov/Archives/edgar/data/1911545/000121390025036973/ea023973601ex21-1_global.htm">List of Subsidiaries.<SUP>(1)</SUP></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black">23.1*</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><A HREF="ea025365101ex23-1_global.htm">Consent of OneStop Assurance PAC, Independent Registered Public Accounting Firm.</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black"> 23.2* </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="ea025365101ex5-1_global.htm">Consent of Olshan Frome Wolosky LLP (included in
    the opinion filed as Exhibit 5.1).</A> </TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-underline-color: black">24.1</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-underline-color: black"><A HREF="#glo_017">Power of Attorney (set forth on signature page of the Registration Statement).</A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-underline-color: black"> 107* </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-underline-color: black"> <A HREF="ea025365101ex-fee_global.htm">Filing Fee Table.</A> </TD></TR>
  </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">Unless otherwise indicated, the
exhibit has been previously filed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">*</TD><TD>Filed herewith.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">**</TD><TD>To be filed by amendment.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>Incorporated by reference to the Company&rsquo;s Annual Report on Form 10-K filed with the SEC on April 30, 2025.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>Incorporated by reference to the Company&rsquo;s Current Report on Form 8-K filed with the SEC on December 11, 2024.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">(3)</TD><TD>Incorporated by reference to the Company&rsquo;s Current Report on Form 8-K filed with the SEC on January 23, 2025.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">(4)</TD><TD>Incorporated by reference to the Company&rsquo;s Current Report on Form 8-K filed with the SEC on March 18, 2025.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">(5)</TD><TD>Incorporated by reference to the Company&rsquo;s Current Report on Form 8-K filed with the SEC on May 22, 2025.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item&thinsp;17.&#9;Undertakings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(1)</TD><TD>The undersigned registrant hereby undertakes:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">(a)&nbsp;To
file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(i)</TD><TD STYLE="text-align: justify">To include any prospectus required by Section 10(a)(3) of
the Securities Act;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(ii)</TD><TD>To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth
in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar
value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum
offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes
in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the &ldquo;Calculation
of Registration Fee&rdquo; or &ldquo;Calculation of Registration Fee&rdquo; table in the effective registration statement; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(iii)</TD><TD>To include any material information with respect to the plan of distribution not previously disclosed in the registration statement
or any material change to such information in the registration statement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>provided, however</I>, that paragraphs (1)(i), (1)(ii) and (1)(iii)
above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports
filed with or furnished to the Securities and Exchange Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities
Exchange Act of 1934 that are incorporated by reference in the registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">(b)&nbsp;That,
for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new
registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to
be the initial bona fide offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">(c)&nbsp;To
remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination
of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">(d)&nbsp;that,
for the purpose of determining liability under the Securities Act of 1933 to any purchaser, each prospectus filed pursuant to Rule 424(b)
as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses
filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used
after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration
statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is
part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify
any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such
document immediately prior to such date of first use.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">(e)&nbsp;That,
for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the
securities, the undersigned registrant hereby undertakes that in a primary offering of securities of the undersigned registrant pursuant
to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities
are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to
the purchaser and will be considered to offer or sell such securities to such purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(i)</TD><TD>Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule
424 (&sect; 230.424 of this chapter);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(ii)</TD><TD>Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to
by the undersigned registrant;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(iii)</TD><TD>The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
or its securities provided by or on behalf of the undersigned registrant; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(iv)</TD><TD>Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">(f)&nbsp;Insofar
as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons
of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the SEC such
indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling
person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling
person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against
public policy as expressed in the Act and will be governed by the final adjudication of such issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">(g)&nbsp;That:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD>For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed
as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the Registrant pursuant
to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it
was declared effective.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD>For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form
of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">(h)&nbsp;That,
for purposes of determining any liability under the Securities Act of 1933, each filing of the Registrant<FONT STYLE="font-family: Times New Roman, Times, Serif">&rsquo;</FONT>s
annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of
an employee benefit plan<FONT STYLE="font-family: Times New Roman, Times, Serif">&rsquo;</FONT>s annual report pursuant to section 15(d)
of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial
bona fide offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="glo_017"></A>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Pursuant to the requirements of the Securities
Act of 1933, the registrant has duly caused this Amendment No. 2 to the registration statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in Seoul, Republic of South Korea on the 19th day of August 2025. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GLOBAL INTERACTIVE TECHNOLOGIES, INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><I>/s/ Taehoon Kim</I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT>&nbsp;</TD>
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taehoon Kim</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> Pursuant to the requirements of the Securities
Act of 1933, this Amendment No. 2 to the registration statement has been signed by the following persons in the capacities and on the
dates indicated. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 30%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT> </TD>
    <TD STYLE="width: 2%"> &nbsp; </TD>
    <TD STYLE="width: 44%; border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT> </TD>
    <TD STYLE="width: 2%"> &nbsp; </TD>
    <TD STYLE="width: 22%; border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"> <I>/s/ Taehoon Kim</I> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 19, 2025</FONT> </TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taehoon Kim</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(principal
    executive officer)</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid"> <I>/s/ Ju-Hyon Shin </I> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    19, 2025&nbsp;</FONT> </TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ju-Hyon Shin</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(principal
    financial and accounting officer)</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid"> <I>/s/ John S. Morris *</I> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    19, 2025&nbsp;</FONT> </TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John S. Morris</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid"> <I>/s/ Jay Hyong Woo *</I> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    19, 2025&nbsp;</FONT> </TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jay Hyong Woo</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aram Ahn</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid"> <I>/s/ Amy Shi *</I> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    19, 2025&nbsp;</FONT> </TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amy Shi</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid"> <I>/s/ Larry Namer *</I> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    19, 2025</FONT> </TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Larry Namer</FONT> </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; width: 5%"> * By: </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%"> <I>/s/ Taehoon Kim</I> </TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 60%"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> Taehoon Kim </TD>
    <TD> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> Attorney-in-Fact </TD>
    <TD> &nbsp; </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 52; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ea025365101ex1-1_global.htm
<DESCRIPTION>FORM OF PLACEMENT AGENCY AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 1.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">August [&#9679;], 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">D. Boral Capital LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">590 Madison Avenue, 39<FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT>
Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">New York, New York 10022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">Subject to the terms and conditions herein (this &ldquo;Agreement&rdquo;)
Global Interactive Technologies, Inc., a Delaware corporation (the &ldquo;Company&rdquo;), hereby agrees to sell up to an aggregate of
(i) [&#9679;] (the &ldquo;Shares&rdquo;) of the Company&rsquo;s common stock, $0.001 par value per share (the &ldquo;Common Stock&rdquo;),
(ii) pre-funded warrants (the &ldquo;Pre-Funded Warrants&rdquo;) to purchase up to an aggregate of [&#9679;] shares of Common Stock (the
&ldquo;Pre-Funded Warrant Shares&rdquo;), and (iii) common stock purchase warrants (the &ldquo;Common Warrants&rdquo; and, together with
the Pre-Funded Warrants, the &ldquo;Warrants&rdquo;) to purchase up to an aggregate of [&#9679;] shares of Common Stock (the &ldquo;Common
Warrant Shares&rdquo; and, together with the Pre-Funded Warrants Shares, the &ldquo;Warrant Shares&rdquo;) directly to various purchasers
(each, a &ldquo;Purchaser&rdquo; and, collectively, the &ldquo;Purchasers&rdquo;) through D. Boral Capital LLC, as Placement Agent (the
&ldquo;Placement Agent&rdquo;). This Agreement and the documents executed and delivered by the Company and the Purchasers in connection
with the Offering (as defined below), including, without limitation, a securities purchase agreement (the &ldquo;Purchase Agreement&rdquo;),
shall be collectively referred to herein as the &ldquo;Transaction Documents.&rdquo; The Shares, the Warrants and the Warrant Shares are
collectively referred to as the &ldquo;Securities.&rdquo; The Placement Agent may retain other brokers or dealers to act as sub-agents
or selected-dealers on its behalf in connection with the Offering. The Securities will be issued under the Registration Statement (as
defined below) and pursuant to the terms of the Final Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Shares, on the one hand, and the Warrants,
on the other hand, are sold together in the Offering but shall be immediately separable and transferable upon issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">The Company has prepared and filed in conformity with the requirements
of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), and the published rules and regulations thereunder (the
&ldquo;Rules&rdquo;) adopted by the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) a registration statement on Form
S-1 (Commission File No. 333-288665), which was declared effective by the Commission on [&#9679;], 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">The term &ldquo;Registration Statement&rdquo; as used in this Agreement
means the registration statement (Commission File No. 333-288665), including all exhibits, financial schedules and all documents and information
deemed to be part of the Registration Statement by incorporation by reference or otherwise, as amended from time to time, including the
information (if any) contained in the form of final prospectus filed with the Commission pursuant to Rule 424(b) of the Rules and deemed
to be part thereof at the time of effectiveness pursuant to Rule 430B of the Rules (the &ldquo;Final Prospectus&rdquo;). The Registration
Statement has been declared effective by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">If the Company has filed an abbreviated registration statement to register
additional Securities pursuant to Rule 462(b) under the Rules (the &ldquo;462(b) Registration Statement&rdquo;), then any reference herein
to the Registration Statement shall also be deemed to include such 462(b) Registration Statement. The term &ldquo;Prospectus&rdquo; means
the Final Prospectus and any amendments or further supplements to such prospectus, and including, which are filed pursuant to and within
the limits described in Rule 424(b) with the Commission in connection with the proposed sale of the Securities contemplated by this Agreement
through the date of such prospectus supplement. The term &ldquo;Effective Date&rdquo; shall mean each date that the Registration Statement
and any post-effective amendment or amendments thereto became or becomes effective. Unless otherwise stated herein, any reference herein
to the Registration Statement and the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein,
including pursuant to Item 12 of Form S-1 under the Securities Act, which were filed under the Securities Exchange Act of 1934, as amended
(the &ldquo;Exchange Act&rdquo;) on or before the date hereof or are so filed hereafter, but prior to the termination of the public offering
contemplated by this Agreement. Any reference herein to the terms &ldquo;amend,&rdquo; &ldquo;amendment&rdquo; or &ldquo;supplement&rdquo;
with respect to the Registration Statement or the Prospectus shall be deemed to refer to and include any such document filed or to be
filed under the Exchange Act after the date of the Registration Statement, any such Prospectus and deemed to be incorporated therein by
reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">The Company hereby confirms that the Placement Agent and dealers have
been authorized to distribute or cause to be distributed each Issuer Free Writing Prospectus (as hereinafter defined) and are authorized
to distribute the Prospectus (as from time to time amended or supplemented if the Company furnishes amendments or supplements thereto
to the Placement Agent).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">1. <U>Agreement to Act as Placement Agent</U>. On the basis of the
representations, warranties and agreements contained in, and subject to the terms and conditions of, this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.5in">(a) The Company hereby authorizes the Placement
Agent to act as its exclusive agent to solicit offers for the purchase of all or part of the Securities from the Company in connection
with the proposed offering of the Securities (the &ldquo;Offering&rdquo;). Until the Closing Date (as defined below) or earlier upon termination
of this Agreement pursuant to Section 7, the Company shall not, without the prior written consent of the Placement Agent, solicit or accept
offers to purchase the Securities otherwise than through the Placement Agent.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.5in">(b) The Company hereby acknowledges that the Placement
Agent has agreed, as agent of the Company, to use its reasonable &ldquo;best efforts&rdquo; to solicit offers to purchase the Securities
from the Company on the terms and subject to the conditions set forth herein. The Placement Agent shall use commercially reasonable efforts
to assist the Company in obtaining performance by each Purchaser whose offer to purchase Securities has been solicited by the Placement
Agent and accepted by the Company, but the Placement Agent shall not, except as otherwise provided in this Agreement, be obligated to
disclose the identity of any potential purchaser or have any liability to the Company in the event any such purchase is not consummated
for any reason. Under no circumstances will the Placement Agent be obligated to underwrite or purchase any Securities for its own account
and, in soliciting purchases of the Securities, the Placement Agent shall act solely as the Company&rsquo;s agent and not as principal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">(c) Subject to the provisions of this Section 1,
offers for the purchase of the Securities may be solicited by the Placement Agent as agent for the Company at such times and in such amounts
as the Placement Agent deems advisable. The Placement Agent shall communicate to the Company, orally or in writing, each reasonable offer
to purchase Securities received by it as agent of the Company. The Company shall have the sole right to accept offers to purchase Securities
and may reject any such offer, in whole or in part. The Placement Agent shall have the right, in its discretion reasonably exercised,
without notice to the Company, to reject any offer to purchase Securities received by it, in whole or in part, and any such rejection
shall not be deemed a breach of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">(d) Each Share and accompanying Warrant are being
sold to the Purchasers at a price of $[&#9679;]. The purchases of Securities by the Purchasers shall be evidenced by the execution of
Purchase Agreement by each of the Purchasers and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">(e) <U>Compensation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(i) As compensation for services rendered,
on the Closing Date (as defined in Section 4 hereof), the Company shall pay to the Placement Agent by wire transfer of immediately available
funds to an account designated by the Placement Agent, an aggregate amount equal to six percent (6.0%) of the gross proceeds received
by the Company (the &ldquo;Placement Fee&rdquo;) from the sale of the Securities on such Closing Date. The Placement Agent may retain
other brokers or dealers to act as sub-agents on its behalf in connection with the Offering, the fees of which shall be paid out of the
Placement Fee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ii) The Placement Agent shall be entitled
to compensation set forth in Section 1(e)(i), calculated in the manner set forth herein with respect to the public or private offering
or other financing or capital-raising transaction, including equity, debt and/or equity derivative instruments, of any kind (&ldquo;Tail
Financing&rdquo;) to the extent that such Tail Financing is (A) provided to the Company by investors that were, during the term of this
Agreement, actually introduced to the Company by the Placement Agent and (B) consummated at any time within the twelve (12)-month period
following the expiration or termination of this Agreement, provided that such Tail Financing is by a party actually introduced to the
Company in an offering in which the Company has direct knowledge of such party&rsquo;s participation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.5in">(f) No Securities which the Company has agreed
to sell pursuant to this Agreement and the Purchase Agreement shall be deemed to have been purchased and paid for, or sold by the Company,
until such Securities shall have been delivered to the Purchaser thereof against payment by such Purchaser. If the Company shall default
in its obligations to deliver Securities to a Purchaser whose offer it has accepted, the Company shall indemnify and hold the Placement
Agent harmless against any loss, claim, damage or expense arising from or as a result of such default by the Company subject to and in
accordance with the procedures set forth in Section 5(c) herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.5in">(g) The time and date of closing and delivery of
the documents required to be delivered to the Placement Agent pursuant to Sections 3 and 4 hereof (the &ldquo;Closing&rdquo;) shall be
at 10:00 a.m. (Eastern Time) on [&#9679;] 2025 (the &ldquo;Closing Date&rdquo;) at the office of Thompson Hine LLP, 300 Madison Avenue,
27<FONT STYLE="font-size: 10pt"><SUP>th </SUP></FONT>Floor, New York, NY 10017, or at such other time and location as the Company and
the Placement Agent shall otherwise agree.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.5in">2. <U>Representations and Warranties of the Company</U>.
The representations and warranties of the Company contained in Section 3.1 and Article IV of the Purchase Agreement are hereby incorporated
by reference in this Agreement, as if made directly by the Company to the Placement Agent on the date of this Agreement, with the understanding
that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.5in">(a) any defined terms used in such incorporated
sections shall have the meanings given to them in this Agreement or, if no definition is given to them in this Agreement, such defined
terms will have the meanings given to them in the incorporated sections;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.5in">(b) in the event of a conflict in meaning or defined
term between the incorporated sections and this Agreement, this Agreement shall control; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.5in">(c) references to &ldquo;this Agreement&rdquo;
in the incorporated sections from the Purchase Agreement means this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">3. <U>Conditions of the Obligations of the Placement Agent and the
Purchasers</U>. The respective obligations of the Placement Agent hereunder and the Purchasers under the Purchase Agreement are subject
to each of the following terms and conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.5in">(a) Notification that the Prospectus shall have
been timely filed with the Commission in accordance with Section 4(a) of this Agreement and any material required to be filed by the Company
pursuant to Rule 433(d) of the Rules shall have been timely filed with the Commission in accordance with such rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.5in">(b) No order preventing or suspending the use of
the Prospectus or any &ldquo;free writing prospectus&rdquo; (as defined in Rule 405 of the Rules), shall have been or shall be in effect
and no order suspending the effectiveness of the Registration Statement shall be in effect and no proceedings for such purpose shall be
pending before or, to the Company&rsquo;s knowledge, threatened by the Commission, and any requests for additional information on the
part of the Commission (to be included in the Registration Statement or the Prospectus or otherwise) shall have been complied with to
the satisfaction of the Commission and the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.5in">(c) The representations and warranties of the Company
in the Purchase Agreement and incorporated by reference in this Agreement and in any certificates delivered pursuant to Section 3(d) shall
be true and correct when made and on and as of the Closing Date as if made on such date. The Company shall have performed all covenants
and agreements and satisfied all the conditions contained in this Agreement and the Purchase Agreement required to be performed or satisfied
by it at or before the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.5in">(d) The Placement Agent shall have received on
the Closing Date a certificate, addressed to the Placement Agent and dated the Closing Date, of the chief executive or chief operating
officer and the chief financial officer or chief accounting officer of the Company, in their capacity as such officers, to the effect
that: (i) the representations, warranties and agreements of the Company in the Purchase Agreement were true and correct when made and
are true and correct as of the Closing Date; (ii) the Company has performed all covenants and agreements and satisfied all conditions
contained herein and in the Purchase Agreement; (iii) they have carefully examined the Registration Statement, the Final Prospectus and
any individual Issuer Free Writing Prospectus and, in their opinion (A) as of the Effective Date, neither the Registration Statement nor
the Final Prospectus included, and as of 8:00 a.m. (Eastern Time) on the date of this Agreement, no individual Issuer Free Writing Prospectus,
included, any untrue statement of a material fact and did not omit to state a material fact required to be stated therein or necessary
to make the statements therein, in light of the circumstances under which they were made, not misleading, and (B) since the Effective
Date no event has occurred which should have been set forth in a supplement or otherwise required an amendment to the Registration Statement
or the Final Prospectus and was not so disclosed; (iv) no stop order suspending the effectiveness of the Registration Statement has been
issued and, to their knowledge, no proceedings for that purpose have been instituted or are pending under the Securities Act and (v) there
has not occurred any material adverse change in the assets, properties, condition, financial or otherwise, or in the results of operations,
or business affairs of the Company and its subsidiaries considered as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e) The Company shall have furnished or caused
to be furnished to the Placement Agent such further certificates or documents as the Placement Agent shall have reasonably requested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4. <U>Covenants and other Agreements of the Company and the Placement
Agent</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a) The Company covenants and agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i) The Company shall prepare the Registration Statement
and Prospectus in a form reasonably approved by the Placement Agent and file such Prospectus pursuant to Rule 424(b) under the Securities
Act not later than the Commission&rsquo;s close of business on the second business day following the execution and delivery of this Agreement,
or, if applicable, such earlier time as may be required by the Rules. The Company will file with the Commission all Issuer Free Writing
Prospectuses in the time and manner required under Rules 433(d) or 163(b)(2), as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ii) The Company shall promptly advise the Placement
Agent in writing (A) when any post-effective amendment to the Registration Statement relating to the Securities shall have become effective
or any supplement to the Prospectus shall have been filed, (B) of any request by the Commission for any amendment of the Registration
Statement or the Prospectus or for any additional information, (C) of the issuance by the Commission of any stop order suspending the
effectiveness of the Registration Statement or of any order preventing or suspending the use of any preliminary prospectus or any &ldquo;free
writing prospectus&rdquo;, as defined in Rule 405 of the Rules, or the institution or threatening of any proceeding for that purpose and
(D) of the receipt by the Company of any notification with respect to the suspension of the qualification or registration of the Securities
for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose, in each case as it relates to the offer
and sale of the Securities. The Company shall not file any amendment to the Registration Statement or supplement to the Prospectus or
any document incorporated by reference in the Registration Statement or any Issuer Free Writing Prospectus related to the offer and sale
of the Securities unless the Company has furnished the Placement Agent a copy for its review prior to filing and shall not file any such
proposed amendment or supplement to which the Placement Agent reasonably objects. The Company shall use its reasonable best efforts to
prevent the issuance of any such stop order and, if issued, to obtain as soon as possible the withdrawal thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iii) If, at any time when a prospectus relating
to the Securities (or, in lieu thereof, the notice referred to in Rule 173(a) of the Rules) is required to be delivered under the Securities
Act, any event occurs as a result of which the Prospectus as then amended or supplemented would include any untrue statement of a material
fact or omit to state any material fact necessary to make the statements therein in the light of the circumstances under which they were
made not misleading, or if it shall be necessary to amend or supplement the Prospectus to comply with the Securities Act or the Rules
or the Exchange Act and the rules and regulations of the Commission thereunder, the Company promptly shall prepare and file with the Commission,
subject to the second sentence of paragraph (ii) of this Section 4(a), an amendment or supplement which shall correct such statement or
omission or an amendment which shall effect such compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(iv) If at any time following issuance of an Issuer
Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with
the information contained in the Registration Statement or would include an untrue statement of a material fact or would omit to state
a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances
prevailing at the subsequent time, not misleading, the Company will promptly notify the Placement Agent and will promptly amend or supplement,
at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict or so that the statements in such Issuer
Free Writing Prospectus as so amended or supplemented will not include an untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in light of the circumstances prevailing at such time, not misleading, as the
case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(v) The Company covenants and
agrees to continue to retain (i)&nbsp;an independent public accounting firm registered with the Public Company Accounting Oversight Board
(the &ldquo;PCAOB&rdquo;) for a period of at least three (3)&nbsp;years after the Closing Date and (ii)&nbsp;a competent transfer agent
with respect to the Securities for a period of three (3)&nbsp;years after the Closing Date. In addition, from the date hereof until one
hundred eighty (180) days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue
or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, <U>provided</U>, <U>however</U>,
that the Company may enter into an agreement to issue of shares of Common Stock with the prior written consent of the Placement Agent.
In addition, from the date hereof until one hundred eighty (180) days after the Closing Date, neither the Company nor any Subsidiary shall
effect or enter into an agreement to effect any issuance by the Company or any of its Subsidiaries of shares of Common Stock or Common
Stock Equivalents (as defined in the Purchase Agreement) (or a combination of units thereof) involving a Variable Rate Transaction (as
defined in the Purchase Agreement). &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction in which the Company (i) issues
or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive additional
shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is based upon and/or varies
with the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such debt or equity
securities, or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial
issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related to the
business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction under, any agreement, including,
but not limited to, an equity line of credit or at-the-market offering, whereby the Company may issue securities at a future determined
price; provided, however, that notwithstanding the foregoing, beginning twenty (20) days after the date hereof, the Company may make sales
pursuant to an &ldquo;at the market&rdquo; offering with the Placement Agent. Notwithstanding the foregoing, this Section 4.11 shall not
apply in respect of (i) an Exempt Issuance, except that no Variable Rate Transaction shall be an Exempt Issuance, or (ii) the filing of
any registration statement on Form S-8 or any successor form thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(vi) The Company shall furnish to the Placement Agent
and counsel for the Placement Agent, without charge and upon request, signed copies of the Registration Statement (including all exhibits
thereto and amendments thereof) and, so long as delivery of a prospectus by the Placement Agent or dealer may be required by the Securities
Act or the Rules, as many copies of any Issuer Free Writing Prospectus and the Prospectus and any amendments thereof and supplements thereto
as the Placement Agent may reasonably request. If applicable, the copies of the Registration Statement, preliminary prospectus, any Issuer
Free Writing Prospectus and Prospectus and each amendment and supplement thereto furnished to the Placement Agent will be identical to
the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation
S-T.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(vii) The Company shall cooperate with the Placement
Agent and its counsel with the offering under the laws of such jurisdictions as the Placement Agent may designate and shall maintain such
qualifications in effect so long as required for the distribution of the Securities; provided, however, that the Company shall not be
required in connection therewith, as a condition thereof, to qualify as a foreign corporation or to execute a general consent to service
of process in any jurisdiction or subject itself to taxation as doing business in any jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(viii) The Company, during the period when the Prospectus
(or in lieu thereof, the notice referred to in Rule 173(a) of the Rules) is required to be delivered under the Securities Act and the
Rules or the Exchange Act, will file all reports and other documents required to be filed with the Commission pursuant to Section 13,
14 or 15 of the Exchange Act within the time periods required by the Exchange Act and the regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(ix) On or before completion of this offering, the
Company shall make all filings required under applicable securities laws and by The Nasdaq Capital Market&nbsp;(&ldquo;Nasdaq&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(x) Prior to the Closing Date, the Company will issue
no press release or other communications directly or indirectly and hold no press conference with respect to the Company, the condition,
financial or otherwise, or the earnings, business affairs or business prospects of any of them, or the offering of the Securities without
the prior written consent of the Placement Agent unless in the judgment of the Company and its counsel, and after notification to the
Placement Agent, such press release or communication is required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(xi) The Company will apply the net proceeds from
the offering of the Securities in the manner set forth under &ldquo;Use of Proceeds&rdquo; in the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b) The Company agrees to pay, or reimburse if
paid by the Placement Agent, whether or not the transactions contemplated hereby are consummated or this Agreement is terminated, all
costs and expenses incident to the public offering of the Securities and the performance of the obligations of the Company under this
Agreement including those relating to: (i) the preparation, printing, reproduction filing and distribution of the Registration Statement
including all exhibits thereto, the Prospectus, any Issuer Free Writing Prospectus, all amendments and supplements thereto and any document
incorporated by reference therein, and the printing, filing and distribution of this Agreement; (ii) the preparation and delivery of certificates
for the Securities to or as directed by the Placement Agent or the Purchasers; (iii) the registration or qualification of the Securities
for offer and sale under the securities or Blue Sky laws of the various jurisdictions referred to in Section 5(a)(vi), including the reasonable
fees and disbursements of counsel for the Placement Agent in connection with such registration and qualification and the preparation,
printing, distribution and shipment of preliminary and supplementary Blue Sky memoranda; (iv) the furnishing (including costs of shipping
and mailing) to the Placement Agent of copies of the Prospectus and all amendments or supplements to the Prospectus, any Issuer Free Writing
Prospectus, and of the several documents required by this Section to be so furnished, as may be reasonably requested for use in connection
with the offering and sale of the Securities by the Placement Agent or by dealers to whom Securities may be sold; (v) the filing fees
of FINRA in connection with its review of the terms of the public offering and reasonable fees and disbursements of counsel for the Placement
Agent in connection with such review; (vi) inclusion of the Securities for listing on Nasdaq; and (vii) all transfer taxes, if any, with
respect to the sale and delivery of the Securities by the Company to the Purchasers. The Company will reimburse the Placement Agent for
all reasonable out-of-pocket costs and expenses, including its legal fees and disbursements, in connection with the purchase and sale
of the Securities contemplated hereby in an amount not to exceed $100,000, however, in the event of a termination without a closing the
amount shall not exceed $50,000, without the Company&rsquo;s prior approval (such approval not to be unreasonably withheld, conditioned
or delayed).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c) The Company acknowledges and agrees that the
Placement Agent has acted and is acting solely in the capacity of a principal in an arm&rsquo;s length transaction between the Company,
on the one hand, and the Placement Agent, on the other hand, with respect to the offering of Securities contemplated hereby (including
in connection with determining the terms of the Offering) and not as a financial advisor, agent or fiduciary to the Company or any other
person. Additionally, the Company acknowledges and agrees that the Placement Agent has not and will not advise the Company or any other
person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company has consulted with its own
advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal of the transactions
contemplated hereby, and the Placement Agent shall have no responsibility or liability to the Company or any other person with respect
thereto, whether arising prior to or after the date hereof. Any review by the Placement Agent of the Company, the transactions contemplated
hereby or other matters relating to such transactions have been and will be performed solely for the benefit of the Placement Agent and
shall not be on behalf of the Company. The Company agrees that it will not claim that the Placement Agent has rendered advisory services
of any nature or respect, or owes a fiduciary duty to the Company or any other person in connection with any such transaction or the process
leading thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d) The Company represents and agrees that, unless
it obtains the prior consent of the Placement Agent, and the Placement Agent represents and agrees that, unless it obtains the prior consent
of the Company, it has not made and will not make any offer relating to the Securities that would constitute an &ldquo;issuer free writing
prospectus,&rdquo; as defined in Rule 433, or that would otherwise constitute a &ldquo;free writing prospectus,&rdquo; as defined in Rule
405, required to be filed with the Commission. The Company has complied and will comply with the requirements of Rule 433 under the Act
applicable to any Issuer Free Writing Prospectus, including timely filing with the Commission where required, legending and record keeping.
The Company represents that is has satisfied and agrees that it will satisfy the conditions set forth in Rule 433 of the Rules to avoid
a requirement to file with the Commission any Road Show.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">5. <U>Indemnification</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a) The Company agrees to indemnify and hold harmless
the Placement Agent, its officers and employees and each person, if any, who controls the Placement Agent within the meaning of Section
15 of the Securities Act or Section 20 of the Exchange Act against any and all losses, claims, damages and liabilities, joint or several
(including any reasonable investigation, legal and other expenses incurred in connection with, and any amount paid in settlement of, any
action, suit or proceeding or any claim asserted), to which they, or any of them, may become subject under the Securities Act, the Exchange
Act or other Federal or state law or regulation, at common law or otherwise, insofar as such losses, claims, damages or liabilities arise
out of or are based upon any untrue statement or alleged untrue statement of a material fact contained in any preliminary prospectus,
the Registration Statement, the Prospectus, any Issuer Free Writing Prospectus or any &ldquo;issuer-information&rdquo; filed or required
to be filed pursuant to Rule 433(d) of the Rules, any amendment thereof or supplement thereto, or in any Blue Sky application or other
information or other documents executed by the Company filed in any state or other jurisdiction to qualify any or all of the Securities
under the securities laws thereof (any such application, document or information being hereinafter referred to as a &ldquo;Blue Sky Application&rdquo;)
or arise out of or are based upon any omission or alleged omission to state therein a material fact required to be stated therein or necessary
to make the statements therein, in light of the circumstances under which they were made, not misleading; provided, however, that such
indemnity shall not inure to the benefit of the Placement Agent (or any person controlling such Placement Agent) on account of any losses,
claims, damages or liabilities arising from the sale of the Securities to any person by or through the Placement Agent if such untrue
statement or omission or alleged untrue statement or omission was made in such preliminary prospectus, the Registration Statement, the
Prospectus, any Issuer Free Writing Prospectus or such amendment or supplement thereto, or in any Blue Sky Application in reliance upon
and in conformity with information furnished in writing by the Agent specifically for use in the Prospectus (the &ldquo;Agent Information&rdquo;).
This indemnity agreement will be in addition to any liability which the Company may otherwise have.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b) The Placement Agent agrees to indemnify and
hold harmless the Company and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or
Section 20 of the Exchange Act, each director of the Company, and each officer of the Company who signs the Registration Statement, against
any losses, claims, damages or liabilities (including any reasonable investigation, legal and other expenses incurred in connection with,
and any amount paid in settlement of, any action, suit or proceeding or any claim asserted) to which such party may become subject, under
the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or
are based upon an untrue statement or alleged untrue statement of a material fact contained in any preliminary prospectus, the Registration
Statement, the Prospectus, any Issuer Free Writing Prospectus or any amendment thereof or supplement thereto, or arise out of or are based
upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading, in each case to the extent, but only to the extent,
that such untrue statement or alleged untrue statement or omission or alleged omission was made in the Registration Statement or the Prospectus
or any such amendment or supplement in reliance upon and in conformity with the Agent Information; provided, however, that the obligation
of the Placement Agent to indemnify the Company (including any controlling person, director or officer thereof) shall be limited to the
amount of the Placement Fee actually received by the Placement Agent hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c) Any party that proposes to assert the right
to be indemnified under this Section will, promptly after receipt of notice of commencement of any action, suit or proceeding against
such party in respect of which a claim is to be made against an indemnifying party or parties under this Section, notify each such indemnifying
party of the commencement of such action, suit or proceeding, enclosing a copy of all papers served. No indemnification provided for in
Section 5(a) or 5(b) shall be available to any party who shall fail to give notice as provided in this Section 5(c) if the party to whom
notice was not given was unaware of the action, suit or proceeding to which such notice would have related and was prejudiced by the failure
to give such notice but the omission so to notify such indemnifying party of any such action, suit or proceeding shall not relieve it
from any liability that it may have to any indemnified party for contribution or otherwise than under this Section 5. In case any such
action, suit or proceeding shall be brought against any indemnified party and it shall notify the indemnifying party of the commencement
thereof, the indemnifying party shall be entitled to participate in, and, to the extent that it shall wish, jointly with any other indemnifying
party similarly notified, to assume the defense thereof, with counsel reasonably satisfactory to such indemnified party, and after notice
from the indemnifying party to such indemnified party of its election so to assume the defense thereof and the approval by the indemnified
party of such counsel, the indemnifying party shall not be liable to such indemnified party for any legal or other expenses, except as
provided below and except for the reasonable costs of investigation subsequently incurred by such indemnified party in connection with
the defense thereof. The indemnified party shall have the right to employ its counsel in any such action, but the fees and expenses of
such counsel shall be at the expense of such indemnified party unless (i) the employment of counsel by such indemnified party has been
authorized in writing by the indemnifying parties, (ii) the indemnified party shall have been advised by counsel that there may be one
or more legal defenses available to it which are different from or in addition to those available to the indemnifying party (in which
case the indemnifying parties shall not have the right to direct the defense of such action on behalf of the indemnified party) or (iii)
the indemnifying parties shall not have employed counsel to assume the defense of such action within a reasonable time after notice of
the commencement thereof, in each of which cases the fees and expenses of counsel shall be at the expense of the indemnifying parties.
An indemnifying party shall not be liable for any settlement of any action, suit, and proceeding or claim effected without its written
consent, which consent shall not be unreasonably withheld or delayed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d) No indemnifying party shall, without the prior
written consent of the indemnified party, effect any settlement, compromise or consent to the entry of judgment in any pending or threatened
action, suit or proceeding in respect of which any indemnified party is a party or could be named and indemnity was or would be sought
hereunder by such indemnified party, unless such settlement, compromise or consent (a) includes an unconditional release of such indemnified
party from all liability for claims that are the subject matter of such action, suit or proceeding and (b) does not include a statement
as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">6. <U>Contribution</U>. In order to provide for just and equitable
contribution in circumstances in which the indemnification provided for in Section 5(a) or 5(b) is due in accordance with its terms but
for any reason is unavailable to or insufficient to hold harmless an indemnified party in respect to any losses, liabilities, claims,
damages or expenses referred to therein, then each indemnifying party shall contribute to the aggregate losses, liabilities, claims, damages
and expenses (including any investigation, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement
of, any action, suit or proceeding or any claims asserted, but after deducting any contribution received by any person entitled hereunder
to contribution from any person who may be liable for contribution) incurred by such indemnified party, as incurred, in such proportion
as is appropriate to reflect the relative benefits received by the Company on the one hand and the Placement Agent on the other hand from
the offering of the Securities pursuant to this Agreement or, if such allocation is not permitted by applicable law, in such proportion
as is appropriate to reflect not only the relative benefits referred to above but also the relative fault of the Company on the one hand
and the Placement Agent on the other hand in connection with the statements or omissions which resulted in such losses, liabilities, claims,
damages or expenses, as well as any other relevant equitable considerations. The Company and the Placement Agent agree that it would not
be just and equitable if contribution pursuant to this Section 6 were determined by pro rata allocation or by any other method of allocation
which does not take account of the equitable considerations referred to above. The aggregate amount of losses, liabilities, claims, damages
and expenses incurred by an indemnified party and referred to above shall be deemed to include any legal or other expenses reasonably
incurred by such indemnified party in investigating, preparing or defending against any litigation, or any investigation or proceeding
by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue or alleged untrue statement
or omission or alleged omission. Notwithstanding the provisions of this Section 6, (i) the Placement Agent shall not be required to contribute
any amount in excess of the Placement Fee actually received by the Placement Agent; and no person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such
fraudulent misrepresentation. For purposes of this Section 6, each person, if any, who controls an Placement Agent within the meaning
of Section 15 of the Securities Act or Section 20 of the Exchange Act shall have the same rights to contribution as the Placement Agent,
and each director of the Company, each officer of the Company who signed the Registration Statement, and each person, if any, who controls
the Company within the meaning of the Section 15 of the Securities Act or Section 20 of the Exchange Act, shall have the same rights to
contribution as the Company. Any party entitled to contribution will, promptly after receipt of notice of commencement of any action,
suit or proceeding against such party in respect of which a claim for contribution may be made against another party or parties under
this Section 6, notify such party or parties from whom contribution may be sought, but the omission so to notify such party or parties
from whom contribution may be sought shall not relieve the party or parties from whom contribution may be sought from any other obligation
it or they may have hereunder or otherwise than under this Section 6. No party shall be liable for contribution with respect to any action,
suit, proceeding or claim settled without its written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">7. <U>Termination</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a) This Agreement may be terminated by the Placement
Agent, in the absolute discretion of the Placement Agent, by notifying the Company at any time at or before the Closing Date if (i) trading
in the Common Stock has been suspended by the Commission or Nasdaq, (ii) trading in securities generally as reported by Bloomberg L.P.
has been suspended or limited, or minimum prices have not been established on securities whose trades are reported by such service, or
on any trading market, (iii) a banking moratorium has been declared either by the United States or New York State authorities, (iv) there
has occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in its effect
on, or (v) any material adverse change in, any financial market which, in the case of clauses (i) through (v), in the reasonable judgment
of the Placement Agent, makes it impracticable or inadvisable to market the Securities or enforce contracts for the sale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b) If this Agreement is terminated pursuant to
any of its provisions, the Company shall not be under any liability to Placement Agent, and the Placement Agent shall not be under any
liability to the Company, except that if this Agreement is terminated by the Placement Agent because of any failure, refusal or inability
on the part of the Company to comply with the terms or to fulfill any of the conditions of this Agreement or the other Transaction Documents,
the Company will reimburse the Placement Agent for all out-of-pocket expenses (including the reasonable fees and disbursements of its
counsel) incurred by it in connection with the proposed Offering or in contemplation of performing their obligations hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>8. Closing</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The obligations of the Placement Agent, and the closing of the sale
of the Securities hereunder are subject to the accuracy, when made and on the Closing Date, of the representations and warranties on the
part of the Company and its subsidiaries contained herein and in the Purchase Agreement, to the accuracy of the statements of the Company
and its subsidiaries made in any certificates pursuant to the provisions hereof, to the performance by the Company and its subsidiaries
of their obligations hereunder, and to each of the following additional terms and conditions, except as otherwise disclosed to and acknowledged
and waived by the Placement Agent to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">(a) No stop order suspending
the effectiveness of the Registration Statement shall have been issued and no proceedings for that purpose shall have been initiated or
threatened by the Commission, and any request for additional information on the part of the Commission (to be included in the Registration
Statement, the Final Prospectus, or otherwise) shall have been complied with to the reasonable satisfaction of the Placement Agent. Any
filings required to be made by the Company in connection with the Offering shall have been timely filed with the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">(b) The Placement Agent shall
not have discovered and disclosed to the Company on or prior to the Closing Date that the Registration Statement, the Final Prospectus
or any amendment or supplement thereto contains an untrue statement of a fact which, in the reasonable opinion of counsel for the Placement
Agent, is material or omits to state any fact which, in the reasonable opinion of such counsel, is material and is required to be stated
therein or is necessary to make the statements therein not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">(c) All corporate proceedings
and other legal matters incident to the authorization, form, execution, delivery and validity of each of this Agreement, the Shares, the
Registration Statement, the Final Prospectus and all other legal matters relating to this Agreement and the transactions contemplated
hereby shall be reasonably satisfactory in all material respects to counsel for the Placement Agent, and the Company shall have furnished
to such counsel all documents and information that they may reasonably request to enable them to pass upon such matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">(d) The Placement Agent shall
have received from outside counsel to the Company such counsel&rsquo;s written opinions, including a negative assurance letter, addressed
to the Placement Agent and the Purchasers and dated as of the Closing Date, in form and substance reasonably satisfactory to the Placement
Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">(e) On the Closing Date, the
Placement Agent shall have (i) received a comfort letter from OneStop Assurance PAC (the independent registered public accounting firm
of the Company), addressed to the Placement Agent, and (ii) received a certificate from the Chief Financial Officer of the Company, addressed
to the Placement Agent, and each in form and substance satisfactory in all respects to the Placement Agent and Placement Agent&rsquo;s
counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">(f) On the Closing Date, Placement
Agent shall have received a certificate of the Chief Executive Officer or other authorized officer of the Company, dated, as applicable,
as of the date of such Closing, to the effect that, as of the date of this Agreement and as of the applicable date, the representations
and warranties of the Company contained herein and in the Purchase Agreement were and are accurate in all material respects, except for
such changes as are contemplated by this Agreement and except as to representations and warranties that were expressly limited to a state
of facts existing at a time prior to the applicable Closing Date, and that, as of the applicable date, the obligations to be performed
by the Company hereunder on or prior thereto have been fully performed in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">(g) On the Closing Date, Placement
Agent shall have received a certificate of the Secretary of the Company, dated as of the date of such Closing, certifying to the organizational
documents, good standing in the jurisdiction of incorporation of the Company and board resolutions relating to the Offering of the Securities
from the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">(h) Neither the Company nor
any of its subsidiaries (i) shall have sustained since the date of the latest audited financial statements included or incorporated by
reference in the Registration Statement and the Final Prospectus, any loss or interference with its business from fire, explosion, flood,
terrorist act or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order
or decree, otherwise than as set forth in or contemplated by the Registration Statement and the Final Prospectus, (ii) since such date
there shall not have been any change in the capital stock or long-term debt of the Company or any of its subsidiaries or any change, or
any development involving a prospective change, in or affecting the business, general affairs, management, financial position, shareholders&rsquo;
equity, results of operations or prospects of the Company and its subsidiaries, otherwise than as set forth in or contemplated by the
Registration Statement and the Final Prospectus, and (iii) since such date there shall not have been any new or renewed inquiries by the
Commission, FINRA or any other regulatory body regarding the Company, the effect of which, in any such case described in clause (i), (ii)
or (iii), is, in the judgment of the Placement Agent, so material and adverse as to make it impracticable or inadvisable to proceed with
the sale or delivery of the Securities on the terms and in the manner contemplated by the Registration Statement and Final Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">(i) The Common Stock is registered
under the Exchange Act and, as of the Closing Date, the Shares and the Warrant Shares shall be listed and admitted and authorized for
trading on the Nasdaq or other applicable U.S. national exchange, or an application for such listing shall have been submitted to the
Nasdaq, and satisfactory evidence of such action shall have been provided to the Placement Agent. The Company shall have taken no action
designed to, or likely to have the effect of terminating the registration of the Common Stock under the Exchange Act or delisting or suspending
from trading the Common Stock from Nasdaq or other applicable U.S. national exchange, nor, except as disclosed in the Registration Statement
and Final Prospectus, has the Company received any information suggesting that the Commission or Nasdaq or other U.S. applicable national
exchange is contemplating terminating such registration or listing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">(j) No action shall have been
taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental agency or body which would,
as of the Closing Date, prevent the issuance or sale of the Securities or materially and adversely affect or potentially and adversely
affect the business or operations of the Company; and no injunction, restraining order or order of any other nature by any federal or
state court of competent jurisdiction shall have been issued as of the Closing Date which would prevent the issuance or sale of the Securities
or materially and adversely affect or potentially and adversely affect the business or operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">(k) The Company shall have
prepared and filed with the Commission a Form 8-K with respect to the Offering, including as an exhibit thereto this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">(l) The Company shall have
entered into a Purchase Agreement with each of the Purchasers and such agreements shall be in full force and effect and shall contain
representations, warranties and covenants of the Company as agreed between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">(m) FINRA shall have raised
no objection to the fairness and reasonableness of the terms and arrangements of this Agreement. In addition, the Company shall, if requested
by the Placement Agent, make or authorize Placement Agent&rsquo;s counsel to make on the Company&rsquo;s behalf, any filing with the FINRA
Corporate Financing Department pursuant to FINRA Rule 5110 with respect to the Offering and pay all filing fees required in connection
therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">(n) Prior to the Closing Date,
Placement Agent shall have received signed Lock-Up Agreements, addressed to the Placement Agent by Changhyuk Kang and each of the Company&rsquo;s
directors, officers, and holders of 5% or more of the Company&rsquo;s issued and outstanding Common Stock, provided such lock-up shall
not exceed 90 days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">(o) Prior to the Closing Date,
the Company shall have furnished to the Placement Agent such further information, certificates and documents as the Placement Agent may
reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">If any of the conditions specified in this Section
8 shall not have been fulfilled when and as required by this Agreement, or if any of the certificates, opinions, written statements or
letters furnished to the Placement Agent or to Placement Agent&rsquo;s counsel pursuant to this Section 8 shall not be reasonably satisfactory
in form and substance to the Placement Agent and to Placement Agent&rsquo;s counsel, all obligations of the Placement Agent hereunder
may be cancelled by the Placement Agent at, or at any time prior to, the consummation of the Closing. Notice of such cancellation shall
be given to the Company in writing or orally. Any such oral notice shall be confirmed promptly thereafter in writing.</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">9. <U>Miscellaneous</U>. The respective agreements, representations,
warranties, indemnities, rights of contribution and other statements of the Company, and the Placement Agent, as set forth in this Agreement
or made by or on behalf of them pursuant to this Agreement, shall remain in full force and effect, regardless of any investigation (or
any statement as to the results thereof) made by or on behalf of the Placement Agent or the Company or the or any of their respective
officers, directors or controlling persons referred to in Sections 5, 6 and 7 hereof, and shall survive delivery of and payment for the
Securities. In addition, the provisions of Sections 4(b), 5, 6 and 7 shall survive the termination or cancellation of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Agreement has been and is made for the benefit of the Placement
Agent, the Company and their respective successors and assigns, and, to the extent expressed herein, for the benefit of persons controlling
the Placement Agent, or the Company, and directors and officers of the Company, and their respective successors and assigns, and no other
person shall acquire or have any right under or by virtue of this Agreement. The term &ldquo;successors and assigns&rdquo; shall not include
any Purchaser merely because of such purchase. The invalidity or unenforceability of any Section, paragraph or provision of this Agreement
shall not affect the validity or enforceability of any other Section, paragraph or provision hereof. If any Section, paragraph or provision
of this Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to be made such minor changes (and
only such minor changes) as are necessary to make it valid and enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">No amendment or waiver of any provision of this Agreement, nor any
consent or approval to any departure therefrom, shall in any event be effective unless and until the same shall be in writing and signed
by the Company and the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">All notices and communications hereunder shall be in writing and mailed
or delivered or by telephone or if subsequently confirmed in writing, or other electronic transmission (a) if to the Placement Agent,
c/o D. Boral Capital LLC, 590 Madison Avenue, 39<FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT> Floor, New York, New York 10022 Attention:
Equity Capital Markets, and to Thompson Hine LLP, 300 Madison Avenue, 27<SUP>th</SUP> Floor, New York, NY 10017, Attention: Faith Charles
and (b) if to the Company, to its agent for service as such agent&rsquo;s address appears on the cover page of the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>This Agreement and any claim, controversy or dispute arising under
or related to this Agreement shall be governed by and construed in accordance with the laws of the State of New York applicable to agreements
made and to be performed in such state.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Agreement may be signed in any number of counterparts, each of
which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. The headings herein
are included for convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation of, this
Agreement. This Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written or oral and
all contemporaneous oral agreements, understandings and negotiations with respect to the subject matter hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Please confirm that the foregoing correctly sets forth the agreement
among us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: justify">Very truly yours,</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">GLOBAL INTERACTIVE TECHNOLOGIES, INC. </TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 5%">By</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; padding-bottom: 1pt; width: 35%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Name:</TD>
    <TD STYLE="text-align: justify">Taehoon Kim</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">Title:</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">Chief Executive Officer&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">Confirmed: </TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">D. BORAL CAPITAL LLC</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 5%">By</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; padding-bottom: 1pt; width: 35%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Name: </TD>
    <TD STYLE="text-align: justify">Phil Wiederlight</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="text-align: justify">Chief Operating Officer</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Issuer Free Writing Prospectuses</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">13</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>3
<FILENAME>ea025365101ex4-3_global.htm
<DESCRIPTION>FORM OF WARRANT OF THE COMPANY TO BE ISSUED IN THIS OFFERING
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Global
Interactive Technologies, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%">Warrant Shares:</TD>
    <TD STYLE="width: 18%; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 40%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: right">Issue Date:</TD>
    <TD STYLE="width: 17%; text-align: right">[&#9679;], 2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">This COMMON STOCK PURCHASE WARRANT
(the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
or its assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00
p.m. (New York City time) on [&#9679;], 2030 (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase
from Global Interactive Technologies, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
shares of common stock, par value $0.001 per share (the &ldquo;<U>Common Stock</U>&rdquo;), of the Company (as subject to adjustment hereunder,
the &ldquo;<U>Warrant Shares</U>&rdquo;). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise
Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated [&#9679;], 2025, among the Company and the purchasers signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">a) <U>Exercise of
Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or
after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed copy submitted by
email (or email attachment) of the Notice of Exercise in the form annexed hereto as <B>Exhibit A</B> (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within one Trading Day following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant
Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the
cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in
which case, the Holder shall surrender this Warrant to the Company for cancellation within three Trading Days of the date on which the
final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total
number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder
in an amount equal to the applicable number of Warrant Shares so purchased. The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise
within one Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree
that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of
Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">b) <U>Exercise Price</U>.
The exercise price per share of Common Stock under this Warrant shall be $[&#9679;], subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">c) <U>Cashless Exercise</U>.
If at the time of exercise hereof, there is no effective registration statement registering, or the prospectus contained therein is not
available for the issuance or resale of the Warrant Shares to or by the Holder, then this Warrant may also be exercised, in whole or in
part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.35in">(A) =</TD>
    <TD STYLE="text-align: left">as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Company&rsquo;s receipt of Holder&rsquo;s Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two hours thereafter (including until two hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>(B) = </TD>
    <TD STYLE="text-align: justify">the Exercise Price of this Warrant, as adjusted hereunder; and</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>(X) =</TD>
    <TD STYLE="text-align: left">the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market other than the OTCQB or OTCQX, the bid price of the Common Stock for the time in question (or the nearest preceding
date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Common Stock are then listed or quoted on the OTCQB or OTCQX,
the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)
if the Common Stock is not then listed or quoted for trading on a Trading Market and if prices for the Common Stock are then reported
on Pink Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share
of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent
appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable
to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>OTCQB</U>&rdquo;
means the OTCQB Venture Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>OTCQX</U>&rdquo;
means the OTCQX Best Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Pink Market</U>&rdquo;
means The Pink Limited Market operated by the OTC Markets Group Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market other than the OTCQB or OTCQX, the daily volume weighted average price of the Common Stock for such date (or
the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on
a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Common Stock are then listed or quoted
on the OTCQB or OTCQX, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or
OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on a Trading Market and if prices for the Common
Stock are then reported on Pink Market (or a similar organization or agency succeeding to its functions of reporting prices), the most
recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock
as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding
and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Mechanics
of Exercise</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">i. <U>Delivery of
Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares issued in connection with an exercise of the Warrant to be
transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account
with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is
then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares
to or resale of the Warrant Shares by the Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical
delivery of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number
of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise
by the date that is the earlier of (i) one Trading Day after the delivery to the Company of the Notice of Exercise and (ii) one Trading
Day after delivery of the aggregate Exercise Price to the Company (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon
delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant
Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that
payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by the Warrant Delivery Date. If the
Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery
Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject
to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing
to $20 per Trading Day on the third Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant
Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer
agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than a failure that is solely due to any action
or inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to purchase (in
an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver in
satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with such exercise by (2) the price at which the
sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of
the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed
rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with
its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000
to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase
obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000.
The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request
of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available
to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect
to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">v. <U>No Fractional
Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As
to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the number of Warrant Shares to
be issued shall be rounded down to the nearest whole number and the Company shall pay a cash adjustment in respect of such final fraction
in an amount equal to such fraction multiplied by the Exercise Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto as <B>Exhibit B</B> duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the
number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with
the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company
or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the
Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of
securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such
number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or,
upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company,
may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation
in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares
of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any
increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company.
The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of
this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial
Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation.
The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">a) <U>Stock Dividends
and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution
or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which,
for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides
outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding
shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of
capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the
number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator
shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise
of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment
made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled
to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision,
combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">b) <U>Adjustment
Upon Issuance of Shares of Common Stock</U>. If and whenever on or after the Initial Exercise Date, the Company grants, issues or sells
(or enters into any agreement to grant, issue or sell), or in accordance with this Section 3 is deemed to have granted, issued or sold,
any shares of Common Stock (including the issuance or sale of shares of Common Stock owned or held by or for the account of the Company,
but excluding any Excluded Securities granted, issued or sold or deemed to have been granted, issued or sold) for a consideration per
share (the &ldquo;<U>New Issuance Price</U>&rdquo;) less than a price equal to the Exercise Price in effect immediately prior to such
granting, issuance or sale or deemed granting issuance or sale (such Exercise Price then in effect is referred to herein as the &ldquo;<U>Applicable
Price</U>&rdquo;) (the foregoing a &ldquo;<U>Dilutive Issuance</U>&rdquo;), then immediately after such Dilutive Issuance, the Exercise
Price then in effect shall be reduced to an amount equal to the New Issuance Price and the number of Warrant Shares issuable upon exercise
of this Warrant shall be increased such that the aggregate Exercise Price payable hereunder, after taking into account the decrease in
the Exercise Price, shall be equal to the aggregate Exercise Price on the Issuance Date provided that the New Issuance Price shall not
be less than $[__]<SUP></SUP> (subject to adjustment for reverse and forward stock splits, recapitalizations and similar transactions
following the date of the Underwriting Agreement). For all purposes of the foregoing (including, without limitation, determining the
adjusted Exercise Price and the New Issuance Price under this <U>Section 3(b)</U>), the following shall be applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(i) <U>Issuance of Options</U>.
If the Company in any manner grants, issues or sells (or enters into any agreement to grant, issue or sell) any Options and the lowest
price per share for which one share of Common Stock is at any time issuable upon the exercise of any such Option or upon conversion,
exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise pursuant to the terms thereof
is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding and to have been issued and sold
by the Company at the time of the granting or sale of such Option for such price per share. For purposes of this <U>Section 3(b)(i)</U>,
the &ldquo;lowest price per share for which one share of Common Stock is at any time issuable upon the exercise of any such Options or
upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise pursuant to
the terms thereof&rdquo; shall be equal to (1) the lower of (x) the sum of the lowest amounts of consideration (if any) received or receivable
by the Company with respect to any one share of Common Stock upon the granting, issuance or sale of such Option, upon exercise of such
Option and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise of such Option or otherwise pursuant
to the terms thereof and (y) the lowest exercise price set forth in such Option for which one share of Common Stock is issuable (or may
become issuable assuming all possible market conditions) upon the exercise of any such Options or upon conversion, exercise or exchange
of any Convertible Securities issuable upon exercise of any such Option or otherwise pursuant to the terms thereof minus (2) the sum
of all amounts paid or payable to the holder of such Option (or any other Person) upon the granting, issuance or sale of such Option,
upon exercise of such Option and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise of such Option
or otherwise pursuant to the terms thereof plus the value of any other consideration received or receivable by, or benefit conferred
on, the holder of such Option (or any other Person). Except as contemplated below, no further adjustment of the Exercise Price shall
be made upon the actual issuance of such shares of Common Stock or of such Convertible Securities upon the exercise of such Options or
otherwise pursuant to the terms of or upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of
such Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(ii) <U>Issuance of
Convertible Securities</U>. If the Company in any manner issues or sells (or enters into any agreement to issue or sell) any Convertible
Securities and the lowest price per share for which one share of Common Stock is at any time issuable upon the conversion, exercise or
exchange thereof or otherwise pursuant to the terms thereof is less than the Applicable Price, then such share of Common Stock shall be
deemed to be outstanding and to have been issued and sold by the Company at the time of the issuance or sale (or the time of execution
of such agreement to issue or sell, as applicable) of such Convertible Securities for such price per share. For the purposes of this <U>Section
3(b)(ii)</U>, the &ldquo;lowest price per share for which one share of Common Stock is at any time issuable upon the conversion, exercise
or exchange thereof or otherwise pursuant to the terms thereof&rdquo; shall be equal to (1) the lower of (x) the sum of the lowest amounts
of consideration (if any) received or receivable by the Company with respect to one share of Common Stock upon the issuance or sale (or
pursuant to the agreement to issue or sell, as applicable) of the Convertible Security and upon conversion, exercise or exchange of such
Convertible Security or otherwise pursuant to the terms thereof and (y) the lowest conversion price set forth in such Convertible Security
for which one share of Common Stock is issuable (or may become issuable assuming all possible market conditions) upon conversion, exercise
or exchange thereof or otherwise pursuant to the terms thereof minus (2) the sum of all amounts paid or payable to the holder of such
Convertible Security (or any other Person) upon the issuance or sale (or the agreement to issue or sell, as applicable) of such Convertible
Security plus the value of any other consideration received or receivable by, or benefit conferred on, the holder of such Convertible
Security (or any other Person). Except as contemplated below, no further adjustment of the Exercise Price shall be made upon the actual
issuance of such shares of Common Stock upon conversion, exercise or exchange of such Convertible Securities or otherwise pursuant to
the terms thereof, and if any such issuance or sale of such Convertible Securities is made upon exercise of any Options for which adjustment
of this Warrant has been or is to be made pursuant to other provisions of this Section 3(b), except as contemplated below, no further
adjustment of the Exercise Price shall be made by reason of such issuance or sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(iii) <U>Change in
Option Price or Rate of Conversion</U>. If the purchase or exercise price provided for in any Options, the additional consideration, if
any, payable upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate at which any Convertible Securities
are convertible into or exercisable or exchangeable for shares of Common Stock increases or decreases at any time (other than proportional
changes in conversion or exercise prices, as applicable, in connection with an event referred to in <U>Section 3(a)</U>), the Exercise
Price in effect at the time of such increase or decrease shall be adjusted to the Exercise Price which would have been in effect at such
time had such Options or Convertible Securities provided for such increased or decreased purchase price, additional consideration or increased
or decreased conversion rate, as the case may be, at the time initially granted, issued or sold. For purposes of this <U>Section 3(b)(iii</U>),
if the terms of any Option or Convertible Security (including, without limitation, any Option or Convertible Security that was outstanding
as of the Initial Exercise Date) are increased or decreased in the manner described in the immediately preceding sentence, then such Option
or Convertible Security and the shares of Common Stock deemed issuable upon exercise, conversion or exchange thereof shall be deemed to
have been issued as of the date of such increase or decrease. No adjustment pursuant to this Section 3(b) shall be made if such adjustment
would result in an increase of the Exercise Price then in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(iv) <U>Calculation
of Consideration Received</U>. If any Option and/or Convertible Security and/or Adjustment Right is issued in connection with the issuance
or sale or deemed issuance or sale of any other securities of the Company (as determined by the Holder, the &ldquo;<U>Primary Security</U>&rdquo;,
and such Option and/or Convertible Security and/or Adjustment Right, the &ldquo;<U>Secondary Securities</U>&rdquo; and together with the
Primary Security, each a &ldquo;<U>Unit</U>&rdquo;), together comprising one integrated transaction, the aggregate consideration per share
of Common Stock with respect to such Primary Security shall be deemed to be the lower of (x) the purchase price of such Unit, (y) if such
Primary Security is an Option and/or Convertible Security, the lowest price per share for which one share of Common Stock is at any time
issuable upon the exercise or conversion of the Primary Security in accordance with <U>Sections 3(b)(i) or 3(b)(ii)</U> above and (z)
the lowest VWAP of the Common Stock on any Trading Day during the five (5) Trading Day period (the &ldquo;<U>Adjustment Period</U>&rdquo;)
immediately following the public announcement of such Dilutive Issuance (for the avoidance of doubt, if such public announcement is released
prior to the opening of the principal Trading Market of the Common Stock on a Trading Day, such Trading Day shall be the first Trading
Day in such five Trading Day period and if this Warrant is exercised, on any given Exercise Date during any such Adjustment Period, solely
with respect to such portion of this Warrant converted on such applicable Exercise Date, such applicable Adjustment Period shall be deemed
to have ended on, and included, the Trading Day immediately prior to such Exercise Date). If any shares of Common Stock, Options or Convertible
Securities are issued or sold or deemed to have been issued or sold for cash, the consideration received therefor will be deemed to be
the net amount of consideration received by the Company therefor. If any shares of Common Stock, Options or Convertible Securities are
issued or sold for a consideration other than cash, the amount of such consideration received by the Company will be the fair value of
such consideration, except where such consideration consists of publicly traded securities, in which case the amount of consideration
received by the Company for such securities will be the arithmetic average of the VWAPs of such security for each of the five (5) Trading
Days immediately preceding the date of receipt. If any shares of Common Stock, Options or Convertible Securities are issued to the owners
of the non-surviving entity in connection with any merger in which the Company is the surviving entity, the amount of consideration therefor
will be deemed to be the fair value of such portion of the net assets and business of the non-surviving entity as is attributable to such
shares of Common Stock, Options or Convertible Securities (as the case may be). The fair value of any consideration other than cash or
publicly traded securities will be determined jointly by the Company and the Holder. If such parties are unable to reach agreement within
ten (10) days after the occurrence of an event requiring valuation (the &ldquo;<U>Valuation Event</U>&rdquo;), the fair value of such
consideration will be determined within five (5) Trading Days after the tenth (10th) day following such Valuation Event by an independent,
reputable appraiser jointly selected by the Company and the Holder. The determination of such appraiser shall be final and binding upon
all parties absent manifest error and the fees and expenses of such appraiser shall be borne by the Company.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(v) <U>Certain Definitions</U>. &ldquo;<U>Options</U>&rdquo;
mean any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.; Convertible Securities.
&ldquo;<U>Convertible Securities</U>&rdquo; means any stock or other security (other than Options) that is at any time and under any circumstances,
directly or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire,
any shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">c) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to all (or substantially all)
of the record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled
to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the
Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations
on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is
taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders
of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>,
that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership
of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held
in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">d) <U>Pro Rata Distributions</U>.
During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets
(or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation,
any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement,
scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant,
then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have
participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the
date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>, that, to the extent
that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares
of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the
benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><U>e) Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary, directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one
or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company
or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other
securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or 50% or more of the
voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common
Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in
one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation,
a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other
Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or more of the voting power of the common equity
of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall
have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence
of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in <U>Section 2(e)</U> on the exercise
of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving
corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental
Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental
Transaction (without regard to any limitation in <U>Section 2(e)</U> on the exercise of this Warrant). For purposes of any such exercise,
the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of
Alternate Consideration issuable in respect of one (1) share of Common Stock in such Fundamental Transaction, and the Company shall apportion
the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components
of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received
in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise
of this Warrant following such Fundamental Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">Notwithstanding
anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at
the Holder&rsquo;s option, exercisable at any time concurrently with, or within thirty (30) days after, the consummation of the Fundamental
Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from
the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised
portion of this Warrant on the date of the consummation of such Fundamental Transaction; <U>provided</U>, <U>however</U>, that, if the
Fundamental Transaction is not within the Company&rsquo;s control, including not approved by the Board of Directors of the Company (the
<U>&ldquo;Board of Directors</U>&rdquo;), the Holder shall only be entitled to receive from the Company or any Successor Entity the same
type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that
is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration
be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from
among alternative forms of consideration in connection with the Fundamental Transaction; <U>provided</U>, <U>further</U>, that if holders
of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock
will be deemed to have received common stock of the Successor Entity (which Entity may be the Company following such Fundamental Transaction)
in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant based on the Black-Scholes Option
Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the day of consummation of the applicable contemplated
Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for
a period equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date,
(B) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the historical volatility function on
Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement of
the applicable contemplated Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater
of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered
in such Fundamental Transaction and (ii) the highest VWAP during the period beginning on the Trading Day immediately preceding the public
announcement of the applicable contemplated Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if
earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant to this <U>Section 3(e)</U>, (D) a remaining option time
equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination
Date, and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds
(or such other consideration) within five (5) Trading Days of the Holder&rsquo;s election (or, if later, on the date of consummation of
the Fundamental Transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">The Company shall
cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;)
to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions of this <U>Section 3(e)</U>
pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable
delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant
a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which
is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the
shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this
Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of
capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the
value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting
the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory
in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the
term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead
to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities,
jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor
Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with
the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company
herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this <U>Section 3(e)</U> regardless
of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental
Transaction occurs prior to the Initial Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Notice to
Holder</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">ii. <U>Notice to
Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock,
(B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize
the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class
or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the
Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of all or
substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice (unless such information is filed with the Commission, in which case a notice shall not be required) stating (x) the
date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is
not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption,
rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share
exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record
shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in
the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that
any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain
entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">h) <U>Voluntary
Adjustment by Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of
this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this
Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any
transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute
and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three Trading Days of the date on which the Holder delivers an assignment form to the Company
assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase
of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">b) <U>New Warrants</U>.
This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together
with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent
or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company
shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with
such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be identical with this
Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">c) <U>Warrant Register</U>.
The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant Register</U>&rdquo;),
in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the
absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual
notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">a) <U>No Rights
as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends or
other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth
in Section 3. Without limiting the rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to Section
2(c), or to receive cash payments contemplated by Section 2(d)(i) and Section 2(d)(iv) herein, in no event will the Company be required
to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">b) <U>Loss, Theft,
Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to
it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">d) <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of this Warrant. The Company further covenants that its
issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant
Shares upon the exercise of this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant
Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market
upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of this
Warrant will, upon exercise hereunder and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued,
fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other
than taxes in respect of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">e) <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder
in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">h) <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder of this Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the Company has caused this
Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GLOBAL INTERACTIVE TECHNOLOGIES, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 35%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page to Common Stock Purchase Warrant
of </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Global Interactive Technologies, Inc.</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">To: </FONT>Global Interactive
Technologies, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(1) The undersigned hereby elects
to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant, and tenders herewith payment of the
exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment shall take the form
of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify">in lawful money of the United States; or</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD>
    <TD STYLE="text-align: left">if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(3) Please issue said Warrant
Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>(To assign the foregoing Warrant, execute this
form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10.5pt">FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>Name:</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Address:</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(Please Print) </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Phone Number:</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Email Address:</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Dated: _______________ __, ______</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Holder&rsquo;s Signature:_______________________________<U>&nbsp;</U></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Holder&rsquo;s Address:<U>&nbsp;</U>_______________________________</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>4
<FILENAME>ea025365101ex4-4_global.htm
<DESCRIPTION>FORM OF PRE-FUNDED WARRANT OF THE COMPANY TO BE ISSUED IN THIS OFFERING
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PRE-FUNDED COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Global
Interactive Technologies, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%">Warrant Shares:</TD>
    <TD STYLE="width: 18%; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 40%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: right">Issue Date:</TD>
    <TD STYLE="width: 17%; text-align: right">[&#9679;], 2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">This PRE-FUNDED COMMON STOCK
PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
or its assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and until this Warrant
is exercised in full (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Global Interactive
Technologies, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
shares of common stock, par value $0.001 per share (the &ldquo;<U>Common Stock</U>&rdquo;), of the Company (as subject to adjustment hereunder,
the &ldquo;<U>Warrant Shares</U>&rdquo;). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise
Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated [&#9679;], 2025, among the Company and the purchasers signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">a) <U>Exercise of
Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or
after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed copy submitted by
email (or email attachment) of the Notice of Exercise in the form annexed hereto as <B>Exhibit A</B> (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within one Trading Day following the date of exercise as aforesaid, the Holder shall deliver the unpaid portion of the aggregate Exercise
Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United
States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.
No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of
any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three Trading Days of the date
on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion
of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares so purchased. The Holder and the Company shall maintain records
showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of
Exercise within one Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge
and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the
number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">b) <U>Exercise Price</U>.
The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the
Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price
of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder
shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance
or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining
unpaid exercise price per Warrant Share under this Warrant shall be $0.0001, subject to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">c) <U>Cashless Exercise</U>.
Subject to the terms and conditions hereof, this Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless
exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing
[(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.35in">(A) =</TD>
    <TD STYLE="text-align: left">as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Company&rsquo;s receipt of Holder&rsquo;s Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two hours thereafter (including until two hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>(B) = </TD>
    <TD STYLE="text-align: justify">the Exercise Price of this Warrant, as adjusted hereunder; and</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>(X) =</TD>
    <TD STYLE="text-align: left">the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market other than the OTCQB or OTCQX, the bid price of the Common Stock for the time in question (or the nearest preceding
date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Common Stock are then listed or quoted on the OTCQB or OTCQX,
the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)
if the Common Stock is not then listed or quoted for trading on a Trading Market and if prices for the Common Stock are then reported
on Pink Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share
of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent
appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable
to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>OTCQB</U>&rdquo;
means the OTCQB Venture Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>OTCQX</U>&rdquo;
means the OTCQX Best Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Pink Market</U>&rdquo;
means The Pink Limited Market operated by the OTC Markets Group Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market other than the OTCQB or OTCQX, the daily volume weighted average price of the Common Stock for such date (or
the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on
a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Common Stock are then listed or quoted
on the OTCQB or OTCQX, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or
OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on a Trading Market and if prices for the Common
Stock are then reported on Pink Market (or a similar organization or agency succeeding to its functions of reporting prices), the most
recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock
as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding
and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Mechanics
of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">i. <U>Delivery of
Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares issued in connection with an exercise of the Warrant to be
transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account
with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is
then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares
to or resale of the Warrant Shares by the Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical
delivery of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number
of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise
by the date that is the earlier of (i) one Trading Day after the delivery to the Company of the Notice of Exercise and (ii) one Trading
Day after delivery of the aggregate Exercise Price to the Company (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon
delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant
Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that
payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by the Warrant Delivery Date. If the
Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery
Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject
to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing
to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant
Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer
agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than a failure that is solely due to any action
or inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to purchase (in
an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver in
satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with such exercise by (2) the price at which the
sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of
the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed
rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with
its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000
to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase
obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000.
The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request
of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available
to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect
to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">v. <U>No Fractional
Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As
to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the number of Warrant Shares to
be issued shall be rounded down to the nearest whole number and the Company shall pay a cash adjustment in respect of such final fraction
in an amount equal to such fraction multiplied by the Exercise Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto as <B>Exhibit B</B> duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the
number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with
the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company
or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the
Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of
securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such
number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% of
the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable
upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions
of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common
Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the
Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be
effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented
in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof)
which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements
necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor
holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">a) <U>Stock Dividends
and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution
or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which,
for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides
outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding
shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of
capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the
number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator
shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise
of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment
made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled
to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision,
combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">b) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to all (or substantially all)
of the record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled
to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the
Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations
on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is
taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders
of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>,
that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership
of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held
in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">c) <U>Pro Rata Distributions</U>.
During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets
(or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation,
any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement,
scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant,
then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have
participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the
date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>, that, to the extent
that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares
of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the
benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">d) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (all of its Subsidiaries, taken as a
whole) directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of greater than 50% of the voting
power of the outstanding common and preferred stock of the Company, (iv) the Company, directly or indirectly, in one or more related transactions
effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which
the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires greater than 50% of the voting power of the outstanding common and preferred stock of the Company
(not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with
the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &ldquo;<U>Fundamental
Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant
Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option
of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock
of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the
&ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares
of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation
in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of
one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be
given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.
The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor
Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in
accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the
Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder,
deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor
Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without
regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies
the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock
pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such
exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity),
and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the
other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">e) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Notice to
Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left; text-indent: 0.5in">ii. <U>Notice to
Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock,
(B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize
the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class
or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the
Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of all or
substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice (unless such information is filed with the Commission, in which case a notice shall not be required) stating (x) the
date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is
not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption,
rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share
exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record
shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in
the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that
any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain
entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this
Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any
transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute
and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three Trading Days of the date on which the Holder delivers an assignment form to the Company
assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase
of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">b) <U>New Warrants</U>.
This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together
with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent
or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company
shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with
such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be identical with this
Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">c) <U>Warrant Register</U>.
The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant Register</U>&rdquo;),
in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the
absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual
notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">a) <U>No Rights
as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends or
other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth
in Section 3. Without limiting the rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to Section
2(c), or to receive cash payments contemplated by Section 2(d)(i) and Section 2(d)(iv) herein, in no event will the Company be required
to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">b) <U>Loss, Theft,
Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to
it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">d) <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of this Warrant. The Company further covenants that its
issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant
Shares upon the exercise of this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant
Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market
upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of this
Warrant will, upon exercise hereunder and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued,
fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other
than taxes in respect of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">e) <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder
in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">h) <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder of this Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the Company has caused this
Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GLOBAL INTERACTIVE TECHNOLOGIES, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 35%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page to Pre-Funded Common Stock Purchase
Warrant of </I></P>

<P STYLE="text-align: center; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><I>Global Interactive Technologies,
Inc.</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">To: </FONT>Global Interactive
Technologies, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(1) The undersigned hereby elects
to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant, and tenders herewith payment of the
exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment shall take the form
of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify">in lawful money of the United States; or</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD>
    <TD STYLE="text-align: left">if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 1in">(3) Please issue said Warrant
Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>(To assign the foregoing Warrant, execute this
form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10.5pt">FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>Name:</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Address:</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(Please Print) </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Phone Number:</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Email Address:</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Dated: _______________ __, ______</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Holder&rsquo;s Signature:_______________________________<U></U></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Holder&rsquo;s Address: <U>&nbsp;</U>_______________________________</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>5
<FILENAME>ea025365101ex5-1_global.htm
<DESCRIPTION>OPINION OF OLSHAN FROME WOLOSKY LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 5.1</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex5-1_001.jpg" ALT="" STYLE="width: 650px; height: 35px"></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">August 19, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Global Interactive Technologies, Inc.<BR>
160, Yeouiseo-ro, Yeongdeungpo-gu<BR>
Seoul, Republic of Korea, 07231</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">Re:</TD><TD STYLE="text-align: justify"><U>Registration Statement on Form S-1</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">We have acted as counsel to
Global Interactive Technologies, Inc., a Delaware corporation (the &ldquo;Company&rdquo;), in connection with the proposed issuance of
(i) up to 2,252,252 shares (the &ldquo;Shares&rdquo;) of common stock, par value $0.001 per share, of the Company (the &ldquo;Common Stock&rdquo;),
(ii) up to 2,252,252 pre-funded warrants to purchase up to 2,252,252 shares of Common Stock (the &ldquo;Pre-funded Warrants&rdquo;), (iii)
up to 2,252,252 common warrants to purchase up to 2,252,252 shares of Common Stock (the &ldquo;Common Warrants&rdquo;) and (iv) up to
4,504,504 shares of Common Stock underlying the Common Warrants and Pre-funded Warrants. The Shares, the Pre-funded Warrants and the Common
Warrants are included in a registration statement on Form S-1 under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;),
filed with the U.S. Securities and Exchange Commission (the &ldquo;Commission&rdquo;) on July 14, 2025 (Registration No. 333-288665) (as
amended, the &ldquo;Registration Statement&rdquo;). This opinion is being furnished in connection with the requirements of Item 601(b)(5)
of Regulation S-K under the Securities Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration
Statement or related Prospectus, other than as expressly stated herein with respect to the issue of the Shares, the Pre-funded Warrants,
the Common Warrants and the Warrant Shares (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">As such counsel, we have examined
such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied
upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified
such factual matters. We are opining herein as to the General Corporation Law of the State of Delaware (the &ldquo;DGCL&rdquo;), and we
express no opinion with respect to any other laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Subject to the foregoing and
the other matters set forth herein, it is our opinion that, as of the date hereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">1. When
the Shares shall have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the purchasers,
and have been issued by the Company against payment therefor (not less than par value) in the circumstances contemplated by the form of
securities purchase agreement most recently filed as an exhibit to the Registration Statement (the &ldquo;SPA&rdquo;), the issue and sale
of the Shares will have been duly authorized by all necessary corporate action of the Company, and the Shares will be validly issued,
fully paid and nonassessable. In rendering the foregoing opinion, we have assumed that the Company will comply with all applicable notice
requirements regarding uncertificated shares provided in the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">2. When
the Pre-funded Warrants have been issued by the Company against payment therefor in the circumstances contemplated by the SPA, the issue
and sale of the Pre-funded Warrants will have been duly authorized by all necessary corporate action of the Company, and the Pre-funded
Warrants will be a legally valid and binding obligation of the Company, enforceable against the Company in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex5-1_002.jpg" ALT="" STYLE="width: 650px; height: 22px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">August 19, 2025</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Page 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">3. When
the Common Warrants have been issued by the Company against payment therefor in the circumstances contemplated by the SPA, the issue and
sale of the Common Warrants will have been duly authorized by all necessary corporate action of the Company, and the Common Warrants will
be a legally valid and binding obligation of the Company, enforceable against the Company in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">4. When
the shares of Common Stock initially issuable upon exercise of the Pre-funded Warrants and the Common Warrants (collectively, the &ldquo;Warrant
Shares&rdquo;) shall have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the
holders of such Pre-funded Warrants and Common Warrants, and have been issued by the Company against payment therefor (not less than par
value) in the circumstances contemplated by the Pre-funded Warrants and Common Warrants, the issue of the Warrant Shares will have been
duly authorized by all necessary corporate action of the Company, and the Warrant Shares will be validly issued, fully paid and nonassessable.
In rendering the foregoing opinion, we have assumed that (i) the Company will comply with all applicable notice requirements regarding
uncertificated shares provided in the DGCL and (ii) upon the issue of any of the Warrant Shares, the total number of shares of Common
Stock issued and outstanding will not exceed the total number of shares of Common Stock that the Company is then authorized to issue under
its Restated Certificate of Incorporation, as amended, and by the board of directors of the Company in connection with the offering contemplated
by the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">With your consent, we have
assumed that the status of the Pre-funded Warrants and Common Warrants as legally valid and binding obligations of the Company is not
affected by any (i) breaches of, or defaults under, agreements or instruments, (ii) violations of statutes, rules, regulations or court
or governmental orders, or (iii) failures to obtain required consents, approvals or authorizations from, or make required registrations,
declarations or filings with, governmental authorities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">In addition, our opinion assumes that each SPA, Pre-funded Warrant and Common Warrant has been duly authorized, executed and delivered
by each party thereto, that each such party is duly organized, validly existing and in good standing under the laws of its jurisdiction
of organization and all jurisdictions where it is conducting business or otherwise required to be so qualified, that each such party has
full power, authority and legal right to enter into and perform the terms and conditions of such SPA, Pre-funded Warrant and Common Warrant
to be performed by it, that the representations and warranties of each such party as set forth in such SPA, Pre-funded Warrant and Common
Warrant when made were, and on the date hereof are, true and complete, and that such SPA, Pre-funded Warrant and Common Warrant constitute
a legal, valid and binding obligation of each such party, enforceable against it in accordance with their respective terms and that the
Company will receive the requisite approval from the Nasdaq Stock Market to list the Shares and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Our opinions are subject to:
(i) the effect of bankruptcy, insolvency, reorganization, preference, fraudulent transfer, moratorium or other similar laws relating to
or affecting the rights and remedies of creditors; (ii) (a) the effect of general principles of equity, whether considered in a proceeding
in equity or at law (including the possible unavailability of specific performance or injunctive relief), (b) concepts of materiality,
reasonableness, good faith and fair dealing, and (c) the discretion of the court before which a proceeding is brought; and (iii) the invalidity
under certain circumstances under law or court decisions of provisions providing for the indemnification of or contribution to a party
with respect to a liability where such indemnification or contribution is contrary to public policy. We express no opinion as to (a) any
provision for liquidated damages, default interest, late charges, monetary penalties, make-whole premiums or other economic remedies to
the extent such provisions are deemed to constitute a penalty; (b) consents to, or restrictions upon, governing law, jurisdiction, venue,
arbitration, remedies, or judicial relief; (c) any provision requiring the payment of attorneys&rsquo; fees, where such payment is contrary
to law or public policy; (d) other applicable exceptions; and (e) the severability, if invalid, of provisions to the foregoing effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">This opinion is for your benefit
in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable
provisions of the Securities Act. We consent to your filing this opinion as an exhibit to the Registration Statement and to the reference
to our firm in the Prospectus under the heading &ldquo;Legal Matters.&rdquo; In giving such consent, we do not thereby admit that we are
in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission
thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%">Sincerely,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>/s/ <I>Olshan Frome Wolosky LLP</I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Olshan Frome Wolosky LLP</TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>6
<FILENAME>ea025365101ex10-13_global.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.13</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of August [&#9679;], 2025, between Global Interactive Technologies, Inc., a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including its successors
and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act of 1933, as amended
(the &ldquo;<U>Securities Act</U>&rdquo;), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and
not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are
hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ARTICLE I.</B><BR>
DEFINITIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">1.1   <U>Definitions</U>.
In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings
set forth in this Section 1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the first (1<FONT STYLE="font-size: 10pt"><SUP>st</SUP></FONT>)
Trading Day following the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, shares of Common
Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Common
Warrants</U>&rdquo; means the common stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a)
hereof, in the form of <U>Exhibit A </U>attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Common
Warrant Shares</U>&rdquo; means the shares of Common Stock underlying the Common Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Company
Counsel</U>&rdquo; means Olshan Frome Wolosky LLP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company pursuant
to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority
of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) securities
upon the exercise or exchange of or conversion of any Securities issued hereunder, and/or other securities exercisable or exchangeable
for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have
not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange
price or conversion price of such securities (other than in connection with stock splits or combinations) or to extend the term of such
securities, and (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors
of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no
registration rights that require or permit the filing of any registration statement in connection therewith during the prohibition period
in Section 4.10(a) herein, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of
raising capital or to an entity whose primary business is investing in securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Initial
Exercise Date</U>&rdquo; shall mean six (6) months from the date of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Per Share
Purchase Price</U>&rdquo; equals $[&#9679;] subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Placement
Agent</U>&rdquo; means D. Boral Capital LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Placement
Agency Agreement</U>&rdquo; means the Placement Agency Agreement by and between the Company and the Placement Agent dated the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Placement
Agent Counsel</U>&rdquo; means Thompson Hine LLP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><U>&ldquo;Pre-Funded
Warrants</U>&rdquo; means, collectively, the pre-funded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance
with Section 2.2(a) hereof, in the form attached hereto as <U>Exhibit B.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Pre-Funded
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in"><U>&ldquo;Prospectus</U>&rdquo;
means the final base prospectus filed for the Registration Statement, including all information, documents and exhibits filed with or
incorporated by reference into such prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act, including all information,
documents and exhibits filed with or incorporated by reference into such prospectus supplement, that is filed with the Commission, and
delivered by the Company to each Purchaser at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.7.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement on Form S-1 (File No. 333-288665) with the Commission, including all
information, documents and exhibits filed with or incorporated by reference into such registration statement, which registers the sale
of the Shares, the Pre-Funded Warrants and the Pre-Funded Warrant Shares to the Purchasers, including all information, documents and exhibits
filed with or incorporated by reference into such registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means, collectively, the Shares, the Common Warrants and the Common Warrant Shares, and the Pre-Funded Warrants and the Pre-Funded Warrant
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares, the Pre-Funded Warrants (if applicable) and
the Common Warrants purchased hereunder as specified below such Purchaser&rsquo;s name on the signature page of this Agreement and next
to the heading &ldquo;Subscription Amount,&rdquo; in United States dollars and in immediately available funds (excluding for the avoidance
of doubt, if applicable, a Purchaser&rsquo;s aggregate exercise price of the Pre-Funded Warrants, which amounts shall be paid as and when
such Pre-Funded Warrants are exercised for cash).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary as defined in Rule 405 under the Securities Act and listed in Exhibit 21 to the Company&rsquo;s Annual Report on
Form 10-K for the fiscal year ended December 31, 2024, as amended thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, The Nasdaq Capital Market, The Nasdaq Global Market, The Nasdaq Global Select Market, the New York Stock
Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Common Warrants, the Pre-Funded Warrants, the Placement Agency Agreement, all exhibits
and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Colonial Stock Transfer, with a mailing address of 66 Exchange Place, Suite 100, Salt Lake City, Utah 84111 and
any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in Section 4.10(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Pre-Funded Warrants and the Common Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&ldquo;<U>Warrant
Shares</U>&rdquo; means, the Pre-Funded Warrant Shares and Common Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ARTICLE II.</B><BR>
PURCHASE AND SALE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">2.1   <U>Closing</U>.
On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery
of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase,
up to an aggregate of approximately $[&#9679;] of Shares and Common Warrants, <U>provided</U>, <U>however</U>, that, to the extent that
a Purchaser determines, in its sole discretion, that such Purchaser&rsquo;s Subscription Amount (together with such Purchaser&rsquo;s
Affiliates, and any Person acting as a group together with such Purchaser or any of such Purchaser&rsquo;s Affiliates) would cause such
Purchaser&rsquo;s beneficial ownership of the shares of Common Stock to exceed the Beneficial Ownership Limitation, or as such Purchaser
may otherwise choose, in lieu of purchasing Shares, such Purchaser may elect, by so indicating such election prior to their issuance,
to purchase Pre-Funded Warrants in lieu of Shares in such manner to result in the same aggregate purchase price being paid by such Purchaser
to the Company. The &ldquo;Beneficial Ownership Limitation&rdquo; shall be 4.99% (or, at the election of the Purchaser, 9.99%) of the
number of shares of Common Stock outstanding immediately after giving effect to the issuance of the Securities on the Closing Date. In
each case, the election to receive Pre-Funded Warrants is solely at the option of the Purchaser. Each Purchaser&rsquo;s Subscription Amount
as set forth on the signature page hereto executed by such Purchaser shall be made available for &ldquo;Delivery Versus Payment&rdquo;
(&ldquo;<U>DVP</U>&rdquo;) settlement with the Company or its designee. The Company shall deliver to each Purchaser its respective Shares
and Common Warrants as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth
in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing
shall occur at the offices of Company Counsel or such other location as the parties shall mutually agree. Unless otherwise directed by
the Placement Agent, settlement of the Shares shall occur via DVP (i.e., on the Closing Date, the Company shall issue the Shares, and/or
Pre-Funded Warrants (if any) and Common Warrants, registered in the Purchasers&rsquo; names and addresses and released by the Transfer
Agent directly to the account(s) at the Placement Agent identified by each Purchaser; upon receipt of such Shares, the Placement Agent
shall promptly electronically deliver such Shares to the applicable Purchaser, and payment therefor shall be made by the Placement Agent
(or its clearing firm) by wire transfer to the Company). Notwithstanding anything herein to the contrary, if at any time on or after the
time of execution of this Agreement by the Company and an applicable Purchaser, through, and including the time immediately prior to the
Closing (the &ldquo;<U>Pre-Settlement Period</U>&rdquo;), if such Purchaser sells to any Person all, or any portion, of any Securities
to be issued hereunder to such Purchaser at the Closing (collectively, the &ldquo;<U>Pre-Settlement Shares</U>&rdquo;), such Purchaser
shall, automatically hereunder (without any additional required actions by such Purchaser or the Company), be deemed to be unconditionally
bound to purchase, and the Company shall be deemed unconditionally bound to sell, such Pre-Settlement Shares to such Purchaser at the
Closing; provided, that the Company shall not be required to deliver any Pre-Settlement Shares to such Purchaser prior to the Company&rsquo;s
receipt of the Subscription Amount for such Pre-Settlement Shares hereunder; provided, further, that the Company hereby acknowledges and
agrees that the forgoing shall not constitute a representation or covenant by such Purchaser as to whether or not such Purchaser will
elect to sell any Pre-Settlement Shares during the Pre-Settlement Period. The decision to sell any shares of Common Stock will be made
in the sole discretion of such Purchaser from time to time, including during the Pre-Settlement Period. Notwithstanding anything to the
contrary herein and a Purchaser&rsquo;s Subscription Amount set forth on the signature pages attached hereto, the number of Shares purchased
by a Purchaser (and its Affiliates) hereunder shall not, when aggregated with all other shares of Common Stock owned by such Purchaser
(and its Affiliates) at such time, result in such Purchaser beneficially owning (as determined in accordance with Section 13(d) of the
Exchange Act) in excess of 9.9% of the then issued and outstanding Common Stock outstanding at the Closing (the &ldquo;<U>Beneficial Ownership
Maximum</U>&rdquo;), and such Purchaser&rsquo;s Subscription Amount, to the extent it would otherwise exceed the Beneficial Ownership
Maximum immediately prior to the Closing, shall be conditioned upon the issuance of Shares at the Closing to the other Purchasers signatory
hereto. To the extent that a Purchaser&rsquo;s beneficial ownership of the Shares would otherwise be deemed to exceed the Beneficial Ownership
Maximum, such Purchaser&rsquo;s Subscription Amount shall automatically be reduced as necessary in order to comply with this paragraph.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2   <U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(a) On or prior
to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser and the Placement Agent the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(i) this Agreement
duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(ii) a legal opinion
and negative assurance letter of Company Counsel, substantially in the form acceptable to the Placement Agent and each of the Purchasers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(iii) a comfort letter
from OneStop Assurance PAC (the independent registered public accounting firm of the Company), addressed to the Purchasers, in form and
substance satisfactory to the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(iv) a <FONT STYLE="background-color: white">certificate
of the Chief Financial Officer of the Company </FONT>in a form and substance reasonably satisfactory in all respects to the Placement
Agent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(v) the Company&rsquo;s
wire instructions, on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(vi) subject to the
penultimate sentence of Section 2.1, a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver
on an expedited basis via The Depository Trust Company Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) Shares equal
to such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase Price, registered in the name of such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(vii) a Common Warrant
registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 100% of such Purchaser&rsquo;s
Shares, with an exercise price equal to $[&#9679;], subject to adjustment therein; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(viii) if applicable,
for each Purchaser of Pre-Funded Warrants pursuant to Section 2.1, a Pre-Funded Warrant registered in the name of such Purchaser to purchase
up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to Pre-Funded Warrants
(as elected by the Purchaser) divided by the Per Share Purchase Price minus $0.0001, with an exercise price equal to $[&#9679;] per share
of Common Stock, subject to adjustment therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(b) On or prior
to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(i) this Agreement
duly executed by such Purchaser; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(ii) such Purchaser&rsquo;s
Subscription Amount (less the aggregate exercise price of the Pre-Funded Warrants issuable to such Purchaser hereunder, if applicable),
which shall be made available for &ldquo;Delivery Versus Payment&rdquo; settlement with the Company or its designee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">2.3   <U>Closing
Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(a) The obligations
of the Company hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(i) the accuracy in
all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all
respects) on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein
in which case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(ii) all obligations,
covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(iii) the delivery
by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(b) The respective
obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(i) the accuracy in
all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all
respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of a specific
date therein in which case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(ii) all obligations,
covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(iii) the delivery
by the Company of the items set forth in Section 2.2(a) of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(iv) the filing of
the Prospectus Supplement with the Commission;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(v) there shall have
been no Material Adverse Effect with respect to the Company since the date hereof; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in">(vi) from the date
hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s principal
Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have
been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service,
or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude
in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser,
makes it impracticable or inadvisable to purchase the Securities at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE III.</B><BR>
REPRESENTATIONS AND WARRANTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">3.1   <U>Representations
and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part
hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section
of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(a) <U>Subsidiaries</U>.
All of the direct and indirect Subsidiaries of the Company are set forth in Exhibit 21 to the Company&rsquo;s Annual Report on Form 10-K
for the fiscal year ended December 31, 2024. The Company owns, directly or indirectly, all of the capital stock or other equity interests
of each Subsidiary free and clear of any Liens.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(b) <U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to
own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in
violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational
or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification
necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected
to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse
effect on the results of operations, assets, business, or condition (financial or otherwise) of the Company and the Subsidiaries, taken
as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely basis its
obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;) and, to the knowledge
of the Company, no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit
or curtail such power and authority or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(c) <U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The
execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further
action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith other
than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or
upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute
the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by
general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting
enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive
relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(d) <U>No Conflicts</U>.
The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the
issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not
(i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of incorporation,
bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse
of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company
or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration or cancellation
(with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or
Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset
of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation
of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which
the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset
of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably
be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(e) <U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection
with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant
to Section 4.4 of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement, (iii) application(s) to each applicable
Trading Market for the listing of the Shares and Common Warrant Shares for trading thereon in the time and manner required thereby, and
(iv) such filings as are required to be made under applicable state securities laws (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(f) <U>Issuance
of the Securities; Registration</U>. The issuances of the Shares, the Pre-Funded Warrants, the Common Warrants and the Warrant Shares
are duly authorized by all necessary corporate actions on the part of the Company. The Shares are duly authorized and, when issued and
paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, and free
and clear of all Liens imposed by the Company. The Common Warrant Shares, when issued in accordance with the terms of the Common Warrants,
will be validly issued, fully paid and nonassessable, and free and clear of all Liens imposed by the Company. The Pre-Funded Warrant Shares,
as applicable, when issued in accordance with the terms of the Common Warrants, will be validly issued, fully paid and nonassessable,
and free and clear of all Liens imposed by the Company. The Company has reserved from its duly authorized capital stock the maximum number
of shares of Common Stock issuable pursuant to this Agreement and the Common Warrants. The Company has prepared and filed the Registration
Statement in conformity with the requirements of the Securities Act, which became effective on [&#9679;], 2025 (the &ldquo;<U>Effective
Date</U>&rdquo;) including the Prospectus and any such amendments and supplements thereto as may have been required to the date of this
Agreement. The Registration Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness
of the Registration Statement or suspending or preventing the use of the Prospectus and/or the Prospectus Supplement has been issued by
the Commission and no proceedings for that purpose have been instituted or, to the knowledge of the Company, are threatened by the Commission.
The Company, if required by the rules and regulations of the Commission, shall file the Prospectus Supplement with the Commission pursuant
to Rule 424(b). At the time the Registration Statement and any amendments thereto became effective, at the date of this Agreement and
at the Closing Date, the Registration Statement and any amendments thereto conformed and will conform in all material respects to the
requirements of the Securities Act and did not and will not contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus, Prospectus Supplement,
and any amendments or supplements thereto, at the time the Prospectus, Prospectus Supplement or any such amendment or supplement thereto
was issued and at the Closing Date, conformed and will conform in all material respects to the requirements of the Securities Act and
did not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading; provided that this representation and warranty
does not apply to statements in or omissions from any Prospectus Supplement made in reliance upon and in conformity with information relating
to the Purchasers furnished to the Company in writing by or on behalf of the Purchasers expressly for use therein. The Company was at
the time of the filing of the Registration Statement eligible to use Form S-3. The Company is eligible to use Form S-3 under the Securities
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(g) <U>Capitalization</U>.
As of the date hereof, the authorized capital stock of the Company consists of 100,000,000 shares of Common Stock, $0.001 par value per
share, 10,000,000 shares of preferred stock, $0.001 par value per share. No Person has any right of first refusal, preemptive right, right
of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents, except as described
in the Registration Statement and SEC Reports. There are no authorized or outstanding options, warrants, preemptive rights, rights of
first refusal or other rights to purchase, or equity or debt securities convertible into or exchangeable or exercisable for, any capital
stock of the Company or any of its subsidiaries, except as described in the Registration Statement and the SEC Reports. All of the outstanding
shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance
with all applicable federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights
or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors
or others is required for the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or other similar
agreements with respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge of the Company, between
or among any of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(h) <U>SEC Reports;
Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by
the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the 12 months preceding
the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials,
including the exhibits thereto and documents incorporated by reference therein, together with the Registration Statement, the Prospectus
and the Prospectus Supplement, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has
received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As
of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange
Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading. The Company is not, and has not been in the past two years, an issuer identified in Rule 144(i)(1)(i)
and has filed with the Commission current &ldquo;Form 10 information&rdquo; (as defined in Rule 144(i)(3)) at least 12 months prior to
the date of this Agreement reflecting its status as an entity that is no longer an issuer identified in Rule 144(i)(1)(i).The financial
statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the
rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared
in accordance with United States generally accepted accounting principles applied on a consistent basis during the relevant periods (&ldquo;<U>GAAP</U>&rdquo;),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and
its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended,
subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(i) <U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within
the SEC Reports, except as disclosed in the SEC Reports, (i) there has been no event, occurrence or development that has had or that could
reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise)
other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities
not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings made with the Commission,
(iii) the Company has not materially altered its method of accounting, and (iv) the Company has not declared or made any dividend or distribution
of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital
stock. The Company does not have pending before the Commission any request for confidential treatment of information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(j) <U>Litigation</U>.
Except as set forth in the SEC Reports there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or,
to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before
or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<U>Action</U>&rdquo;), which (i) adversely affects or challenges the legality, validity or enforceability of
any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have or reasonably be expected
to result in a Material Adverse Effect. The Commission has not issued any stop order or other order suspending the effectiveness of any
registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(k) <U>Labor Relations</U>.
No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could
reasonably be expected to result in a Material Adverse Effect. To the knowledge of the Company, no executive officer of the Company or
any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure
or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor
of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries
to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal,
state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and
wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have
a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(l) <U>Compliance</U>.
The Company and its Subsidiaries have been and are in compliance with all applicable laws, rules and regulations, except where failure
to be so in compliance would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(m) <U>Environmental
Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution
or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata),
including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or
hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating to
the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as
all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits,
plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have received
all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and
(iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii),
the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(n) <U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except
where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification
of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(o) <U>Title to
Assets</U>. Except as otherwise disclosed in the Registration Statement and the SEC Reports, the Company and the Subsidiaries have good
and marketable title in fee simple to all real property owned by them and good and marketable title in all personal property owned by
them that is material to the business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens
as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such
property by the Company and the Subsidiaries and (ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves
have been made therefor in accordance with GAAP and, the payment of which is neither delinquent nor subject to penalties. Any real property
and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with
which the Company and the Subsidiaries are in compliance, with such exceptions as are not material and do not materially interfere with
the use made or proposed to be made of such real property, improvements, equipment or personal property by the Company or such subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(p) <U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights
described in the SEC Reports as being owned or licensed by them or which are necessary for the conduct of their respective businesses
as currently conducted or as currently proposed to be conducted and which the failure to so have could have a Material Adverse Effect
(collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). Neither the Company nor any Subsidiary has received, since the
date of the latest audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge
that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected
to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there
is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken
reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure
to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(q) <U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged. Neither the Company nor
any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires
or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(r) <U>Transactions
With Affiliates and Employees</U>. Except as set forth in the SEC Reports, to the knowledge of the Company, none of the officers or directors
of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently
a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including
any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal
property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer,
director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other
employee benefits, including stock option agreements under any stock option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(s) <U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance, in all material respects, with any and all applicable
requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations
promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries
maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance
with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s
general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such
disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits
under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules
and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company
and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date,
the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange Act the
conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as
of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such
term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially
affect, the internal control over financial reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(t) <U>Certain Fees</U>.
Except as set forth in the Prospectus Supplement, no brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company
or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with
respect to the transactions contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(u) <U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be
or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The Company
shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration under the
Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(v) <U>Listing and
Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has
taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock
under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.
The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is
or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such
Trading Market. The Company is, to its knowledge, in compliance with all such listing and maintenance requirements. The Common Stock is
currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company
is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with
such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(w) <U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms
that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information
that it believes constitutes or might constitute material, non-public information which is not otherwise disclosed in the Prospectus Supplement.
The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities
of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries,
their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, taken as a
whole, is true and correct in all material respects and does not contain any untrue statement of a material fact or omit to state any
material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not
misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to
the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(x) <U>No Integrated
Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, neither the Company,
nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security
or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with
prior offerings by the Company for purposes of any applicable stockholder approval provisions of any Trading Market on which any of the
securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(y) <U>Tax Status</U>.
Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect,
the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign income and
franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other
governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations
and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the
periods to which such returns, reports or declarations apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(z) <U>Foreign Corrupt
Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person
acting on behalf of the Company or any such Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts,
entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign
or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii)
failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the
Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(aa) <U>Accountants</U>.
The Company&rsquo;s registered independent accounting firm is OneStop Assurance PAC, an independent registered public accounting firm.
To the knowledge and belief of the Company, such accounting firm is a registered public accounting firm as required by the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(bb) <U>Acknowledgment
Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting solely
in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby.
The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity)
with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their
respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely
incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions
contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(cc) <U>Acknowledgment
Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except
for Sections 3.2(f) and 4.9 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been asked
by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company,
or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified term; (ii)
past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &ldquo;derivative&rdquo;
transactions, before or after the closing of this or future private placement transactions, may negatively impact the market price of
the Company&rsquo;s publicly-traded securities; (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions to which
any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the Common Stock, and (iv)
each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo;
transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various
times during the period that the Securities are outstanding, including, without limitation, during the periods that the value of the Common
Warrant Shares deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the
value of the existing stockholders&rsquo; equity interests in the Company at and after the time that the hedging activities are being
conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(dd) <U>Regulation
M Compliance</U>. The Company has not (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization
or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid
for, purchased, or, paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person
any compensation for soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and (iii),
compensation paid to the Placement Agent in connection with the placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(ee) <U>Stock Option
Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance with the
terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the Common Stock
on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company&rsquo;s
stock option plan has been backdated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(ff) <U>Office of
Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent,
employee or Affiliate of the Company or any Subsidiary acting on behalf of the Company or such Subsidiary is currently subject to any
U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(gg) <U>Money Laundering</U>.
The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance in all material respects with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or
any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">3.2   <U>Representations
and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the
date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate
as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(a) <U>Organization;
Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company
or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise
to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such
Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership,
limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a
party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute
the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i) as limited
by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(b) <U>Understandings
or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement
or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty
not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement, Prospectus, Prospectus Supplement
or otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in
the ordinary course of its business. Such Purchaser is acquiring such Securities as principal for his, her or its own account and not
with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable
state securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable
state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the
distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty
not limiting such Purchaser&rsquo;s right to sell such Securities pursuant to a registration statement or otherwise in compliance with
applicable federal and state securities laws).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(c) <U>Purchaser
Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which
it exercises any Common Warrants, it will be either: (i) an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2), (a)(3),
(a)(7) or (a)(8) under the Securities Act or (ii) a &ldquo;qualified institutional buyer&rdquo; as defined in Rule 144A(a) under the Securities
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(d) <U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(e) <U>Access to
Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits
and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed necessary
of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities
and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results
of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity
to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary
to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither the Placement
Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect to the Securities
nor is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes any representation
as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public information
with respect to the Company which such Purchaser agrees need not be provided to it. In connection with the issuance of the Securities
to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(f) <U>Certain Transactions
and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has any Person acting
on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or sales, including Short
Sales, of the securities of the Company during the period commencing as of the time that the Company or any other Person representing
the Company first contacted the Purchaser regarding the material pricing terms of the transactions contemplated hereunder and ending immediately
prior to the execution hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby
separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge
of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the representation
set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision
to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement or to such Purchaser&rsquo;s
representatives, including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates,
such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence
and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a
representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar
transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company acknowledges and agrees that the representations
contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely on the Company&rsquo;s representations
and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document or any other
document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated
hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty,
or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE IV.</B><BR>
OTHER AGREEMENTS OF THE PARTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> 4.1 <U>Absence of Legends</U>.
The Securities shall be issued free of legends.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">4.2   <U>Furnishing
of Information</U>. Until the earlier of the time that (i) no Purchaser owns Securities (ii) the Common Warrants have expired or (iii)
the Pre-Funded Warrants have been fully exercised, the Company covenants to timely file (or obtain extensions in respect thereof and file
within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act
even if the Company is not then subject to the reporting requirements of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">4.3   <U>Integration</U>.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section
2 of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations of
any Trading Market such that it would require shareholder approval prior to the closing of such other transaction unless shareholder approval
is obtained before the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">4.4   <U>Securities
Laws Disclosure; Publicity</U>. The Company shall (a) by 8:00 a.m. on [&#9679;], 2025, issue a press release disclosing the material terms
of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto,
with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company represents
to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the
Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents in connection with the transactions
contemplated by the Transaction Documents. In addition, effective upon the issuance of such press release, the Company acknowledges and
agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any
of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates on the one hand, and any of the Purchasers
or any of their Affiliates on the other hand, shall terminate. The Company and each Purchaser shall consult with each other in issuing
any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any
such press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release
of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall
not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly
provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing, the Company shall
not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory
agency or Trading Market, without the prior written consent of such Purchaser, except (a) as required by federal securities law in connection
with the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required by law or regulation,
Trading Market or FINRA rules or regulations, in which case the Company shall provide the Purchasers with prior notice of such disclosure
permitted under this clause (b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">4.5   <U>Non-Public
Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its
behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes constitutes,
material non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information and agreed
with the Company to keep such information confidential. The Company understands and confirms that each Purchaser shall be relying on the
foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company, any of its Subsidiaries, or
any of their respective officers, directors, agents, employees or Affiliates delivers any material, non-public information to a Purchaser
without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality
to the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates, or a duty to
the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates not to trade on the
basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent that
any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company
or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The
Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">4.6   <U>Use
of Proceeds</U>. The Company shall use the net proceeds from the sale of the Securities hereunder as set forth in the Prospectus Supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">4.7   <U>Indemnification
of Purchasers</U>. Subject to the provisions of this Section 4.7, the Company will indemnify and hold each Purchaser and its directors,
officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person
holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning
of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners
or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such
title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any and all losses,
liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court
costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of
or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement
or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their
respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions
contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser Party&rsquo;s representations,
warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such
stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which
is finally judicially determined to constitute fraud, gross negligence or willful misconduct), the Company will indemnify each Purchaser
Party, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including,
without limitation, reasonable attorneys&rsquo; fees) and expenses, as incurred, arising out of or relating to (i) any untrue or alleged
untrue statement of a material fact contained in such registration statement, any prospectus or any form of prospectus or in any amendment
or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material
fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus or supplement thereto, in
the light of the circumstances under which they were made) not misleading, except to the extent, but only to the extent, that such untrue
statements or omissions are based solely upon information regarding such Purchaser Party furnished in writing to the Company by such Purchaser
Party expressly for use therein, or (ii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or
any state securities law, or any rule or regulation thereunder in connection therewith. If any action shall be brought against any Purchaser
Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in
writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to
the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense
thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (x) the employment
thereof has been specifically authorized by the Company in writing, (y) the Company has failed after a reasonable period of time to assume
such defense and to employ counsel or (z) in such action there is, in the reasonable opinion of counsel, a material conflict on any material
issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for
the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under
this Agreement (1) for any settlement by a Purchaser Party effected without the Company&rsquo;s prior written consent, which shall not
be unreasonably withheld or delayed; or (2) to the extent, but only to the extent that a loss, claim, damage or liability is attributable
to any Purchaser Party&rsquo;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party
in this Agreement or in the other Transaction Documents. The indemnification required by this Section 4.7 shall be made by periodic payments
of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity
agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or
others and any liabilities the Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">4.8   <U>Reservation
of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all
times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares
pursuant to this Agreement, Pre-Funded Warrant Shares pursuant to any exercise of the Pre-Funded Warrants and Common Warrant Shares pursuant
to any exercise of the Common Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">4.9   <U>Listing
of Common Stock</U>. (a) The Company hereby agrees to use its reasonable best efforts to maintain the listing or quotation of the Common
Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote
all of the Shares and Common Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and Common Warrant
Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading
Market, it will then include in such application all of the Shares and Common Warrant Shares, and will take such other action as is necessary
to cause all of the Shares and Common Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The
Company will then take all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and
will comply in all respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of the Trading
Market. The Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company
or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company
or such other established clearing corporation in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10   <U>Subsequent
Equity Sales</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(a) From the date
hereof until one hundred eighty (180) days thereafter, neither the Company nor any Subsidiary shall issue, enter into any agreement to
issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, <U>provided</U>, <U>however</U>,
that the Company may enter into an agreement to issue of shares of Common Stock with the prior written consent of the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(b) For a period
from the date hereof until one hundred eighty (180) days thereafter, the Company shall be prohibited from effecting or entering into an
agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination
of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction in which the
Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right
to receive additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is
based upon and/or varies with the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance
of such debt or equity securities, or (B) with a conversion, exercise or exchange price that is subject to being reset at some future
date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly
related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction under, any agreement,
including, but not limited to, an equity line of credit or at-the-market offering, whereby the Company may issue securities at a future
determined price; <U>provided</U>, <U>however</U>, that notwithstanding this Section 4.10, beginning twenty (20) days after the date hereof,
the Company may make sales pursuant to an &ldquo;at the market&rdquo; offering with the&nbsp;Placement Agent. Any Purchaser shall be entitled
to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect
damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(c) Notwithstanding
the foregoing, this Section 4.10 shall not apply in respect of (i) an Exempt Issuance, except that no Variable Rate Transaction shall
be an Exempt Issuance, or (ii) the filing of any registration statement on Form S-8 or any successor form thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">4.11   <U>Equal
Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is
also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right
granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers
as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition
or voting of Securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">4.12   <U>Certain
Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it nor
any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales
of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such time that
the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section
4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated
by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4, such Purchaser
will maintain the confidentiality of the existence and terms of this transaction. Notwithstanding the foregoing and notwithstanding anything
contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation,
warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the
transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section
4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance
with applicable securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced
pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty
not to trade in the securities of the Company to the Company or its Subsidiaries after the issuance of the initial press release as described
in Section 4.4. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate
portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the
investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set forth above
shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase
the Securities covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">4.13   <U>Exercise
Procedures</U>. The form of Notice of Exercise included in the Common Warrants set forth the totality of the procedures required of the
Purchasers in order to exercise the Common Warrants. No additional legal opinion, other information or instructions shall be required
of the Purchasers to exercise their Common Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall
be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required
in order to exercise the Common Warrants. The Company shall honor exercises of the Common Warrants and shall deliver Common Warrant Shares
in accordance with the terms, conditions and time periods set forth in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE V.</B><BR>
MISCELLANEOUS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">5.1   <U>Termination</U>.
This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever
on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated
on or before the [fifth (5th) Trading Day] following the date hereof; <U>provided</U>, <U>however</U>, that no such termination will affect
the right of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">5.2   <U>Fees
and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses
of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without
limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered
by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">5.3   <U>Entire
Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus Supplement,
contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements
and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents,
exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">5.4   <U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via email
attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a
Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via email attachment
at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New
York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent by U.S. nationally recognized
overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices
and communications shall be as set forth on the signature pages attached hereto. To the extent that any notice provided pursuant to any
Transaction Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">5.5   <U>Amendments;
Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in
the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares based on the initial
Subscription Amounts hereunder or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought,
provided that if any amendment, modification or waiver disproportionately and adversely impacts a Purchaser (or group of Purchasers),
the consent of such disproportionately impacted Purchaser (or group of Purchasers) shall also be required. No waiver of any default with
respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver
of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any
party to exercise any right hereunder in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately,
materially and adversely affects the rights and obligations of any Purchaser relative to the comparable rights and obligations of the
other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment effected in accordance with
this Section 5.5 shall be binding upon each Purchaser and holder of Securities and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">5.6   <U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">5.7   <U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other
than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or
transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by
the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">5.8   <U>Third-Party
Beneficiaries</U>. The Placement Agent shall be a third party beneficiary of the representations and warranties of the Company in Section
3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit of the parties
hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by,
any other Person, except as otherwise set forth in Section 4.7 and this Section 5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">5.9   <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting
in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action
or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section
4.7, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">5.10   <U>Survival</U>.
The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">5.11   <U>Execution</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file, or by electronic signature such signature shall create a valid and binding obligation of the
party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo;
signature page or electronic signature were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">5.12   <U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">5.13   <U>Replacement
of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall
issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of
and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of
such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable
third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">5.14   <U>Remedies</U>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers
and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may
not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby
agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would
be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">5.15   <U>Payment
Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser
enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part
thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required
to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without
limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration
the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such
payment had not been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">5.16   <U>Independent
Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several and
not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For
reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through
Placement Agent Counsel. Placement Agent Counsel does not represent any of the Purchasers and only represents the Placement Agent. The
Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not
because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained
in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and
the Purchasers collectively and not between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">5.17   <U>Liquidated
Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents
is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been
paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due
and payable shall have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">5.18   <U>Saturdays,
Sundays, Holidays, etc.</U> If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">5.19   <U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,
stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">5.20   <B><U>WAIVER
OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES
EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>Global Interactive Technologies, Inc.</B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify">Name:</TD>
    <TD STYLE="width: 31%; text-align: justify">[&#9679;]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="text-align: justify">[&#9679;]</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 64%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 36%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address for Notice</U>:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">160, Yeouiseo-ro, Yeongdeungpo-gu</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seoul, Republic of Korea, 07231</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: [&#9679;]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-Mail: [&#9679;]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone: [&#9679;]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With a copy to (which shall not constitute notice):</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Olshan Frome Wolosky LLP</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1325 Avenue of the Americas, 15th Floor</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, New York 10019</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: [&#9679;]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 8pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email: [&#9679;]</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.3pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[PURCHASER SIGNATURE PAGES TO <FONT STYLE="text-transform: uppercase">Global
Interactive Technologies, Inc.</FONT> SECURITIES PURCHASE AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Purchaser: ________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Purchaser</I>:
_________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: _______________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address of Authorized Signatory:_________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Facsimile Number of Authorized Signatory: __________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Address for Delivery of Common Warrants to Purchaser
(if not same as address for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DWAC for Shares:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subscription Amount: $____<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares:
_________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-funded
Warrants __________________ Beneficial Ownership Blocker &#9744; 4.99% or &#9744; 9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Warrants __________________ Beneficial Ownership Blocker &#9744; 4.99% or &#9744; 9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EIN
Number: _______________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to
purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the
Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii)
the Closing shall occur on the first Trading Day following the date of this Agreement and (iii) any condition to Closing contemplated
by this Agre</FONT>ement (but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed
of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead
be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate
or the like or purchase price (as applicable) to such other party on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>7
<FILENAME>ea025365101ex23-1_global.htm
<DESCRIPTION>CONSENT OF ONESTOP ASSURANCE PAC, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">Exhibit 23.1</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 80%"><IMG SRC="ex23-1_001.jpg" ALT=""></TD>
  <TD STYLE="white-space: nowrap; text-align: left; width: 20%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>Onestop Assurance PAC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>Co. Registration No.: 201823302D</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>10 Anson
Road #06-15</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>International Plaza</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>Singapore, 079903</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>Email:</B> <B>audit@onestop-audit.com</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>Website:</B> <B>www.onestop-ca.com</B></P>
</TD></TR>
</TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><U>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.9pt 0pt 1.15pt; text-align: left">We hereby consent to the incorporation by reference in the Registration Statement on Form S-1 (No. 333-288665) under
the Securities Act of 1933 of our report dated April 29, 2025 which includes an explanatory paragraph as to ability to continue as going
concern, with respect to the consolidated balance sheets of Global Interactive Technologies, Inc. (formerly as &ldquo;Hanryu Holdings,
Inc.&rdquo;) and its subsidiaries (&ldquo;the Company&rdquo;) as of December 31, 2024 and 2023, and the related consolidated statements
of operations and comprehensive loss, stockholders&rsquo; equity, and cash flows for each of the years in the two-year period ended December
31, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.15pt">We also consent to the reference to our firm under the
heading &ldquo;Experts&rdquo; in such Registration Statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 277.8pt 0pt 1.15pt">/s/ OneStop Assurance PAC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 277.8pt 0pt 1.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 277.8pt 0pt 1.15pt">OneStop Assurance PAC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.15pt">Singapore</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.15pt">August 19, 2025</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>8
<FILENAME>ea025365101ex-fee_global.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024-2025 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FE.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.2b -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: 3db8e4544e35ec62e10177470f991a14 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
<head>
  <title>Filing Fee Exhibit</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="fee_001">S-1/A</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="fee_002">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="fee_003">0001911545</ix:nonNumeric>
      <ix:nonNumeric name="ffd:RegnFileNb" contextRef="c_report" id="fee_004">333-288665</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-08-18</xbrli:startDate>
          <xbrli:endDate>2025-08-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_10">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>10</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-08-18</xbrli:startDate>
          <xbrli:endDate>2025-08-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_2">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>2</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-08-18</xbrli:startDate>
          <xbrli:endDate>2025-08-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_3">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>3</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-08-18</xbrli:startDate>
          <xbrli:endDate>2025-08-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_4">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>4</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-08-18</xbrli:startDate>
          <xbrli:endDate>2025-08-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_5">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>5</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-08-18</xbrli:startDate>
          <xbrli:endDate>2025-08-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_6">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>6</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-08-18</xbrli:startDate>
          <xbrli:endDate>2025-08-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_7">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>7</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-08-18</xbrli:startDate>
          <xbrli:endDate>2025-08-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_8">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>8</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-08-18</xbrli:startDate>
          <xbrli:endDate>2025-08-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_9">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>9</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-08-18</xbrli:startDate>
          <xbrli:endDate>2025-08-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001911545</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-08-18</xbrli:startDate>
          <xbrli:endDate>2025-08-18</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: right">Ex-Filing Fees</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center">CALCULATION OF FILING FEE TABLES</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="fee_005">S-1</ix:nonNumeric></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="fee_006">Global Interactive Technologies, Inc.</ix:nonNumeric></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="fee_007">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="fee_008">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="fee_009">Common Stock, par value $0.001 per share ("Common Stock")</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457oFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="fee_010">457(o)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_011">2,967,014.44</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_012">0.0001531</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_013">454.25</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_2" format="ixt:booleanfalse" id="fee_014">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_2" id="fee_015">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_2" id="fee_016">Pre-funded Warrants to purchase Common Stock ("Pre-Funded Warrants")</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(2)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_2" format="ixt:booleantrue" id="fee_017">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="fee_018">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="fee_019">0.0001531</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="fee_020">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_3" format="ixt:booleanfalse" id="fee_021">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_3" id="fee_022">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_3" id="fee_023">Common Stock underlying the Pre-Funded Warrant</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(3)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457oFlg" contextRef="c_offering_3" format="ixt:booleantrue" id="fee_024">457(o)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_3" id="fee_025">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_3" id="fee_026">0.0001531</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_3" id="fee_027">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_4" format="ixt:booleanfalse" id="fee_028">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_4" id="fee_029">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_4" id="fee_030">Warrants to purchase Common Stock ("Common Warrants")</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(4)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_4" format="ixt:booleantrue" id="fee_031">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_4" id="fee_032">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_4" id="fee_033">0.0001531</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_4" id="fee_034">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_5" format="ixt:booleanfalse" id="fee_035">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_5" id="fee_036">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_5" id="fee_037">Common Stock underlying the Common Warrants</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(5)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457oFlg" contextRef="c_offering_5" format="ixt:booleantrue" id="fee_038">457(o)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_5" id="fee_039">2,967,014.44</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_5" id="fee_040">0.0001531</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_5" id="fee_041">454.25</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_6" format="ixt:booleantrue" id="fee_042">Fees Previously Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_6" id="fee_043">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_6" id="fee_044">Common Stock</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(6)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457oFlg" contextRef="c_offering_6" format="ixt:booleantrue" id="fee_045">457(o)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_6" id="fee_046">2,032,985.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_6" id="fee_047">311.25</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_7" format="ixt:booleantrue" id="fee_048">Fees Previously Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_7" id="fee_049">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_7" id="fee_050">Pre-Funded Warrants</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(7)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_7" format="ixt:booleantrue" id="fee_051">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_7" id="fee_052">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_7" id="fee_053">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_8" format="ixt:booleantrue" id="fee_054">Fees Previously Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_8" id="fee_055">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_8" id="fee_056">Common Stock underlying the Pre-Funded Warrant</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(8)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457oFlg" contextRef="c_offering_8" format="ixt:booleantrue" id="fee_057">457(o)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_8" id="fee_058">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_8" id="fee_059">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_9" format="ixt:booleantrue" id="fee_060">Fees Previously Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_9" id="fee_061">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_9" id="fee_062">Common Warrants</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(9)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_9" format="ixt:booleantrue" id="fee_063">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_9" id="fee_064">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_9" id="fee_065">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_10" format="ixt:booleantrue" id="fee_066">Fees Previously Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_10" id="fee_067">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_10" id="fee_068">Common Stock underlying the Common Warrants</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(10)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457oFlg" contextRef="c_offering_10" format="ixt:booleantrue" id="fee_069">457(o)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_10" id="fee_070">2,032,985.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center">&#160;</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_10" id="fee_071">311.25</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_072">9,999,998.88</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_073">1,531.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_074">622.50</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_075">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="fee_076">908.50</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="fee_077">Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(2)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_2" id="fee_078">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $4,999,999.44.<br/><br/>No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(3)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_3" id="fee_079">Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act.<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(4)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_4" id="fee_080">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $4,999,999.44.<br/><br/>No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(5)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_5" id="fee_081">Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act.<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(6)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_6" id="fee_082">Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act.<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(7)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_7" id="fee_083">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $4,999,999.44.<br/><br/>No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(8)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_8" id="fee_084">Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act.<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(9)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_9" id="fee_085">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $4,999,999.44.<br/><br/>No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(10)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_10" id="fee_086">Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act.<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.</ix:nonNumeric></td></tr>
  </table>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !F .,# 2(  A$! Q$!_\0
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MW4)202H)'BD9+N"0,AME!QY%_#?7$LRF9?E\E)/-<$IE&(-?T7D7T<?#_/\
M+8XK+>,,YS&=2"A'&9<LIQ>5PKRLHMRH5:F,5-2E%S]KAZ35-2DU!>\OPK&_
M2.\1\GQ<:F=<+Y)E> J5(PIT,TR?C'+L54<JD8*G1JU<+R.M-R5.E[6U+VTZ
M7M)*G[1K^PS2O$6BZ[8PZGH>I6.LZ=< -#?:7>6M[:R@@$!)X)GC8_,ORAL@
MD#&:U!,2 ?)E +!>1'D9.,D"0D#G/<XZ U_(9\)/VFOBK\ -537/ ?B"[ATY
M+A9-1\(ZA///X6U:"*196M!I!>5; W<:FW?5K5WNK02&>"UFD1(S_2'^R_\
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M22%!)"DNQ &<*B*SNQ[*BLS' 4$D"A98RR#Y@S;2JM\K$-O(^5E4YQ&[%>'
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M\LOG<VJ<-K+I/ UL&\7*#5E2AS-MJZ@_L-]&KM=-SMA'%<\7)Z<RO[G2ZO\
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MA\VH5:K2@FJ,7V56U-W[_&]>FA_5U>"J4IQ?2,FK.VJC*U]^MO\ -;G^=?\
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MC5]KIOROS\U^*_ ^3/VRO^"DW[<O[>-^\_[5/[0WCWXE>'K*]74],\ 12_\
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M8VYX-I15TDDG;5V\SUHPC"+C%6337?=-?DS_  G-421=;UYC')QK_B-B-C#
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MU:#5;R%BFEVX\)^$-:NK:>1)5N+F**W 42&1/Y3O@YHG@/PO\#O^":^F?\%
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MQ;35M0_9FN?#4.JW>EZ=IEFNNK'+X-N]6\0N;2/G1<_LEZQ^TK+;?\$YK?\
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MI?BJTT?7-;2UMEMM5\*7GBZ\30M%N$A]5U;X(_LJ_M$>(?\ @G3X,^ OAO\
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M3RQ[#OLC!OE9-FTKC 20!)?.MPLB(!Y=LY9((BA"*['>?F1Y?)DSG*X42JJ
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@,JDCNEQ)</.\5OB:W+2.I12YGW8^2/G]YL4444BC_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2      04  DE$_]L
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MF?J[7_?J?[T/\_7O^'&OY>W_ 'G?\-/_ $I_I'_[./?OZI\U?]&R[_[)YO\
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M?RF/PF%Q='&9:S)9;*U<-#CJ"EB%C)4UE9.D:+^68#VW--%;PM/,VE$!9B>
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M:2G4>25P+R/[G>TVWEWE2P>6UBBLX(UJ[X!I6O?(U6;)Q4D\ /(=$+27%W(
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MJG>==RSL-,@  L;Y'>Q\\K;;?VQ/8DD; >A=6#'\] _9T'-\4"2-O,@_R/\
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M] +H?_B?_P!E3?&K_P 3_P!-_P#OQ=N>R?F'_D@7W_//-_U;;IZW_P!R(_\
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M1BJRAS/:_09KJIV_AN0I)5JNS=AXV.0N!39.FJ#N"FACT)%+3Y.5M33\8_\
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M&V+7XFCV5BYBP-,PJ>Q,[B9I89=2U%%35":2+D1Y[H;VVS<IS+":2W1$"YR
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M+_Q)G<O_ +W%=[D#W8_Y7>Y_TD/_ %:7HOVG_<%?M/\ A/1#.[_F%T-\(/\
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MJ\MZ JREM0/D2!UNM>X!Z/\ KWOW7NO>_=>Z][]U[K4@_P"%9?\ S)KX<_\
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M\N[Y1T?S+^%_Q_\ D-'40S9O>NQ:.CWU%"CQ+1]D[3GJ-I=ATJP2P4TD-/\
MWOPM7)3^@*]+)%(A:-T=L(.:-F?E_?[K:6X1.=)QF-NZ,XKQ4BOH<<>AQ:S"
MXMTF'F,_:,'^?1T_9!THZ][]U[KWOW7NO>_=>Z^1-\L/^RIODK_XG_N3_P!^
M+N/WG1R]_P D"Q_YYX?^K:] 6X_W(D_TS?X3T 'LXZ9Z^NU\4/\ LEKXU_\
MB >G/_?=[<]X';K_ ,E2Y_YJR?\ 'ST/8_[-?L'^#H?O:#J_7O?NO=>]^Z]U
M[W[KW7O?NO=?&G]] .H_Z^RQ[Y_]2!U[W[KW7O?NO=$1_FA_]NX_G+_XJOW?
M_P"^_P Y[$?)_P#RM>V_\]4'_5Q>DUY_N)+_ *5O\'16/Y7?_;D[HS_Q6;LO
M_P!SNP/9ISG_ ,KY>?\ /0/\*]-V?^X"?Z7H,O\ A-W_ -NL>LO_ !)G<O\
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M>C'KWOW7NO>_=>ZQS30T\,M142QP001O-//,ZQ0PPQ*7DEED<JD<<:*2S$@
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MU[W[KW7O?NO=>]^Z]U[W[KW09]T_\R<[9_\ $9[\_P#>6ROM1:?[E1?Z=?\
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M],47S:ZLP?W':'Q^P,]%VU18^&%:C=?1M/)4Y*HW#.%C\M5D>JJZ:6L)NO\
MN%JJUW9A2P()C]H^;/W7N1Y>O&_0NV'AUKVS< !\GP/],%X9Z)MWM/%B^H3X
MDX_,?['6AC[R=Z#'1K_A-\P.S_@M\CM@_(OJJ;SY7:E6]%N7:U1634>'[ V+
ME'ACW3L7/2115 7'YRCB!BF,,S4-=#3UD:&:GCL1<R<OV?,VT2;3>X#Y5@*F
M-Q\+C[*Y%14$BHKTHMKA[682IY<1ZCTZ^IE\:/D=U9\L^D=@]_=-YZ'/[$[
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MSN7_ -[BN]KO=C_E=[G_ $D/_5I>F]I_W!7[3_A/05=<?]Q-7?W_ (H5AO\
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MN48.;]I^D+>'/$2\3\0&I0JPXZ6X&F0:'-*%98WC6<NNE5."/\WSZWB.K?\
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MJ_:W2G7^6J*:?)XG"Y"KAJLYNK<HH9JG'1[SWM445-)7QTTLU/2T]'2TB2U
MION9LI>1>3XN3]K-N["2YF(:5Q6A(%%1:T.E:FA(!))-!6@"U_>&\E# 45<
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M;JR.&CE5I<><]!MNA-3%&ZPR24XD*>0LS!3WPLK6*>POHXPLTHE5V'%@GA:
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M+] 8&#,)0/4K15$RTW=F,JJB%%J)&A%1&LD:RMZ5+,/9M-[C^W5XJF[N%>G
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MWZ]^XO\ AO\ QG_H;K8B_ED_ [_AN;XS1_'3_2K_ *8_'O\ W9OG^^/]QO\
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M.9/^:<'^&7KUY_N=;?:W^ =>_GQ?\SW_ ).G_B^NS?\ WL>J??O;C_DG[_\
M\\$O_'7Z]N7QP?\ -1>E'_PIK_[=F5'_ (G[JC_W&W9[I[0_\KG'_P TI?\
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MQ_W$U=_?^*%8;_W)Z4]JKG_IT5O_ ,]Y_P"K<O55_P"2N?\ FG_E'7OY3O\
MV]A_G@?^);ZP_P#=YV[[]SG_ ,J1RW_S3G_PQ=>L_P#<ZY^U?\!Z]_-B_P"W
ML/\ (_\ _$M]G_\ N\ZB]^Y,_P"5(YD_YIP?X9>O7G^YUM]K?X!U[^?%_P S
MW_DZ?^+Z[-_]['JGW[VX_P"2?O\ _P \$O\ QU^O;E\<'_-1>E'_ ,*:_P#M
MV94?^)^ZH_\ <;=GNGM#_P KG'_S2E_X[UO=_P#<)OM'^'J_'9W_ !Z.UO\
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M2.9/^:<'^&7KUY_N=;?:W^ =>_GQ?\SW_DZ?^+Z[-_\ >QZI]^]N/^2?O_\
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M #@L_P#MNZDK_@.?<W_E.VO_ )S7?_;%U[_AV#X[?\\9W3_Z#NQO_MC>_?\
M!K>U?_1OW7_G!9_]MW7O^ Y]S?\ E.VO_G-=_P#;%U[_ (=@^.W_ #QG=/\
MZ#NQO_MC>_?\&M[5_P#1OW7_ )P6?_;=U[_@.?<W_E.VO_G-=_\ ;%U[_AV#
MX[?\\9W3_P"@[L;_ .V-[]_P:WM7_P!&_=?^<%G_ -MW7O\ @.?<W_E.VO\
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M<$%)53 @E12G@FWO#G[OO-D_MW[PV)W$&&.XD;;[I6%"@F<(-6131,L;-6M
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M/_H.[&_^V-[]_P &M[5_]&_=?^<%G_VW=>_X#GW-_P"4[:_^<UW_ -L77O\
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MN_O_ !0K#?\ N3TI[57/_3HK?_GO/_5N7JJ_\E<_\T_\HZ]_*=_[>P_SP/\
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M.W_/A.EO_16[&_\ K%[]_K3>U?\ TS.U?]RZS_ZT]>_UTO<W_IH]T_[+[O\
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M,9^:'HR/N4NHNZ][]U[KWOW7NJFOYM?_ #*WJO\ \/\ K_\ WG:SWA;]]O\
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M]:>O?ZZ7N;_TT>Z?]E]W_P!;>O?[+;\=O^?"=+?^BMV-_P#6+W[_ %IO:O\
MZ9G:O^Y=9_\ 6GKW^NE[F_\ 31[I_P!E]W_UMZ]_LMOQV_Y\)TM_Z*W8W_UB
M]^_UIO:O_IF=J_[EUG_UIZ]_KI>YO_31[I_V7W?_ %MZ]_LMOQV_Y\)TM_Z*
MW8W_ -8O?O\ 6F]J_P#IF=J_[EUG_P!:>O?ZZ7N;_P!-'NG_ &7W?_6WKW^R
MV_';_GPG2W_HK=C?_6+W[_6F]J_^F9VK_N76?_6GKW^NE[F_]-'NG_9?=_\
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M\C[>VT;7:;_&MQ)MR, M28M;E2Q*D#4!I  .#FH/E66^D\:5[<Z1(1GSH/\
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MRVKGKG;8K,;=L>\7UG;J21%!=SPQ@L:L0D<BJ"3DFF3TP?[+;\=O^?"=+?\
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M%65@0P-CQ[JZ)(ACD 96!!!%00<$$'B#U>.22*198F*LI!!!H01D$$<"/(]
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MJG&;%V;M796.K*HUU7C]I;>Q&W**JK3#%3FLJ:3#T='!/5&"!$\C*7T(HO8
M>Q/LG+G+W+-LUGRY86^WPNVMH[:"*!&<@*798E4%J*!4BM !P Z#F\\P[_S'
M<+=\PWUQ?RHNA7N)I)W5*DZ5:5F(%230&E23Y])_<O3'3V],M-GMX]4=:[LS
MM1%!#/FMR[%VOG<M/#31B&FBFR.4Q=56214\2A45G(1186'LLWCD+D7F&].Y
M;_LMA?7! 4RW%G;S2%5^%2\D;-0>0K0>71EM7/7.VQ68V[8]XOK.W4DB*"[G
MAC!8U8A(Y%4$G)-,GI@_V6WX[?\ /A.EO_16[&_^L7LK_P!:;VK_ .F9VK_N
M76?_ %IZ,?\ 72]S?^FCW3_LON_^MO0LXG$XK XR@PN#QF/PV'Q=+#0XS$XF
MBIL=C,=14R"*GHZ"@HXX:6CI8(U"I'&BHJBP 'L;V=E9[=:16&WQ)!!"JI''
M&JI'&BBBHB* %4 4    P.@;>7EYN-U)?;A*\\\S%Y))&9W=V-69W8DL2<DD
MDD\>G#VIZ3=8IX(*J":EJH8JFFJ8I(*BGGC2:">"9#'+#-%(&CEBEC8JRL"&
M!L>/=71)$,<@#*P(((J"#@@@\0>KQR212++$Q5E(((-"",@@C@1Y'H&_]EM^
M.W_/A.EO_16[&_\ K%[ /^M-[5_],SM7_<NL_P#K3T./]=+W-_Z:/=/^R^[_
M .MO7O\ 9;?CM_SX3I;_ -%;L;_ZQ>_?ZTWM7_TS.U?]RZS_ .M/7O\ 72]S
M?^FCW3_LON_^MO7O]EM^.W_/A.EO_16[&_\ K%[]_K3>U?\ TS.U?]RZS_ZT
M]>_UTO<W_IH]T_[+[O\ ZV]"UBL5B\%C:##83&T&'P^*I(*#&8G%4=/C\;CJ
M&EC6&EHJ"AI(X:6CI*:% D<<:*B*   ![&]G9V>W6D5AM\2000JJ1QQJJ1QH
MH 5$10 J@"@   &!T#;R\N]PNI+Z_E>>>9B\DDC,[N[&K,[L268DU))))X]3
M_:GI-U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=!
MMVST[U7WOL?,=:]R]?[3[,V'GHO%E-K;QPM%F\5.5OXJF.&LBD:CR%*QUP5,
M!CJ() 'C=6 (56=[>;=<+=V,K0RIP9"5(_,=5=$D4HXJ#Y'K46^?_P#PF >+
M^,=C_P OC=I>(":MJ/CMVAFW:5%2.>4TO6_9V0=WG+LL<4&/W&=5R\DF7/IB
M$Y\K^\KC3:<TQZO+QXP ?^;D8H/S2G^D/'HBNMF!J]J:?T3_ )#_ )_V])S^
M7?\ \)C<[G#A.T/YA.=DV[AW6GR%%\<]@9L-N.NBDBCE2F[,[!Q<C4VWU#%D
MFQV!EJ*ID(/\2I9%:+V]S7[QJNJSY46IX&XD7''C'&>/VN/]IY]:M-F_'=G_
M &H_RG_-^WK<0ZIZBZOZ+V+A.L^G-@[5ZTV#MV$PX?:FSL-18/#TFH+YZEJ:
MBBC^ZR%8ZZZBJF,E34RDR2N[DL8&O+V[W"X:[OI&FE?BSDLQ_,_ZAT?(B1J$
M04 \AT(OM+U;KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
6]U[KWOW7NO>_=>Z][]U[KWOW7NO_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %1 E@# 2(  A$! Q$!_\0
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M_M?1:%<.8K+Q;8SZ85)PHF $\7X[XB@_W\=ZSCHVC1[)G[0F&.XAN+:0'RY
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M*&XC8N\I/D0KOEVGDCT'N:Z?X ? GQ;^U_\ %B'POH16QL84\Z_U"0$P:=:
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M45U6W\[/^D+_ *].^>[CV/4^A)[$4 6*6DSWI=P[G% "]J,TU9/,;:@:0^B
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M<H'U!C_*N+NDK8^&6I#2O'VF"0XM[PFRESTVR@H"?HQ5O^ UG->Z7#<^]_\
M@C?\23HWC;XA_#2YF)2\@CUBR4]#)"WE2X]V22,_2.OU*U+[7_9MX;!$>_\
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MJQII*ZC;[>N__P#7345<:U=C0CT.XF^:>YV$\D+S4J^';8'#2L6_ 5ZS\,O
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M 'YD-?T#[E;!1@Z'[K*<AAV(]J_G6^+4?]NZ'H/B11DZA91RRL/^>J'RY?\
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MC'TS7S+\1O\ @L1XVUIIH/ 7@?3M"AW82[U21KR4CGG8NU5./=J^)(]0\(V
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M^A4][]R4TC"G4VM"!C5&?2I/QJ-C0 TBHVPO7I0T@%1-=?8[.YO\X,.(XO\
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M_E4\W8JPBVZKU.*TK71KNXC\R*UD>(=9"-J#_@1P*YV7XA74?%A;6]@.S1Q
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MG?;'S' ]S%YH_&OQX^&MP?$GP9\3Z1R\^F-%K$(SS^X<QR@?6&[9C[6WM7]
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M (%$T;?C72_ME>'6\*_&Z#7(H\0ZM;0WN0.#)'^[<?4[%)_WO>K7Q.TR#6/
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M3I\IE*GE37)W3(MM,TAP@1MV?3%-=S722/--0A^U6,T>,DKD?4<BNI^!\_\
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ME\/Y-%\>?#KXC6<>PWEK)I=Q*!QYMN_FQ$^Y65A](ZZHZJS(/D?XN:''H/Q
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MJS1K(@D7:PR 1D'H>G%?+G_!2[X8GXG?LB^)9X(1+?\ AR2'7H/4+$2DV/\
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M6]NM-11!$-A2.,;FP3AW).>./:O-_$7CZ[\4>$?"^AW=I"#H,)@CO0Y,DJD
M8(Q@ !4]?NU,IJ,+)V?EWN;87!5,1BE5G%SI*4K.>[C*/:6NDEI=7M*Y]%PQ
MV2?&^YB&#HGC_P />8,?=>5%P?Q,39_&O)/&=[:ZA\$="TR^O85\2^%]3FTL
MVSR#S9(5)3('4C'E'/\ LFO/KSQ;K6H66DVL^J7!@TF(PV(C/EM A&" RX;D
M #KTK(VY8L<LYZLQRQ^I[UG.LI)I+?\ 6WZGH83)I4)0G.IK'EV_N\T5KYP:
M3\UN>F-\7!!\-?">FV4EW:^*_#MXSVMXJ Q" [UV,2>048#;_LBO2_#^K>/?
M$T6EZ]JI\.^$O#5PT.H7^J6I2.XNH58.%8[BPW8P0>Q/-?--(RF155V9T4Y5
M&8E1] >!4QK26YT8C)Z-56II)MMW:YFN9W=M5;757ND^AU'Q0\4VOC;XA:YK
M5BI6RNIQY)(P61$5 V/?;G\:YFDVXHK&3<FVSVZ-*-"E&E#:*27HE8****DU
M/-OVD/"9\9?!+Q39HF^XMK?^T(>,G="=YQ]4#C\:^,O@]>'7/"/B[PT?GDGT
M]KRU7OYUHQN5Q[F'[8OXBOT6,<4RM%.N^&0%)%/\2D88?B":_-WPRS_!OXZ7
M-I<KYD>BZHZ21L/];#'(=X^CP^8O_ Z]/"RO&4?F?EG&.&Y:M+$KJG%_+5?F
M_N,>1=U4KA>]=+XR\-MX/\5ZQH3-Y@TZ[EM5DZ^8BL0CCU#+M8?6N>G7K7I;
MZGYL8UPM7/!]Y]C\36F>$N UNP/^T/E_\>VU#<+[5G2.\+"6,[9(V#J?0@Y%
M#5U8$[.Y<U&'^RO$W<+OP/H>,_ES^-;\,SVT\<L9Q)&V15+Q_"LTEM?Q<1W"
M+(/;<H('X#;^=2VLWVBVBE'\2@GZ]ZZ*$KHZZ+LW$[*+Q=9&(&19(Y.Z!<_D
M:HW'C#;E;:U5!_>D./T%9NCZ2VK7)0MLB0;I''7V ]S79:/X3BNKZVLM/TY[
M^^G<10PHAEEE<]%5>Y/H!72>@G)HY%M2U;56VQM*P_NP+@?G_P#7J6W\)WMP
MP:4I!ZF1MS?I7>ZII%]H-]+I^H6DUA=0G:]O,A1D; R".Q'0CL<BJE ^7NS"
MM_"%K'@S2R3GT'RBM6RTF"&6.*UM%,TC!(U1-SNQ. !W))["N^\"Z+H>M>'=
M72Y.FMK@NHT7^U=1^Q);V30R[[B,]'=)A%E3N^7 "_-D=K?>/OAKX/M8?^$5
MT*.\U!KD7,>H+'*9K:%5F$.'GV^7<*YMIFV@KNA(!PY%2Y=+"O;1(\PA\">)
MKI9VCT+4'6WMENYW\AML,)02!W)X4;&#'/0')KK-2_9_\4Z-X3U'Q#J7V2UM
M;!L36JR&2Y.TCSU"@8W1#=D$C.Q]N=IK0\:?M%:IXFO)IK#2;73$FF>=TN7^
MT@^:MXL\13"J8W2^EB(^]LCC&?EKB/%WQ,\4>-KZ\O==\07=P]V,3QI(+>%U
MWLX4QQ[5(W2.WS \NWK2]YB_>/R/3+'PYX#^%4]M>W_B;1_&=U-"OG::L:R1
M%6C^UPD*<L QBMXV;@C[2ZD#:U9'C'XM>&[K6O#EYH7AQ&G\.:A93VEVT MC
M=VUL6589N2QRD5H=S L&\W/&,^*S:]IUF"HN%8]2L(W<_A6;<^,.HM[8^S2M
MC]!3Y>K%RQO=L]JU/X^>*M5TBYLWCT^TN9GA8:A8VRQ2QK&KQE%&"!NB,$19
M=I*6L0)/-<=XZ\::CXYU[4M;\1WYN+B^NY+R2.65O(C=R3B.,DA% .T =  *
M\SN/$&H77!G\M?[L0V_KUJ@V9&W,2[?WF.3^M-12V%>,?A1U]SXJL8>(R]PW
M_3->/S-9EQXON9,B&&.$>K'<:PJ6F',RQ=:G=WG$UQ(ZG^$':/R%5@ .G%+1
M3("J/A36+GPCX^L[^S;R[FWN$GMVZ8D5A)'_ ./JM7:PO$2-#<6]U&=K#C<.
MQ!R#_GTK"JKQ,*RO&_8]*^*>CVNC>/\ 7(M/7;I<\_VZP]/LMPJSP8^D<J#\
M*XFX7.:]&\8L/$'P]\%^(TY:.*71+G'8Q$30$_\ ;&X$8_Z]SZ5Y_,M<<=CB
M>YB72?-[5U'PG<W7B"_TAFP-4LY(%S_ST RA_ \_A7.W:_A6Y\.YK>WU'4)Y
M$_TRT@6^MY <$"*13,!ZYA,I_P" TI_"QQW1]E?\$C?B0?"/[0WBKP/</Y-I
MXGTPSV\3'_EXMSYJ#Z^4\WY"O??^"E?A*]T?QIX \;Z=&66Z#:5<+_#YL;>9
M$3]5=Q_P"OSM\.^-)O@5^TMX3\9VSF./2]6BNY"@^] 7!E4>QC=TK]X?'W@'
MPS\5-'TJWURRCUC2K>]AU.WC9OW<C*K;"<=5(?.._%3+WXC5XL_*G7OA[XC^
M,WC[3XY-,:2&WA'FM:1E_P .!UK>O/V6/C5<:PEIX%\&:M8Z>J@-=7S+9Q-[
MYD(S^%?IYXL\0Z3\(?AYKWB"/3H[?3='L9+QK33HDB,NQ<K&N !N8X49[FOC
M+X._\%%O%_B#XG>&=*^(?@C2_#WACQ3-';:=?V%TTDUM)+(8X3*&^\I<;"1@
M@G.,5ER1C9-FBC*2;2NCS/P;_P $G_'/B;4FU/QWXUTK1#.YDFATY'OK@L22
M<D[4_P#'C7TK\/?^":?P=\%K"^JV^J^+[I1EFU.Z,4)/M%%CCV+&OJJ82B*0
M1;!/@[/,SMW8XW8YQGK7S_H\/Q;UC0HX;*_UW3M8A5GU&37+:V@B^W.L0VV[
M;<2V:,LS';\Q$J[78J16W)$CGDMF>I^%_AMX#^%=F3H/AKP_X7@CQNFM[2*)
MAD\%I"-W)]37(_&[XYZC\-KI-/L=!DU"ZN+7S[?4+ES]GW9(V@#E\ <@$?>6
MN8E_95N?%$%Y#XJ\537,4I$06W#W#SPQMOA,[3'#,&>?("@$2X&W KWFQTFT
ML;#3[1(5DBL(DBMS*H9D"H$!!QP=HY(Q3DM-&=.%JTJ-53KT^>*Z7L+I=U+?
M:797,\!MIYH(Y9(3UC9E!*_@21^%6*6218U+R.J+U+,<#]:YOQ)\2/#OA)K5
M-3U)(I+H%H(XU,C2@$@[0O7HW_?)]*9RMIMLZ.G*">!7F/\ PM36?$(/_",^
M&9KF*:'?;75XQ".Q##[J X"OL!)( W'TJ";PI\0/%!N?MVN#1;.X,:B*WDV2
MK'@[R-@;:^)&&-W\"'<*9)Z5<:I9VOF^==P1>45$F^0#86SM!YXS@X^E<I/\
M7O#?VBXM[*YEU6>"VEN66QB,J[8P21N'&>%_[[3^\*M:=\,]$M]#N]-O;5-2
M6^4+>R2@HUSAW=2Q4@Y4N0&SNP!SQ6WI?AS2M%</I^G6UF_S8>*,!AN.2-W7
M!/;/8>@H&>=W/Q$\7:]]DCT'PTR1W5DDYGE)/EL617*/C:=K,ZC/]PL0%QF4
M^$OB%KUNXU'Q-!I)D@\O;:1Y:-B"K$;3Z'(RQY4=,\>H;BW4D_6B@1!86\EI
M86MO-.UU+#$D;W#C#2L% +D>IQG\:D^[(?>GFF-RP'>@9^,__!4KX=CX9_M:
M6OBV*'&F>*[*&_?CY6F0>1<+]2%5C_UTHKZ\_P""MOPC_P"$Z_9PM?%MK#OU
M#P?J"W#L!EOLD^V*4?0/Y#?0&BBR9.Q^75(:#2'UIB$ZTC=J4TUJ (V'6JLH
MXS5MORJO+TH S;A:R[A>M:]PO6LRX7K0!L^"7:XM];TT'YIK<7$8_P"FD9X_
M1C^5>P_L.^)!H_Q'\1^''?$6I6?VB%2>LD+;A^/EN_Y5X?X3NOL7B;3W+;%D
MD\EF] X*'_T+/X5T7@'7?^%=?'3PSJS_ +JWAOTBF[8A<['_ /(;USU(\RE'
MN>OE>)^JXRC6Z)Z^CT?X-GZ24M*R^6[(>JG%)7A']#!112T#-6Z\6:S?^&[#
MP_<7IDT>P=I+>UV+\C$L<[L9_C8=<8-9.*!2XIMM[D0IPIIJ"M=WT[O=C<4Z
MC]:*18E%'I2T )12TE "44M% "4444@"OA3]LCP__P (K\;;378XO]'U:UAN
MFXX:2,^5(/Q"*3_O>]?==?./[<GA+^UOAII>O1)NFT>^V2-Z0S#:?R=(_P#O
MJNO#2Y:B\SY3B;#?6,MFUO"TONW_  ;/#?B9'_:5OX7\0 ^8-2TM+6=_6XLS
M]E8GW:..WD_[:5P$JYKM?#\X\2?!&]AW;KC0K^&^0?\ 3&91:S_^/QV)_P"!
MFN-D6O8CM8_#I=S*N%_*LR9>HK:N(ZRIU]JLDVY%.K>!(>\EHSPGUP#N'\U'
MX5G^'9O,LVCS_JV_0\_XU?\ !LWG+JNGG_EM$LT8_P!I3C'_ (\#_P !K%T5
MOLNJ3V_\+ @?AR/TIT7RRL;TW:29Z)X-D7-W'_'\K_AR/\_6O</V;_B1I'PE
M^,WA[Q+KUDEYI%NSQW#&#S9+8,I"W$2X)WHVTC'.-P'6OG"UNY;&X2>%MKK^
M1'<'VK>7QE^[^:T;S/9QMKO:OH>FFG'E9]+_ +6_QV\/_'WQIHNJ^'M/U"Q@
MTVSELY)-0CCC-QNE,@D"J2P^\V=_/2O#3A>6( ]37'7'BJ^FR(_+MU_V1N/Y
MG_"LRXN9KLYGE>;_ 'FX_+I22LK#4HQ5D=E=:]I]LV&F65@<[8QO.:S+CQCU
M%O:D_P"U*V/T%<V%[8I:HGG9?N/$&H7.?W_E+_=B7'Z]:H2;I6+2,TC'NQ)H
MHH)N^HG2BG4FX9X^8^@YH$&**ZG0_ACXEUZ]6VBTR2T!BDF::^_<1I&AP[$M
MC@$@<<Y8#J174VO@/3?A_P")O";>)H+?Q%IFK$P7069HK>V8S+\RR@@29MWC
ME0[E \Y2W"D&>9$\R/+-W6M#0=#NO$>K6.G6:,UQ>S""'Y&8,YZ ;023]*[[
MPGJ7@"WTW1M3U5V@O]/AOK-],2Q-Q+<%BS6ETV<0LT9G;*NP#?9U&,&M7Q%\
M<M+N_"OV+1-&N-&U&RU>WOM):-QY%FD$TTJ2!,X61C.ZL!D$!,M\HS/,^B)Y
MGT1YQXC\$ZWX1M=,N-7L&LX=1B\ZV?>KAQM1B"5)PP62-BIYPZGN*PZV?$/C
M#6/%3+_:5YYL2LKI!&BI$A6)(@54#C$<4:?1%SG%8]4K]2U?J%4=:M_M&G2^
MJ_./PZ_IFKU(RA@5/((P:&KJPI+F5CK_ (63CQ#\*?&6@M\TUK!'K-LO^W:R
M'S,>YM[FY/TB'I7(2CKFM7X"ZY;^%_B;9QZ@V-.DE-O> ]&MW#0SC_OQ+-^E
M1>(-#N?#6M:CH]X,7>GW,MG-_OQN4;]5-><M)-'FO8YV[6I/"-_!I?C#2I[L
M[;%YOL]UGC]Q(#'+_P".,U.N$XK(NH]P84Q'HGQ:T>?^P-+GN.;VQ$FF71[^
M;;N8SGZ_,?RK]J/V&?B.?BS^R9\/]6EF,]];6']E7;,<MYUJQARWN51&_P"!
M5^+=CX@G^('ACQ*M_L^V)+%>Y7@',8CD;ZX0L?=B:^^_^",OQ(-QX5^(7P]N
M9")]/NXM9MHV/\$B^3-CZ-'#_P!]5G#:SZ&DM[]S]"O%GA>Q\>>$-5\/ZB#]
MAU*V:WD*C)7/1A[@@'\*_.O1?V$/B1-\=_#B2Z##I/AK0]6M+ZY\33WZ7 O(
M[>02!HDW;LR; -FT%2V3BOTKB^5F7T.1^-<%XLD^(=SXIELM$M[6WT8*DL&I
M;DYW12+)%*&.<K($=64'^$'@DT.G&4E)[HUC6G3@X1V9Z&V69G(^\<XK$U?Q
MEHFA*?MFI6\;@?ZI7#2'@GA1ST!_*N+M_ NKZ==:7KWB3QH\)LU2XOK='(MI
M)5.YR"67:I"IQ@@888^:L#^T_A7X3U3?;:5+<7-I$X^T)'(ZJ,I#L ) ;+1J
MH !^97[[C6ASG5-\6FU;3;BY\-Z%>:T\5W'9[3\GS.D;@X&3C#L#QP8V!Q5+
M37^)^NLHF6T\.6\T@,DTRI++;J 2RH@/.2552>H1F.-P%:'PSNM0?5=9C_X1
M*+PSH<D<,ULT0 \V;:/-W8^4@[DV[>/E?/)KT"@#S*'X)IJ"@^(?$6HZQN"E
MX1(50'#*RJ23A2I Z!N"<\FNUTOPGI6D6%I9PVB20VAD:$W $C(78LY!([DF
MMBCI0,9#"EO D,,:Q0IPL<:A57Z <"GTFX4;O04@%I,BF\GO2[?6@ W>@I>?
MI0%Q3@-Q % #=H[Y-+@+TKDI?B"LEN/L6E7ES<E PM]H#=P1@9Z?ES5F67Q/
M<0VSQ06UM+EEFC)R.)2 0Q/=,-T]?:F!-X^\&:?\1O WB#PKJJ;]-UJPFL+@
M8Z)(A7</<9R/<"BM32X;BUTVWBO)OM-RB[7E_O<]?KC%% '\\?3ZT4&BF0)2
M=*=_*FT ,:H).]3FH9%H HSKQZUFW"UK3+6;<K0!DR[E.5.&'(([&M[XAK]N
M2UU2,$"X1)]P[%@-WY$J/PK$N!70%?[4\"HO5[65X/P/S+_X\W_CM1+1IE+9
MH_13X8^*!XT^'/AK7-V][W3X7E(_YZA=LG_CZM73U\[_ +#OB@:Q\)KS2'?,
MVCZ@RJN>1%*-Z_\ CXEKZ'KP:D>2;B?T1E>(^MX*E6ZM*_KL_P 1>****S/3
M"EI*6@844?C10 4GTI:2@ HHI* %HHHH 2BBBD(2N6^*GA7_ (3?X:^)]""A
MY;VPE6)3_P ]5&^/_P ?1:ZJE1BC!AU!S33<7=&56G&M3E3EM)6^\_.3]GN<
M:EX@N?#<K!8M<MIM*PW9[A-L1_"Y2U/X5@,K!<,I1NZGJ#Z5N?$/0IOAC^T#
MKNG6;&WVWS2V3XQL63$UN1_NL8_^^:T_BS9PP^/-2O+1/+L-7\O6+51T6*Z0
M3A1_NF1D^J&OH8N[NNI_-]:E*C.5*6\6TSA;A?:LJY7&:V9ES69=+P<5H<Y%
MX?O!8>(+&8G:AD\ISZ*XVD_KG\*3Q%"=)\2E\;1O#?AZ?D15"Y7Y6QU[5N^-
M -0L=/U)1GSXE=C_ +1^]_X]Q^%3M),M;%S-%5=,F^T6$+]3MP?J.*M5Z2U1
MZ*=U<***[;PK\.[?Q-X=@O?[4E@OKJ]FL8(4LVD@C:..*0M/(#F-661B"%('
MEL3@#-#=MP;2W.)I,\9[>O:O5]<^'/ACX>Z?=OK&N0ZMK\)G$6D%6BCD"[(@
MD@XD1R7ED4XP1 .N\5!9_%/2= U[Q!<V.D0WFDZ[;V<L^FBW6*.&X4+YZ 2*
M^%(>Y4,G_/12,8(J>;LB>;LCA=$\*:WXDN(X=,TNZNWDW898B$PNW<2QX 7S
M$R3P P-=QX#^!>J>*]1UB#4;V'0X]#OH;355F4O+ KN$,B_P$+DMRPRJL1P*
M7Q!^T5XPUI)XK2XCT:&;8T@MB9'\Q9_/#(S?< <E0J@#R]L9W!1CSJ_U*[U2
MZNKF[N))Y[IM\[$[1*>VY5P#CL,8%+WF/WF>A>$]%^'FD>)=9@\6ZK)?:5!:
M0W-G)9%_-ED9 [0%8U9?,5F6-P7 &UR&.,ULZ3\>--\$F]7P[X=L;J5KIKB"
M\GL([=?X3$K1GS&Q&V\XW<DJ000"/&L8&!Q13Y>X<O<[W6_CAXPUN,0+J(TV
MU4*L<5FIWQJ"AVB:0O+@F.,D%^2B^E<(SNRJC.[JH"@,Q(  "@<^@ 'T ':D
MHJDDAV2V$I:**!B44M% !1110!B7DBZ;XAMKIP3"Q!D [K]UQ^(S^=>M_&*/
M[?KNEZ_NW_V[I=O=RN.AN(P;:X/U,MN[_P#;05Y3XBM_,LUD[QMS]#Q_A7HV
MFWH\4?!>$\M>>'M05CSG_1KE!&WX+-;(?K<>]<%5<L[G#45I-'$7"Y%95PF,
MUMS+Q67<QXI&!J_#>_2S\4?9I?\ 47T+VSC_ 'AD?JH_.OH/_@GGX\;X5_MJ
M^&[>>7RK/Q$)M#N,G +3#Y/_ "/''7RU;WC:9J%K=K]Z"59/R.?Z5V?BK4KG
MPCXRT?Q/I3^7=65U!J%M(,_?5@RGC_:3/_ JSVGZE[Q]#^C"3Y95;L1BN=\3
M>'M;UG4H9-/UW^R[-8@LD:H69G#[N ,?*RY4\@]QC%6/!GBZS^(7@C0/%&G$
M-8ZS80:C!@YPLL:N!^&['X5N*?E'&:L#S^U^!OAN328;'6/M/B".+S/^/R5E
M#;T17W!3R3LR3GDLQ[UV5GX>TK3HXX[73+2!8W\Q-L*DJW]X$@G/)YSGD^IJ
M_P ^E!!]: %.*3=GI0%_&C;2 3FC;3L48H 3% 6EI10 E%+24 %%+Z4E,!$4
M1@A $#')"C&3Z_6EJ*XNH;.&6:>5(8HU+R.[ !%'4GT%<-%\:?#UQK%CIT:W
MOFW;1!'DMV1<22QQ(>>?]9+&I],L?X30!WU% HI ?SL^IHI>:*H@2D-*U)0
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MMI;23(_AD0IG\,Y_"OSL^".H+X-^)RZ?K(\JV6Y:RU%#VA;?;7(_"*:4_P#
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%%%(#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %R 7L# 2(  A$! Q$!_\0
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M"6D/R]>GK0!U].5V7H:P?"GB>V\6:0][!"]O)#,UO<6\C!FBD4\C(X/UK<H
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MA+8,I;_=SQUYJ36M"M]+\&Z;H,/AN;6M.MU6-X8)Q&Z[5X?DC=DDYY[UVU%
M'E.@^&-;L?AV^GZCHMO>737C'3+*XVR+8QL<*7;N%&2?7IWIUKX4\1:'XHM;
M?3WO)+(36\INEF58F'/VDRIG)9CC'H, 8Q7JE% %'5-'L-:MEM]0A,T2MO"B
M1DY^JD5D?\(!X9_Z!S?^!,O_ ,572U3OM3M-.3=<3!3V4<L?PII-NR$W;<QO
M^$ \,_\ 0.;_ ,"9?_BJKW'AP>'Q]M\.7:V4@YDM;J9G@N!Z'<25;T8?B#4%
M_P"+;F;*6:"%/[S<M_@*P)IYKE]\\KR-ZL<UU0PLG\6AC*LEL=+9_$+2[H-
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M2]U^?^9RSP\XZK4T**0,&&0<@]Q2UZESG"BBB@ HHHH **** "BBB@ HHHH
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M+\H'8#%>CGJ:X\1&FFG3>AM!R^T%:MA?YQ#,>>BL>_M652.ZQH7=@JJ,EB<
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M5?7ZCK7M8FC[2-UNCE/>**;'(DT221L&1P&5AT(-.KQ1A1110 4444 %%%%
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M135.*UL!I:AKM_J=M';W+H44ACM0*78#:"Q[G'%:/@2Z^R^,+(]I=T1_$?\
MUJYRKVBS?9]<L)<XVW"'_P >%*<%R.* ^A:***\ 84444 %%%% !1110 444
M4 %%%% !1110 4444 %<YXF;][;KZ FNCKFO$W_'Q!_N'^=>)GK_ -AG\OS.
MS!?QT<[>22PV-Q+;Q>;,D;-''_>8#@5PW@_Q5J>M:U!;R7L-Y$]JTUY&L'EF
MSD!P$SGYN>*[74K1K_3+JS29H6GB:,2+U3(QFN2TCP?JEE?V5U+<:=$UA:/;
MPFUB8&8L,!I,]0#SCZU\7A'A_85%4MS/:_I_GVMYW6A[%7GYX\NQH:[J>J2>
M(K'0=)GBM99X)+F6XDC\S:J\  >Y[UDQZ_XAU7P;_:UO>V%@]HLRW;21%M[Q
MG'R]@#6C>>']=DN],U>"_LCK%M;O;SF2-O*D5NX Y!%9EUX#U7^Q=-TRSU*U
M:""1KB[2XC8K<REL\@?PCTKKHO"J$(MQNK:M7_FYNFS5K&4O:MMV?]6M^MR*
M7Q=K[Z9I%T(%@>XLQ.R^06$TGF!=F?X1M^:NFT75Y-9U&YG2>);!5V6T.1OE
MP>93W"YX'KUI+C2]7U#2+;3[ZZM4#OB\>U5D#1#HB ],]"?2J=CX1ELO%!U%
M9;<6JS22QJJD289 @C/;:,9%93EA9TY+2,M;6UZ_GV\BXJHI+=K0ZB4X0UU'
MA./9H@?_ )Z2,WZX_I7+3?ZLUUWAC_D7[?'JW_H1KOX;BG7D_(PS%_NUZFO1
M117W1X@4444 %%%% !1110 4444 %%%% !1110!\Y:]"MGXNU>W081+I\?0G
M/]:A%:'BR"9_'6L,D,A7SSR%)["J/E2J/FC<?537N47>"!C:*,$=0116X@HH
MHH *D@8K<1,.H<']:CIT8S*@_P!H?SI/8#Z/0YC4^H%.ID7$*#_9%/KYT844
M44 %%%% !1110 4444 %%%% !1110 4444 %<[XF7YK9_P#>%=%6+XDCW643
MC^%_YBO)SF'/@:B\K_<T=6$=JT3F****_,CZ,****UIT:E5VIQ;]$3*<8_$[
M!11BEQ7JTLCQM3[%O5V.66-HQZW(Y1F,UTG@^7?HS1D\QS,,>W7^M<\PRI%:
M'A*X$.I75H3Q*HD7ZCK_ #KZ?*LHJ8.;G.2>FR/.Q6+C6CRI'8T445]$>>%%
M%% !1110 4444 %%%% !1110 4450UN^73M%N[MCCRXSM^O0?K0!YM'(+O7+
M^YQ_K)V(_.M< 8Z"L718B(@S<L>2?>MNNV&B-!C0Q/\ >C1OJH-1&PLVZVL)
M_P"V8JQ15W8%%]'TZ3[UG%^ Q43>'M*;_ET4?1C6G13YI=PL8S>%]+;I%(OT
M<TV/PC8-<1;'F!WC^+/>MNK.GIYFH6Z_[8H=226XK([91A0/04M%%><0%%%%
M !1110 4444 %%%% !1110 4444 %%%% !5#6(O.TN8#J!N'X5?IKH'C9#T8
M8-9U:<:L'"6ST*C)Q:DNAP&*6GRQF*9XV&"C$4RN*EE>#I?#37SU_,VGB:TM
MY!1117H)**LD8-M[A1113$%5O.;3]0@O4_Y9/DCU7N/RJS4<R!XR#0!Z#%*D
MT22QL&1U#*1W!I]<CX2U;RV.DW#<C+0,>X[K774 %%%% !1110 4444 %%%%
M !1110 5PGQ U+S'MM'A;EB)9L=A_"/ZUUNK:I!H^FRWEP?E0?*O=F[ 5Y=:
M"?4M0FU"Z.99FW'V] *N$;LI(NI+!IFG/=7+;(8EW,0"<#Z#K5/3_%^EZAH%
MWK0\Z"SM'=)3,F&!7&>/Q%:US=1:=9274R2-'$NYEB0NQ'LHY->6Z=%<ZIX!
M\3Z5!97BWDMS)=QI+ R"1"RD $]3P>*Z6[#.]T7Q5:ZU?260M+RSNDB$PBNH
M]I>,]&'/2G:SXKTW0[^TLKGSGGN9%11'&2%W' +'H*YJTU)KSQ,_B2+3K\66
MGZ3Y+JT!1Y9"02JJ>N,4>.]56XM-&CBL;]I!=V]ZZI;,VV,<D$@?>'I2YG8+
MG2:]XGAT L9M.O[B*-/,FFMXMR1+ZL2:CD\8::EW;PHL\D<JPL9T3Y(_-_U>
M[OS6!X\NX-2TOR4?78Y)K;?!!;V[&*<GD+(,?F#BEN='DOK+18GL6M]=N8(U
MG>/*Q6ZI_&RCY2RY^4>I]J&W?0#L++58=0N[R"W1V2U?RGFQ\C/W53WQWKH=
M!B\S5%;'"*6KS3P?-JEMJ?\ 9CQRI9PI,)(GAVB$A\(0_P#&6&23DUZUX:@P
MDTY[D**4I>XP>QO4445RD!1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 <GKUOY.HF0#Y91N_'O6776:[:_:+ NHR\1W#Z=ZY.@#EM2\<V>G7MW$;
M"\GM;%TCO+R,#RX&;H#SD]><5M:OJ]IHND3:G=L?L\2AOD&2V> ![DD5P'BS
M1?ME]JNG:3#K2W>HR1^<@CQ:.1C]X7/8#L.]=-K?V:_TW4M#OM-U&2TMK>)C
M/ F3*<C'E^K C- $MGXN6Z-[!+I%_;W]K&LOV)E4R2(WW2N#C_"HH/'%JT&J
M&[T^\L[K3=GG6LH!<[SA<$'')KG]'L;E=1U?79DUR:T-FEI$TRA;J3GYF51@
MC';OUIWA;3-][X@^T65^^@7$:MNU&,_:)7 Y_P!H@<X_#% '31^++>2U1A:3
M_;7NS9BRR"_F+][GI@#DFN@KS&33-3TZ.#5K2WN[0W/FA(X$,LMNNTF,-G)R
M[8+'Z"O1K!KE].M6O%"W1B4S*.@?'/ZT 1W4#966)BLB'<K#J"*ZWP[XA35(
MOLUP5COHQ\R]-X_O"N<?&WFLJZ@?SEGA=HY4.493@@T&%6O&GH]SU>BN.T7Q
MHA*VNL8AEZ"<#Y'^OH?TKKU=74,C!E(R"#D&@TA-25T.HHHH+"BBB@ HHHH
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M?>/^%=/;VT5K$(H8PB#L*EHK:,4MCR*V(G5?O,****HP"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@"M<:?:77^NMT8^N.:S9O#%FYS&\D9^N1^M;=%!G*E"6Z.7D\*RC
M_5W2'V9<57;PS?CHT3?1J["B@Q>$I/H<9_PC>H_W8_\ ONG#PUJ!Z^4/^!5V
M-% OJ=/S.4C\*W)_UEQ&OT!-6XO"L _UMQ(WLH KH**32>YTT%[!MT]+F?!H
MFGVY!6W#$=WYJ^JJB[54*/0#%+10DD:2G*7Q.X4444R0HHHH **** "BBB@
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M'&DRB!85N99Y[R2SBMTCS(SQMAVQGA!CEC6PFKZ;)=3VJ7]JUQ I::(2J6C
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M$G[YT92/*VXSWQUQ@5'I7@G7I+>TT_4;:S@M]-TFXT^&99O,^T-)@*^W'R@
M=^<U9S'70^.?#TUS;1#4(D6YM!=Q32,%C*%MN,D_>SVK:O\ 4+;3=-N-0N9
MMM!&97<<_*!FO/;7P-?70@;4M+L!Y/AY]-6,LL@$V[AAP,9'.>HS6AJOAG7=
M0\":'X=AGAAD40)?SN=X58P"0!_%EE ^F: .DTWQ-I.IZ#::U'=)#972Y1KA
MA&0>?E.3P1@\>U6+?7-)NYXH;?4[.:69=\:1SJQ=?4 'D5P$?@37%D6PO6LK
M_3QK4.I[M@C7!!\U/+Y&,X('?)I\?P]N(1(]M:6=O<'Q$]]'-$ K);%2, @<
M=?NT =['K.ERFY$>HVCFU!,X693Y0'7=SQ^-10Z_IUQ=K!;W,4RE'<S1R(R+
ML(# G.<\^E>8Z=\-]9ATJ]M);6)9UTFXL(I_M8*SM)T.T*, ]3N)(-;NO>!+
MR_M+>UTZ.UM8TT:6S;;\J^:QC." .AV$$T =I'KND36,E['J=F]K&</,LZE%
M/H3G JW;W5O=P)/;SQRPN,J\;!E8>Q%>=W/AO7KK3YI+?P[I&F2M<V[-!!*K
M/*D8.3N*[%;D;>.F<UDV?@#Q/#"Z[HHMTTL@07&<!G9AT '?T% 'KLDB11M)
M(P5%&23VJI_:^GG_ )>XO^^J-6_Y!-S_ -<S7"JK;E^4]1VH.2O7E3DDD>A2
M75O"0)9XXR1D!G R*6*>*8$Q2HX'7:P-<#\5=)L+OPS;7DUG%+<I>6D2RLN6
M"-.@9<^A!/YUSM]%>>'->\:WVA7C6$&FR:>4LXH5,4H**"#D9 P3TQ0=9[)4
M<<T4O^KE1^,_*P/'K7E<WC/4_P#A/(+:"]G,#ZHUE-:3",!8]A.0@&\#(R')
MY]*QM+\12Z2;S4KB62"YN/#]N;<PPC+LLL@8HI^7Y<@GT'- 'N-%>-V/BOQ!
M?R?V9#K,H0ZU;6J7BB*9_)DB9F&X+L/(X..*L/XGU>.*QL=2\02V5HNHWUK/
MJGDIN?R@/*5LJ5!.3VYQ0!ZVKJZAD8,IZ$'(I'=8T+N0% R2>U<I\,2S?#C1
MF9BY,3$L1@M\[<UTFH?\@^X_W#0 W^U+'_GZC_.K/F)N"[AN(R!GDCUK@@IX
MX/Y4_7=2M="^(VD:GJD_V73VTN: 7$F?+\S>C!2>@. <?2@#N?.C\MI/,38N
M<MN&!CKS1%-%<1B2&1)$/1D8$'\17CEO+97'PQGT^]U![*66]>_ D@=QY#7#
M%&E0<^4W0^QK8\#^(M'TK^U5F73;2W:X18[G3VD%I<OY98B-6^ZP"G..#0!Z
M8'4L5# LO4 \BG5XSX/UV_A\:0:U?:?J=M;>(W>.66X7$ .<VVSG^X".0.M>
MS4 03WEO;,!-*J%N1N/6DAO;:X?9#,CMC.%-8?B4$W%O@$_(?YU%X=!&HOD'
M_5G^8KYZ6:U5F'U3E7+>U]>U_0[UA8NA[6^ITX=&9E#*67J >13J\@O?$(@\
M0>*]3T^\G6UGN[&S6[@"[58*0XWN-J@="V#BLVW\=:K<RVMMJ'B:33;8+>K]
MJ6.-FE,3+Y>6V[>AZ@#/XU]"<![C17BNN>/-?M='L[G[9/;:E'ID%TT#)&D<
MSLW/RL"S\#D+C;FM73]>\0O?1:G+J\KP/XC?3#9&%/+$)SCG&[(]<T >JU#/
M=06VWSI53=TW'K4U8'B4$BWP#U;^E959N$')&M&"G-19KQ7UK.^R*=';K@&G
MM<P).L#31K,PRL9<!C]!7,Z "-3&0?N'M7F^L_V;CQ7'?KGQ@VK9TO*M]H*9
M3RO+/]S&>G'7-30J.I'F95>DJ<^5'N+.J#+L%'3).*=7B>N+=)=^,+635+K[
M4VH:>\4<F#M4F/YU&.@.1Z<<UH:GXE\1:6FK::=5EDCM-7@MFU"1(T>.&2+>
M<G;M'S8&XCC-;F!ZY17DV@:SXCUW7='TV;7I$MGMKF9I[5$)G$<P5,L5QT."
M5 ![5;\)>)]4NO&GV"^U.2\$QN,I $:*,(?EW+M#Q'''S9R: /3JJW&I65I)
MY=Q<QQOC.UC@XJU7#>+03K*X!/[I>WN:UI04Y<K(G+E5SL;:^M;S=]GG27;]
M[:<XIR75O*^R.>)W_NJX)KF/!X(2]R".!V^M>8>%K\V/A74;G39-%_MF"VGD
MC^SQLU\,2_,7SP1M]!Z4JD%"3BAPES*Y[Y17E"^*-6U[Q3!:Z;K4L>DW6I>3
M'<V\2G=&MN'8*67^]GGM67<^-O$4+ZHT>JR/=QPZ@;BS,"XL1%_J7Z9^;W)S
MFLRCVNBO$V\:ZZMA,MMKDEWI_P!LM8WU3RXXS$'B+2+N*[1A@!DCC.*]-\%7
M]]J?A&PN]2ECFNI%;=+&,!P&(#=!U '3B@#=DD2*-I)&"HH)9CV%97_"4:%_
MT%+;_ONK>K?\@>]_ZX/_ .@FO##&^W[C?]\F@#WQ9HG6-ED4B093G[PZ\4N]
M-^S<-^,[<\X]:\S\<V6H7USX)CTN=H;Z+S9X#V9TA#!6]CC'XUSKZAKFD>)-
M7U[5GN;._O\ 2HG\B(*QLD-P$5?F^48 R6/3)- 'MS.BLJLP!8X )Z_2G5XQ
M8>(KJ]U/0[C5+TRVUAK\MNMT[*PV-;_(&9 %.6; ..>*GLO%6NZOXB73]/U:
M=6OEO$5)UBS;O'GRSL493D=&)R#F@#V"FF1!((RZ[R,A<\D?2O)6\7>(=5\/
M7.LI>C3(!<P6/ERA4PZ@^>0Y4A27^4%ACY?>F1^+[XV5OJ+2W3M%IM]^_-O&
M\I*2HJLI'RL.>O /7% 'K]%<%\._$%_JVHZW975X;RWM# T$S.CL=Z$L-Z *
MPR/3BN]H 3&1@TFQ/[J_E110 ,BNN&4,,YP1FD,<9W913N^]D=?K110 A@B,
MAD\I-Y_BVC/YTODQ'&8D^4$#Y1P#UHHH 18(4 "11J!R % Q0T,3KM:)"N=V
M"HQGUHHH >JJBA54*!T &*7K110 FQ?[H_*FR11RKMD177KAAD444 +Y:'.4
M4Y&T\=1Z4T6\(01B&/8.B[1@?A110 XQH0%**0N" 1TIW:BB@!"H/4 T;0.@
M _"BBE9 ,\B$QF/RDV-R5VC!_"N7O;: _$G2E,,9']G3\%1_?2BBF!U#PQ2,
M&>)&(X!90<4OE1@8"+UW=._K110 _M2$ ]0#]:** #:HZ #\*:88FD$IC0R*
M,!RHR/QHHH #%&S;FC4MC&2*&BC8.&C0A_O J/F^M%%  L4:8VHHVC P.@]*
M!%&CM(L:*[?>8* 3]3110 ^D*J>2H/U%%%  %5>@ ^@J-;:"-RZ0QJQZD* :
M** '+#$@4)&BA>5 4#'TK \;PQ?\(3KC>6FY[-PQVC)X[T44 :FFP0_V-:Q^
M4FQH4RNT8/RCM5T *    . !110 I&1@TSRH_P#GFOY444 *44D$J,KT..E(
MT4;YW(K9&TY&<CTHHH 000A-@BC"]=NT8XK.U^*.+P]JLT:*DOV25MZC#9V'
MG-%% &=X$@B_X0+2$\I-CVP9EVC#$G))]23S71B*,  1H !M QT'I110 1PQ
.1#$<:(/15 I]%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %A 1@# 2(  A$! Q$!_\0
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M KS)(O$'@OQYXBU&V\.W6LZ?K+)/&]FR[HW4'Y6!Z#D\UZ;10!Y+I_@^ZMO
M-ZOB#0[R\N=2U5K][33I1YUH3]UE.1DC^M4+[PQXUUGP);?;EOKBXT_5Q<VL
M$TJK=O;#IEAP''45[310!X_<^&;C4O#GBFXM=$\1)JEW8+;HVK3J\D_S9VJ
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M?[HIU% #=B_W11L7^Z*=10 W8O\ =%&Q?[HIU% #=B_W11L7^Z*=10 W8O\
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M6%Z_B&*0;) ())8O+9NNX8P.!QS[UV]=)X85%4M15<3S\9N@HHHJSA"BBB@
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M]G8#B:".3\>1_2O=*\5^*N/^$R@_Z]5_F:Z<-_$ Y0=*6D7[HI:]M$A1110
M4444 %6]+<QZO9..JSH?_'A52I['/]HVN.OG)_Z$*4MF!]&T445\X4%%%% !
M574EW:9<CUC;^56J9,@DAD0_Q*12>Q479IGG%%*05)4]0<4E<1],%%%% !11
M10!)I4@@\1V+G@%]GYC%>C5Y9=.T+1SI]Z-@X_ UZ=;S+<V\4Z$%9%##'O73
M2>AX^/C::D2T445J>>%%%% !1110 4444 %%%% !1110 5X1\1[C[3X^N5!X
MABCC_'&?ZU[J[K&C.Y 51DD]A7S9J%\=6U^_U DD3SLZY_NYX_3%=>%C>=P
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M10 4444 %% Y.!R:VM-\)ZYJI'V?3Y%0_P#+24;%_6IE)15VP,6K%G8W6HW
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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D* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" *>!*\# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!****!A1110(**
M**!BT44E A:*2EH **** $I:** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "DI:0T +124M !124M "44M% "4M%)0 4M%% !24M)0 M
M%%!H 3-%%% Q:***!!1110 4444 %%%% !1110 E+110 4E+24 +1110 444
M4 %%%% !1110 4444 %%)2T %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%)0 M%)2T %%%% !1110 4444
M%)2T4 %%%)0 M%)2T %%)2T %%%% !1110 44"B@ HHHH 2BE-)0 4444 +0
M*2EH *2EH- "4M)2T %'-%)0 M%%% !124M !24M% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4E%% "T444 &**** "BBDH 6BBB@ HHH[T %%%%
M!1110 44"B@ HHHH *04M)0 M%%% !1110 4444 %%%% !24M)0 4M)10 M%
M%)WH 6BBB@ HHHH 2BBB@8M%(:6@04444 %%%% !111F@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH 2EHHH **** "DI:* "C%%% !1110 4E+2
M4 +1110 444E "T44E "T444 )2TE+0 44E% "T444 %%%% !1110 4444 )
M1110,44444""BBB@ HHHH **2B@!:2EHH 2EHI* "EI*6@ HHI* %HHS10 4
M444 %%)10 M)2T4 %%)10 M%%)WH ****!A12TE "BBDI:!"44M% !0*2CK0
M,*6BB@0E%%% Q:***!!124M !1110 4444 )WI:** "BBB@ HQ24M "4M%%
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MP7//-+\*ZCJ,.GM?W.ZUC165"*DNO ]W%J$C64H6&1LD;<UZ%&BQQJBC"J,
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M6DH 6BBB@04444 %%%% !110: $I:** "BBB@ I*6B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **2
MEH **2EH 2EHI.U "T4@I: "BDI: $HHI:!A124M @HHI* %HHHH **** $H
MHH[T#"BBB@!11110(**** $I:2B@!:**2@!:*** $I:** $I:** "BBC% "4
MM%% !110: "BBDH *6DH- Q:2BB@!:*2B@ I:2B@ I1244 +1110(**** $I
M:2EH *,T44 %%%% !1110 E%+24#%HHHH$%%%&* $I:** "BBB@ HI*6@ I*
M**!A1110(*6DI: "BBB@!*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HH%% !1110 4444 %)2T4 %%%
M% !1124 +2444#"EI**!!1110 M%)10 O>BDHH 7-%)10 4444 %%%% !111
M0 444E Q:***!!1110 M%)10 M%)10 M%)10 M&**3- !2TE% !2TE% "T4E
M% !1110,6DI*6@04444 %%)2T %%%% Q:2BB@04444 %%%)0 M%%% Q:*2B@
M!:*2B@ HHHH **** "BBB@04444#"BBB@04M)10,6BDHH$+2444 +1244 +1
M244#"BBDH$+1244 +1110,6BDI:!!124M !1124 +124M !1110 44E+0 E+
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 AHH-% PHHHH **** %S1
M244"%HHI* "C-%% Q:2BB@ HHI*!"YI,U4OM2M=-A,MU,L:CU-<?=_%30K:0
MHLJOCN#0!W>:,UYR?C!H@ZX_.D_X7%H?J/SH&>CYHS7F_P#PN+0O4?G1_P +
MCT+U'YT7 ](S1FO-_P#A<>A>H_.D_P"%QZ%ZC\Z+A8])S1FO-_\ A<>A>H_.
MD_X7'H7J/SHN%CTG-)FO./\ A<>A>H_.D_X7'H7J/SHN@L>D9HS7F_\ PN/0
MO4?G2_\ "X]"]1^=%PL>CYHS7G'_  N+0O4?G1_PN/0O4?G1=!8]'S1FO./^
M%QZ%ZC\Z3_A<>A>H_.BZ"QZ1FC-<-I_Q2\/WTHC-PD;'U-=A;7<-W$)8) Z-
MR"*!%K-%-!I0: '44E+0 4444#"BBB@0444R218T+NP51U)H ?29KD]5^(>B
M:7(8VN$=QU -8Y^+NBYZ#\Z!GHF:,UYW_P +>T7T'YTG_"WM%]!^= 6/1<T9
MKSK_ (6_HGM^=)_PM_1/;\Z L>C9HKSG_A<&B>WYT?\ "X-$]OSH"QZ+FC->
M<_\ "X-$]OSH_P"%P:)[?G0%CT;-&:\Y_P"%PZ'[?G1_PN'0_;\Z+H+'HV:7
M->;_ /"X=#]OSI?^%PZ)[?G1<+,]&S1FO.?^%PZ)[?G1_P +@T3V_.@+'HV:
M,UYU_P +@T3V_.D_X6_HGM^= 6/1LT9KSH?%_0RP!( ]<UTVC>+])UL 6MRA
M<_PYH"QOYI:9NI0:!#Z*04M !1110 4444#"BBD- A<TE96K>(M-T9"UW<(A
M]":Y27XM:(CE0P8>N:!GH%%>>?\ "W=%]OSI/^%NZ+[?G0!Z)FC->=_\+=T7
MV_.D_P"%O:)[?G0%CT7-&:\Y/Q?T3V_.D_X7#H?M^= 6/1\T9KS@_&'0_4?G
M2?\ "XM#]1^=%PL>D9HS7F__  N+0O4?G1_PN+0_4?G1<+'I&:,UYO\ \+BT
M/U'YT?\ "XM#]1^=%PL>D9HS7F__  N+0_4?G1_PN'0_4?G1<+'H^:,UYQ_P
MN'0_4?G2_P#"X=#]1^= 6/1LT9KSC_A<&A^H_.M?2OB+H6JR"-+E%<]!FBX'
M89HS422K(@9&!4]"*>#0(>*6F@TZ@ I:2B@ I1110 E%+24 %+244#%HI**!
M!2TE% Q:*.]% A*6BB@ H%)2B@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EHH 2B
MBB@84444 +1110(*2EI* "BBB@84444 %5KV[2RLY+B0X5%)JR:XOXF7CVOA
M64(<%R!0(\G\2Z_J'B[5Y$BD9+1&P,'&:JP^'K55^?+'OFK6DVRV]BO'S-R:
MO5ZM'#QC&[6IG*39E?\ "/V)_@'Y4G_".V'_ #S'Y5K45O[.'8F[,G_A';#_
M )YC\J/^$<L/^>?Z5K44>SAV"[,G_A'+#_GF/RH_X1RP_P">8_*M:BCV<.P7
M9D_\(Y8?\\Q^5'_".6'_ #S'Y5K44>SAV"[,C_A'+#_GF/RI?^$<L/\ GF/R
MK6HH]G#L%V9/_".6'_/,?E2?\(Y8?\\Q^5:]%'LX=@NS(_X1W3_[@_*C_A';
M#_GF/RKN/#NA6NKQR&6<(R#.#65=60346M;8^9@X!%0E3;<;;#U.<_X1RP_Y
MYC\J0^'-/_N#\J[9= \O1Y;J8XD7/%6/"WAE-=AD=Y NT&I;I)-V#4\VN_"M
MNZ%K=F20=".*W?A]XPOM"UE=(U*0M"YPC,:V=6TM=.ED57W;7VUQOB*V"FWO
M8^)(Y!R*QK48RASP*C)WLSZ4CD#J&!R",BI0:YSPM?&]\.V4S'+&,9K>1LUY
MY9.*=3%-.%(!:***!A1110(*\H^)GB^>*5='TYCYK_>([5ZE._EP._H,UX*L
M1U#Q=?7<WS;)&49^M!OAZ3JU% I:?X561!-?.SR-R<G-:7_",Z=C'EC\JV:M
MV=H+E');!6J/I5AZ-..QS7_",:=_SS'Y4?\ ",:=_P \Q^5=5#8)(OS-@TY-
M.1II%+X"FEH'+1[')?\ "+Z=_P \A^5+_P (OIW_ #R'Y5UESI8@B:029 Z5
MFT]"HTZ4E=)&)_PBVF_\\A^5'_"+:;_SR'Y5MT4%^QI_RHQ/^$6TW_GD/RH_
MX1;3?^>0_*MNB@/8T_Y48G_"*Z;_ ,\A^5'_  BNF_\ /(?E6W10'L:?\J,3
M_A%=,_YY#\J/^$6TS_GD/RK;HH#V-/\ E1B?\(MIO_/(?E1_PB^F?\\Q^5=#
M:Q)/<I'(VU6/6M;6M%M]-A1TG#%ATI:&<HT8R46M6<3_ ,(OIO\ SR'Y4?\
M"+Z;_P \A^5=+86$EY.@ PA/)JS>Z:D.K):*>#CFC0'&BI<MD<<_A33'4C8!
M^%8-]HE]X>F%_I<SA4.2H->RZKX8ALK>*191\PYKE)XE</$W*GBC1F'LJ&(A
M[J.I\ ^+5\2:0OF'%Q'\K#Z5V2M7A7@-VTCQO/:*<12+N ^IKV]'S21\[4@X
M2<7T+0-.%1J:>*#,=12"EH **** "L/Q5KT6@:-+=.1OP=H]ZVS7D7Q>NWDF
MM+('Y&;D4#2N['G=W<ZAXEOI+JZE?RRW"YXQ4JZ-:JO(S^%7H8UBA5%& !5B
MVB$TZQDX!-;**2.Z-.*1E?V/:?W?TH_L>T_NC\JZ--,5IFC+].E07=FMNN5;
M.#@T]"K1[&'_ &/:?W!^5!T:T/\ !^E:%%.R'RKL9W]BVG]P?E2?V'9_W/TK
M2HHL@Y8]C,_L*S_N#\J/["LO[@_*M.BBR#E78S/["LO[@_*C^P;+^Y^E:=%%
MD'*NQF?V#9?W!^5']@V7]P?E6G119!RKL9G]A67]S]*/[#LO[@_*M/CO6W%I
M-M)IWVCSAD"E9"Y5V.1_L*S_ +@_*C^PK+^X/RK:AM9+B0K$,@=ZMW]@MI:0
MN#\SCFBR"R['-'0K+^X/RJC=Z 8AYUE*T<B\C!Q7H%IH<=QIOV@N <5BW$(A
MD*AMU*R8G&+TL=%\+O&T]S(='U%SYR<*3WKUP-7S7;9T[Q?8W4/R[GYQ7T3:
MS>9;Q-ZJ#65K.QQ3CRNQH*:?FH$/%2@T$#Z6D%%(8M)12YH$%)0** %Q1BDH
MH ****!A1110 M%%% @HHI* #%+110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (:6@
MT4 %)110 44M)WH&%+12=Z!"TE%% PI:2B@ HHHH$(:X'XK?\BV/]Y?YUWU<
M#\5?^1<'^\O\Z:W \[MO^/9/I4M16W_'NGTJ7D] 37NK8P"BBBF 4444 %%%
M% !1110 4444 %%%% $L-Q-;[C$Y7=P<&GVEY):7'GK@OG/-5Z*5D!HS:W=3
MP/"Q&UNM,L-8N],5EMGVANM4:3-+DC:UAW9+-<2W,C/*Q)8Y/-8^O?\ (./^
M]6I67KW_ "#C_O5-1>XP6YZMX%?'A:R'^P*ZZ)LUQO@8_P#%+V?^X*Z^$UXI
ML7%J05$E2BD M%%% !1110!7O/\ CSF_W37B6G_\A/4/^NS5[9>?\><W^Z:\
M3TX?\3+4/^NS4UN>CEW\<U*>DKQYV'&:913/I&3"ZE  S33/(Q)W'GK4=% <
MJ)&GE=-C,2OUJ.BB@$K!1110,**** "BBB@ HHHH  2#D=14DMQ+/CS'+8Z9
M-1T4"LBY#J,T$0CCP,=ZAFNY9K@3L?G'>H:*!<D4[V+=QJ=W=(J2R$A>G-5/
MK110-14=C"T@8^(:'_8'\Z]KB:O%-*./B"G^X/YU[/"U2?*8O^-(OH:F'2H(
M^E3"@Y1U+2"EH ***#0 TUXY\5.==M/]X5[&:\<^*G_(=M/]X4UN7#XD<P.E
M.CD:)PZ]131THKH/1+ O9@2<C)ILMS),H#XP*AHHL(****!A12T4A"4444QA
M1110 4444 %2":18S&&.T]LU'10!8M[R2V5A'CFDGNY;A%5SD+TJ"B@5BW'J
M5Q%!Y*M\E5"23DG)HHH S[C_ )#.G_\ 72O?[!O]$@_W!_*O ;C_ )#-A_OU
M[W8'_18/]P?RK"7Q'%6^(U8S4Z]*K1U86D8D@I:04M(!:2BB@844M)0 4O:D
MI:!""EI,TM "44M% !24M% "44M% PH%%% @HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *2EI* "BBB@84M%)0 M)2T4""BDHH ***#0 4444 --<#\5?^1<'^\O\Z[X
MUP/Q5_Y%P?[R_P Z:W \\MO^/=/I6_;Q10V(DV[G-8%M_P >Z?2M&UOC NQQ
ME:]J:;6AG!I/4DU"%%C251@MU%6K?28[NRB8,%8GG-9MQ=F>0$CY1VJ]'KGE
M[%6)0B]JEJ5E8&U<?_8+8(+@-V%/_P"$>;**)%R>OM49\02'),2Y[4U=>F5]
MVT9I?O!:%;4;'[#)M#!A[52JS=7C7?WACG-5JUC>VHF%%%%4(**** "BBB@
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M46%%%% !1110 4444 %%%% $L2!T<GM4530D!) 34- BA<?\AFP_WZ]YL?\
MCU@_W!_*O!KC_D,6'^_7O-C_ ,>L/^X/Y5A+<XJWQ&I%T%65JM%TJRO2D8D@
MI:04M( I:2EH *2EI*!A2TE% !2TE% @I:*2@!:**#0 4444 %%)2T %%%%
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M 4444# TM)10(****!A112T )12TE "TE%+0 E%%% !2TE+0(**** "BBB@
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M9W 8K/N9"( O;=6QJ??ZUB77^J7_ 'JYKV/?BSZ \$?\BO9?[@KKH:Y'P/\
M\BO9?[@KKX:A%ER.I1425** '4444@%I#2TAH K7G_'G-_NFO+/!>D'5?$-^
MK#]VL[$UZG>?\><W^Z:Y7X8QJ+G5&QS]H;FDW8WHU73;DMST"TLH;.(1Q(
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M4M(*6D 4444#"BEI* "BEI#0 4444 %%%% !1110 M)0*6@0E***!0 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG*4[K8[:-6$86>YZ-%IB6\YDB4+GKBM.*1EX)KRH_%1SS]G7\Z;_ ,+2?/\
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MX8L98RNS&:%\+Z< O[O)6MCYJ/FH S#X=L#_ ,LZMVFG6]F284VYJQ\U'S4
M/HIGS48:@!]%,^:CYJ '$9&*HOI%H[L[1Y+=:N8:C#4 4ET:S5PPC&14CZ9:
MR8W1+Q[59^:CYJ (;>Q@M23$@7-6::-W>G4 ?/GCO_DJ-E_O+_.O4;;[B_2O
M+_'0)^*5E@?Q+_.O4+;[B_2M(DLTHN@JP*KQ=*L+3$/I:2EI %(:6D- #37F
M'C;_ )&^R_WA7I[5YSXG@%QX[TY#TWC-#&CH]'\/O>8EFX3TKIXM#LXE "9J
M[;Q+% B*, "I:BY11_LBT_YYT?V1:?\ /,5>HI 4?[(M/^>=']D6G_/.KU%
M%'^R+/\ YYBC^R+/_GF*O44 4?[(L_\ GF*3^R+/_GG5^B@"A_9%G_SS%']D
M6?\ SS%7Z* *']D6?_/.C^R+/_GF*OT4 4/[(L_^>8H_LBS_ .>=7Z* */\
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M 4;1Z"F[32[30 ZBF;31M- #Z*9M-&TT /HIFTT;30 X@&C IN#1M- #L"C
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M,2EHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB@ HHHH **** "BBB@ HHHH 2BBEH&)12TE !2T4&@0E%%% PHHHH .]%%%
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MX:NIO/\ CSF_W37+?#'_ %^J?]?#4I%(]&KG-2\02V-_L"KY2GG/6NCK$O\
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M:7I5"'BEI!2TAA2TE+0(**** "BDI: $I:2EH **** $HI:* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HI*6@ HHHH **** "BC-% !12&EH
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M&I*3<*-PH 6BDW"DW"@!U%-W"EW"@"*XC\V%D]:QK?2YH[@9^Z,\UN[A1N%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%%% !1110 4444 %%%% !1110 4444 %)2TE PHHHH **** %I***!!1110
M4444 %%%% #34;U(:8PH XGQ=X#T[Q)&S.@2?LP&*\LN?@WJ44I%O,-G;+5]
M!NN:@:.BP[GSV?A'K0_Y:K_WU2?\*EUK_GJO_?5?0!2F&.BP7/ ?^%2ZS_SU
M7_OJC_A4NL_\]5_[ZKWPI2;*+!<\#_X5-K/_ #U7_OJC_A4VL_\ /5?^^J][
M\NC918+G@G_"IM9_YZK_ -]4O_"IM9_YZK_WU7O6RC918+G@O_"I]9_YZK_W
MU2?\*GUG_GJO_?5>][/:DV46"YX+_P *GUG_ )ZK_P!]4?\ "I]9_P">J_\
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M#_A$_&7_ $$G_P"_AI/^$2\9?]!)_P#OX:]@\NC91RH+GD'_  B7C+_H)/\
M]_#1_P (EXR_Z"3_ /?PUZ_L-+LHY4%SQ_\ X1+QE_T$G_[^&C_A$O&7_02?
M_OX:]@V4NSVHY4%SQQ_!OC"5=KZB^#_TT-:&B?"LK=+<ZK.TS YP6S7J@2G"
M.BR"Y7M+2*T@2&% J*,  5HQ+BF(E6$6F(F05**C05(*0#J*** %I*** &FH
MI%612K %3U!J4TQA3 \Y\3?#2TU.9KJR)AF//'%<R/ WB>TRD-\^T=/WAKV=
MA4#+2L.YX\?"7BW_ )_W_P"_AJ)O"7B[_H(/_P!_#7L+)3"G-%@N>/'PCXO_
M .@@_P#W\-1GPCXP_P"@B_\ W\->QE*;Y=%@N>._\(CXQ_Z"+_\ ?PTG_"(^
M,?\ H(O_ -_#7L?ETGET607/'?\ A$?&/_01?_OX:/\ A$?&/_01?_OX:]B\
MND\NBR"YX]_PB/C'_H(O_P!_#1_PB/C'_H(O_P!_#7L/E^U&RBP7/'O^$1\8
M_P#01?\ [^&C_A$?&/\ T$7_ ._AKV'91LHL%SQ[_A$?&/\ T$7_ ._AH_X1
M'QC_ -!%_P#OX:]A\NC919!<\>_X1'QC_P!!%_\ OX:7_A$/&/\ T$7_ ._A
MKV'91LHL@N>.GP?XP(P=1?\ [^&G6?PLU"\NA)JUV\B@Y(WYKV$1TX1T607,
MS1]&M='LUM[6,*H'4#K6S$M-5*L1KBF(EC%6%J)14JT .I:2EI %+244 +12
M44#"BBB@ HHHH *6DI:!"&BEI* "@T"B@84HI*44""BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ [T4=Z* $HI<TE !1110 &BEI* "BBEH&)1110(**** $--(IQH- $
M3+492I\4TK3 KF.F&.K)6DVT 5O+I#'5K92;* *OET>75G91LH K>71Y=6=E
M&R@"KY='E5:V4;* *OETGEU:V4;* *OET>75K91LH K>71Y=6ME&R@"N(ZD6
M/%2A*<%H 8%J0"E Q3@*  4ZDI:0"TE%% !0:** &FFD4\TF* (66HF2K.*0
MK3 J&.F&.KA2DV4 4_+H\JK?ET>70!4\NCRZM>71Y= %3RZ/+JWY='ET 5/*
MH\NK?ET>70!4\JCRJM^71Y= %7RZ/+JWY='ET 5/+H\NK?ET>70!5$=/$=6/
M+I0E $2IBI%6G[:4"@!0*<!0!3A2 **** "DI:* &FFD4^DQ0!$5J,I5C%-*
MT 5BE,,=6BE)LI@5?+IOEU;V4;* *OET>75KRZ/+H J>72>55SRZ/+H I^71
MY57/+I/+H J>51Y57/+H\N@"GY5'E5<\NCRZ *GE>U'EU;\NCRZ *OETHCJS
MLI=E $ 2I%6I E*!0 **D%(!3J0"T444 %%%+0 4E+10 E%%+0 E%%+VH 2B
MBEH **2B@ HHZ4M "=J!2T4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 C*&&",BH4MK>(DK&H_"IZX;5M7U"/6Y[9.(@#C'TI-C1KZKX<
M_M"<213*B]QBM73=-ATZT6! #CJ:Y/0_%$T-M#'>*=K D,?:M+3/%*WU^L)Q
MMD.$Q1H!TGEH$*X&WN*:(8B#M48/6L#5M=D@U!K&)"3CDXK-MO$[11>1 &DE
M#'=GG%%P.RVQA?+P,>E-2WACSL0#/6O/[OQ)=S:I#- #C.UDJ^?$EY=ZK;)"
MF$+!7'O1<+'9^3%L*;!M/48IJVL*@ 1C .>E<[XHU.\L+FR6 #:\BAJB?Q7(
ML^%BS$K;7;'0T7 V+C1UNM1CNI6!$8^5:T'MH9&W/&I(]169?ZTMI;V]QC,4
MN.?K6;<^+56=X(%W.#QQ0!T;6ENV,QKQTXJA%HD::H;YR"P^Z/2N8U+Q7=D1
M)$FV16 <5=/C';<"/"[5P&]>:+H#K)%1QM< @]C3/LD!()C7(Z<5B:[J2VPM
M9]S ,"<#O5/3?%LEW<0JT1$4IV@X]*+@=!J=C_:%FT 8*<<&LW1O#::;*\LK
MK([#&<=JIZ[K#:=KEIN9O)<\@?2LC4?%$C7ER+9F"E %SV- '>)!;C<$5>>H
MIZQ1+&4"C:>HK@Y8[[1/L5Z;AY!<$;E9LCFJ-EXGO4.I+<,0AW>4V>A[47"Q
MZ2RQB/:<!/2@QQ&,*0NP=*X&TEOM?-O:"=D'EABRM@FJ>I:G?Z;;26,DS?+,
M%#@\XHN!Z4L46TJ%&#U% MX@ -BX'M7$>&;Z=]7CBCFDEA*DOO.<&N\H3N#(
MS#&RA2@P.@Q39+6"1@SQ@D>U34E,13.FPF]6ZP-Z]*NT44 )2TE% P/-0&RM
MRVXQKN]:DF<QPNXY*C-<Q<>,H+<JK [B^TCTH Z80Q*I4*!GFN>N?#'VG4?.
M>=?++;MF*S-3\1/(7D@+ A3M]#66^NZF/LDQSNVY*CO4W&>ABRME0+Y:YQCI
M6!/X2\^^\YYE,6<[<5FW?BL%[>5]RN%^91ZUIZ5XGDO;R&*6/:DPRAQZ4]!'
M0"T@4+F,94=:D*1R 9 8"N6UO5+ZWU^*VB \I@V?RK+T;Q/<VJ#[2I,)8C<:
M+A8[WR8\#Y1QTHD2-QAP"!ZURT/C&.:^C08\IS@>M4O&=]+%JUA"LSQPRL-V
MPX.*+A8[-K:"3!:-3CI3UBC7HH'&*XK5;UK#0TBM;ES-(V 9&YK/U?Q%>0Z'
M8RP2;IEE"28/7UHN%CT-[>!\!D4XH>W@D #1J<=.*X&X\17%Q.AB<C%OEAGO
M5+_A)-0M=4LV+%H6B^<9HN%CTDVENV"8UXJ1HXI(]A4%?2O.Y=>N[AIHH)?E
MDF"J<] :W]$A>QU,6[W;2DC)#-DT7 Z-;6!5*B-0#UXIHM[<+Y81<'M6'JWB
M*2RU(6<,>YL$GBLJ'Q"UUJ:3(^ ,Y4GBBX':+!$JX"#!I1#$  $&!TKB+WQ?
M<265S'$%\Z/'3ZU/;>*KE?+A>/+  N<47"QUWV:#.?+7/TH%K 'WB-=WTKED
M\7L)%>6/$+':#CO4*>,Y9(3,D64,A1>.XHN@.P6VAC8LJ ,>^*DKBT\97!D4
M/"0-WS<=J[""036\<HZ.N13N!)112T )2T44""BBHYY!# \G]T9H ?44EO%,
M<R(&^M<K!XP=Y%>2(K"S%0V/2FP>,VG1W6/C<53CJ12N,W9]#MY]02Z95^4
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M("LBXSD5.J(%VJ %]*\U75+VZU6!8G?RA@]>M=+X8U&[N3>&Z'R12, ?847
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MNF@1@649/-%@N<E!H.HZ3#;36N7E2,(P%1S>%KS4(O.N<^8\H<J?2NZ+H.K
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*8WD4#(]<5F:?X3#ZI/+<[A'@!1GK71ZAH]OJ%FEO(/E3[M 'G6GZ_?7=P+
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M@KM&.#BM&#28+?319*#Y8IV X&,ZF;A5-[+M;)-6DU"]U"4P-<M$L/?/WJ[
M:);!PVWD55NO"UG/M(RI!YP<9I68[G+Q:A?WEQ"OGNH1B#CO4>FZU>S:C&PD
M8GS2C*?05VUOH5K;NC(O*56C\,VD5Z;A!@DYQ[T6%<VHW#QJ0><<T^H+:V6W
M4JI)R:GJA!1110 44&B@ HHHH **** "BDZ4M !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %)WHHH 6BBB@ HHHH ***#0 4=Z** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ I*6@T )2T44 %%%% !1110 4E+10 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2TE !2TE+0
M4444 %%%% !24M% !24M% "4M%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !111WH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $S2TE% "
MT4@I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "@444 %%%)0 4M%% !1110 4444 )UI:** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6DH *6DI: "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!****8"T4E+2 **** "B
MBB@ HI*6@ HHHH **** "BDI: "BBB@ HHHH **** "BBB@ HHHH **** "B
MBDH 7O24&B@8O:BBB@0E+110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 9I*** "EI*6@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H[T44
M%%%% !1110 4444 %%%% !1110 4444 )12T4 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "4M%% !24M% !
M1110 4444 %%%% !1110 4444 ':BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** $HI:* $I:** "BBB@ HHHH **** "BBB@!*6BB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
? "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (C!+\# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7D;R6IO[3RUG"C<=I!/\.3Z<=<D9\GL3>/XA^%<6N&86:VZ/;ELXW^:WEX_
M6_X8KZ*?[C?0T",#P=XQT_QMI$NI:;#=10Q3F!EN556W!5;(VL1C##O69X=^
M*/A[Q/XFGT*P^TBXC$A26546.?8<'80Q)R,L.!P">*\T\ ^(!X:^!'B*_239
M<&^DAMR'"MYKQ1*I7/4KDMCT4USR:]X:\/Q>!=4T6_:74=,.-41('61D<[W4
M%@%;&Z5,YS\P],A7&>_W?C'3[+QO8>$Y(;HW][ 9XY%5?*"@.<$[LY_=MV/4
M5T->3ZXRO^TAX5=&#*VEN00<@C;<UZQ3$%%%%, HHHH **** "BBB@ HHHH
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M1=S?ZT="/7G&#[90A!1113 **** "BBB@ HHHH **** "BBB@ HHHH ****
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MF7)QTS]"*\WO_P#DY+3/^P6W_H,E>K4(04444P"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** .1\1_$*P\-^(;?0WTK5]0OI[<7$<>GVZRD
MKEATW Y&PGITJM?_ !-T_2?#J:UJ6AZ]90/>?9!%<VBQR[MF\-M+_=QD9'<&
MN4\:#6#\>=#_ +!-B-1_LD^7]NW^5C,^<[>>F<>]=7XET#6_$GPQU'3=:6QD
MUAHVEC&GJQ0NAW(%W\@G&TG_ &C2&='X@UZR\-:!=:S?^8;6V4,PB7<S9(4
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M^\N1V+<^UVEU%?64%W Q:&>-98R1C*L,CCZ&A")J***8!1110 4444 %%%%
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M9[%S);+J-WYJ1/P=P&,YR >N.!Z5W%%%, HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *\ZO_ (2VQU:ZU#0/$&K:"UY*)+F&RF*Q
MOZ@ $$<DGDD#)P .*]%HH XE_AEICCP[NU#49&T.[DNXY)9%=YW>02-YAV\_
M,HY&.,]^:U/$_@^R\57&E37D]Q$VFW(N(Q"5 8\'!R#QP*Z*B@#G-(\'6>E>
M*]7\1FXGN=0U+"EIMN(HQCY%P!Q\JCG/"CW)9>^"K*\\=Z?XM%S/%>VD)A\M
M NR12'&3QG.'/?L/2NFHH YV;P=8S>.K?Q8T]P+R"W-NL0*^61\PR>,Y^8]Z
MZ*BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X
M[Q-\/+3Q+XBM]<.KZKIU]!;BW1["81D+ECUQG)WD=>E;/AS07\/6$EJ^KZGJ
M9>4R>;J$_FNO &T'TXSCW-;%% '"^&_A5H7ACQ7/KUF\S2-O\B!]NRWWGG;@
M9X&5'/0GKUJQXG^'5GXF\16VNG5M4T^^MX!;QR6,PC(7+'(.,@G>P//2NRHH
ML!Q<GPZBN/"VIZ#>^(=;OX;\QDRWEP)7BV,&&S(X!(&:O:UX&TK7O!UMX:O&
MG^RVR1+#,I'F(8QM#9QC)&0>.A/2NFHH QO#GANT\->&;?0;26:2V@5U5Y2"
MYWLS'. !U8]JS]!\":=H'@^[\-17%S-9W8E61Y& ?$B[3@@8''M74T4 >:2?
M!Z"]N8X]7\4Z]J>E1.LD5C<W)89''S-Z8R/E"D \$5Z4JJBA54*JC  & !2T
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 445XC\0OBG=7$[Z9X<F:.U5BCWD38>X8=1&1T0?WAU[''WDW8:5SU;4?%.C
MZ9<FTEN_-O!UMK:-II1]50$K]3@5D7GCIK9>=&EMR?NG4+VWM@?SD)_2OFMO
M%6I01&R2Z:. 9#10 (K9Z@[<;OQS3K6]UFXCS9Z?=RQCO$A(_05G>3+]U'T'
M_P +"N^UGX>Q[^(XO_B*/^%A7G_/GX>_\*2+_P"(KP=;CQ&O_,$OS]8G_P#B
M:D^V>(O^@#>_]^F_^)H][N*\>Q[I_P +"O/^?/P]_P"%)%_\11_PL*\_Y\_#
MW_A21?\ Q%?/LGB>]BD:.2T*.I*LK-@@CJ",4W_A*KK_ )]A_P!]_P#UJ/>[
MCNNQ]"?\+"O/^?/P]_X4D7_Q%'_"PKS_ )\_#W_A21?_ !%?/?\ PE5U_P ^
MP_[[_P#K4?\ "577_/L/^^__ *U'O=PNNQ]"?\+"O/\ GS\/?^%)%_\ $4?\
M+"O/^?/P]_X4D7_Q%?/?_"577_/L/^^__K4?\)5=?\^P_P"^_P#ZU'O=PNNQ
M]"?\+"O/^?/P]_X4D7_Q%'_"PKS_ )\_#W_A21?_ !%?/?\ PE5U_P ^P_[[
M_P#K4?\ "577_/L/^^__ *U'O=PNNQ]"?\+"O/\ GS\/?^%)%_\ $4?\+"O/
M^?/P]_X4D7_Q%?/?_"577_/L/^^__K4?\)5=?\^P_P"^_P#ZU'O=PNNQ]"?\
M+"O/^?/P]_X4D7_Q%'_"PKS_ )\_#W_A21?_ !%?/?\ PE5U_P ^P_[[_P#K
M4Y/$]Y(ZHEIN=CA55\DGT'%'O=PNNQ] M\0[M5+&S\/D 9(7Q%$3^ V<FA?B
M)=,H866@A3V;Q#$K?D4KPS[9XB_Z -[_ -^F_P#B:C:X\1MTT2_'_;)__B:/
M>[A>/8^AK3QVUPI/]BS7!'WCIU[;W('Y.#^E:VF^+-&U.Z%I#=^5>'I:W4;0
MRGZ*X!;ZC(KY7N[_ %>V0?;;"ZA0_P#/52 ?S%1-XDU"\5+66[EDA'"12L65
M?0 '@?A1>2#W6?8]%>&_#WXI7=G+'IGB*X::R9@BWDK9>V8]!(3U0]F/3N<=
M/<JT3N0U8****8@HHHH ***\0^(/Q3NKF=],\.S-':*Q1[N)L/<,.HC8=$']
MX=>QQU3=AI7/5M1\4Z/IER;26Z,MX.MM;1M-*/JJ E?J<"LB\\=-;+SHTMN3
M]TZA>V]L#^<A/Z5\VOXJU*"(V2731P#(:* !%;/4$+C=^.:=:7FM7,>ZRTV\
MFC'>)&(_05G>3+]U'T%_PL*[[6?A['OXCB_^(H_X6%>?\^?A[_PI(O\ XBO"
M5E\2K_S M0/UB?\ ^)I_VGQ)_P!"_?\ _?E__B:/>[A==CW/_A85Y_SY^'O_
M  I(O_B*/^%A7G_/GX>_\*2+_P"(KY]D\37L4C1R6921"596;!4CJ",4W_A*
MKK_GV'_??_UJ/>[A==CZ$_X6%>?\^?A[_P *2+_XBC_A85Y_SY^'O_"DB_\
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MS_VR?_XFI1<^)/\ H7[_ /[\O_\ $T>]W"\>Q[G_ ,+"O/\ GS\/?^%)%_\
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MLW7@8[?$L!7/!-H0?_0JD9X;17N/_#-U]_T,EO\ ^ K?_%4?\,W7W_0R6_\
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MXGWLQ0+'>PQ7"8'4;=A/UW(U><5]*_%3PGJOB_Q#;V7]FS"T6 O97\3-($F
MS(LBC(5&54 /7<N1NR5KG&_9NO QV^)8"N>";0@X_P"^J /#:*]Q_P"&;K[_
M *&2W_\  5O_ (JC_AFZ^_Z&2W_\!6_^*H \1C* _.I8>U/WP?\ /)OSKVO_
M (9NOO\ H9+?_P !6_\ BJ/^&;K[_H9+?_P%;_XJ@#Q3?!_SR;\Z9(4.-BE?
M7)KV[_AFZ^_Z&2W_ / 5O_BJ/^&;K[_H9+?_ ,!6_P#BJ /$U:+R&5D'F=FR
M<_3'3_\ 745>X_\ #-U]_P!#);_^ K?_ !5'_#-U]_T,EO\ ^ K?_%4V[B2L
M>'5VWPCLWO?BCHBI%YBQ2M,_&0H5"<GTYQ^.*Z76O@!XAT]4_LVX35"T;L1&
MJQ;6!7"G>XZY;D=-OO7LW@;X>:7X)@G6R1S=31[)+V3!D;YFZ=E'W3C'IG.*
M0SM**X?0?#OB"U\4W,U[JU^;.%B4D:9F%V&.0"K2N@ 'WML4)#8VG;FN.\6P
M^-K?QYKTL%CK5YIEPML=.-K=W(BB($8D.V&9,# DR#R6VD8!)(![0RAE*L 5
M/!!'6O)OB-\%=)U_3YK[P[:16&KQJ66&$!(KC ^Z5Z*W'!&!D\^H[GPHM\+/
M=<QW<49CC")=R.[@@<D[V9@3U.2?3)QFNAH ^+--$DUG,SQG[98 B6-Q@R1C
M[RMGVSU[@^M?0'PKUIK[P_)I<LAD?3M@A<YR]NXS$?P 9?HHKS'Q9%!I7QZU
M:WA0+#<.KLG8L\:.Q_$LWYUT7PP/]F^)[2U,C,6@N["0D\,\4BNOY(Q%*]I(
MK=,]HHHHK4S"BBB@#B?B;K1T[PZ+"*7RY=0W([CJD"C,K?EA?7Y\CI7SUJTA
ML]/CG*A+J]4&-!_RRB_A _#!^I'I7KGQ3+W^MRV8E*_N+:TB(_@DFE8O^:1K
M7%:591:]\:-,L9%'V>"3>4Q\N$4R8QZ':!66\F:/2*/0?AM\)=/T73H-2URT
MCN]6F <13+N2V!Y"[3P7]2>AX'3)]$N-;T_3]9BTV\\Q)' (('R@D$@>IX4]
M!6[:PA5$C#YCT]A4%UHFGWMZEY<0;YT7:K[R,=>< ]>3SUJV^Q!E3^,-)L[B
MZA2*>0VNSS'BCR/F;;U]CU]*Z6LK_A&M&\R>0:?"'G0)*P&"X!W<_CS6K4C/
MD_XX::]A\4+Z4QJD=Y%%<1[1C(VA"?KN1J\ZK[*\=> =*\>:9';WS/!<P;C;
MW46"T9/4$'JIP,CVZBO)V_9NO0QV^)8"N>";0@_^A4 >&T5[C_PS=??]#);_
M /@*W_Q5'_#-U]_T,EO_ . K?_%4 >(QE ?G4L/:G[X/^>3?G7M?_#-U]_T,
MEO\ ^ K?_%4?\,W7W_0R6_\ X"M_\50!XIO@_P">3?G3)"AQL4KZYKV[_AFZ
M^_Z&2W_\!6_^*H_X9NOO^ADM_P#P%;_XJ@#Q16B\AE9!YG4-DY^GI4->X_\
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M_P 51_PS=??]#);_ /@*W_Q5 'BF^#_GDWYTR0H<;%*^M>W?\,W7W_0R6_\
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MB@ HHHH **** "BBB@#Q_P <IN\32R'^'6]-0?3R9&_G7(^!LM\>;?N<R_\
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ME\O<95!VJP/3OG@_A6X "&'8T ?*_CLX^/-R?]N+_P!)TKJ/!L>/%NGR=_\
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MZ_WHO_2=*Z[P;\OB>Q.,[]?U$<_P[;93Q]=W/T%*6Z]2H]3V2BBBM3,****
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M+Z/[*L NH1+\I#1N[1M')N).%CPWRKL+,17?Q-N16P1E0<'/]>?SIV#C&:
M* /ESXC_ /)?[O\ WH?_ $G2NI\'?\A[3_\ L9=0_P#2,5RWQ(_Y+_=?[T/_
M *3I74^#O^0]I_\ V,NH?^D8I/H-'LE%%%:D!1110!Y'XR8-JUZ5((_X22P'
M'_7H]<K\-?\ DOD?^[+_ .B378>-;>*VF18D50WB"UD;:,99H[@D_7)KC_AK
M_P E\C_W9?\ T2:QB[JYI)6=CZ<*YI-I[M3J*HD ,# HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *0C/UI:* &[.O/7K@=:<!@8%%% 'RIX\_P"2\7/^
M_%_Z3I77^#O^1BT[_L9=1_\ 2-:Y'QY_R7BY_P!Z+_TG2NN\'?\ (Q:=_P!C
M+J/_ *1K2EN-'LM%%%:D!1110!Y/XV8-X@FP0<:SI@./^N<U<;X!_P"3@['_
M 'IO_2>2NO\ %]O%;ZDJQ(JAM9LI&P,99GNR3^M<AX!_Y.#L?]Z;_P!)Y*QB
M[ZFLU9V/J C/(X-)\_M3J*H@0# JCK&DVVM:=)972Y1N0PZJ>Q%7Z* /&]6^
M%^L76KP1(()=-5@S?/MS@ #(_"NL\!_#Z'PDLMS<-%->NS;&1>(D/\(/?I7<
M45STL/"D_=N;5*TJBM(*0J""" 0>"*6BN@Q*ECIEEIJNME:QP!SEM@QDU;Q1
M10 4444 %%%% !1110 4444 %%%% 'RW\1?^3@;S_>A_])DKJ/!__(R:;_V,
M>I_^DB5R_P 1?^3@;S_>A_\ 29*ZCP?_ ,C)IO\ V,>I_P#I(E)]!H]EHHHK
M4@**** /)?&S!M>FP0<:YIHX_P"N,M<1X)_Y+U:?[TO_ *3O7;>,K>*VU"-8
MD50VN6<C8&,LQNB3]<FN)\$_\EZM/]Z7_P!)WK&#OJ:35M#U6[MQ.6!]:SGT
M=#6R_P!X_6FU1)BIHJ)(&':M:--B 5)24#"DS0324 &:*,TF:!BYHS32<5&T
MRKU-#:6Y23>Q-FBH%N$;H14H;(I)I[ XM;CJ7--S2YIDBYI:;3LT"%J*5-Z$
M5)2T 9 TL";>*U(EVJ!3\4HH$>1>.?\ DO-U_O1?^DZ5UW@[_D9M-_[&#5/_
M $ECKD?'/_)>;K_>B_\ 2=*Z[P=_R,VF_P#8P:I_Z2QT/<:/9****T("BBB@
M HHHH **** "BBB@ HHHH **** "BBB@#R'Q?/+-?E)X&ADA\0VB8+ [EVW#
M*PP3U5E.#@CFN1\ ?\E^M/\ ?D_]$-78^-_^0Y<?]A_3O_2>2N.\ ?\ )?K3
M_?D_]$-6,5;0TD[ZGU'5)]'TR2]^VOIUHUV&#>>8%+Y'0[L9R,"KM9]WKND6
M%['97FJV-O=R@&.":X1'?)P,*3DY/%42:%%%% !1110 5DWGAK2+^]>[N;3?
M+)L$F)'59=IRN]00KX_V@?2M:BFFUL7"I.#O!V] HHIL<B31K)&ZO&X#*RG(
M(/<&D0.HHHH **** &A$$AD"KO( +8Y(&<#]3^=.HHH 9'%'"@2*-40$G:HP
M.3D_K3B RE6 (/!!I:* ,>\\+Z5? K<0,R,?F4.1N'H2.<>V:UD1(XUCC551
M0 JJ,  =A3J*226PW)O=GRUX]_Y+_??]=(__ $0E=5X-_P"1JT[_ +#NJ_\
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MR[KEE88)ZJRG!P<YXKD_ /\ R<'8_P"]-_Z3R5V?CC_D8)?^PQIG_HN:N,\
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MX=1;?,UMU_/Y&Q\$/%5[J^GWFBW<<2IIL<8@\L'(4[@0Q/'88'UKI5T/Q1!
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M ,GLH'Y_SKSJ'XB^)$274)+6W?3O."  8,?JH.<\CG)!K;EBA>UC]B'W_P#
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M&,<444 -2-(UVHJJOH!BG444 %%%% !1110!\J^/?^2[W'^]%_Z3K77>#O\
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M_2=*ZOPMY\>LV=S#")1!XBOO,!?;A'2WBW#@YP9 <=Z4MQH]GHHHK4@****
M"BBB@ HHHH **** "BBB@ HHHH **** /'_%'2V_[&"+_P!'WU<GX '_ !?Z
MT_WI/_1+5UGBK<EPMO)&R/#XAMP=Q!W!VNY5(P3QMD7K@YSQ7)^ /^2^VO\
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M\M)K>&-[87"O%.Z2R;FC=I&=00PZM*YYRN2,J0H  -:YU[1K-[A+K5K"!K8
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MYXM7.UHHHIE&5XEU"73/#UW<V_\ Q\8$<)XX=V"*>?0L#^%<%&D%C&MM%TB
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\N?$;_DX"Z_WH?\
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M+A&Q[!E8?A7(> /^3@[+ZS?^D[UU?B<_O8/^PY!_Z4WU<IX _P"3@K+ZS?\
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MN,G.9/\ #CPG<BW$ND[OLT)MX2+B4%(R@38"&^[M'3IEF/5F) .H08C4;R_
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M'O@9S0!J4444 %<99^$/"?AJ[@M+>&>&:[5%C5GDE#^2&8 $Y"M@LV!@G:Q
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MK&BH#XEL6(4 9)M')/U)-<S\,O\ DO7_ &SE_P#11KJ/&?\ R%KS_L9-/_\
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M;HI5#*?4&IJK6%E#IMA!9P#$4*!5JS63M?38YY6YGR[!1112)"BBB@ HHHH
M**** /ECQ_\ \EUE_P"V7_HA:ZKP=_R,6G?]C+J/_I&M<KX__P"2ZR_]LO\
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MG_@0G^-'_"OO&O\ SYI_X$)_C7O5%/VTNPO[2J?RK[CP;_A7WC7_ )\T_P#
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MI_Z2QURGCS_DN\__ &R_]$+75^#O^1ETW_L8=4_])8Z'N-'LE%%%:$!1110
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M79Y;?<4>P_"N@. ,FF[QZ5!R%>"WAMT*6\2HI.2%&!GUJTHVKBF[QZ4>9[4
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MB>6SMDY8FK264A(VKBK37=K$C,B@XJC-JLK\+P*A&3-J_4I\2--4]1868_\
M)2.O0O!O_(U:=_V'=5_])XJ\[NV+?$/2F/4Z?9$_^ D=>B>#?^1JT[_L.ZK_
M .D\54]T)'LE%%%:D!1110!Y'XV_Y#-S_P!C%IW_ *2O7,?#3_DO8_ZYR_\
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M'XG#_B_3_P"[%_Z)%=%X-_Y#VG_]C-J'_I&*YWXG?\EY;_=B_P#1(KHO!O\
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MZ0/+NMQ/& 0N01GG-0CX@:8T4C+!<DQ@LV4V@J 22">O0\5T<MA9S@":UAD
MQ@,@.,=*8^F:?(I5[*W8%MY!B!RWK]: #3+X:EIZ7038'+ #/H2*O$GRZCCC
M5%"1H%7T P*F*?)B@#,U;5$TBTCN'B>16F2+"#)^8XSBN=C\>P/<&$VKAFB:
M1/PZ@^E=>\:N )$#8.1D9P?6H38V9.3:PY_W!0!S[>.+&./<UK< X+ 8 RHW
M9;K_ +)XKI8Y!)$DB]& 8?C6=J>@:;JUND%U;CRU;("';Z\<=N36G'& JHHP
MJ@ ?2@![G) K$UO7&TB2%%MC+YD<DA;. H1<GM6XZYY%0O%'(?WD:L<%?F&>
M#U% '+0^.[,Q&2XL[B)5!9V&&"C+ 'UYV&E'C_3/*W_9[H?(7(*8/!QCFNB%
MC9KNQ:PC=RV$'/\ G)IG]EZ=M"_8;?:%V@>4,8]/I0!-:W*7EG#<Q_<E4.N?
M0U;4Y45#'&JHL<:A448  P *F P,4 +1110!\L^//^2[3?\ ;+_T0M=7X._Y
M&;3?^QAU3_TFCKE/'G_)=IO^V7_HA:ZOP=_R,NF_]C#JG_I-'0]QH]DHHHK0
M@**** "BBB@ HHHH **** "BBB@ HHHH **** /(_''_ "&Y_P#L/Z;_ .D\
ME>>Z+(8?B7JTJ_>33[MA^%NU>A>./^0W/_V,&F_^D\E>>:.,_$C6!_U#KO\
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M?_I(E<[\2O\ DODOTB_]$K71>#O^1DTW_L8]3_\ 21*3Z#1[-1116I 4444
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M':KJG(% "T444 ?+/CS_ )+M-_VR_P#1"UU?@[_D9=-_[&'5/_2:.N5\>_\
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M 9%:F)UM%9NC6VI6MJ5U.]^US,%);"C:VT!@,*ORY&1GGFM*@ HHHH ****
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M5.HDGHSHQ$'4@VUJCH/ASK!N/#>5#EPQ5MW(!]0?3VK0\2ONT"[SR=A)K%\
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MNH_^D:UR_P 0O^2YGZ1?^B173^#?^1BT[_L9M1_](UK26X(]GHHHK4@****
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M<(VCD5BP4@CE221S5[[!:>2L/V:+RU)(7:, GK_.A[&TD?>]M$S9#9*CKZT
M5I=9MXG=?+E;:_E@JOWF'4#Z5&OB&Q8!B9%C.<2,N <=?Z5<DT^SE9VDMHF+
MXW$H#G%.-E:E-AMXBOIL&.N?Z"@#/3Q'9R,51)B<D#Y.N 2?RVFD?Q%:K#YB
MQ3-QT 'WL$XZ]< UH?8;4,S?9XMSDECM'/;^I_.F#2[ 8_T.'@;1\@Z?Y)H
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M -$M76^.?^0_+_V&=+_]%S5R7P\_Y+_;_P"[-_Z):LENRWT/IRBBBF(****
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ML,9^ZQR"O0AF!&"14#>"]#:2VD^S2"2UM(;.W83-^ZCBD62/ )QD.B')!SM
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M !1110!Y'XY_Y#<__8P:;_Z3R5RWPY_Y+P/]U_\ T774^.?^0W/_ -C!IO\
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MVUO;N26BAB5$8G@Y &#FFC2-,$R3#3K02H@17\A=RJ&#  XX 95./4 ]JN4
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M%%% 'D7C?_D,7/\ V,6G?^DSUSGPP_Y+O)_UQE_]%UT?CC_D,7/_ &,>G?\
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M.<BKT#!;$N>W6J2,9$''-2WCBVT>4[N6&/Q/%>>];1._:[+4,*WFABV;^.+
M^O:N!F+@-&ZD%2017>:=+BV0 \  "L;5M&DFU3$$>1/\WX]Z[L!4M4E!G#CX
MOV:DOF<C'>/&A0*I!/<5JV9(B$BC#'TJS=^#=2A93%!O!ZX/2IH='O[:!5EM
MW!Z<"O8DKH\6$DF;OQ$_Y+B/]R/_ -%5TO@S_D8M/_[&;4O_ $C6N:^(G_)<
M5_W(_P#T572^#/\ D8M/_P"QFU+_ -(UJ);EH]GHHHK4@**** /)O'7_ "'I
M/^PSI?\ Z!-7*?#O_DOT/^Y+_P"B6KJ_'7_(>D_[#.E_^@35ROPZ_P"2_0_[
MDO\ Z):LENRWT/IJFR?ZMOI3J;)_JV^E,%N4ZIQ7DTFJ3VC6<J11H&6X/W7)
M["KE%;)G0FE>Z(XY6=W4QE0IP">]2D8[YI**1(Z/_6+5RJL*EI >PJU42W,Y
M[A1114D!1110 4444 %%%% !1110 4444 ?,7Q,_Y+VW^[%_Z)%=!X-_Y&/3
M?^QDU/\ ])$KG_B;_P EZ;_<B_\ 1(KH/!O_ ",>F_\ 8R:G_P"DB4GT&CV:
MBBBM2 HHHH \D\=?\AV3_L.Z9_Z)EKD? 7_)=1_N2_\ HHUUWCK_ )#LG_8=
MTS_T3+7(^ ?^2Z#_ ')?_11K-;EL^G7^X*Q];NM0M([=K"%92\HC<$9P#T/X
M&MK&5Q495AVS0(XB?QM?6RJ9=+V N%W.' )+*-HX^]\WTJP/$^IRZ/?7(TXQ
M3Q!/+78QP6Z@Y'\/?%=1/907)0SVZ2&,[DWKG:?45-M/]V@#E+CQ'J:V.G7-
MMITT@F1Q*CQ$.K@87CL"?TJE!XPUEH]D^BO'($7=*4?:I(ZD 'BNXVG^[1M/
M]V@#A+3Q5KZQ![G3L@IG+1N,'CT'3FGQ>*]<+^9+IFU&) 78V$'!!;C)]./6
MNXVG^[1M/]V@#!T76M0U&Y*7>FFUC(8J23D$8Z_7/Z5T$?4TW:?2I%7:* '4
M444 %%%% !1110 4444 %%%% 'RWX^_Y+K)](O\ T2*ZCP;_ ,C+IW_8PZI_
MZ31UR_C[_DNC_2+_ -$BNH\&?\C+IW_8PZI_Z31T/<:/9:***T("BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@#R/QS_R&Y_\ L8--_P#2>2N6^''_ "7?
M_@#_ /H%=3XY_P"0W/\ ]C!IO_I/)7+_  W_ .2[G_<?_P! K);LM]#Z7GGB
MMK>2XN)4BAB4O)([!510,DDGH .]4K?7=/N;B*W625)9<A%FMY(LL 3L^=1\
M^T%MOWMHW8QS5RZMHKRTFM9U+0S1M'(H8C*D8(R.1P>U4+?3+HW-M)J%[]J^
MQY,!$80LQ!7S),<%MK%< !<ECCE0C$6+C5M-M&F6YU"TA: (THDF5?+#G:A;
M)X!/ SU-6998X(7EE<)&BEF9C@ #J:P]0\*P:CJW]I2WERLR(Z1*H7;'O0(Q
M QSP"><\GG<%0+>UK3WU'27@A*B='CG@WL54RQ.LB!B 3M+(H.!G&: 'V>KV
ME]*(8C.DI3S!'<6\D+,O&2 Z@G&1G'3(SC(ITFKZ9#,89=1M$E$R6Y1IU#"5
MAE4QG[Q'('4BJFEV%Y:W$?FJD=O#$T:!KN6ZD<L5.2\@!&,$=6SD<C: 6GP[
M";VZN?.*M<D*X2-5'EY8E.G=F=MWWLNW.,  &S1110 4444 %%%% !52RU.S
MU!&>VFWH!N#%2H9><.N1\RG!PPR#U!-6)H8KF"2">))895*21R*&5U(P00>"
M".U8,_AQ;Z748KH(MI<::+"+8%+1*3+YFT,"H!5H^Q!V#(P!0!LV]]9W<<,E
MM=P3).ADB:.0,)%&,LI'4<CD>HI]Q<1VT7F2$XW*@P,Y+$*!^)(K%TKPK%I-
M[%=1W]V[(LJM&[!D;S)&D8_,"WWF/.[)P,DXK0U>SN+RUC%K,$EAF281O]R;
M:<A&."5!(!RO((!PPRK %I+B-X?-+!5W%3NXP0<8_/BHK'4K'4XY)+"]MKM(
MY#$[02K($<8RI(/!&1Q[UEG0+B]TY8M0U"9)OM1NPMMMV1$YQ&-R_.JD[LL,
MEAN&W"JNEIFG+IEM]G2:21!M"[S]T!54 ?@N3[DF@!UYJ-I8&);F=4>9MD4?
M5Y#U(51RV!R<#@ GM4\4L<\*30R+)$ZAD=#D,#R"#W%8MKH=Q)<W%]>W4L=V
M]PQC-O*558E9A&I'1OD(R""H)) #$L=>UM(+&V6WMHQ'&I)P.222222>2222
M2>222>30!\Q_$#_DOMW_ +T?_HE:Z;P9_P C3I__ &'M5_\ 1$5<S\0/^2^W
M7^]'_P"B5KIO!G_(TZ=_V'M6_P#1$5)[H:/9:***U("BBB@#R+QQ_P ABY_[
M&/3O_29ZYWX7_P#)=Y?^N,O_ *!71>./^0Q<_P#8QZ=_Z3/7._"__DNTW_7"
M7_T 5DNI;/I:FNBR(4=0RL,$$9!%.HIB.9MOA]X5M)$>+1XOD?S%1W=T#=,[
M6)'Z5TU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?,OQ2_Y
M+LG_ %RB_P#1=;O@O_D/6'_8SZA_Z1BL+XI_\EVC_P"N47_HNMWP7_R'K#_L
M9]0_](Q2?0:/9J***U("BBB@#R+QK_R%KO\ [&73_P#TD:O,[$X^)-X3_=/_
M *"*],\;?\A:[_[&73__ $D:O+[<X^(MX<]C_P"@BL'LS3JC1UV-;CQ!91D9
MQDFCPY OVN_7L7Q^%2W$1N-<67G;'&<FIM"A,2W$C C?(34W]VP_M%'6?#MO
M!I\LT#-N3YL$\5R/SA-X'&<5Z+K#;M+N%'78:X:##:/<1A<R;P1CK5P=UJ3+
M?0KR']TN>^:KH<2 ^AJQ=1M"4C8?,%&?J>:K)]ZGT8[ZH]2#;HT/JHJ'4IO(
MT>[DS@B)L4L)S!'_ +@_E6;XKG\G0'0'F5E7^O\ 2OFZ<>:I&/F?1U9<M-R\
MCB%Y%.J.+[M+*VU>.IKZ4^9(I'W-["FIS(OUIIIT?^L7ZU;V$MSM-.;; OO4
MC+ONVDQG8NT?4U5MG"P)SVJ[&"(U)ZM\QKP)Z2;/HH:Q2+$(/&3CZ4S7U*Z0
MN/\ GHM+$WS"HO%$FW18AW,J_P C65-7JQ7F74=J4F3:7=K]F0,I#CJ#3M<E
ME%I#+$Y4J3\R]JIZ?/<-:1LJ!^*GDN?/@DM)HBC./ESTW=JJG:%?F\R*J]I1
MY48\>OZC&>+R3\:L+XFU(=;D'ZK6,Z,A/F1LN#@Y%-W(>XKZ!'SLCMOB)_R7
M%?\ <C_]%5TO@S_D8M/_ .QFU+_TC6N;^(O_ "7%?]R/_P!%5TG@S_D8M/\
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M%#BUNAN$H[JQ\R_$W_DO3?[D7_HD5T'@W_D8]-_[&34__21*P/B;_P EZ/\
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M1110 4444 %%%% !1110 4444 %%%% 'D?CG_D-S_P#8P:;_ .D\E<O\./\
MDNY_W'_] KI_'7_(>E(^Z-=T\$>K>0V#^ ##\:YGX;_\EW/^X_\ Z!62W9<N
MA],X/]XT8/\ >-+13$)@_P!XT8/]XU%-=10MM;>6QG:D;.0/4@ XZ&I$=9$#
M(<@T#L[7%P?[QHP?[QI:0D*I)Z"@08/]XT8/]XTT3(S  G)]C_GL:?0 F#_>
M-&#_ 'C2US6N>*?L%P;6S1)95_UC/DJI]..I_E4RDHJ[-:-&=:7+!:G28/\
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M=;#U*+M-!M/]\_I1M/\ ?/Z4ZD9E12S$ #J35G.)M/\ ?/Z4;3_?/Z4*ZL2
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M47=NQYP@P*@D;<Y]*[I_A+X[VX707_[_ ,?_ ,54/_"H/'G_ $ '_P"_\?\
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M0BU&X_B"OY5\Z^A\6CV>BBBM2 HHHH \D\=?\AV3_L.Z9_Z)EKDO '_)=/\
MMG)_Z+-=;X[_ .1@<_P_VUIP(]6\I\'\ &'XUR7@#_DN9_ZYR?\ HLUE'=ER
MZ'LWQ5X\& _]/"?R->';J^C_ !5H7_"1^'9].$@CD<!HW/0,.F:\?E^%OBB-
MRJVT$@[,LPY_.DY-;'W?#N-PM/"NG5FHM-[Z;V.1W4N^NJ_X5CXJ_P"?.+_O
M\M+_ ,*R\4_\^<7_ '^6FJC/HGC\%_S]C]Z.5W4NZNI_X5EXI_Y\HO\ O\M+
M_P *S\4_\^47_?Y:M560\?@O^?L?O1RV^EW5U'_"L_%/_/E%_P!_EI?^%:>*
M?^?.+_O\M6JK)>.P7_/V/WHYJ HTZ"5ML>X;C[5T,S:)=+)=#"+PI0_*1@'D
M =2>*E_X5IXI_P"?*+_O\M'_  K3Q3_SYQ?]_EJO:G/5Q.#FT_;)>C0QTT6*
M62V4JS.0@*G.!N7G)Z'&ZL*\,"7DB6Y)B4[5)_BQW_&NA_X5KXH_Y\XO^_RT
MO_"M?%'_ #YQ?]_EJU5MU(IXC!P=_;I_-'+[Z7?73_\ "MO%'_/G%_W^6E_X
M5MXH_P"?.+_O\M:*N:O&X/\ Y^Q^]',;J7?73?\ "M_$_P#SYQ_]_EI?^%;^
M)_\ GSB_[_+5JNNY#QN#_P"?L?O1S.^EW5TW_"M_$_\ SYQ?]_EI?^%<>)_^
M?./_ +_+5K$+N2\9A/\ GY'[T<SNKU7X3$G3M1/;S5_E7))\-O$S, ;6%1ZF
M85Z?X,\-OX:T=H)I%DN)7WR%>@] *SKUU*'+<\;.<7AY85PIS3;:VU/G[Q__
M ,ET?_=B_P#1(KJ/!G_(RZ=_V,6J_P#I-'7,>/\ _DNC?[L7_HD5T_@K \36
M6[G/B#4@G^R1;KN_,%?RKSI;GQ:/9:***U("BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@#R7Q[&8]<NV/W(]0TN^8^B8FB)_,"N8^'P$'QY17.#)&^W/?
MY#_@:[+XK6#%DF4/MU&T:R<@XS+&PF@'XD2"O*KK7Y='\4:+XPLU#%2K2(IP
M#U#)GMU=<UDOB:-'LF?7=%9^B:U8>(='MM4TV<36MPFY6'4>H([$'@CUK0ID
ME*\MGF;_ ):^6=N1"P5CC/!)_AY[8/%68$9(L/MW%F8A>@R2:@>VN2Q*7K(#
M(&QL!P.ZU+!'-&9/.G\T,V4&P+M'IQU^M2MS63]VUR:FN,HP&#D=Z=2,"RX!
MQ5&1"D;AT)5<#/.!GO\ KS^IJ>HECD&<RY^;/W>WI4M !7EUV%BU6[6\221A
M*V=C!"3GKR#7J-8VK^'+757\[<8;C&#(HR&^H[UE5@Y+0]# XB%&;Y]F<->-
M:G CAF5_+3!:4$?=';:/YUZ!X?61-!LQ*26\O(R<_*3D?IBLRQ\&VUO.LMS.
M;D*<A-FU3]>3FNEJ:4&G=FF.Q5.I%4Z>MNH4QPW#)@D9X-/ICHS,"'( QQ6Y
MY8D:ORS]2 *DIB*PSN?=SZ8I] "$ @@C(/4&H(UD\W#H1&N=N6%3L"5(!P>Q
MIBQN,#S2<'N.H]* )***S?$&NV7AK0KO5]0DV6]LA8@=6/91[DX ^M 'SEXZ
M3S?C]>!>=AC)]OW2_P"-=1X'@:7Q-I4B'*/>ZK? CNA\J('\P:\RTG5I[[7=
M7\67VWS7+RC.=NXG(7Z9V@>U>L_"?3C]KFN"'$>FV:6"DG(\V1C-./P8H*3^
M)(I;-GJE%%%:F84444 >2^.XFCUR[S]U=3TR^8^B;982?S KG?AL!!\>65S@
MR02[<]_D_P#K&NL^*U@Q=95#[-1M&LV*G_EK$WG0+^)$@KRV?Q#+H?BS1/&5
MF@?:0TB*< @Y#IGMD%US675HT>R9]<T50T76;#Q!I%OJFFSK-:W"[D8=1Z@C
ML0>".QJ\V<?*<'WIDE=D<L?E8@ @#(VGKR?_ -56:A47 4;F0G;Z=ZD3?L'F
M8W=\=* '5'*"4X!)SV.#_,5)37#';M/?GZ4 11*XER8PHVXXZ=!TY^O;M4]1
MKYNX9"XR>_:I* "O)FRL\@N4D:7<=V6P=V><Y!YKUFN=UGPK%J$[7-M((9FY
M92,JQ]?8UC5@Y+0]++\1"C)J>SZG%W)B+G:CAL#DN".@[8KT+PZ)1H%GYV=V
MPXS_ '<G;^F*Q+'P65E#W]PK*#_JXL_-]2<8_+\:ZY55%"J J@8  P *FE!I
MW9KC\33J15.#O;J+3)58[67)*G.!WX(_K3ZCE$A'[M@#@]?7MVKH/($C#[LM
MG@8R<<_E4M,'F;SG&WMSS3Z "LY[6432+&7\B24/)\_S9X^Z>R\<CZX[5HU3
M(U 1X#0,P0_,21N;MD8X&.329I!M;%P    8 HIL>_RU\S&_ W;>F>^*I:WK
M-EX>T6ZU7491':VR%W/<^@'J2< #U(IF9\[_ !-Q/\>%5&#&.&(. ?NGR^_Y
MC\ZV_!4;MXFTU!RK:WJEV#ZH(4B!_-J\ZT_6IM8\5:OXNU#&69I=I;@?W4!/
M8?*HKU+X46,LFH--(SE-,L1;?,O6:9_.D&?5?E'XTGND4MFSUBBBBM3,****
M /)/'431ZY=@_=_M?3+UCZ(8Y(<_FM8'PR A^.\RN<&2WDV>_P H_P #74_%
M>PD\P2H'V:C9FT)7_GM$_G0K]3^\%>73>(9-"\7Z+XQLT#@8:1 < @@ATS]"
MZYK);M&CV3/JR_U.*P>*-HIII9<[(X4W,0.I^@IMEJT5[</!Y%Q!*JAPD\90
MLI.,C_.:HPS:=XPT6SU;2[PX8>;:W47WHST((_1E-7[#3VMF>XN9?/O)0!)+
MC P.BJ.PIDC6US3%;:UY&#YGEX/][_/?I5R>>*UMY)YG"11J7=CT '4UBR^%
M;6:>6:2YN2\K9<Y7E?[O3IP.>O'6M34;3[=IMS:YP98R@/H2.#0!2AUY7DA$
M]A>6T4[!8IIE7:Q/0$ DKGMD"KESJEE92B*YN8XG*E\,<<#//Z'\JQH='U&Y
M,"WT=G JLKSM [N964@X&<!02,]ZO:KH%OK$T;W$TRJBD!$( R01GIG/- &C
M;74-Y L]O()(VZ,*EJK862:?:^2LCR9=G9WQEF8Y)X '4U:H **** "BBB@#
M)D\0V<=TR$,;9'\J2Z&/+23^Z3GKVST!XJ]=7UK9!#<S+&'.U2W<UAS:%.^M
MR.MM:FPEGCG?+<Y52#\FW!R2#G-:VIZ7'JD*1232QHK!B(\?-@YYR#Z4 36E
M]:WP<VLZ2A&VMM/0U#J>H/81Q&.#SGE<HJ[]O12QY^BFFZ5I$.DK((I99-^T
M9D(^4*, # ' %0:KIMQ<74%Y:R!Y(01]GF<B)L@C=Q_$ 3^!Q[T 78;^&33$
MOW/E0M$)27/W1C/-2V]Q%=0+-"^^-NAP1G\ZI66D);:+_9LLTDZE"K,YSP>P
MSG '0"IM/T^/3;/[/"S,-Q;+ #DG/0  ?@* (+_6X+*=+>..2ZN"P#PP#<R+
M@G<?RZ=^U7;6Z@O+=9[>021MG!'MU'L:P;7PF@MHS=7ER;OSFFDEBD*9))RH
M'I@X]?>KNLZEIOA3PU=7]QMM[*TB)PHQST 'J22![DT ?._C]1/\<]J$$QQQ
M[L=OW8_Q%=)X+@D?Q/I@7E#K.J7H([H(DB!_[Z->;Z7J\VI^)-6\67X&XEI-
MN?ESV4$]A\JBO5?A/8RM?/,Y?R],L1:?,.LTS^=*,^J_(/QI/6212V;/5Z**
M*U,PHHHH \I\?H(=9O)7X2"YTN]8_P"R'FB)_/%<AX+7R/CO"'X,D<NWW_=M
M_@:[CXK:>S>5,%/EW]K)8.=V,RJ1- /IN1^?>O)KW7)M+\0Z+XOM!N="K2J#
M@'LR^P/SKGWK):29H]DSZVB?SH@<_,.#3]AK \/Z_9ZWI=OJNFS"6VG7(]1Z
MJ1V(KH8Y%D7<IXJFB!NPT;#4E%(9'L-&PU)10!'L-&PU)10!'L-&PU)10!'L
M-&PU)10!'L-&PU)10!'L-&PU)10 T+\I!YS7G&I?"^22[DDL+Z-(G8L(Y5/R
MY[9%>DT5M2K3I.\&=.'Q57#MNF[7/*O^%6:G_P!!"T_)O\*ZCPSX2C\++-<R
M7'GW<J[ 0N H]JZMW6-=S' KG_$&NVNC:5=:KJ$GEVMLA8^I]%'J2< >YK6>
M*JU(\LGH;5\RQ%:#A.6C\CP+QXOG?'1@A!,:1;L=OW0_Q%=+X+@=_%&F%.4.
MK:K>@CNGEQP@_P#?1KS;2M7GU+Q%JWBR^QN)>3&3MR3PH]A\JBO5OA/82&]D
MF;S!%IEDMF-W3SI7\Z89[E3L%<;UDD<2V;/5J***U,PHHHH \G\?1F+6[N1N
M$AO-+OG/HF9HB?SQ7)>"%\CX[1AS@R1R[??]VW^!KN/BM8,3',H;9J%J]BY#
M8S*C": ?]]*_YUY->:[+I7B31?%]HH9E*M(H. >H9/8'YUS[UDM),T>R9]>#
MH*6L[0M;L/$6C6VJ:;.)K6=-RD=0>ZD=B#P16C3)"BBB@ HHHH **YSQ)XYT
M#PG/!!K%VT,DRED C9L@?05B?\+E\$?]!.3_ ,!W_P * .^HK@?^%R^"/^@G
M)_X#O_A1_P +E\$?]!.3_P !W_PH [ZBN!_X7+X(_P"@G)_X#O\ X4?\+E\$
M?]!.3_P'?_"@#OJ*X'_A<O@C_H)R?^ [_P"%:.B?$KPOXAU2/3=-OGENI 2J
M&%ESCKR10!UM%%% !1110 445G:]K=EX<T.[U;4)-EM;(7;U8]E'N3@#W- '
MSAXY3SOCM*%.=BQ;L=OW2_XBNH\$P/)XFTMDY1M2U6^!'=-L<(/YUYGI.K3Z
MAX@U?Q7?8WL7D ).W).0H]L[5%>L?"?3W^V2SD2"+3;);)<\CSI',TPSW()0
M4GK)%+9L]5HHHK4S"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#(\3:#%
MXDT"YTR5_+:0!H90,F*13E6'T('U&1WKYBUB"ZT^[O=)U6W,,H<^='_<?^\O
M^R>"/PQ[_6E<UXL\$Z7XMA5KE?)O8EVPW2*"RCT8'AESV/O@@\U,E?5%)]&?
M-GA/QSXD\!74R:1<(8)75Y8)8PZ2XSCW'7^$@_E7L6E?M'Z.]OC6=%OK>Y7
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M&S][<LIR,9&"/3D=^3_LC_J+^&O_  9I1_9'_47\-?\ @S2CGCW#DEV/4/\
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M\&:4?V1_U%_#7_@S2CGCW#DEV/4/^&C?"?\ T#=8_P"_47_QRC_AH[PG_P!
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M)_T$_#G_ (,EHYXAR2.__P"%]^"_^@%>?^ L7_Q='_"^_!G_ $ KS_P%B_\
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M%:C_ )=H?^_8J>B@!%55&%  ] *6BB@ HHHH **** "BBB@ HHHH *1E###
M$>A%+10!!]BM3_R[0_\ ?L4?8K7_ )]H?^_8J>B@"#[%:?\ /K#_ -^Q1]BM
M/^?6'_OV*GHH @^Q6G_/K#_W[%'V*T_Y]8?^_8J>B@"%;2V1@R6\2L.A" $5
M-110 5"]K;R.7>WB9CU)0$FIJ* (/L5I_P ^L/\ W[%'V*T_Y]8?^_8J>B@"
M#[%:?\^L/_?L4?8K3_GUA_[]BIZ* (/L5I_SZP_]^Q1]BM?^?:'_ +]BIZ*
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G HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ,#!5\# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 ':BCM10 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 ':BCM10 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ':BCM
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 44F1ZBD\Q <%U_.@!U%-\Q/[Z_G2[E_O#\Z %HI,C
MUI<T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !VHH[44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%)10 M)110 4444 %+244 %%&#2X/I0 E%+@^E)@^E !11@T8
M/I0 448-&#0 44N#28- !12X-&#0 E%&#Z48/I0 448/I1@T %%&#Z48/I0
M448-&#Z4 )2$TN#2'- #6/%4I/\ 6FKC=*I2?ZPT"'K4RU"M3+0!**<*:*<*
M!CJ*!10 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 ':BCM10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 )12FDH ****  #)Q4Z0C&3UI(4.=QJQ4MCL-"C'2C:/2G9'
MJ/SHJ1C=H]*7:/2EHS0 FT>E)M'I3NM% #=H]*7:/2EHH ;M'I1M'I3J* $V
MCTHVCTI:* &[1Z4;1Z4ZB@!NT>E&T>E.HH ;M'I1M'I3J* &[1Z4;1Z4ZB@!
MNT>E(44CI3S10!1GBV#(Z5FO_K#6[(H9"#6%(-LS#TJTR6.6IUJ!:G2F(E%.
M%-%.% QU%%% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 =J*.U% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4E+24 +24M)0!;C^Z*<?NGZ4V/[@IQY!'J*S*/,[KQ
M#J#^*+BU63$4>.*O-\0Q"ZQ?99&.=N1ZU=N?!;2:Q+?12$>9U&:?'X(A786<
MDJVZ@"HOQ%AE!6.W<R+]Y?2J*>.+B\U#RTC80;23[5=E^'D0F>:&5D9SSCTJ
MPG@2.)T,<K#Y<-[T 1V?C3<JQQ0/(%^^P[4K^/XHY3FW?RO[U+'X&^S3 V\[
MJA^^ >M,D\ H\Q_?OY7]V@!$^(<9#NUM($'W3ZUK>'O%,>N2,BH5([&J,G@:
M![81!SP<BK/AWPF-$NGG\UCGM0!U%%%% !1110 5BW.NI;ZB+;'&#DUL/G8V
M.N.*YFX\.2W#23F1A*QR!0 J^)'-WL*_+FKFJZT]DT2HIR^.:H1>'95C$A/[
MT'I5O5M.N+J./8BD@ 9/:@ 'B./<L3#$A7.:L_VY;B/[P+8R<&L7_A';@2!S
M@DKC)/2B'0;J'='L5@W\1/(H V;;7K:2$O(X&.N34RZW9L!B09/09KFF\+72
MPR(&SN.>M6=-\.RQ7,<DH!53TH ZM6WJ&'0\TZD4 * .@I: $;H:PKC_ (^'
MK=/0UA7'_'R_UJHB8+UJ=*A6IDJB244^F"G@T#%HHHH ***6@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** #M11VHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DI:* $HHHH
M MQ_<%/ID?W13ZS*"BH^6-+@'H: 'YHIFVEV^] #J*;M]Z-M #J*;@B@'(H
M=1FH_O'KQ2[<]#0 _-%-V?6C8: '44W;1MH =133D4O44 +2<4TX'5J;N7^]
M0!+2<4S*D9W5 UY IP9!GZTTF]A-I;ENDJK]MA_O?K4\<BR+E>E#30E)/8>>
MAK"G_P"/E_K6Z?NUA3_\?+_6G$;%6IUJ!:F6J$2BG"FBG"@!PHI*6@!:***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH .U%':B@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ [44=J* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ I*6B@ HHHH **** "DI:* $I.]+24
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC78X"[B,XR$.*L+KC:8HMX(Y'.W=SR:G\0:#=WVII=VP!QC@FEM]!NVN/.F
M4[-N :WO'E5Q%9/&4JXDF@98@<,2.]3/XKE#&40M]F'\6*2Y\+R3V;0$_><-
M43>&+TO]F\P_9#C/-"]F!0.OWLMY>!@3;J@/':M.+Q),52&SA>0JH9N,TVZ\
M,7(GF\AOW<J!3SZ4B^'+^RD62S<@LH5N:;Y&!9G\3SAE2&!S(%W.,=*J_P#"
M9R2NL<$+-)C+#'2I;GP_?*RRV\A\QEVOS1IWA62RN/.+99E(;ZFE[E@&2>,7
M$$3)"P=NN1TJU>:K)<6]F4.UI'P:HS>%KOR-L>&)/<]*2VT>[AN88'8MY9W9
M-%H;H"G=ZY,GB. +,!",*PSWJ/5M1#ZNQ>=E382N&QS6L?!B20RN[G[07+*:
M2'PCO.;G#D1E03ZU2E "UIEW>3>%VEY,N/E/K6#97,T;>8\KI<9.5<]:ZNRT
MR>WT7[%O(91A2*QH_#-Y->(]S@!"?F!Y-2G'4"A8:U=RP!KO=M\P@$<5JQ>)
MKB=PMK;N\2_*S8S4<?ABZ3]R6S$&+#FG0^']0LIMEM(1 QRW-#Y&!4L?$K0Z
MC=1'+2&3(7T%6)/&;I=,@C)13AN*:?!T@N);E'(F9LY]J:OA.Y6Y8X#(_P!X
MDTW[-@:-AXBN-1U#R886\L8W,172#I6-HND-ILLK$\,!6U6,K7T&%%%%2 E%
M+24 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 =J*.U% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 )FEI*6@ HHHH **** "BBB@ HHHH ***
M2@ I#UI:0T 7(_N"GFF1_<%.Q6914OO^/&;_ ':\GE/^D2#_ &C7K%__ ,>,
MOTKS%+)IYI7YP&-4I1BKR9Y6/IRJ2C&"NQ/">GV\^H3(ZJ)6R0QK=O=%V*\4
MP5V8X4XZ"L^PT&9KZ.ZMI2CKU!.*ZR^$YLLL%,JCM6,G[QZ5",HTTI;GG?BK
MP!:C2H[DLHF7G@=:JVT'E6T<?H*Z&=-6U"15N%Q;IZ]ZK:A%"A'E@J1US6M+
M0\_,:<YKF6R-[P2,3./:NW'\5<3X*(,[_2NV'\55/<VP/\%&7K^J?V/H\MV%
MR5'%?.^NZ_>ZY=O+/(VW/"YKZ,UJP74M'GMR,[E.*^<;W3GTW5I()D("-64B
MZ[>G8J:7J!TW4(YCG;GFO6(O'%E#I)D$J,Y7 QUKAGM]+NU4%&7CGBE_L*Q5
M RO(4)Z9K!QN[FE.MR1MN<YJMX^I:G+<G.&8D4NGWUS87<<T$C!@P[UT4]KI
M]OI\J(I,A/!-5O"?AZ77=7CB"GRU;+&M$K*R.:3<I7ZGO/A>_EU'08)YP=Y'
M.:VC]T^M5K&SCL+&.WC&%459_A-:G<MCR[Q!]M&HR!9R/F_2L6X\/7&M8_TT
MJ5'K5?QG>7D&KS;7(&X]Z30]5ABTV>6>X(D"''S=\5YOL^63DGU.]SYHV:-G
MP=%>:1J[V<EUYRL#^'%2:E%']HF:20A\\#-<[\-[N;4/$\LCREP">IS6OX@C
M\[5'S,J!3SDXKJDE**<V8TY2IMJGNQ(+D-"8\L<'KNKTKPR[/I:YSQTS7D4%
MAF1R+I3QQAJ]8\(;QHZJ_4<9K:G&'*Y(YYU*CDHS-\]#6%<?\?#_ %K=/0UA
M7'_'R_UK2(F*E3+4*U,M422"G"FBG"@8V2-94*.,@TL420IL086G4$X!-%P'
M45CIKBO!/)CB)B#^%)#XCLIH ?, <CIFE<#9HK*37+5$!FD7<?0U875;1XS(
M)5VKU.:=P+M%48=7LIYA%'*I8].:IWVOQ:?,$EY!;;Q2N!M45FC7;$X!E )&
M>M-'B#3RQ E&1[T[@:E%48]8LY9A$D@9CZ&GSZG:V\HCD<;CVS1<"W16<VN6
M"$@RCCWH.N6(4-YH(/O1<#1I,#.<#-9:>(+-YG3=@)_%VJ3^W+$QEA*#CMFE
M<#1I:R=.UF*]MY9SPB,1^52_VY8[2WFCCMFG<#1I*S)=>LD@:19 2!T!YIMA
MK<-SIWVR4A4YI7 U:*K6]_;W,>^.08/J:@GUJSAWJ9 649X-,#1HKGT\46WV
M225V&Y>@%++XB2/2X;TCY9*5PL;]%9T.MV4JKB4 D9P34[:A;JBN9!AC@<T[
M@6J*SGUNQ238906] :#K=B'V&9<_6BX&C25F_P!OV':4<^]7XI5FC#H<J: '
MTM)2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 ':BCM10 4444 %%%%
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MC!AZBE) &2<"@ HJ);F!VVK*I;TS4M !2'K10>M %R/[@I],C^X*?6913O\
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !VHH[44
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MW(.W>2<BHK^^\5>!]=MVOKEY(Y&Z%\BM+X<(O_"T-0X'$AK4^.&/M-AP/O4
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M5T&04UP2A ZFG5'.Q2%F'4"DW97&E?0X'4?"&HRZJ]RLR,K<X[U'_P (M?\
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 =J*.U%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1124 %%
M%% !1110 444G- "T4E% "T4E+0 44E% !FBBB@ HS110(**2CF@8M%)10 M
M%)10 M)FBD- "T4W-&: '4&FYI: +T7W!3Z9%]P4^LRADD:R(5;H:A@L88&+
M*.35FBH=.+:DUJ4I-*R95DL(9)?,9>:LJ J@#H*6BB,(Q;:6X.3>C"BBBK)"
MBES24 5[BSCN1AQ2Q6D4,1C5>#UJ>@5G[*'-S6U*YY6M?0J0Z?##(74<U;I:
M2G"$8*T58)2<G=A12T59(E(0",'I2T4 4_[-@,OF;>:?/8Q7&-PZ59HK+V-.
MS5MR_:3O>Y'#"L"!4'%24M)6B22LB&[ZL****8"'H:P[C_CY?ZUN'H:P[C_C
MX?ZU41,%J9:A6IEJB244X4T4X4 .HH%% PI:!10 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1124 %%%% "T444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 ':BCM10 4444 %%%% !1110 4444
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M/9@5/LY]:/LY]:L455P*WV;WI?LQ/0UIZ;:B\U"* ]&.#7I:>'-,M;0/*BX
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M0&'3%<;I.%5-&OUGGI<C-\=OI0?O4=Q1_%7<><<1XNNELK@SO]U5I-$OUOK
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MJU.-."::WN7ATJEJ/W!5T=*I:C]P5UK<&45J9:@6IEJR25:>*8M/% QU%%%
M"T444 %%%% "&BEHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ [44=J* "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *2EI* *.K_P#(*N/]PUY39:7/JE^T,*DY
M;DUZOJB&339T7JRX%1>&=$CTZU\QE'FN<YKII5O90;ZBM<S]+\#6EO"IG^=^
M^16I_P (KIW_ #R7\JW*QKKQ%;6EY]GE7#>N:YW5J2=[E61'_P (KIW_ #R7
M\J/^$5T[_GDOY4A\5V(!R1D=LT\^*=/$:N9%!8XQFE[2?<-!O_"*Z=_SR7\J
M/^$5T[_GDOY5;LM:M;^3RX&#,.N*TJ/:3[A8P_\ A%=._P">2_E2?\(KIW_/
M)?RK=J![J)"0S 8ZT>TGW"QE?\(KIW_/)?RI#X5T[_GDOY5KK=1.0 PR:FH]
MI/N%C"_X173O^>2_E1_PBNG?\\E_*MVD/ H]I/N!A_\ "*Z=_P \E_*C_A%=
M._YY+^5:7V^+S2A."*D^UPGHX-'M)]PL9/\ PBNG?\\E_*C_ (173O\ GDOY
M5J_:X?[XI/ML(.-PH]I/N%B*STRVL$VPH!]!5K8/2E#!AD=*6H;;=V,;L'I2
M[!2TR241XSWI .V"C8*BFNXX,;NII%O86A,NX8% #WMXY!AU##T-0R:792H5
M:W3!]J1M2@! W#F@ZC"!DGBFFT!RNK^#(DNDN[,;<') K2B!5%!ZBMR2426I
M=>A%8P^\:U]I*2M+H2R5:F%0K4P[5(&G#_JQ]*67_4O_ +II(?\ 5K]*67_4
MO_NFLRCYB\:7=Q'XGN@DK#GBF^&O#&I^)(Y9H[AU5!DG--\:C/BJZ^M/T;QI
M-X9LI;>*,GS!C(K2<+0O!:F$*EYVDR+06ET_Q7):33,=I*D_C7H>KV-EJ4,:
M>:RE5P3BO,/#UTUYXG-Q)]Z1MQ_$U[?;^'_M%NLN\#<,UY.,E6A73I;V/4PR
MINDU4VN<QH^F66E6\\7G.WF>HIUIIFG00N%9BQ.=VVK.I6Q@:2(,,KWJ3PU-
M;;'M[E@7;@9K@]O6KMQFSM]C3II2B,C:*%8HXV+ /G)%>@^&F#6C$>M>=:JW
MV9V$0S@\5W/@II'THM)U)S6^"HS=3VS]#+%2BJ?(CG=?NWAUIR/NAN:VGOX[
MS0I%')4"L;Q'$)-4E1?O%JGTBU:6TF@#;2P[UZ52"B[+J>33FW*YCC5_L\31
MF(8S@&M83*WAUIMH&"215%O#>H@E201GCBMV309FT$VOFA7;K7+*C[KC%:G>
MJJ3O<Y6WOK&^B5X,>:C@,*ZG5-2BCT2.!B0S#L*Y&S\%7.B2R7<ER#%NW$8J
M]>:U!J$*0Q1$%1C=ZTJ-%TE)2V,J]93LT]1EM#%*\;ER6SQFO0KN(2Z%L[%*
M\TMXYQ<(0"%S7ILS,NA@]3LKNI04:2=]SAHSO-M+4XN+3[BWBE8<K@X%59!,
M=.D"<,3@ULF^<6[JT9Y'6H-,B2Z22-B!N]:S<4>TG+DDV<G:6]U;K*WWMG4Y
MKJ-#N1/HDV\9&.:MP:!%'#+$EPN9*M6VE6FEV)MI9U!EZ>]:25.*DJ>QY,(5
M>>,JC.*O;ZU@U2$1)L;<.@KUG3&WZ?"Y[J#7)3>#[*XG2X,BY7D&NPL8E@M4
MC4Y"C KGPT6FV^IV8APTY"R>AK#G_P"/E_K6X>AK"G_X^7^M=\3C8JU.M0K4
MRU1)**=3!3Q0,!0:6DH N1_<%*:2/[@IQZ5F497B$%M"N0!D[37CO@O1EEFO
M6F78Q)Q^=>TZK_R#9<C/%>>:65263";<FN6O4Y6H]SMPR]V3(?['MDB\B:3.
M&)%7K2UL(#'MDVA&!.!4M]'8H/,D.'QTS5*..V>W\SD(3US4Q<FKHISZ7+NI
MZFL>H)+"=R!2,5YU<1W6H>)Y&A)12><5UVM6CVT<$T)RA'!KCIM6DM-;<[>2
M>:ZL&XRJZ;VU-G']U?[BIK>FS17+21@\=6JR-7U*UT=D9F,>W')I-?\ %!EM
MA%';E?4U$U[+J&B^6L!P!R:WQ4)MQ45<SH0B^;VAL>"]3DD=IKB4@*#MKLM%
MUA[_ ,0QHI+)SS7G?@Z-KMY8-APH(Q7=>%=/^S:VOSC/I7-._->6Y+I1LU$]
M2[B@_>H[BC^*M#@.'\6QV$UZ$NPN<<9KB+ZVU YCT.,H ?O#C-=9XFT^'4O$
ML:,^&4 XS6S%"+.  !1M'I7%5G&G+35O\#H@Y5J?(]$OQ. FAU2+PX5U1B9"
M1C)S5&UL0@8C@D5TWBR\6XM508SD=*R9F6VMGD/0+6]6M)81.&FH\)%1Q,HR
MVLC*-U$EV+?>=QJU<67FPGYLX&:P9)5>*6[$9RN2'K8\.:F-6L)2>J9%<J=:
M,HNYZ"E3E=)'0>"8$:VNHF'&ZM*YMH;1E\M% ]:I>#62(79<X&_K6C?6:ZA*
M1!<J1W IYHIRJ63:CU/.P*H\UYVO=[E6ZN;:1$5 ">Y%=_I( TR/'H*X:P\/
M1V^U.6YR3FN^LHQ'9J@Z 5MAJ\)TU3CNC*O1<*\I)WB]BR.E4M1^X*NCI5+4
M?N"NI;F;*"U,M0K4RU8B5:>*8M/% #J6D%+0 4444 %%%)0 4"B@4 +1110
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M_P"/A_K75$Q8JU,M0K4RU0B44X4T4X4 +1110!;C^X*<W2FQ_<%./2LQE>\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM2UTW-?:STUV*UI9K:@X.3ZU:I,TN:UA",%RQV(E)R=V%%&:3-62!Z&L.?\
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MBBB@ HHHH **** "BBB@ [44=J* "BBB@ HHHH **** "BBB@ HHHH ****
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M,&G44 )@TF#3J* $P:3!IU% #<&C!IU% #<&C!IU% #<&EP:6B@!,&C!I:*
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MP.N/#%J/7-86K9/B:;']P5\_E<8_7*B.O-JDHX2,EN-TZXM-3D)G8P7?<L<
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M]\B'YO+P.3UH ]BHKRVV\5:F-<ABO#L1R  IS7I\3;HD;U&: 'T444 %%%%
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MXUS\L8Z4^YUNY6WN)(Y29!&./2EDTG4HHVL$0M$3\K <"I5\.7$,5R@^;?&
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MM $6VC;4VVC;0!#MI=E2[:-M $6VC;4NVC;0!%MHVU+MI=M $6VE"U)BE H
MC"TX"GXHQ0 @%/%(!3A0,<*44E** %H-%!H MI]T4ZFQ_<%#_=-9LI$;2X.!
M2><U1TC$ 9-<SFSH4$2>:U'FM5:*=)L[3G%2YJ54;5TQN"1)YK4OFFHZ*?.Q
M<J)/-/I1YK5'FBCF8<J'^:U'FFF4E'/(.5%F-]U/JO%]ZK%;P=T8R5F,9\4S
MS33&^\:8TJ)]Y@/K3N8N3)O--'FFJ_VB'_GHM'VB'_GHM%Q<Q8\PT>8:K_:8
M?^>BT"XB)P)%HN',6/,-'F&H_>EHN',Q_F&CS#3**+A=DBR9.#5;4?N"I1]X
M5#J/^K%5$I.Z**U,M0K4RUH!,M/%,6GB@8M%%% !2TE+0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M &*,4M% "8JCJ6EQ:E#L?KV-7Z0TTVG= <[8^#8XK@22.&4'(%=8L:Q0A%&
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MBTM)2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 =J*.U% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1110 4444 %%%% !1110 =J*.U% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %!HHH 3^(5<7[HJG_ !"KB_=%3(:&R1+*I5AD5GMHT1)(
M)K2=@J%CT KE6\:0+J,MIL'[L]:(SE'9D3IQG\2-?^Q8_4TG]B1^IKFV^(UK
M'-)&\>-GZU=LO&(NM[&(!0N0<U?MI]R/J]/L:W]B1>II?[$B]36%)X^M8P^5
MY6JS_$:WV1F.+<6&2*/;3[A]7I=CI3H<7J:3^PHO4USB_$6#S45H<!JZ_3KU
M;^T6=1@-1[:?<7U:EV*7]@0^I_.F-X=@/<UMT4_;U.X?5J7\IAKX;M]P))K6
MM[:.VB"1C %345,JDY_$RX4H0^%!7+^+?!\/BF-$FD954YP#BKGB#6I='$3)
M$'#MCK51?&VG(%69]LA&2,5F:BZ7X-L=,LD@CC7*#&['-.N?!FGWDHDGB5V'
M3<,TT^-+!E)C.X \\477BZ%%A:! XDK'V%.][%\\A&\"Z2R%?LL>#_LBLX_"
MW02Q8P\GV%6G\<0))-&4&Z, U+'XRAGLYIHTR8UW8IQI0B[H3DWN9I^%6@G_
M )8_H*C?X3Z&1\D>&[&M:W\:VGE(;G]VSC(&*E?QKI2$ R]>.E:-)BN9>G_#
MBTLKL3EV<CH&.:V9_"UO-&J#Y .?EXK1T[58-2WF Y"^U7ZS]C#L5SR[G/V7
MAB*SO_M*R.3MQC-;P&*=25HDEL1<BN?]0U8J]:VKG_4-6*O6M(DLG2IEJ%*F
M6F(D%+313J!A1110 $9!!Z54&F6@D+^2A8]\5<HH KO96\B[6B4CZ5&FFVD:
M;!"F/I5RDH K'3[4Y_<H,C!XJ!]'M3MV(%VG/ Q6C10!4GT^VN,&6)6(Z$BG
M1V%M&A5(E"GJ *LT4 4CI5F91)Y";A[5+/907*!)8U8#H"*L44@*)TJS*@>2
MF!TXJ5;&V0Y6%0?85.QPC'T%<Y>>)#:Q3/L!,; 8S0!8U?PW!J>SC;M]*NZ?
MI,-A9"V"Y7WKF?\ A,Y(R[2Q *!P,U<T+Q2^J331M'C8NX&C0#I7MXW559 0
MO3CI3RH*[2..F*XV;Q=<P>;,\"^1&Y7.:KVWCQKB5ML/R8)%%P.RDTZUD0(T
M2X'3B@:?:C;^Y3Y>G%9MGJES+H[7LL04X^49K%D\93V<3/<P@ _=P<T =4^E
MV<@PT"=<_=IZ6%M$A5(5 (P<"N.@\;7%QL2.W!=SQS4Y\6W,,Y2>$+M'/-%P
M.E72;),D0)S_ +-(+'3UC9-D>T]>*YQO%=P$+O"/+D4E#FLJ#6;F.!VN%($I
M&WGWI7 [ZVM;>W!,"* >X%6:KV.#9QGU -6*H HHHH *0TM(: +2?<%.S34^
MZ*=691A^(M=.C1(P0G=WQ7+R>+KJ/56E7YH<#(':NMUW11K%N(BY7%9L/@VW
MBB=-Y.X8/% &7'XM,,H=,LTAP >U=1H>K_VK S$893@US&H^#)#- +5R &R6
M%=5HNE+I=ML#;F8Y)- &G129I: "BDI: "BBB@ HHHH ,TA-(>:,4"%S1D4T
M TNV@8X'-%(!BEH **** "BBB@ JCJ/W!5ZJ.H_ZL4UN(H)4RU"E3K5DDJT\
M4Q:>*!BTM)2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 =J*.U% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %(:6B@!!]X5;'054'WA5M?
MNU,AH9<1":!HR<!ABN9;P=I[ MN^<GDYKIY06C('6LP6ERY/S8_&I&9C^"])
MDR649(]:DL_"=A:R.5.0RXQFM#[)<$XW'\ZFCM)58L7)XH Q[CP9IEP-K+WR
M>:9;^"-*M+D2[>@X!-;3V\XD5E/'UHN;>9R&#8H RF\(:7)(6*#)]*W;*VBL
M[98(ONK5."WN$EW$Y%7;=74'?0!/0:*6@!*6DI: ,_4K"WOQ&DY'RG(%8UQX
M*TN2832 @_6M/5+>Y>XBE@/"G)%5KZ&_O53R_DV]>: *L'A73($E56'S'UZ5
M8A\.Z<B1IN!V#CFJHTC4%#2&0DD],T0:5J(FWM(=IZ#- B7_ (0_37G:4<N>
MO-6%\,V$(D4# ==I&:DM(;RVN6+?,A]34]]'/+M,>0:!F=<>$=.N7C;'^K4+
MP:AD\#::^?E/)SUK:TV*>)6$IS6A0!2T[3H=.B*0C -7:** "BBB@"*Y_P!0
MU8J]:VKG_4-6*O6KB)DZ5,M0I4R]*9(\4ZFBG4#%HHHH **** "BBB@ HHHH
M **** "BBB@!",@CUK NO"]M=7#R,3ACDC-=!12 YMO!]E)+OD!/MFK6G^'K
M;31*T(^9QBMFEHL!R5IX25VF^U'<CR%L5:@\(6$$I9%X/:NCHHL!FSZ>!I)L
MX>!C K(M?"%NUH4NOG8^]=3118#G[7PK9VQ4J.5.11<^%;2ZN/-D_0UT%%%@
M.?3PK:J_.2HZ#/2I)?#5I+&B$<)TYK<HHL R*,11+&O11@4^BBF 4444 %(:
M6D- %I/NBG4U/N"E/2LRA<TFZDZTNT4 &11FC%&* #(HW48HVT &11NHQ2[1
M0 FZC=2[11@4"#=128&:7% PI,BHG?G%-R?6E<AR)\BEW"J^3ZT9/K1<.8L;
MA1NJOD^M&3ZT7#F)\BER*KY/K1D^M%PYR?(HR*@R?6C)]:+ASEC-4M1^X*G1
MR#4&H?ZL52'>Z*"U.M0+4RU8B9:>*8M/% Q:6DI: "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH .U%':B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "D-+2&@!/XA5Q>@JF/O"KB]!4R&A'=8T+,< =36)/XOT6VE,<EVH85
MF^-/$4&DQ+#*^W>/6O.KE-,U12T4X+'DX:O+Q&/5&?+RM^9UTL,ZD;W/3F\?
M>'U.#>I^5 \?^'S_ ,OJ5Y -$L)<A)BS>S5:/@ZW2XA4NWSXSS3CCXR5[#>&
ML[7/6[?QKH=RY2.\0G&:8_CC08W*->*"*\I3PU!!J1$4CA0,'YJ?<^';%)/O
M2%V&>M/ZYKHB?8KN>H_\)YH&<?;5_*GCQQH;=+M:\ELM$L)I6C_>!QZFII/#
MMO##O+MDDX -'UQ[<H>QCW/5/^$WT/\ Y^UI/^$XT(?\O:UY.NC)N6)0Q+'-
M:R>&[ QC=+\RCYN>E95<P]EO$N&'4]F>EVGBK2;V01PW*ECTK:5@R@J<@UXW
M%:Z;:',=R%<?[5=_X2U1;VV,7FARG?-7AL<JT^6UB:N'Y%>YTCNL2%W("CJ3
M6)-XOT6"8Q-=IN'&*XOXP>*+C1]/2SMF*O*<$BO%M-N)YY@\DSLQ.22:]_#8
M7VNK9R];'U&GB72Y!E;A2*F&N6!_Y;"O.?#UA;G2%N)F8].]:9-B@!#,?;-;
MRP=-.R;.J-!,[7^V++&?-%0OX@TY#AI@*YJV^QS?*I;/IFH-9L;>"'S'R!6;
MPU-.S;+6'C>S9UR:]I[XVS U9&H6Y7.\8KBK*S@33OM8W8[9JM'XA6"Y6*;E
M#Z5+P\&[19/L%?0[QM3M5ZR"H9=>T^(9><"L>X$$EHMRF2I':L74=-CU&Q:6
M%F!'49IPPT);L7L5:YTZ^+M&:41_:T#$X%;44J31AXV#*>A%?,7B2WGM)SLD
M<,.A!KTCX/\ B6ZU&"2PNG+M']TGT%&(PGLES)G-)6=CU.Y_U#5BKUK:N?\
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M6L^;WDD>S2^'8DU6(:=:B]20H<9P*X/5O%5[J#!&D.U3ZUUWBNY6\T -!D*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M#M11VHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI*
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M17/^H:L9>M;-S_J&K&3K3B2R9*F6HDJ84Q#A3J04M PI:2EH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ Q1110 4444 %
M(:6D- %M/N"E(&TYZ4D?W!2O_JV^E048CW>C0W4EJ0HDD/S #K5J+2M,16"0
M1 2#GWK@-5B2VU:>6-BTA;[F>:;_ &I>""-S*5FS]P]:0'HD>E:?$K!(8P&&
M#[U%'HNE1,S);Q#=P:XF7Q)<BW0(2SC[P%5!JNI31!8G8[Y/RH [Y/#^D*Q*
MV\633QX?TT'(MD'X5P]G>:BNHK"\^&# ;3W%>E)G8N>N* %50JA0, # I:**
M "BBB@ HHHH S;_1;74'#RJ X[U _AJP:-1L QU..M4-5UVXAU06<!VD#))K
M.N_%-VA.#PORMQU- '0#P_IA(41IGTI8_#=A&6Q&NT]L5PA\27%G="Y+$J?X
M:U8/&=U*ICV$,W1L<4 =*GARPB#?*O-(WA[3I5V;5S7+:GK.IQO;DS#:S<X%
M5HM<O4U,O%)A%3)!H [>'0K")AL1=P&*EN-'M;FU%NZ#:.GM7$-XKN(-TXR6
M8U-_PFEV4B+(44]6(XH ZR'0K&V,;!%!C.036HI!'!!%8&JRS7?ATSP2@-MS
MN%2^%YI)M)4RMN8'&: -NJ.H_P"K%7JHZC]P4UN(H)4RU"M3K5DDJT\4Q:>*
M!BTM(*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** #M11VHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ H-%(: $_B%75^Z*HGKFKJ'*BI8
MT-F"&,B3[M44BL/-""-=WTJW=QM+ 57KUK)@M+A[D,P*@=ZX:U:I":C%7N=%
M.G&46VRY(=-C<HP3([4QGTN0+D)R<"L:[\/W;7K3"0L#VJ-?#]VI5LG[W3TK
ML,#>CT:T\TR[00>V*LC3;52"(EX]JEMHS%;HC') Q4U %9K&W?&Z,''J*0:=
M:@$"%>?:K5% $<<:Q+M08 I]%% !12TE %'4+6TN5'VE V.F1FJL>G:3(/,$
M,>$'<5-J44I</&"P]*IQZ;<2V<J;BC/FN+VU3V_L[:&_LX^SYKZCIH=$D'SI
M$1TZ"EMK'1#,(X8XMX] *P3X8O4C*[F;)ZU;TC0+JSU 22$D#OZUVG.;7_".
M:67#FUC)Z_=JV^GVSJJM$I"]!BK0Z4E RNEA;1H46-0IZC%,ETRSFC"/ A4=
M,BKE% $-O:Q6J;(E"K[5-124 +24M)0!%<_ZAJQEZUJ7L@2''<UF(*N(F3)4
MPJ)*F%,D<*6D%+0,*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *0TM(U %J/[@I]10ME:DSQ4,HJOIE
MD\WFM;H7]<5!<:'8W$BN8$##N!5'5-6FMIQ&$/6KPOI?[/\ /V<XKC6+IN4H
MKH;NA-14NY(FCV"?\NL>3P3MIZ:991_=MXUYSTK+TS59[F<QLAZT:GJL]M<+
M&J'K4?7J7L_:]"OJT^?DZFK_ &=:&83>0GF#^+%6JS6O9AI_GA.2*IZ5JL]U
M,49#5O%TU*,.K)5";BY=C>HK U359[:X5%0XK5L9WN+=79<9JJ>)A.HZ:W0I
M491@IO9EJBBBNDQ"BBB@#'U'P_!?W*S[F1QU*]ZK3>%+6697+M@=1ZUT-% &
M!+X3L)1@KQ]*C3PC:);M&&;)Z'TKHZ* .>/A6W>!(WD=BIR":9)X/M7D#K(Z
MD#!QWKI** .?E\)V,D'EX(QWQ4<GA"TD@CB+-A:Z2B@"FFGQ)8?9!]S&*?96
M<=E#Y4?W<YJS10 E4M1^X*O5FZ@^Y@HIK<3*JU,M0K4RU9)**>*8M/% Q:6D
MI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH .U%':B@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **2EH **** "BBB@ HHI* %I*** &FGP3;3M:F&HG% &F&!'!S2X]
MJR1-(G0FD-[**GE'<UZ*Q_MTM)]NFHY0N;5%8OVZ:C[=-1RL+FU16+]OFH^W
MS4<K"YLT5C?;YJ/MTU*P7-FBL;[=-2_;I:?*PN;&,CI1BL?[=-2?;IJ7*%S9
MI:QOMTM)]OFI\K"YM45C?;YJ3[?-1RL+FU25C?;IJ7[?-1RL+FS25C_;I:/M
MTU%@N;-1R3)$I)(K*-[,14+.\A^8DT<H7'W$QGDSVH44Q14JBJ$2+4HJ-:D%
M #A2TE+0 4M)10 M%)2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1244 +1110 4AI::: $20QM[5;25&'!JDPJ$EE/!Q2:N%
MR[+9P3OO=034GD1^5Y7\/I6:9I1T8TS[1+_>-9^RC=NQ?.]KFG%:0PON10#1
M+:0RON=0369]HE_OFC[1+_?-+V,;6MH'.[WN:WDQ^5Y?\/I3(K2&!MT:@&LO
M[1+_ 'S1]HF_OFG[*-[V%SLU);2&9BSJ":EC18UVKTK%^TS?WS1]HF_OFFJ:
M3ND#FVK&[D49%8?VF;^^:3[3-_?-5RBN;N11D5A?:9O[YH^TS?WS1RA<W<BD
MR/6L/[3-_?-'VB;^^:.4+F[D49%87VB;^^:7[1-_?-'**YN9%&16']HF_OFC
M[1-_?-'*.YMY'K1D>M8GVB;^^:/M$W]\T<H7-S(I-P'>L3[1-_?-!GE/5C1R
MA<TI[M(U(!R:S&<R.6/>F\DY/-. JDK"N/45*M1K4@H$2"GBF"G4#'4M-%+0
M M%%)0 M%)FB@!:*2E% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 ':BCM10 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 &DI:* $HI:* $HI:* &&F,*FP*3 ]!0!59:C*U>VK
MZ#\J-B_W1^5 &>4I-M:&Q?[H_*C8G]U?RH S]E&RM#8G]U?RHV)_=7\J ,[;
M1MK1V)_<7\J-B?W%_*@#.VT;:T=B?W%_*CRT_N+^5 &=MHVUH^6G]Q?RHV)_
M<7\J ,[;1MK1V)_<7\J-B?W%_*@#/VTFVM'8G]Q?RHV)_<7\J ,_;1MK0V)_
M=7\J-B?W5_*@#.VTNVM#8G]U?RHV)_=7\J ,_;2[:O[$_NK^5&Q/[J_E0!0V
MTX+5W8O]T?E2[%_NC\J *86G 5:VK_='Y4;5]!^5 $(%/%/P/04N!Z4 -I:6
MB@!**6B@!**6B@!*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "D-+10 VEI:* $I:** $-!I:* (R*C*U8Q28'H* *A6F;*O;5_NC\J-B_
MW1^5 %#91LJ_L7^Z/RHV+_='Y4 9^RC;5_8O]T?E1L3^Z/RH H;:3;6AL3^Z
MOY4;$_NK^5 &?MHVUH;$_NK^5&Q/[J_E0!G[:-M:&Q/[J_E1L3^ZOY4 9^VE
MVU?V)_=7\J-B?W5_*@10VT;:O[$_NK^5&Q/[J_E0,H;:-E7]B?W5_*C8O]T?
ME0!0V4;:O[%_NC\J-B_W1^5 %#;2[:O;%_NC\J78O]T?E0!1"TX+5S8O]T?E
M1L7^Z/RH J@5(!4VU?[H_*C ]!0!&!3J?@>E&!0 VEI:* $HI:* $HI:* $I
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !VHH[44 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!VHH[44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !VHHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
2**** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  Z!#L# 2(  A$! Q$!_\0
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M>,AGUW1H8:A37UJG/#Q2=:IB)<DV^6E'3F?O-%%%>.?>A1110 4444 %%%%
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MI8'PFSG&\.PQ"A.$,WEG<Z>/KX:%6\/KE+".3A4I1]O3BY3A*-G*'[>UYO\
M%[X2^ _CI\-?&'PG^)>@V7B3P7XWT6\T36-.O;>&<HES$RV^I6#S1R?8M8TF
MY\G4M&U. +=Z9J=K:WUK)'<01N/2*S=9UG2/#ND:GK^OZG8:+H>BV%WJFKZO
MJEW!8:;IFFV$#W-[?W][<O';VEI:6\<D]Q<3R)%%$C.[*JDU\32G4IU:=2C*
M<*T*D)TITW)5(U8SBZ<J;A[RFIJ+CR^]S623;L_Z(QE#"8K"8K#8^EAZ^!Q&
M&Q%'&T<7&E/"U<)5HU:>*IXF-;]S+#SP\JRK*K:G[/G<W&,7.'\C'_!&SQ1X
MR_91_P""CGQG_8I\3:Q=7NB>(Y_B-X,FLHII6TF?QW\)I[[6-&\66]L6\FV;
M5/"&C^(;=IDC26YBO]-@N"WV2W6+^OFOXZO^"9<UW^U5_P %D_BE^TAH5A='
MP7H6N_''XIB^2WECM;?1_%:ZQX&\$6EY+M*0ZAJ%GXEMKQ+61UEN#INHR(KI
M;3[?[%:^V\0HK^V\+4G&,,;6R7*ZN91BDK8V5!JIS*.TW!+F3U]V-[I19_.W
MT6ZDWX>9SAL/4K5N'\!X@\9X+A*M6E4J.?#M+,E+"JE4J:SP\:TY>RE'W'[2
MHXJ+G42****^%/Z2"OR-_P""Y'_*-[XR_P#8R?"3_P!6CX4K]<J_(W_@N1_R
MC>^,O_8R?"3_ -6CX4KW.&?^2BR+_L;8#_U(B?G/B_\ \FI\2/\ LB.)?_59
M5-/_ ((C_P#*-?X!_P#81^+?_JXO'=?J_7Y0?\$1_P#E&O\  /\ ["/Q;_\
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M=Y-*]])/9)QA2C9IW:>DG-R;E.'*KR<FW>"]U/2VJ2U;YGXN^ 6^*/PX\5>
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M93GV;Y=)Q6(P$LPKWHX.&,I1]CB:E*#]R=2*IU:<G2J?$G_!,C]A&/\ 8,^
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M;%K6:!C^J-1PPQ6\44$$4<$$$:0PPQ(L<4,42A(XHHT 2..-%5$10%50%4
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MO?XFSFGG^;U\SI4*F&A5I8:DJ56<*DU]7HJDY.5-1A[[7,DEHM&V]3\Q\(.
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M*V/B354O+^WM+B>RN?&GB#POX>2/3;>:34;L7FLVTCVMM,EJEQ<M%!)\I?\
M#6WQW_Z1Y?M2?^%3^S1_\_2ONZBMZ%?#TH.-7 4L3)R;52>)QE)I-*T.7#SC
M!I--\S7,[M-V2/'S++<UQE>-7 \2X[)Z*I1@\+ALIR#'4Y5%*;E6=;-,-6Q"
ME-2C%TXR5**IIQBI2FW\(_\ #6WQW_Z1Y?M2?^%3^S1_\_2C_AK;X[_](\OV
MI/\ PJ?V:/\ Y^E?=U%;?6\%_P!"C#_^%N9__+3S_P"PN(?^BZS;_P 1W@[_
M .83X1_X:V^._P#TCR_:D_\ "I_9H_\ GZ4?\-;?'?\ Z1Y?M2?^%3^S1_\
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MT/["XA_Z+K-O_$=X._\ F$^$?^&MOCO_ -(\OVI/_"I_9H_^?I1_PUM\=_\
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MZS;_ ,1W@[_YA/A'_AK;X[_](\OVI/\ PJ?V:/\ Y^E'_#6WQW_Z1Y?M2?\
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M2?\ A4_LT?\ S]*/^&MOCO\ ](\OVI/_  J?V:/_ )^E?=U%'UO!?]"C#_\
MA;F?_P M#^PN(?\ HNLV_P#$=X._^83X1_X:V^.__2/+]J3_ ,*G]FC_ .?I
M1_PUM\=_^D>7[4G_ (5/[-'_ ,_2ONZBCZW@O^A1A_\ PMS/_P"6A_87$/\
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MMX+_ *%&'_\ "W,__EH?V%Q#_P!%UFW_ (CO!W_S"?"/_#6WQW_Z1Y?M2?\
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M'?\ Z1Y?M2?^%3^S1_\ /TH_X:V^._\ TCR_:D_\*G]FC_Y^E?=U%'UO!?\
M0HP__A;F?_RT/["XA_Z+K-O_ !'>#O\ YA/A'_AK;X[_ /2/+]J3_P *G]FC
M_P"?I1_PUM\=_P#I'E^U)_X5/[-'_P _2ONZBCZW@O\ H48?_P +<S_^6A_8
M7$/_ $76;?\ B.\'?_,)\(_\-;?'?_I'E^U)_P"%3^S1_P#/TH_X:V^._P#T
MCR_:D_\ "I_9H_\ GZ5]W44?6\%_T*,/_P"%N9__ "T/["XA_P"BZS;_ ,1W
M@[_YA/A'_AK;X[_](\OVI/\ PJ?V:/\ Y^E'_#6WQW_Z1Y?M2?\ A4_LT?\
MS]*^[J*/K>"_Z%&'_P#"W,__ ):']A<0_P#1=9M_XCO!W_S"?"/_  UM\=_^
MD>7[4G_A4_LT?_/TH_X:V^.__2/+]J3_ ,*G]FC_ .?I7W=11];P7_0HP_\
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35TJ6&<8.,FJCC[63FU-M1A;_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ex5-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  B!#<# 2(  A$! Q$!_\0
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MF.3_ %-RK_H/XK_\3;BW_P">I\(?\*+_ &[?^C]_"W_B'_@G_P">=1_PHO\
M;M_Z/W\+?^(?^"?_ )YU?=]%']JXG_GSEO\ X:<L_P#F8/\ 4W*O^@_BO_Q-
MN+?_ )ZGPA_PHO\ ;M_Z/W\+?^(?^"?_ )YU'_"B_P!NW_H_?PM_XA_X)_\
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M^C]_"W_B'_@G_P">=1_PHO\ ;M_Z/W\+?^(?^"?_ )YU?=]%']JXG_GSEO\
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M_P">=1_PHO\ ;M_Z/W\+?^(?^"?_ )YU?=]%']JXG_GSEO\ X:<L_P#F8/\
M4W*O^@_BO_Q-N+?_ )ZGPA_PHO\ ;M_Z/W\+?^(?^"?_ )YU'_"B_P!NW_H_
M?PM_XA_X)_\ GG5]WT4?VKB?^?.6_P#AIRS_ .9@_P!3<J_Z#^*__$VXM_\
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M )YU?=]%']JXG_GSEO\ X:<L_P#F8/\ 4W*O^@_BO_Q-N+?_ )ZGPA_PHO\
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M_B;<7_\ SY/A#_A0?[<7_20"R_\ $3/A?_\ -51_PH/]N+_I(!9?^(F?"_\
M^:JON^BC^U<3_P ^LN_\-.6?_,H?ZF91_P!!O%/_ (FW%_\ \^3X0_X4'^W%
M_P!) ++_ ,1,^%__ ,U5'_"@_P!N+_I(!9?^(F?"_P#^:JON^BC^U<3_ ,^L
MN_\ #3EG_P RA_J9E'_0;Q3_ .)MQ?\ _/D^$/\ A0?[<7_20"R_\1,^%_\
M\U5'_"@_VXO^D@%E_P"(F?"__P":JON^BC^U<3_SZR[_ ,-.6?\ S*'^IF4?
M]!O%/_B;<7__ #Y/A#_A0?[<7_20"R_\1,^%_P#\U5'_  H/]N+_ *2 67_B
M)GPO_P#FJK[OHH_M7$_\^LN_\-.6?_,H?ZF91_T&\4_^)MQ?_P#/D^$/^%!_
MMQ?]) ++_P 1,^%__P U5'_"@_VXO^D@%E_XB9\+_P#YJJ^[Z*/[5Q/_ #ZR
M[_PTY9_\RA_J9E'_ $&\4_\ B;<7_P#SY/A#_A0?[<7_ $D LO\ Q$SX7_\
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M #54?\*#_;B_Z2 67_B)GPO_ /FJK[OHH_M7$_\ /K+O_#3EG_S*'^IF4?\
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M\1,^%_\ \U5'_"@_VXO^D@%E_P"(F?"__P":JON^BC^U<3_SZR[_ ,-.6?\
MS*'^IF4?]!O%/_B;<7__ #Y/A#_A0?[<7_20"R_\1,^%_P#\U5'_  H/]N+_
M *2 67_B)GPO_P#FJK[OHH_M7$_\^LN_\-.6?_,H?ZF91_T&\4_^)MQ?_P#/
MD^$/^%!_MQ?]) ++_P 1,^%__P U5'_"@_VXO^D@%E_XB9\+_P#YJJ^[Z*/[
M5Q/_ #ZR[_PTY9_\RA_J9E'_ $&\4_\ B;<7_P#SY/A#_A0?[<7_ $D LO\
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M'^IF4?\ 0;Q3_P")MQ?_ //D^$/^%!_MQ?\ 20"R_P#$3/A?_P#-51_PH/\
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MU/P;?V,=M!LL+*]L6M+*\TR%D\FUOM"G%KJ6BSQ*CZ?J%C975L8Y;>-E^!_
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M'K/Q*^!?[5?Q;^-WP_T[XD?##4_#WQC\0>+=7UOXFZ=X-O/C]\/;'Q+X%O\
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MZ39>&O /@7PS;>+;?6I=)M-.TFQEU;6%LI(8[S7]:U#>]Y%:6EW+%\*OV--
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MN859-J3JXRKSQA/FA'ZDHHHK@/I0HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
5BB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ex23-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !$ /@# 2(  A$! Q$!_\0
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M?155[ZPM-3LI;.^MX[BWE&UXY!D$5T4<1.D]'H8SHTYZRBG\CYZ\%>-_#-E
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M[G)JE\.[B6Z^'^CR3.7<0F/)]%8J/T HHH D\;QS+X:GOK:]NK2YL0;B)X'
MRP'1@00RG/0UY[\+=<U+X@:PVH^(+HS/I1W6L4:*D8=A@L0!R0"<<\9HHH&>
MRUXA\1/%NO\ @?Q4MAI&J3&VOCYS)<A9?*9CR$)&0/;FBB@1ZMX5TN#2?#UM
M#"\LAD!GEDE;<\DC_,S$^I)I_B/2;?5]'>.9Y8W@(N(9H6VO%(G*LI]?\:**
M /*?!WB#5O'^OSZ+KUZTEA:.)#%$BQ^<5.0)"!DC(!P,=*]LHHH YG35 ^(>
MNMW-I:_^SU6\*J+#Q5XFTF#Y;..:.YCC[(TJY<#T!(SCW-%% &GXSNIK+P7K
M-S;OLECM)"K#L=O6C3-*LU\$6NEB(?9&L%B*>JE.?YT44 5?A]/+<>!=+,SE
MVCC,09NI"L5&?? %2ZR,^+_#1]&N?_15%% &3\1M'M+JVTO4W5EN[6_MU21#
M@E6D7*MZCH<>HKMZ** . ^(ZR:!:/XKTJXEM=4C00N4P4F3J ZD$''8\$59^
M&]W?:WHYU[4K^XN+JY C,9(6*,#^Z@  /OR:**!G1^(QN\+ZL#T-E,/_ !PU
LX!X=^*?BF*XTG2EN8/LJO#;A?(7.S(7K]***!'TE1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Aug. 18, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001911545<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Global Interactive Technologies, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-288665<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-1/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Aug. 18, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock, par value $0.001 per share ("Common Stock")<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 2,967,014.44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 454.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Pre-funded Warrants to purchase Common Stock ("Pre-Funded Warrants")<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $4,999,999.44.<br/><br/>No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=3', window );">Offering: 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock underlying the Pre-Funded Warrant<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act.<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=4', window );">Offering: 4</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Warrants to purchase Common Stock ("Common Warrants")<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $4,999,999.44.<br/><br/>No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=5', window );">Offering: 5</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock underlying the Common Warrants<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 2,967,014.44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 454.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act.<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=6', window );">Offering: 6</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 2,032,985.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 311.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act.<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=7', window );">Offering: 7</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Pre-Funded Warrants<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $4,999,999.44.<br/><br/>No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=8', window );">Offering: 8</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock underlying the Pre-Funded Warrant<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act.<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=9', window );">Offering: 9</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Warrants<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $4,999,999.44.<br/><br/>No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=10', window );">Offering: 10</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock underlying the Common Warrants<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 2,032,985.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 311.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act.<br/><br/>Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#8217;s securities that become issuable by reason of any share splits, share dividends or similar transactions.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457oFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection o<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457oFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=6">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=6</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=7">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=7</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=8">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=8</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=9">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=9</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=10">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=10</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Aug. 18, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 9,999,998.88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">622.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">1,531.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 908.50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>11</ContextCount>
  <ElementCount>20</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea025365101ex-fee_global.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea025365101ex-fee_global.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea025365101ex-fee_global.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="ea025365101ex-fee_global.htm">ea025365101ex-fee_global.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="84">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>30
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea025365101ex-fee_global.htm": {
   "dts": {
    "inline": {
     "local": [
      "ea025365101ex-fee_global.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 20,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/ffd/2025": 3,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 11,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 84,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025365101ex-fee_global.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025365101ex-fee_global.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025365101ex-fee_global.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025365101ex-fee_global.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025365101ex-fee_global.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea025365101ex-fee_global.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>31
<FILENAME>0001213900-25-078182-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-078182-xbrl.zip
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:+FAT;5!+!08      0 ! $H   !^#@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>ea025365101ex-fee_global_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-18</startDate>
            <endDate>2025-08-18</endDate>
        </period>
    </context>
    <context id="c_offering_10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>10</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-18</startDate>
            <endDate>2025-08-18</endDate>
        </period>
    </context>
    <context id="c_offering_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-18</startDate>
            <endDate>2025-08-18</endDate>
        </period>
    </context>
    <context id="c_offering_3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>3</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-18</startDate>
            <endDate>2025-08-18</endDate>
        </period>
    </context>
    <context id="c_offering_4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>4</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-18</startDate>
            <endDate>2025-08-18</endDate>
        </period>
    </context>
    <context id="c_offering_5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>5</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-18</startDate>
            <endDate>2025-08-18</endDate>
        </period>
    </context>
    <context id="c_offering_6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>6</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-18</startDate>
            <endDate>2025-08-18</endDate>
        </period>
    </context>
    <context id="c_offering_7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>7</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-18</startDate>
            <endDate>2025-08-18</endDate>
        </period>
    </context>
    <context id="c_offering_8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>8</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-18</startDate>
            <endDate>2025-08-18</endDate>
        </period>
    </context>
    <context id="c_offering_9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>9</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-18</startDate>
            <endDate>2025-08-18</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001911545</identifier>
        </entity>
        <period>
            <startDate>2025-08-18</startDate>
            <endDate>2025-08-18</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="fee_001">S-1/A</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="fee_002">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="fee_003">0001911545</dei:EntityCentralIndexKey>
    <ffd:RegnFileNb contextRef="c_report" id="fee_004">333-288665</ffd:RegnFileNb>
    <ffd:FormTp contextRef="c_report" id="fee_005">S-1</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="fee_006">Global Interactive Technologies, Inc.</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="fee_007">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="fee_008">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="fee_009">Common Stock, par value $0.001 per share ("Common Stock")</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c_offering_1" id="fee_010">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_011"
      unitRef="USD">2967014.44</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_012"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_013"
      unitRef="USD">454.25</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_2" id="fee_014">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_2" id="fee_015">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_2" id="fee_016">Pre-funded Warrants to purchase Common Stock ("Pre-Funded Warrants")</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_2" id="fee_017">true</ffd:FeesOthrRuleFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_2"
      decimals="INF"
      id="fee_018"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_2"
      decimals="INF"
      id="fee_019"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_2"
      decimals="INF"
      id="fee_020"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_3" id="fee_021">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_3" id="fee_022">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_3" id="fee_023">Common Stock underlying the Pre-Funded Warrant</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c_offering_3" id="fee_024">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_3"
      decimals="INF"
      id="fee_025"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_3"
      decimals="INF"
      id="fee_026"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_3"
      decimals="INF"
      id="fee_027"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_4" id="fee_028">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_4" id="fee_029">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_4" id="fee_030">Warrants to purchase Common Stock ("Common Warrants")</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_4" id="fee_031">true</ffd:FeesOthrRuleFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_4"
      decimals="INF"
      id="fee_032"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_4"
      decimals="INF"
      id="fee_033"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_4"
      decimals="INF"
      id="fee_034"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_5" id="fee_035">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_5" id="fee_036">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_5" id="fee_037">Common Stock underlying the Common Warrants</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c_offering_5" id="fee_038">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_5"
      decimals="INF"
      id="fee_039"
      unitRef="USD">2967014.44</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_5"
      decimals="INF"
      id="fee_040"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_5"
      decimals="INF"
      id="fee_041"
      unitRef="USD">454.25</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_6" id="fee_042">true</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_6" id="fee_043">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_6" id="fee_044">Common Stock</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c_offering_6" id="fee_045">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_6"
      decimals="INF"
      id="fee_046"
      unitRef="USD">2032985.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeAmt
      contextRef="c_offering_6"
      decimals="INF"
      id="fee_047"
      unitRef="USD">311.25</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_7" id="fee_048">true</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_7" id="fee_049">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_7" id="fee_050">Pre-Funded Warrants</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_7" id="fee_051">true</ffd:FeesOthrRuleFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_7"
      decimals="INF"
      id="fee_052"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeAmt
      contextRef="c_offering_7"
      decimals="INF"
      id="fee_053"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_8" id="fee_054">true</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_8" id="fee_055">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_8" id="fee_056">Common Stock underlying the Pre-Funded Warrant</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c_offering_8" id="fee_057">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_8"
      decimals="INF"
      id="fee_058"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeAmt
      contextRef="c_offering_8"
      decimals="INF"
      id="fee_059"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_9" id="fee_060">true</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_9" id="fee_061">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_9" id="fee_062">Common Warrants</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_9" id="fee_063">true</ffd:FeesOthrRuleFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_9"
      decimals="INF"
      id="fee_064"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeAmt
      contextRef="c_offering_9"
      decimals="INF"
      id="fee_065"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_10" id="fee_066">true</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_10" id="fee_067">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_10" id="fee_068">Common Stock underlying the Common Warrants</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c_offering_10" id="fee_069">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_10"
      decimals="INF"
      id="fee_070"
      unitRef="USD">2032985.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeAmt
      contextRef="c_offering_10"
      decimals="INF"
      id="fee_071"
      unitRef="USD">311.25</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_072"
      unitRef="USD">9999998.88</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_073"
      unitRef="USD">1531.00</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_074"
      unitRef="USD">622.50</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_075"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="fee_076"
      unitRef="USD">908.50</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="fee_077">Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;).&lt;br/&gt;&lt;br/&gt;Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#x2019;s securities that become issuable by reason of any share splits, share dividends or similar transactions.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_2" id="fee_078">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $4,999,999.44.&lt;br/&gt;&lt;br/&gt;No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_3" id="fee_079">Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act.&lt;br/&gt;&lt;br/&gt;Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#x2019;s securities that become issuable by reason of any share splits, share dividends or similar transactions.Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_4" id="fee_080">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $4,999,999.44.&lt;br/&gt;&lt;br/&gt;No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_5" id="fee_081">Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act.&lt;br/&gt;&lt;br/&gt;Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#x2019;s securities that become issuable by reason of any share splits, share dividends or similar transactions.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_6" id="fee_082">Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act.&lt;br/&gt;&lt;br/&gt;Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#x2019;s securities that become issuable by reason of any share splits, share dividends or similar transactions.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_7" id="fee_083">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $4,999,999.44.&lt;br/&gt;&lt;br/&gt;No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_8" id="fee_084">Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act.&lt;br/&gt;&lt;br/&gt;Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#x2019;s securities that become issuable by reason of any share splits, share dividends or similar transactions.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_9" id="fee_085">The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $4,999,999.44.&lt;br/&gt;&lt;br/&gt;No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_10" id="fee_086">Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act.&lt;br/&gt;&lt;br/&gt;Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant&#x2019;s securities that become issuable by reason of any share splits, share dividends or similar transactions.</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
